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Abstract 
Background 
There is limited research on outcomes following lower limb amputation to assist health 
professionals with clinical decision making. Comorbidities contribute to high mortality 
and potentially impact on functional outcome in people with atraumatic causes of 
amputation however there is no gold standard for measuring burden of disease. Amputee 
rehabilitation models of care have been based predominantly on low quality studies and 
expert opinion. In Western Australia, long term rehabilitation outcomes were unknown. 
No clinical prediction rules (CPRs) have been developed or validated to identify people 
with lower limb amputation at risk of becoming prosthetic non-users after discharge 
from rehabilitation. During prosthetic gait retraining, locomotor tests including the 10 
metre walk test (10MWT), timed up and go test (TUGT), 6 minute walk test (6MWT) 
and four square step test (FSST) may be used by health professionals to measure 
locomotor performance and gauge progress with rehabilitation but data to assist with 
interpretation of locomotor test performance for people with lower limb amputation is 
scarce. It was unknown whether performance on a single locomotor test can be used 
during rehabilitation to identify future prosthetic non-use in people with lower limb 
amputation. 
Objectives 
The studies in this thesis were developed to address the knowledge gaps associated with 
predicting and measuring outcomes following lower limb amputation. The global 
objectives were: 
1. To develop Clinical Prediction Rules (CPRs) for prosthetic non-use at 4, 6, 8 and
12 months after discharge from rehabilitation in people with lower limb
amputation.
2. To validate CPRs for prosthetic non-use at 4, 6, 8 and 12 months after discharge
from rehabilitation in people with lower limb amputation.
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3. To develop performance thresholds for locomotor tests during rehabilitation that 
identify risk of prosthetic non-use in people with lower limb amputation within 
12 months of rehabilitation discharge. 
4. To describe long term rehabilitation outcomes such as locomotor function, return 
to driving and work in people with lower limb amputation using the Locomotor 
Capabilities Index 5 (LCI5) and a previously piloted survey. 
5. To map comorbidities (including musculoskeletal and mental health issues) 
present at rehabilitation admission in a cohort with lower limb amputation.  
 
Methods CPR development 
A retrospective cohort study of 135 consecutive participants from Royal Perth Hospital 
(RPH), the state rehabilitation centre, was performed to develop CPRs. Potential 
predictor variables were abstracted from the medical records blinded to the participant 
interviews. The participants were interviewed to determine if they were prosthetic non-
users and the time after physiotherapy discharge that they stopped using their prosthetic 
limb. Chi squared tests were used to determine if the potential predictor variables had a 
significant univariate association (p < .1) with prosthetic non-use. The significant 
variables were further reduced to a subset of predictor variables or flags (p < .05) using 
backwards stepwise logistic regression. CPRs were generated for 4, 6, 8 and 12 months 
for prosthetic non-use. Chi squared analysis was used to determine the positive and 
negative likelihood ratio of prosthetic non-use for having 1 or more variables for 
prosthetic non-use (p < .05).        
 CPR validation 
A prospective cohort study of 66 consecutive participants from RPH was performed to 
validate the CPRs generated from the retrospective study. CPR and descriptive variables 
were abstracted from the medical records. Participants were interviewed to determine if 
they had become prosthetic non-users and the time they stopped using their prosthetic 
limb after physiotherapy discharge. Chi squared analysis was used to determine the 
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positive and negative likelihood of prosthetic non-use if 1 or more variables were 
present for the timeframes (p < .05).  
Locomotor tests 
A retrospective cohort study of 201 consecutive participants from RPH was performed 
to determine if locomotor tests during rehabilitation could identify people at risk of 
prosthetic non-use at 12 months after discharge. Locomotor tests performed during 
rehabilitation and descriptive variables were abstracted from the medical records. 
Participants were interviewed to determine if they were prosthetic users or non-users at 
12 months after physiotherapy discharge. Receiver operating characteristic curves were 
used to determine performance thresholds for people who were prosthetic non-users at 
12 months after rehabilitation discharge. Chi squared analysis was performed to 
determine the relative risk (RR) of prosthetic non-use if the threshold was present. 
Long term rehabilitation outcomes 
A survey study of 201 consecutive participants from RPH was performed to determine 
long term, self reported rehabilitation outcomes including wheelchair use, locomotor 
function, return to driving and work. The Locomotor Capabilities Index 5 (LCI5) was 
used to measure locomotor function in people who continued to use their prosthesis after 
rehabilitation discharge. Descriptive statistics were generated for the survey items. 
Comorbidities 
Comorbidities (including musculoskeletal pathology and mental illness) were abstracted 
from the medical records for 201 consecutive participants from RPH. Comorbidities 
present at hospital admission were analysed. Number of comorbidities, Charlson 
Comorbidity Index (CCI), Combined Age - Charlson Comorbidity Index (CA-CCI) and 
Functional Comorbidity Index (FCI) scores were generated for each participant and 
analysed for the cohort.  
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Results CPR development 
At 4 (& 6), 8 and 12 months after discharge prosthetic non-use was 11% (15), 15% (20) 
and 19% (25). CPRs were identified for 3 timeframes as results were identical for 4 and 
6 months after discharge. Likelihood Ratios of non-use were retrospectively 32.0 (4 & 6 
months), LR+ = 3.5 (8 months) and LR+ = 26.4 (12 months). 
 CPR validation 
The developed CPRs were prospectively validated for 4 (& 6), 8 and 12 months. There 
was a high level of concordance for continued prosthetic use between the CPR 
development and validation cohorts. Likelihood Ratios of non-use were prospectively 
43.9 (4 & 6 months), LR+ = 33.9 (8 months) and LR+ = 2.8 (12 months). 
 Locomotor Tests 
At 12 months post-discharge 18% (36) of participants were prosthetic non-users. 
Performance measure thresholds and RR of prosthetic non-use (95% CI) were:  
10MWT: If speed was < 0.44 ms-1 (Area Under the Curve (AUC) = 0.743), RR 
of non-use = 2.76 (CI, 1.83 to 3.79, p < .0001).  
6MWT: If distance was < 191 m (AUC = 0.788), RR of non-use = 2.84 (CI, 2.05 
to 3.48, p < .0001).  
TUGT: If time was > 21.4s (AUC = 0.796), RR of non-use = 3.17 (CI, 2.17 to 
4.14, p < .0001).  
FSST: If time was > 36.6s (AUC = 0.762), RR of non-use = 2.76 (CI, 1.99 to 
3.39, p < .0001).  
 Long term rehabilitation outcomes 
At median, 1.5 (IQR, 1.2 to 2.2) years after discharge, 74% (n = 149) of participants 
reported that they were prosthetic users. LCI5 scores were significantly different (z > 
2.10, p < .036) for all known groups at high risk of prosthetic non-use except the 
Aboriginal and above transtibial amputation level (z < 1.56, p < .12) groups. Ceiling 
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effect for Total LCI5 score was observed in 25% of the cohort. Return to driving and 
work were 91% (n = 111) and 62% (n = 56) respectively in sub-groups who were drivers 
and workers prior to amputation. 
Comorbidities 
Comorbidities that impact on mortality and function were high in the cohort with lower 
limb amputation. For the total cohort, the number of comorbidities were median = 10 
(Interquartile range (IQR) = 5 to 15), FCI median = 3 (IQR = 1 to 5), CCI median = 2 
(IQR = 1 to 4) and CA-CCI median = 4 (IQR = 1 to 6). 
Discussion and conclusion 
Very few Clinical Prediction Rules are established in rehabilitation and rarely 
prospectively validated. This thesis generates and validates a set of prediction rules to 
assist clinicians in testing modified models of care to optimise outcomes for individuals 
at higher risk. These validated CPRs for prosthetic non-use in people with lower limb 
amputation contribute to evidence based health reform of the amputee rehabilitation 
model of care and assist health professionals to develop targeted models of care for 
people at high risk of prosthetic non-use. The locomotor performance thresholds will 
help health professionals to identify people with lower limb amputation at higher risk of 
prosthetic non-use. The 10MWT and 6MWT had the greatest utility however further 
validation is required. The long term, self reported rehabilitation outcomes will assist 
with future resource allocation however high ceiling effect was observed for the LCI5 
scale so further research to develop a measure of self reported locomotor function is 
warranted. Comorbidity indices defined mortality risk and the impact that disease has on 
function. The CCI would be useful in future studies of people with amputation to enable 
standardised comparison of case mix between institutions. 
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CA-CCI – Combined Age Charlson Comorbidity Index 
CCI – Charlson Comorbidity Index 
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Clinical Prediction Rule – CPR 
COPD – Chronic Obstructive Pulmonary Disease 
CVA – Cerebrovascular Accident 
FCI – Functional Comorbidity Index 
FIM – Functional Independence Measure 
FSST – Four Square Step test 
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HbA1c – Glycated Haemoglobin 
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LCI5 – Locomotor Capabilities Index 5 
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MFCL – Medicare Functional Classification Level, K-level 0 to 4 
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xxiv 
Glossary
Term Definition 
Aboriginal Aboriginal and Torres Strait Islander people are the 
first inhabitants of Australia. An Aboriginal person is 
of Aboriginal descent, identifies as Aboriginal and is 
accepted as an Aboriginal person by their community. 
The research in this thesis was conducted in Western 
Australia (WA) and only people who identified as 
Aboriginal participated. People of the Torres Strait are 
of Melanesian origin from the Torres Strait Islands and 
east coast of Australia. 
Above transtibial 
amputation level 
Amputation at knee disarticulation level and above. 
Activities of daily living Functional tasks that a person performs every day (e.g. 
showering, dressing, eating, sit to stand).  
Admission date The date that the intervention or service commenced. 
Ambulation Movement also referred to as walking. 
Amputation The surgical removal of part or all of an upper limb or 
lower limb. 
Amputee A person with limb loss or deficiency 
Amputee rehabilitation The process that aims to restore function, vocation, 
recreation and socially reintegrate a person who has 
undergone amputation. 
Ankle disarticulation Amputation through the ankle removing the foot. 
Atraumatic amputation Amputation that results from circulatory, infective or 
cancer causes.  
Bilateral amputation Amputation of limbs on both sides (i.e. both upper 
limbs or both lower limbs amputated).  
xxv 
Clinical Prediction Rule Clinical prediction rules are statistically derived tools 
that assist health professionals with clinical decision 
making based on a parsimonious subset of predictor 
variables. 
Clinical utility The usefulness of a test at determining a diagnosis or 
outcome 
for an intervention and how effectively the test can be 
implemented into clinical practice. 
Comorbidity Any disease or procedure a patient has in addition to 
their primary disorder (e.g. a person with diabetes and 
peripheral neuropathy). The operational definition of 
comorbidity in this thesis was any condition that was 
documented in the medical record including 
musculoskeletal pathology and mental illness. 
Componentry Parts of the prosthesis (e.g. socket, knee, foot, pylon, 
liner, suspension system). 
Congenital limb 
deficiency 
Absence of a limb or part of a limb that is present from 
birth 
Contracture Tightening of a muscle resulting in reduced joint range 
of movement (e.g. hip and knee flexion contractures). 
Contralateral limb The limb on the opposite side. 
xxvi 
Definitive prosthesis The prosthesis which is prescribed approximately 6 
months after commencing prosthetic gait retraining 
once the residual limb volume has stabilised and the 
person with lower limb amputation has learned to walk. 
In WA the new prosthetic components are funded 
based by Western Australian Limb Service for 
Amputees (WALSA) on the patient’s Medicare 
Functional Classification Level (MFCL) K-level 
(mobility level), clinical assessment and approved by 
the Therapeutic Goods Act (TGA). This prosthesis is 
replaced approximately every 3 years in WA. The 
definitive prosthesis meets standardised criteria for 
comfort, fit, alignment, function, appearance and 
durability. 
Disarticulation Amputation through a joint (e.g. wrist, knee, ankle). 
Discharge date The endpoint of an intervention or service (e.g. 
physiotherapy discharge).  
Doffing Taking the prosthesis off. 
Domiciliary Rehabilitation that takes place in a patient’s home. 
Donning Putting on the prosthesis. 
Dysvascular amputation An amputation that is caused by circulatory issues 
associated with peripheral arterial disease and diabetes. 
Early walking aids An inflatable device (e.g. Pneumatic Post Amputation 
Mobility Aid (PPAM Aid)) that is used by 
physiotherapists in some rehabilitation services (e.g. 
United Kingdom) to enable patients to mobilise prior to 
commencing prosthetic gait retraining. Early walking 
aids are not used in the RPH model of care in WA.  
Fall An unexpected event where a person comes to rest on 
the ground, floor or lower level. 
xxvii 
Full-time prosthetic user A person who functionally uses their prosthesis 7 days 
per week. 
Gait Walking 
Gait speed How fast a person is walking. 
Inpatient A patient residing in the hospital to receive treatment 
or rehabilitation. 
Interim prosthesis The first prosthesis that is fitted after amputation 
surgery (approximately 3 weeks and onwards) so that 
prosthetic gait retraining can commence. The prosthetic 
components used in manufacturing the prosthesis are 
approved by the TGA. This prosthesis is generally used 
for the first 6 months of walking while the residual 
limb maturates and oedema stabilises. The fit is 
managed using stump socks, packing of the prosthetic 
liner and socket. If the socket becomes too large a new 
socket is cast, manufactured and fitted by the 
prosthetist. A cosmetic cover is generally not fitted to 
this prosthesis because it is adjusted frequently. This 
prosthesis is also referred to as the temporary 
prosthesis in some countries. In WA this prosthesis has 
basic prosthetic components (e.g. SACH foot, total 
elastic suspension belt and mechanical knees) unless 
clinically indicated (e.g. residual limb with split skin 
graft requiring a silicone liner, pin lock total surface 
bearing prosthesis). 
Intermittent pneumatic 
compression pump 
therapy 
A pump machine that is used to manage oedema and 
shape the residual limb in people with amputation. 
Knee disarticulation Amputation through the knee joint. 
xxviii 
Locomotor tests 
Major lower limb 
amputation 
Managing prosthetic fit
Mechanical knee 
Medical record 
Medicare functional 
classification level 
(MFCL) K-level 
Mental illness 
Microprocessor knee 
Tests administered by physiotherapists and health 
professionals to assess gait speed, endurance and 
balance (e.g. 10MWT, TUGT, 6MWT, FSST). 
Amputation from transtibial level and above. 
Adding or removing stump socks to accommodate 
changes in the volume of the residual limb. 
A prosthetic knee component that enables a stance 
and swing phase of gait in people with knee 
disarticulation, transfemoral and higher levels of 
lower limb amputation. Mechanical knees may be 
single axis, polycentric, hydraulic, pneumatic, have 
weight activated stance control or manual locking. 
The amount of stability during the stance phase of 
gait and responsiveness during swing phase to 
changes in gait speed depend on the mechanical set 
up of the knee component.   
The written and electronic data that a hospital 
maintains on an individual patient receiving 
assessment and treatment. 
A 5 point scale is used by amputee rehabilitation 
services to subjectively classify patients with lower 
limb amputation and allocate prosthetic 
components. Patients are rated from K0 (i.e. non-
prosthetic) to K4 (i.e. high functioning active adult, 
child or athlete). 
A health problem that affects how a person feels, 
thinks, behaves or interacts with other people that is 
diagnosed based on a set of criteria (e.g. depression, 
anxiety, personality disorder, schizophrenia). 
A knee that has a computer processor (sensor) that 
enables stance control and modifies the swing 
phase of gait as walking speed changes (e.g. C leg 
and Rheo knee). In WA microprocessor knees are 
only available to compensable patients and are not 
funded by the WALSA. 
xxix 
Minor lower limb 
amputation 
Mobility aid 
Model of care 
Monitoring skin on 
residual limb (stump) 
Multidisciplinary team 
Musculoskeletal 
pathology 
Oedema 
Osseointegration 
Outcome measures 
Amputation at ankle disarticulation level and below 
including partial foot and toe amputations. 
A device used to reduce weight bearing or improve 
balance when walking (e.g. walking stick, elbow 
crutches, walking frame). 
The way health services are delivered for a person, sub-
group or clinical cohort. In a model of care evidence 
based practice is implemented to match patients to 
interventions.  
Checking the skin on the residual limb for signs of 
pressure, blisters or wounds when using a prosthetic 
limb. 
Team of health professionals providing specialised 
amputee rehabilitation to patients including: 
rehabilitation medicine physician, physiotherapist, 
prosthetist, nurse, occupational therapist, podiatrist, 
clinical psychologist, social worker, dietitian, orthotist 
and other health professionals or specialties as required 
by individual patients with amputation. 
Any injury to the muscle, joint, bones, ligaments or 
tendons in a person. 
Swelling of the tissues (e.g. residual limb). 
A surgical procedure that involves the insertion of an 
implant to the residual skeleton so an artificial limb can 
be suspended without a prosthetic socket. 
An objective test that can be used to assess a patient 
before and after an intervention has been performed. In 
cohorts with amputation outcome measures may 
encompass physical and psychosocial domains of 
function (e.g. Locomotor Capabilities Index 5, 
Amputee Mobility Predictor, Trinity Amputation and 
Prosthesis Experiences Scale (TAPES)). 
xxx 
Outpatient A person receiving medical treatment or rehabilitation 
who is residing in their own accommodation. 
Outreach A service that travels to and provides rehabilitation to 
patients that live in country regions and are not residing 
close to metropolitan healthcare facilities. 
Partial foot amputation Amputation through the bones of the foot. 
Part-time prosthetic user 
Phantom pain 
Phantom sensation 
Physiotherapist 
Prosthesis 
Prosthetic adjustment 
Prosthetic alignment 
Prosthetic casting 
Prosthetic fitting 
A person who functionally uses their prosthesis less 
than 7 days per week. 
Pain that extends beyond the end of the residual limb in 
the limb that has been amputated. 
The feeling that the limb which has been amputated is 
still present without pain. 
A health professional that provides exercise, mobility 
and prosthetic gait retraining, oedema management, 
pain management and other interventions to patients 
with amputation. 
The artificial limb. 
Modifying the prosthesis to improve comfort, fit and 
function (e.g. packing the liner, changing alignment, 
modifying the socket). 
The position of the prosthetic socket in relation to the 
knee and foot components including bench, static and 
dynamic alignment of prosthesis. 
Plaster of Paris model of the residual limb taken by the 
Prosthetist to manufacture the prosthesis.  
Application of the customised artificial limb to the 
person with amputation after it has been manufactured 
by the prosthetist.  
xxxi 
Prosthetic foot Artificial foot that can be non-articulated (e.g. SACH 
foot), articulated (e.g. single or multiaxial), dynamic 
response (store and return energy, e.g. Vari-Flex), 
range of motion (height adjustable foot), hydraulic or 
microprocessor (e.g. Ossur proprio foot).  
Prosthetic gait retraining  The process of learning to walk, do functional, 
vocational and recreational activities using a prosthetic 
limb. 
Prosthetic knee Artificial knee joint component that may be mechanical 
(e.g. single axis, polycentric, weight activated stance 
control, manual locking, hydraulic, pneumatic) or 
microprocessor (e.g. C-leg, Rheo knee). 
Prosthetic liner Soft material that is used between the residual limb and 
prosthetic socket to protect the residual limb, improve 
the socket comfort and in some cases provide 
suspension. 
Prosthetic non-user A person who does not use their prosthesis on any days 
of the week for functional activities or has a prosthesis 
for cosmesis only. Also referred to as abandonment of 
prosthetic use.  
Prosthetic running A method of locomotion that involves moving fast with 
a flight phase where both the prosthetic and remaining 
feet (in people with unilateral amputation) are off the 
ground. 
Prosthetic suspension System that is used to attach the prosthesis to the 
person with amputation (e.g. Total elastic suspension 
(TES) belt, supracondylar suspension, silicone liner 
with pin lock, vacuum suspension). 
Prosthetic user A person who functionally uses their prosthetic limb 
for locomotor activities on all or some days of the 
week. 
xxxii 
Prosthetist A health professional who designs, fabricates and fits 
prostheses.  
Pylon A rigid tube between the socket or knee component and 
foot component to enable weight bearing. 
Rehabilitation Medicine 
Physician 
Doctor with specialist training in rehabilitation. 
Remaining limb The upper and lower limbs that have not been 
amputated. 
Residual limb (stump) The part of the limb that remains after amputation 
surgery, also referred to as a stump. 
Rigid Removable 
Dressing 
Dressing applied in the early post-operative stage to 
patients with transtibial amputation to protect the 
residual limb from trauma and manage residual limb 
oedema in preparation for an interim prosthesis. 
Senior Physiotherapist 
Amputee Rehabilitation 
Physiotherapist with specialised training in amputee 
rehabilitation who manages the physiotherapy team. 
Silicone liner A roll on liner used to minimise the shear forces on the 
residual limb and suspend the prosthesis. 
Silicone sock A sock made out of silicone material to minimise the 
shear forces on the residual limb. 
Socket Part of the prosthesis where the residual limb is 
enclosed. 
Solid Ankle Cushion Heel 
(SACH) foot 
Non-articulated prosthetic foot that simulates normal 
gait through compression of a heel cushion and 
flexibility of the toe. This type of foot is used for 
interim prosthesis in WA. 
Stump bandaging The use of a compression bandaging to manage 
oedema and shape the residual limb for a prosthesis. 
Stump pain Pain occurring from structures within the residual limb 
(e.g. neuroma, wound pain) 
xxxiii 
Stump shrinker Compression garment (e.g. Juzo) that is used to 
manage oedema and shape a residual limb for a 
prosthesis. 
Stump sock Cotton or woollen sock that is used to manage the fit 
of a prosthesis. 
Telemedicine The use of encrypted videoconferencing to provide 
healthcare for patients that reside in country regions 
(e.g. Telehealth videoconferencing is used by RPH 
amputee multidisciplinary rehabilitation team for 
assessment and treatment of patients who live in 
regional and remote WA). 
Transfemoral amputation Amputation above the knee joint, through the femur 
bone. 
Transtibial amputation Amputation below the knee joint, through the tibia 
and fibula bones. 
Traumatic amputation An amputation that is caused by injuries sustained in 
an event or accident (e.g. motor bike accident, shark 
attack, bomb blast). 
Unilateral amputation Amputation of one upper or lower limb on the body. 
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Chapter 1 Introduction 
1. Introduction
People with lower limb amputations can be classified into two population profiles: 
traumatic and atraumatic (Meier & Melton, 2014; Schoppen et al., 2003). The person 
with traumatic amputation is characterised by younger age, less comorbidities and 
the potential to rehabilitate to a high level of functional ability. The person with 
atraumatic amputation is generally older, with multiple comorbidities and circulatory 
or infective impairments that ultimately led to the amputation (Meier & Melton, 
2014; Schoppen et al., 2003). Chronic systemic diseases including diabetes, 
peripheral arterial disease, cardiac disease and renal failure combined with risk 
factors such as smoking, physical inactivity and obesity are common in this sub-
group (Fortington et al., 2013; Jones et al., 2013; Schoppen et al., 2003; World 
Health Organisation, 2016). These comorbidities may influence the ability to 
participate in prosthetic rehabilitation successfully and increase the risk of mortality 
(Fortington et al., 2013; Jones et al., 2013; Schoppen et al., 2003). In atraumatic 
cases, the remaining lower limb is often in a ‘pre-amputation’ state with up to one 
third of patients having their contralateral lower limb amputated within 3 years of the 
primary amputation (Lim et al., 2006).   
Multidisciplinary rehabilitation plays an important role in restoring function of 
people with lower limb amputation for activities of daily living, work and recreation 
(Broomhead et al., 2012; Czerniecki, Turner, Williams, Hakimi, & Norvell, 2012a; 
Meier & Melton, 2014; US Department of Veterans Affairs, 2008). However, limited 
research exists regarding long term functional outcomes of people with lower limb 
amputation who have been discharged from rehabilitation services (Department of 
Health, 2008; Jones, Hall, & Schuld, 1993; Lim et al., 2006; Meier Iii & Heckman, 
2014; Schoppen et al., 2003). In Western Australia, it was identified that 
rehabilitation outcomes of people with lower limb amputation including prosthetic 
use were unknown (Department of Health, 2008).  
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Diabetes is the leading cause of lower limb amputation in developed countries 
(Moxey et al., 2011; World Health Organisation, 2016). The World Health 
Organisation (WHO) identified that lower limb amputation is 10 to 20 times greater 
in people with diabetes (World Health Organisation, 2016). Aboriginal people (the 
first inhabitants of Australia) have high rates of diabetes related lower limb 
amputation and often reside in locations that are geographically isolated from health 
services however their rehabilitation outcomes have not been reported (Norman, 
Schoen, Gurr, & Kolybaba, 2010).  
 
The costs associated with rehabilitation following lower limb amputation represent 
high and long term expenditure to healthcare services (Blough et al., 2010; Ma, 
Chan, & Carruthers, 2014; Schaffalitzky, Gallagher, MacLachlan, & Wegener, 
2012). However, studies have reported rates as great as 51% for abandonment of 
prosthetic use at 1 year after amputation and 5 year mortality up to 77% in people 
with atraumatic causes of lower limb amputation (Davies & Datta, 2003; Fortington 
et al., 2013; Jones et al., 2013; Nehler et al., 2003; Schaffalitzky et al., 2012). 
Therefore, functional outcome of people with lower limb amputation warrants further 
investigation due to the potential for high levels of disability, healthcare costs and 
resource utilisation.  
 1.1. Predictors of locomotor outcome following lower limb amputation  
Locomotor outcome of people with lower limb amputation has been associated with 
several variables including comorbidities, age, condition of the remaining limb, 
mobility status prior to amputation, skin integrity, ethnicity, socioeconomic status, 
cognition, social support, level and number of limbs amputated, quality of residual 
limb, contractures, wound healing, post-operative complications, residual limb 
oedema, pain, energy cost of prosthetic gait, falls and rehabilitation models of care 
(Adams, 2005; Bhangu, Devlin, & Pauley, 2009; Czerniecki et al., 2012a; Meier Iii 
& Heckman, 2014; Nehler et al., 2003; Sansam, Neumann, O'Connor, & Bhakta, 
2009; Schoppen et al., 2003; Taylor et al., 2005; Waters, Perry, Antonelli, & Hislop, 
1976). Not fitting a prosthetic limb and prosthetic non-use after discharge from 
rehabilitation have been associated with different comorbidities (Resnik & Borgia, 
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2015; Sansam et al., 2009; Schoppen et al., 2003). However, since there is no 
standardisation for measurement of comorbidity in people with lower limb 
amputation (Fletcher et al., 2001; Gailey, Allen, Castles, Kucharik, & Roeder, 2008; 
Gailey et al., 2002; Resnik & Borgia, 2015; Schoppen et al., 2003; Taylor et al., 
2005), the ability to determine the impact of multiple comorbidities (the usual 
presentation) on outcomes is yet to be investigated. 
  
From a clinical perspective, single limb balance, muscle strength and endurance in 
the remaining limb are important pre-prosthetic measures of impairment that 
determine walking ability, however these assessments have rarely been included in 
lower limb amputation cohort studies (Gailey et al., 2002; Raya, Gailey, Fiebert, & 
Roach, 2010; Schoppen et al., 2003).  
 
To date studies have focused on surgical outcomes, people with limited rehabilitation 
potential (e.g. house or bed bound prior to amputation), variables associated with not 
fitting a prosthesis rather than abandonment of prosthetic use or sub-groups (e.g. 
geriatric, unilateral, vascular amputation) limiting the generalisability of results (Lim 
et al., 2006; Resnik & Borgia, 2015; Sansam et al., 2009; Schoppen et al., 2003; 
Taylor et al., 2005).  
 
The literature has demonstrated univariate association of many variables with 
prosthetic non-use following lower limb amputation but few studies have employed 
multivariate regression or prospectively validated findings derived from retrospective 
cohort analysis (Sansam et al., 2009; Schoppen et al., 2003; Taylor et al., 2005). 
Therefore the combination of variables which are most significant for predicting 
prosthetic non-use following amputation are poorly understood (Sansam et al., 2009).  
 1.2. Clinical Prediction Rules (CPRs) 
Clinical Prediction Rules (CPRs) are tools that assist health professionals to make 
evidence based decisions and assign patients to interventions using a subset of 
predictor variables (Beneciuk, Bishop, & George, 2009; Cleland, Childs, Fritz, 
Whitman, & Eberhart, 2007; Laupacis, Sekar, & Stiell, 1997). CPRs have been 
developed and validated for patients with neck pain, lower back pain and ankle 
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fractures (Beneciuk et al., 2009; Cleland et al., 2007; Laupacis et al., 1997). If CPRs 
were developed and validated to identify accurately people with lower limb 
amputation who were at risk of prosthetic non-use, health professionals could use 
this evidence to improve clinical decision making and stratify patients into targeted 
models of care (Childs & Cleland, 2006; Laupacis et al., 1997). CPRs have the 
potential to improve efficiency of health services and lead to cost savings (Childs & 
Cleland, 2006). Accurately matching patients to rehabilitation interventions is 
important due to resource limitations (Childs & Cleland, 2006; Sansam, O'Connor, 
Neumann, & Bhakta, 2014). For example, the health policy of Slovenia allows 
people with lower limb amputation to be issued with a either prosthesis or 
wheelchair, but not both of these mobility devices (Erjavec, Vidmar, & Burger, 
2014).  
 1.3. Locomotor outcome measures following lower limb amputation 
Evaluation of locomotor outcome following rehabilitation for lower limb amputation 
is important for determining if rehabilitation interventions and models of care have 
been effective (Heinemann, Connelly, Ehrlich-Jones, & Fatone, 2014; Meier Iii & 
Heckman, 2014). However, studies (Borrenpohl, Kaluf, & Major, 2016; Gaunaurd et 
al., 2015; Heinemann, Ehrlich-Jones, Connelly, Semik, & Fatone, 2016) have 
demonstrated that the use of outcome measures to assess locomotor function in 
people with lower limb amputation by health professionals was inconsistent. 
Gaunaurd et al. (2015) and Jette, Halbert, Iverson, Miceli, and Shah (2009) reported 
that more than 48% of health professionals surveyed did not routinely use outcome 
measures with patients. Health professionals have identified cost, equipment, time, 
training, staffing levels, difficulty with interpretation and relevance of the test as 
some of the barriers to using outcome measures in clinical practice (Gaunaurd et al., 
2015; Heinemann et al., 2014; Heinemann et al., 2016; Jette et al., 2009; Smart, 
2006).  
 
The Functional Independence Measure (FIM) and the Medicare Functional 
Classification Level (MFCL) are two commonly used outcome measures during 
amputee rehabilitation (Borrenpohl et al., 2016; Condie, Scott, & Treweek, 2006; 
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Gaunaurd et al., 2015). The FIM has issues with observed ceiling effect and 
responsiveness in amputation cohorts (Condie et al., 2006). The MFCL is used to 
subjectively classify potential or actual locomotor function of a person with lower 
limb amputation from non-prosthetic (K-level 0) to high functioning (K-level 4) 
(Borrenpohl et al., 2016; Gaunaurd et al., 2015). Studies have called for the MFCL to 
be supplemented with objective outcome measures (Borrenpohl et al., 2016; 
Gaunaurd et al., 2015).   
 
The 10 metre walk test (10MWT), timed up and go test (TUGT), 6 minute walk test 
(6MWT) and four square step test (FSST) are examples of objective outcome 
measures that health professionals may use during prosthetic rehabilitation to assess 
locomotor function (Dite, Connor, & Curtis, 2007; Heinemann et al., 2014; Resnik & 
Borgia, 2011; Stevens, 2010). Reduced walking distance, low walking speed and 
increased time taken on balance tasks following lower limb amputation have been 
associated with impaired locomotor function and increased risk of falling (Dite et al., 
2007; Heinemann et al., 2014; Resnik & Borgia, 2011; Stevens, 2010). It is unclear 
whether performance on locomotor tests during rehabilitation can be used to identify 
people with lower limb amputation at future risk of abandoning prosthetic use.  
 
The Locomotor Capabilities Index 5 (LCI5) is an amputee specific outcome measure 
that has been used to assess locomotor function with a prosthesis for a series of basic 
and advanced locomotor tasks (Franchignoni et al., 2007; Franchignoni, Orlandini, 
Ferriero, & Moscato, 2004). The questionnaire format of the LCI5 makes it a useful 
tool for long term follow-up of people with lower limb amputation. In a longitudinal 
study of a cohort with lower limb amputation from vascular causes, it was 
demonstrated that LCI5 scores at 12 months after amputation had not returned to pre-
operative levels (Czerniecki et al., 2012a).     
 
There are no gold standards for measuring locomotor function in people with lower 
limb amputation and few health professionals use objective outcome measures with 
their clients (Gaunaurd et al., 2015; Heinemann et al., 2014; Heinemann et al., 2016; 
Resnik & Borgia, 2011). Further research is required to determine the utility of 
locomotor tests during rehabilitation and whether a single locomotor test can be used 
across functional domains to identify risk of future prosthetic non-use. 
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1.4. Statement of the problem 
Lower limb amputation is a public health issue of global significance due to the 
potential for high disability, costs and utilisation of health resources (Blough et al., 
2010; Moxey et al., 2011). People with atraumatic causes of amputation have 
increased risk of mortality at 1 and 5 years after surgery due to high burden of 
disease but there is no consensus on the most effective method for measuring 
comorbidity (Fortington et al., 2013; Jones et al., 2013). Prosthetic gait retraining is 
an intensive intervention that occurs over a protracted timeframe following lower 
limb amputation with the aim of restoring quality of life (Reiber et al., 2010; 
Schaffalitzky et al., 2012). However, a high proportion of people with lower limb 
amputation who participate in this expensive multidisciplinary rehabilitation 
intervention abandon prosthetic use after discharge (Blough et al., 2010; Reiber et 
al., 2010; Schaffalitzky et al., 2012). Prosthetic gait retraining is not without health 
risk due to potential complications such as falls, fractures and myocardial infarction 
(Bailey & MacWhannell, 1997; Broomhead et al., 2012; Broomhead et al., 2006; 
Sansam et al., 2014).  
 
There is limited research on rehabilitation outcomes following lower limb 
amputation to guide clinical practice and develop amputee rehabilitation models of 
care (Department of Health, 2008; Sansam et al., 2009). In Western Australia, long 
term rehabilitation outcomes such as rates of prosthetic and wheelchair use, return to 
driving and work were unknown (Department of Health, 2008). Locomotor function 
has been associated with several variables in univariate studies however clinical 
prediction rules have not been developed to identify people at risk of prosthetic non-
use following discharge from rehabilitation (Sansam et al., 2009). Furthermore, 
clinical prediction rules have been developed for many medical conditions but 
validation studies are rare (Childs & Cleland, 2006; Laupacis et al., 1997). The use 
of outcome measures during rehabilitation is low so there is a paucity of performance 
data on locomotor tests for lower limb amputation cohorts (Gailey et al., 2002; 
Gaunaurd et al., 2015; Heinemann et al., 2014; Resnik & Borgia, 2011). Therefore, 
further studies are warranted to improve prediction of prosthetic non-use, measure 
comorbidity, assist with interpretation of locomotor tests and evaluate rehabilitation 
interventions in cohorts with lower limb amputation (Heinemann et al., 2014; 
Sansam et al., 2009).   
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1.5. Significance of this research 
Research in this thesis will make the following original and significant contributions 
to evidence based practice for people with lower limb amputation: 
 
• The first study to develop CPRs for prosthetic non-use following discharge 
from rehabilitation.  
• The first study to validate CPRs for prosthetic non-use following discharge 
from rehabilitation.   
• The first study to generate performance thresholds for locomotor tests that 
identify increased risk of prosthetic non-use at 12 months following discharge 
from rehabilitation. 
• The first study to determine rehabilitation outcomes for Australian Aboriginal 
people with lower limb amputation. 
• Determine the clinical utility of comorbidity indices and locomotor tests in 
people with lower limb amputation. 
• Improve knowledge of long term rehabilitation outcomes and 
sociodemographics of people with lower limb amputation in Australia. 
 
This research will contribute to evidence based health reform of the Amputee 
Rehabilitation Model of Care in Western Australia (Department of Health, 2008) and 
lead to potential cost savings through development of targeted models of care. 
Accurate prediction of prognosis following lower limb amputation facilitates more 
effective patient counselling regarding expected outcome (Sansam et al., 2014; 
Schaffalitzky et al., 2012) and potentially drives technical innovations to restore 
locomotor function in sub-groups at high risk of prosthetic non-use. The findings of 
this thesis may be potentially transferable or translated to other healthcare settings 
across the world.     
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1.6. Study objectives 
The aims of this research were: 
1. To develop a set of Clinical Prediction Rules (CPRs) for people with lower 
limb amputation that identify which factors in combination are predictive of 
prosthetic non-use at 4, 6, 8 and 12 months after discharge from 
rehabilitation. 
2. To validate the CPRs that identify prosthetic non-use at 4, 6, 8 and 12 months 
after discharge from rehabilitation in a prospective cohort of people with 
lower limb amputation.  
3. To determine whether different tests of locomotor performance during 
rehabilitation were associated with significantly greater risk of prosthetic 
non-use at 12 months post-discharge from rehabilitation. 
4. To gain knowledge on the balance and locomotor skills of known groups at 
high risk of discontinuing prosthetic use and test the construct validity of the 
10MWT, TUGT, 6MWT and FSST in these groups. 
5. To describe long term self reported outcomes of people with lower limb 
amputation after rehabilitation discharge including sociodemographic 
characteristics, complications of amputation, prosthetic locomotor function 
using the locomotor capabilities index 5 (LCI5), mobility without a 
prosthesis, use of wheelchair and assistive devices, return to driving and 
work.  
6. To investigate rehabilitation outcomes in Aboriginal people with lower limb 
amputation. 
7. To map comorbidities (including musculoskeletal pathology and mental 
illness) that are present at hospital admission in a cohort with lower limb 
amputation and evaluate construct validity of using comorbidity indices in 
people with lower limb amputation. 
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1.7. Thesis Outline  
This research addresses the limited literature on rehabilitation outcomes following 
lower limb amputation. The Royal Perth Hospital (RPH) amputee rehabilitation 
model of care, physiotherapy intervention, outcome studies and measurement of 
locomotor function have been explored in the literature review (Chapter 2). How to 
read the thesis and common methods have been outlined in Chapter 3.  
 
Chapters 4 and 5 detail the development and validation of clinical prediction rules for 
prosthetic non-use. The relationship between locomotor test performance during 
rehabilitation and prosthetic non-use at 12 months after discharge from rehabilitation 
is reported in Chapter 6. The construct validity of locomotor tests in known groups at 
high and lower risk of prosthetic non-use is examined in Chapter 7, Part A. To 
improve knowledge on long term activity and participation limitations following 
amputation, self reported locomotor function, return to driving and work have been 
analysed in Chapter 7, Part B. This chapter includes a known groups analysis using 
the LCI5.  
 
Comorbidities have been mapped and the utility of comorbidity indices to measure 
burden of disease have been explored in Chapter 8. The contribution of this research 
to the evidence base, limitations of the research and future research directions have 
been discussed in the final thesis chapter. 
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Chapter 2   Literature Review 
 2. Introduction 
Lower limb amputation is a life changing event that impacts on functional, work, 
social and recreational activities. In this thesis chapter key principles of amputee 
rehabilitation including: levels of lower limb amputation, aetiology, incidence, 
comorbidities, the amputee rehabilitation model of care, selection criteria for 
prosthetic rehabilitation, rehabilitation interventions, prosthetic use and prosthetic 
non-use have been defined. Significant literature on functional outcomes following 
lower limb amputation and common outcome measures have been explored to 
identify knowledge gaps in the evidence base and support the research directions of 
this thesis. This literature review has also incorporated grey literature such as clinical 
practice guidelines and health policy documents where published research was not 
available. 
  2.1. Definition of Lower Limb Amputation  
Lower limb amputation is the acquired surgical removal of the leg, foot or toes from 
the body (Lusardi & Pepe, 2013). Congenital limb deficiency is the partial or 
complete absence of a limb that is present at birth, which may or may not result in a 
future lower limb amputation to enable fitting of a prosthetic limb (Lusardi & Pepe, 
2013; Nielsen & Jorge, 2013). The focus of this thesis is on outcomes following 
lower limb amputation. Common levels of lower limb amputation have been 
summarised in Table 2.1 (Lusardi & Pepe, 2013; Murphy, 2013). The residual limb 
or stump is the part of the lower limb that remains after amputation surgery. In this 
thesis, major lower limb amputation has been defined as amputation from transtibial 
level and above. Minor lower limb has been defined as ankle disarticulation and 
below, including partial foot and toe amputations. 
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Table 2.1: Common levels of amputation defined. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Lusardi & Pepe, 2013; Murphy, 2013). 
 
  
Major Lower Limb 
Amputation Levels 
Definition 
 
Hemipelvectomy Amputation through the sacroiliac joint or ala of 
the ilium. 
 
Hip disarticulation Amputation removing the whole lower limb at 
the hip joint. 
 
Transfemoral amputation Amputation through the femur. 
 
Knee disarticulation Amputation removing the tibia and fibula at the 
knee joint. 
 
Transtibial amputation Amputation through the tibia and fibula. 
 
Minor Lower Limb 
Amputation Levels 
Definition 
 
Ankle Disarticulation (Syme) Amputation through the talocrural joint. 
 
Partial foot amputations 
Boyd 
 
Pirrogoff 
 
 
Chopart 
 
Lisfranc 
 
Transmetatarsal  
 
Metatarsal ray 
resection 
 
 
Fusion of the calcaneus and tibia with removal of 
distal structures. 
 
Wedging transection of the calcaneus, with 
fusion of the calcaneus and tibia and removal of 
all distal structures. 
 
Amputation through the midtarsal joints. 
 
Amputation through the tarsometatarsal joint. 
 
Removal of all 5 metatarsals proximal to their 
metatarsal heads. 
 
Amputation removing a whole metatarsal bone. 
 
Toe amputation 
Phalangeal 
amputation 
 
Digit amputation at the distal, middle or 
proximal interphalangeal joints. 
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For the studies in this thesis amputation level has been classified as transtibial and 
above transtibial level of amputation (i.e. knee disarticulation amputation level and 
above). Major bilateral lower limb amputation has been defined as transtibial 
amputation level or higher of both lower limbs.  
 
Osseointegration involves the surgical insertion of an implant to the residual skeleton 
so an artificial limb can be suspended without a prosthetic socket (Brånemark et al., 
2014; Haggstrom, Hansson, & Hagberg, 2013). This procedure represents a potential 
treatment option for people with transfemoral amputation who have had difficulties 
with conventional prosthetic socket fit, skin breakdown and fluctuations in residual 
limb volume due to oedema (Brånemark et al., 2014; Haggstrom et al., 2013). The 
studies in this thesis do not include participants who have undergone 
osseointegration surgery as in Western Australia (WA) at the time this research was 
conducted osseointegration was not a routine surgical procedure for people with 
lower limb amputation.  
 2.2. Aetiology of Amputation    
The main causes of amputation include circulatory issues, infection, trauma and 
cancer (Nielsen & Jorge, 2013). Peripheral arterial disease is a common cause of 
circulatory amputations (Nielsen & Jorge, 2013). Infected diabetic foot ulcers, 
osteomyelitis and meningococcal septicaemia are examples of infective causes of 
amputation (Nielsen & Jorge, 2013). Lower limb injury sustained in motor bike 
accidents, work place accidents, burns, shark attack, warfare, civil unrest and 
terrorism are some mechanisms of traumatic amputation (Nielsen & Jorge, 2013). 
Osteosarcoma and skin cancer are forms of cancer that may result in amputation 
(Nielsen & Jorge, 2013). In this thesis the cause of amputation has been 
dichotomised for analyses into traumatic and atraumatic amputation. The participants 
with circulatory, infective and cancer causes of amputation were classified as having 
an atraumatic amputation.   
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2.3. Incidence and prevalence of amputation  
There is wide global variation in lower limb amputation as the incidence ranges from 
5.8 to 31 per 100 000 total population (Moxey et al., 2011). The incidence is higher 
in people with diabetes, ranging from 46.1 to 9600 per 100 000 population (Moxey et 
al., 2011). Ziegler-Graham, MacKenzie, Ephraim, Travison, and Brookmeyer (2008) 
estimated that 1.6 million people from the United States of America (USA) had an 
amputation in 2005 and projected that this figure would rise to 3.6 million by 2050. 
The aetiology of amputation included atraumatic (peripheral arterial disease and 
diabetes related amputation) in 54% (n = 846 000), trauma in 45% (n = 704 000) and 
cancer in 1% (n = 18 000) of cases (Ziegler-Graham et al., 2008). 
  
In contrast to the public health context of developed nations, higher prevalence of 
traumatic amputation has been documented in developing nations, warzones and 
areas of civil unrest (Department of Health, 2008; ICRC, 2015; Pasquina, 2010; Van 
Brakel, Poetsma, Tam, & Verhoeff, 2010; Wallace, 2012; Ziegler-Graham et al., 
2008). For example, Van Brakel et al. (2010) reported traumatic causes of 
amputation for 91.2% (n = 746) of people from Vietnam with 48.4% (n = 396) of 
amputations due to injury from land mines. In 2014, the International Committee of 
the Red Cross (ICRC) provided physical rehabilitation services to over 318 000 
people with a disability and fitted 20 101 prostheses to people with amputation of 
developing nations (ICRC, 2015).  
 
In the Iraq and Afghanistan conflicts improvised explosive devices (IEDs) were the 
main weapon that caused traumatic amputation and complex limb injuries in soldiers 
(Clasper & Ramasamy, 2013; Pasquina, 2010; Wallace, 2012). Wallace (2012)  
reports that until September 2010, the number of major and minor limb amputations 
in soldiers from the USA were 1158 in Iraq, 249 in Afghanistan, 214 in unaffiliated 
conflicts and 34 in Yemen, Pakistan and Uzbekistan. High rates of traumatic 
amputation have also been reported in soldiers from the United Kingdom (UK) 
(Wallace, 2012). Three Australian soldiers sustained traumatic amputations from 
2002 to 2012 during the Afghanistan conflict (Wallace, 2012). 
 
In Australia the literature has focused on the incidence of lower limb amputation 
caused by diabetes and peripheral arterial disease with limited published data on 
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other causes of lower limb amputation (Baba, Davis, Norman, & Davis, 2015; Davis, 
Norman, Bruce, & Davis, 2006; Dillon, Kohler, & Peeva, 2014; Dillon, Fortington, 
Akram, Erbas, & Kohler, 2017b; Kurowski et al., 2015). The age standardised 
incidence of major lower limb amputation was stable at 37.41 ± 1.01 procedures per 
100 000 population per annum in Australia between 2000 and 2010 but there has 
been a significant rise in minor lower limb amputations (Dillon et al., 2014). Dillon 
et al. (2017b) reported that of the 3409 amputation procedures performed in WA 
between 2007 and 2012 a total of 10.7% (n = 366) were transfemoral and 15.2% (n = 
519) were transtibial levels of amputation. The WA rates of major and minor lower 
limb amputation levels were consistent with the other Australian states and territories 
in this study (Dillon et al., 2017b).  
 
The geographic variation for incidence rate of lower limb amputation in Australia 
between 2007 and 2012 was described by Dillon et al. (2017b). The crude national 
incidence rate of lower limb amputation (all causes) was 44.0 per 100 000 person-
years for males and 20.9 per 100 000 person-years for females in this study (Dillon et 
al., 2017b). In Western Australia, the crude incidence rate of lower limb amputation 
was 40.6 per 100 000 person-years for males and 20.2 per 100 000 person-years for 
females (Dillon et al., 2017b). The majority of states and territories had similar crude 
and age adjusted incidence rates of lower limb amputation for males and females to 
the national incidence rate (Dillon et al., 2017b). Higher relative risk of lower limb 
amputation was associated with older age, male gender and type 2 diabetes for the 
majority of states and territories (Dillon et al., 2017b). However, in the Northern 
Territory both the crude and age standardised incidence rates of lower limb 
amputation were higher than the national rate and amputation occurred at a younger 
age (Dillon et al., 2017b). Reduced relative risk of lower limb amputation was 
associated with male gender and type 2 diabetes in the Northern Territory with 
younger age at amputation being identified as a confounding factor related to these 
findings (Dillon et al., 2017b). Dillon et al. (2017b) identified that the effect of 
indigenous status on the incidence rate of lower limb amputation was an area for 
future research. 
  
It has been estimated that a lower limb amputation is performed due to diabetes 
related complications every 3 hours in Australia and reported that Aboriginal people 
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aged 25 to 49 years from WA, were 38 times more likely to have a lower limb 
amputation from diabetic causes (AIHW, 2008; Bergin et al., 2012; Department of 
Health, 2010; Norman et al., 2010). However, amputation has been the primary 
endpoint of epidemiological research in Australia and rehabilitation outcomes of 
Aboriginal people have not been investigated (Bergin et al., 2012; Department of 
Health, 2010; Norman et al., 2010; Schoen & Norman, 2014; Vos, Barker, Begg, 
Stanley, & Lopez, 2009). Rehabilitation outcomes for Aboriginal people with 
amputation may potentially be affected by higher disease burden and rates of 
diabetes, geographical isolation from health services and cultural factors which 
influence health behaviours (Schoen, Balchin, & Thompson, 2010; Vos et al., 2009).  
 
A total of 2095 major lower limb amputations were performed in WA from 2000 to 
2010 (Kurowski et al., 2015). Kurowski et al. (2015) reported that the average annual 
rate of total amputations were 724 per 100 000 population per annum in people with 
type1 diabetes, 564 per 100 000 population per annum in people with type 2 diabetes 
and 66 per 100 000 population per annum in people with cardiovascular disease 
without diabetes. Baba et al. (2015) investigated the temporal changes of prevalence 
and associated variables in people with lower limb amputation and type 2 diabetes 
for phases 1 (1993 to 1996) and 2 (2008 to 2011) of the Fremantle Diabetes Study in 
WA. There were 15 lower limb amputations at baseline for both phases 1 and 2 
(Baba et al., 2015). After adjustment for diabetes and important between group 
differences, it was demonstrated that the risk of amputation had declined by 72% 
over the 15 year duration of study (Baba et al., 2015). The variables independently 
associated with lower limb amputation during phase 2 were: history of lower limb 
bypass surgery or revascularisation, past or current hospitalisation for foot ulcer and 
fasting glucose serum (Baba et al., 2015). The decline in lower limb amputations 
were attributed to health systems change with the introduction of government funded 
primary podiatry services and multidisciplinary high risk foot clinics in tertiary 
hospitals (Baba et al., 2015).   
 
The Department of Health in WA reported that 2553 amputations were performed in 
public and private hospitals from 2000 to 2007 (Department of Health, 2008). Of 
these 68.3% (n = 1743) were from atraumatic causes including atherosclerosis, 
diabetes and osteomyelitis (Department of Health, 2008). The remaining 31.7% (n = 
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810) were from other causes of amputation including trauma, cancer and acquired 
deformities of the toes (Department of Health, 2008). Amputation was higher in the 
elderly, as individuals aged 65 years and older accounted for 59% of the cases 
(Department of Health, 2008). A further 30% of lower limb amputations included 
individuals aged 45 to 64 years (Department of Health, 2008). Major lower limb 
amputations represented 38.1% (n = 973) and minor lower limb amputations 
represented 61.9% (n = 1580) of all amputations (Department of Health, 2008). A 
diagnosis of diabetes was present in 46.2% (n = 1179) of all cases of lower limb 
amputation (Department of Health, 2008).  
 2.4. Comorbidities 
Diabetes, peripheral arterial disease, cardiovascular disease, renal failure, chronic 
obstructive pulmonary disease and dementia are common comorbidities that may be 
present in people with atraumatic causes of lower limb amputation (Fortington et al., 
2013; Jones et al., 2013). These chronic diseases contribute to high mortality rates up 
to 48.3% at 1 year and 77% at 5 years post-surgery in people with atraumatic 
amputation (Fortington et al., 2013; Jones et al., 2013). Comorbidities are an 
important consideration for health professionals when stratifying patients for 
rehabilitation interventions and predicting outcomes however there is no consensus 
on the most appropriate method of measuring comorbidity in lower limb amputation 
cohorts (Roffman, Buchanan, & Allison, 2016a).  
 
Musculoskeletal pathology (e.g. back and shoulder pain, knee and hip osteoarthritis) 
and mental health issues (e.g. depression, anxiety) impact on functional outcome 
following lower limb amputation however little is known about the type or 
prevalence of these comorbidities at rehabilitation admission because research has 
focused on these conditions as long term sequelae of amputation (Gailey et al., 2008; 
Gallagher & Maclachlan, 2004; Singh et al., 2009; Struyf, van Heugten, Hitters, & 
Smeets, 2009). Furthermore it was highlighted in a literature review by Mueller 
(2016), that physiotherapists were not recognising the musculoskeletal pathology 
associated with patients having a comorbid diagnosis of diabetes. The prevalence of 
musculoskeletal pathology such as tendinopathy, neck, shoulder and low back pain is 
higher in people with diabetes (Mueller, 2016). Structural changes to bones and soft 
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tissues (i.e. skin, nerve, tendon, ligament and muscle) may occur due to the 
metabolic complications of diabetes (Mueller, 2016). Mueller (2016) reported that 
these structural changes increase the potential for injury with lower force and impair 
locomotor function. This has implications for exercise prescription and rehabilitation 
outcomes following lower limb amputation. The research in this thesis will 
contribute to the evidence base for clinical practice by examining musculoskeletal 
pathology in known high risk groups including people with diabetes and amputation. 
 
Comorbidity indices including the Charlson Comorbidity Index (CCI) and Functional 
Comorbidity Index (FCI) have been developed for predicting mortality, function and 
measuring burden of disease in other clinical populations (Charlson, Pompei, Ales, & 
MacKenzie, 1987; Groll, To, Bombardier, & Wright, 2005; Roffman et al., 2016a). 
There have been limited studies using comorbidity indices in people with lower limb 
amputation (Davie-Smith, Paul, Nicholls, Stuart, & Kennon, 2016; de Laat, Dijkstra, 
Rommers, Geertzen, & Roorda, 2014; Fortington et al., 2013; Gailey et al., 2002; 
van Eijk et al., 2012; Webster et al., 2012). Comparison of these studies is difficult 
due to variation in study methodologies with some researchers excluding diagnoses 
such as diabetes or peripheral arterial disease, others reporting scores or using the 
comorbidity indices to generate a standardised list of conditions (Davie-Smith et al., 
2016; de Laat et al., 2014; Fortington et al., 2013; Gailey et al., 2002; van Eijk et al., 
2012; Webster et al., 2012). Further research in heterogeneous amputation cohorts is 
indicated to map comorbidities (including musculoskeletal pathologies and mental 
health issues) and to establish clinical utility of comorbidity indices in the WA public 
health context. 
 2.5. Amputee Rehabilitation Models of Care  
The Department of Veterans Affairs (2008) in the USA recommend a 5 stage 
rehabilitation model of care for people with amputation. The 5 stages of 
rehabilitation documented in the literature (Department of Health, 2008; Knapp, 
2013; Lusardi, 2013; Nielsen & Jorge, 2013; Roffman, Buchanan, & Allison, 2016b; 
US Department of Veterans Affairs, 2008) include: pre-operative, post-operative, 
pre-prosthetic, prosthetic and long term follow-up (see figure 2.1 for the Royal Perth 
Hospital (RPH) multidisciplinary model of care for amputation rehabilitation).   
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Figure 2.1: The 5 stages of Multidisciplinary Amputee Rehabilitation 
model of care at Royal Perth Hospital (RPH)  
(Roffman et al., 2016b; US Department of Veterans Affairs, 2008).   
5 Stages of Multidisciplinary Amputee Rehabilitation at  
Royal Perth Hospital (RPH) 
1. Pre-operative 
• Assessment & consultation in 
RPH Multidisciplinary 
Outpatient Clinic or as an 
inpatient on RPH surgical 
ward 
2. Post-operative 
• Daily physiotherapy as 
inpatient on RPH surgical 
ward 
• Post-operative assessment by 
Rehabilitation Physician & 
Senior Physiotherapist 
Amputee Services 
3. Pre-prosthetic rehabilitation  
• 2 physiotherapy sessions per 
day as inpatient on RPH 
amputee rehabilitation unit 
4. Prosthetic rehabilitation  
• 2 to 3 outpatient 
physiotherapy sessions per 
week at RPH  
• Interim prosthesis fitted by 
RPH prosthetists 
• Definitive prosthesis fitted by 
Private Prosthetic Service 
Providers 
5. Long term follow-up  
• RPH Multidisciplinary 
Amputee Outpatient Clinic 
(includes Telehealth) 
Physiotherapy Discharge 
In summary pre-prosthetic rehabilitation 
intervention included: strengthening, 
balance, stretching and cardiovascular 
exercises, wheelchair mobility, transfers, 
home modifications, assistive devices, 
oedema management, stump care, 
stump desensitisation and graded motor 
imagery for management of phantom 
pain. 
In summary prosthetic gait retraining 
intervention included: therapeutic 
exercise, oedema management, stump 
care, learning to don, doff and manage 
prosthetic fit, sit to stand, weight shift 
and walking drills in the parallel bars, 
transfers using the prosthesis, walking 
indoors and outdoors, stair climbing, 
progression of mobility aids, carer 
education, running, sport and work 
specific locomotor activities. Prosthetic 
adjustments were performed during 
physiotherapy sessions and new sockets 
manufactured as required by the onsite 
RPH prosthetists. The multidisciplinary 
rehabilitation team referred 
participants for a definitive prosthesis 
when gait retraining was completed and 
residual limb volume had stabilised. 
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Although amputee models of care vary between inpatient, outpatient, domiciliary, 
outreach and telemedicine settings, the consensus of contemporary literature 
(Broomhead et al., 2012; Czerniecki et al., 2012a; Department of Health, 2008; 
Geertzen et al., 2015a; Geertzen et al., 2015b; ICRC, 2015; Kurichi et al., 2009; 
Meier Iii & Heckman, 2014; Pasquina, 2010; Sansam et al., 2014; Stineman et al., 
2010; US Department of Veterans Affairs, 2008; Wong et al., 2016a) has been that 
healthcare from a comprehensive multidisciplinary team specialised in amputee 
rehabilitation optimises outcomes for people with lower limb amputation. The 
multidisciplinary team includes: rehabilitation medicine physician, physiotherapist, 
prosthetist, nurse, occupational therapist, podiatrist, clinical psychologist, social 
worker, dietitian, orthotist and other health professionals or specialities as required 
by individual patients (Broomhead et al., 2012; Department of Health, 2008; Meier 
Iii & Heckman, 2014; Nielsen & Jorge, 2013; Pasquina, 2010; Sansam et al., 2014; 
US Department of Veterans Affairs, 2008).  
 
Meier Iii and Heckman (2014) emphasised the importance of inpatient, outpatient 
and long term follow-up stages in their review of contemporary amputee 
rehabilitation principles but identified that there has been a shift away from inpatient 
rehabilitation in many USA healthcare facilities. Meier and Melton (2014) report that 
an interim prosthesis can be cast and fitted, once the residual limb wound has healed 
and the oedema has been managed. An interim prosthesis is the first prosthesis fitted 
(approximately 3 weeks and onwards) after amputation surgery so that prosthetic gait 
retraining can commence. The interim prosthesis is generally used by the patient for 
the first 6 months of walking while the residual limb maturates and oedema stabilises 
(Meier & Melton, 2014). Oedema management following amputation surgery 
minimises healthcare costs by reducing the number of prosthetic sockets required 
during the interim prosthetic stage (Meier & Melton, 2014). A definitive prosthesis is 
usually prescribed at approximately 6 to 8 months once residual limb oedema has 
stabilised and the patient has learned to walk with a prosthesis (Meier & Melton, 
2014). Meier Iii and Heckman (2014) also called for health professionals to evaluate 
the rehabilitation outcomes of people with lower limb amputation. In the UK model 
of care, Sansam et al. (2014) reported that prosthetic gait retraining was performed as 
an outpatient service with patients trialling an early walking aid (i.e. an inflatable 
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device such as the Pneumatic Post Amputation Mobility Aid (PPAM Aid)) during 
physiotherapy sessions until a definitive prosthesis was prescribed.  
 
Improved locomotor and mortality outcomes in people with lower limb amputation 
have been associated with amputee models of care that include an inpatient 
admission to a specialised multidisciplinary rehabilitation unit (Czerniecki et al., 
2012a; Stineman et al., 2008). In a prospective cohort study by Czerniecki et al. 
(2012a) of 199 participants with dysvascular lower limb amputation (due to diabetes 
or peripheral arterial disease), successful mobility at 12 months was 17% more likely 
in participants who underwent rehabilitation as inpatients in a comprehensive 
multidisciplinary rehabilitation unit. Successful mobility was defined as the same or 
improved locomotor capabilities index 5 (LCI5) score for participants in this study 
(Czerniecki et al., 2012a). Stineman et al. (2008) reported improved rates of 1 year 
survival and discharge home in people with amputation who underwent rehabilitation 
during the acute post-operative stage in a comprehensive multidisciplinary inpatient 
rehabilitation unit.  
 
In developing nations people with amputation may travel from remote regions to 
receive prosthetic rehabilitation at healthcare facilities (ICRC, 2015; Rau, Bonvin, & 
de Bie, 2007). In contrast to developed nations, prosthetic gait retraining is 
performed over short time frames of 3 to 7 days in developing nations such as 
Myanmar to address social needs of the patients (Rau et al., 2007). A polypropylene 
prosthesis has been designed to ensure prostheses are useable in the environmental 
conditions of developing nations and cost effective (ICRC, 2015). In parallel to their 
physical rehabilitation program, the ICRC have implemented a social inclusion and 
participation program to facilitate social and economic reintegration of people with 
disabilities into their community (ICRC, 2015).  
 
In the Western Australian public health context at Royal Perth Hospital (RPH), the 
state amputee rehabilitation centre, patients received specialised amputee 
rehabilitation from a comprehensive multidisciplinary team during both the inpatient 
and outpatient stages of their rehabilitation (see figure 2.1) (Department of Health, 
2008; Roffman et al., 2016b). In WA amputee services have been centralised in the 
capital city of Perth (Department of Health, 2008; WALSA, 2016).  
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In the patient centric amputee rehabilitation model of care at RPH, amputation 
surgery was day 0 and physiotherapy commenced day 1 in the post-operative stage. 
During the inpatient admission (pre-prosthetic stage of rehabilitation) patients 
achieved independent mobility without a prosthesis and participated in twice daily 
physiotherapy sessions (Department of Health, 2008; Roffman et al., 2016b). There 
were no breaks in physiotherapy intervention between the pre-prosthetic and 
prosthetic rehabilitation stages (i.e. after inpatient discharge, patients received 
outpatient physiotherapy for exercise training and oedema management 2 to 3 times 
per week while waiting for their residual limb wound to heal). This was to ensure 
that patients did not decondition while waiting to commence prosthetic rehabilitation. 
 
In the RPH model of care, 3 weeks after amputation surgery and 6 months after 
commencing prosthetic gait retraining were the earliest timeframes for prescription 
of interim and definitive prostheses respectively. These timeframes for interim and 
definitive prostheses were similar to those described by Meier and Melton (2014). In 
WA all prosthetic components used to manufacture prostheses were approved by the 
Therapeutic Goods Administration (TGA) (WALSA, 2016). Interim prostheses were 
manufactured using lower cost, basic prosthetic components except for complex 
cases where non-standard prosthetic components were clinically indicated (WALSA, 
2016). The interim and definitive prostheses provided to RPH patients in this thesis 
have been outlined below.  
 
Prosthetic feet can be non-articulated (e.g. solid ankle cushion heel (SACH) foot), 
articulated (e.g. single or multiaxial), dynamic response (store and return energy, e.g. 
Vari-Flex), range of motion (height adjustable foot), hydraulic or microprocessor 
(e.g. Ossur proprio foot) (Carroll, Rheinstein, & Pollard, 2013). All interim 
prostheses at RPH had WillowWood Ohio SACH feet with titanium pyramids. The 
SACH foot is the most basic type of prosthetic foot that simulates normal gait 
through compression of a heel cushion and flexibility of the toe (Carroll et al., 2013).  
 
For patients with transtibial amputation, a supracondylar suspended patella tendon 
bearing prosthesis (PTS) with a pelite liner was the most common interim prosthetic 
suspension system, socket and liner manufactured at RPH. For patients with 
transfemoral amputation, quadrilateral and ischial containment sockets were 
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manufactured depending on the individual’s clinical needs. A total elastic suspension 
(TES) belt was the main type of suspension used for people with transfemoral 
amputation. For complex transtibial and transfemoral amputation cases (e.g. split 
skin graft, short residual limb or invaginated scar tissue) total surface bearing 
prostheses with pin lock silicone liners were used for sockets and suspension. These 
prosthetic socket, liner and suspension systems have been well documented for 
clinical management of patients with lower limb amputation in the literature (Knapp, 
2013; Psonak, 2013).  
 
Prosthetic knee components may be mechanical (e.g. single axis, polycentric, weight 
activated stance control, manual locking, hydraulic, pneumatic) or microprocessor 
(e.g. C-leg, Rheo knee) with a computer processor (sensor) that enables stance 
control and modifies the swing phase of gait as walking speed changes (Psonak, 
2013). Mechanical knee components were used in interim knee disarticulation and 
transfemoral prostheses at RPH. Polycentric knee components with 4 bar linkage 
systems were the main type of mechanical knees used in the manufacture of interim 
prostheses. Polycentric knee components have been reported in the literature as 
having increased stability during the stance phase of gait which is helpful in patients 
with short residual limbs and hip extensor muscle weakness (Psonak, 2013). Due to 
the linkage system of 4 bars (or more) the design of the polycentric knee is closer to 
the anatomical knee than single axis prosthetic knee components (Psonak, 2013). The 
following mechanical knee brands and product codes were used for the manufacture 
of interim prostheses at RPH:  
• Regal, 2-01-4S3S 4 bar mechanical knee joint (AK)  
• Regal, 2-01-S700 polycentric K2 knee joint with stance flexion (AK/KD)  
• Regal, 2-01-S500 polycentric 4 bar knee joint (AK/KD)  
• Regal, 2-01-S400 polycentric 4 bar knee joint (AK/KD) for patients with 
higher body weight and knee disarticulation  
• Regal, 2-01-A41 polycentric 4 bar linkage knee joint (AK)  
• Ottobock, 3R60 hydraulic controlled polycentric knee joint  
• Ottobock, 3R80 modular knee joint with rotatory hydraulic  
• ST&G, 1321 polycentric 4 bar   
• ST&G, 1322 polycentric pneumatic 4 bar knee. 
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Similar to the literature (Knapp, 2013; Psonak, 2013; Ries & Vaughan, 2013), 
prosthetic fit was managed using stump socks, packing of the prosthetic liner and 
socket modification at RPH. Law Comfort Stump Socks were used for managing 
prosthetic fit in patients with transtibial amputation. The cotton stump sock product 
codes of the most frequently used Law Comfort stump socks include:  
• 28M16 
• 26M16 
• 27M16. 
 
Nylon stocking was used for the pull through stockings in the PTS transtibial 
prostheses. Tubifast stockinette (yellow line) and Heller woollen stump socks were 
used for patients with tranfemoral amputation. Dermaseal silicone socks and Iceross 
silicone liners were used with patients that had fragile skin and split skin grafts. 
Silicone socks and liners protect bony prominences and reduce shear forces on the 
residual limb to minimise skin breakdown (Knapp, 2013). If the socket became too 
large a new socket was cast, manufactured and fitted by the RPH prosthetist. A 
cosmetic cover was generally not fitted to the interim prosthesis because it was 
frequently adjusted by the RPH prosthetists during physiotherapy sessions for 
prosthetic gait retraining. 
 
Prosthetic gait retraining was performed as an outpatient rehabilitation service 2 to 3 
times per week for approximately 6 to 12 months and patients were discharged when 
their rehabilitation goals had been achieved (Department of Health, 2008; Roffman 
et al., 2016b). Telehealth videoconference (Department of Health, 2008; Roffman et 
al., 2016b) was used for follow-up of patients that lived in rural and remote locations 
of WA. The principles of this WA amputee rehabilitation model of care with the use 
of telemedicine1 were similar to those described in the literature (Broomhead et al., 
2012; Geertzen et al., 2015a; Geertzen et al., 2015b; Meier Iii & Heckman, 2014; 
Meier & Melton, 2014; Sansam et al., 2014; US Department of Veterans Affairs, 
2008). However, the WA model of care differed from other Australian states where 
prosthetic gait retraining was performed as an inpatient rehabilitation service (Batten, 
                                                             
1 This was the endorsed WA amputee rehabilitation model of care during the period 
research this thesis was conducted and prior to implementation of activity based 
funding in 2014. 
24 
 
Kuys, McPhail, Varghese, & Nitz, 2015; Hordacre et al., 2013a; Hordacre, 
Stevermuer, Simmonds, Crotty, & Eagar, 2013b; Wu, Chan, & Bowring, 2010).  
 
In WA, the definitive prosthesis was prescribed by the rehabilitation medicine 
physician once the patient’s residual limb volume had stabilised and the person with 
lower limb amputation could walk. In the definitive prosthesis stage, patients were 
funded for prosthetic sockets, suspension systems, knee and foot components with 
more advanced technology (e.g. vacuum suction or pin lock suspension, multi axial 
or dynamic response feet, pneumatic or hydraulic knees) and greater cost. The 
patient selected a private prosthetic service provider from Fremantle Orthotic 
Services (FOS), The Limb Clinic (TLC), South West Orthotic and Prosthetic 
Services (SWOPS) and Orthotic and Prosthetic Solutions (OPS) (private prosthetic 
companies in WA during this research) to manufacture their definitive prosthesis 
once it was prescribed (WALSA, 2016).  
The new definitive prosthetic components funded by WALSA (2016) were based on 
clinical assessment of the patient’s Medicare Functional Classification Level 
(MFCL) K-level (mobility level). Levels of funding by WALSA (2016) for 
prosthetic components (per foot and knee unit) in the definitive stage were as 
follows: 
• K1 (mobility level 1) – home walker, funded for a standard SACH foot, 
standard knee or safety knee 
• K2 (mobility level 2) – restricted outdoors walker, funded for a prosthetic 
foot up to a maximum of $850 (AUD) and a standard knee 
• K3 (mobility level 3) – unrestricted outdoors walker, funded for a prosthetic 
foot up to a maximum of $850 (AUD) and a prosthetic knee up to a 
maximum of $2900 (AUD) 
• K4 (mobility level 4) – unrestricted outdoors walker with very high demands, 
funded for a prosthetic foot up to a maximum of $1300 (AUD) and a 
prosthetic knee up to a maximum of $3200 (AUD). 
 
WALSA (2016) did not fund microprocessor knees, recreational or waterproof 
prostheses (e.g. swimming or shower prostheses). These prostheses or components 
were accessible in the definitive phase by patients who were compensable or self 
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funding. Patients were able to self fund the gap between their maximum level of 
WALSA funding and a higher rated prosthetic component (WALSA, 2016). In WA, 
the definitive prosthesis was replaced approximately every 3 years (WALSA, 2016). 
The WALSA funding model described was stable during the research in this thesis. 
 
In the literature, clinical research has examined the impact of the prosthetic 
components and design on functional outcome and quality of life (Ali et al., 2014; 
Esquenazi, 2004; Fatone & Caldwell, 2017; Gailey et al., 2010; Laferrier & Gailey, 
2010; Samuelsson, Toytari, Salminen, & Brandt, 2012). In people with transfemoral 
amputation the use microprocessor knees have been associated with improved 
function, reduced falls and healthcare costs (Hafner & Smith, 2009; Mundell, 
Maradit Kremers, Visscher, Hoppe, & Kaufman, 2017). However, abandonment of 
prosthetic technology such as microprocessor knees for wheelchairs as a primary 
mobility device has also been identified (Karmarkar et al., 2009; Schaffalitzky et al., 
2012). The reality of working in the public health context is that budgets are limited 
and resources need to be allocated to optimise the prosthetic outcome for the case 
mix efficiently. Cost effectiveness is therefore a major consideration for the use of 
prosthetic technologies in amputee rehabilitation models of care.  
  
The literature has demonstrated that amputee rehabilitation models of care vary 
widely throughout the world and have largely evolved through the political, funding 
and sociodemographic contexts of the countries where they were implemented as 
well as the patient’s own rehabilitation goals and expectations (Broomhead et al., 
2012; Department of Health, 2008; Department of Veterans Affairs, 2008; Hordacre 
et al., 2013b; ICRC, 2015; Rau et al., 2007). Although locomotor outcomes and 
survival rates for subgroups with lower limb amputation have been associated with 
specialised amputee rehabilitation from comprehensive multidisciplinary teams and 
inpatient settings (Czerniecki et al., 2012a; Stineman et al., 2008) there are no clear 
guidelines on the most effective method of service delivery (e.g. inpatient, outpatient, 
domiciliary, outreach) or the intervention intensity and duration required to achieve 
successful outcomes. A proposed advantage of the long term follow-up phase in the 
RPH 5 stage amputee rehabilitation model of care (see figure 2.1) is, if a patient 
develops any issues related to their amputation there is linkage with the specialist 
amputee rehabilitation multidisciplinary team so the issues that may lead to 
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prosthetic non-use could be addressed. However, there is limited literature on the 
impact of amputee rehabilitation models of care on locomotor outcomes and cost 
effectiveness. Yamato et al. (2016) identified that inadequate reporting of 
interventions in clinical research were a major challenge to using the research for 
clinical decision making or replicating studies. This statement holds true for the 
reporting of amputee models of care with the majority being grey literature 
developed by expert multidisciplinary rehabilitation teams. By reporting the RPH 
amputee model of care and rehabilitation interventions (see section 2.8 and appendix 
2.1), this thesis contributes to the evidence base for future clinical research and 
model of care development at other healthcare facilities around the world.  
 2.6. Costs associated with amputation 
In a systematic review Highsmith et al. (2016a) demonstrated that there has been 
limited literature on the economic impact of major lower limb amputation and the 
cost effectiveness of prosthetic interventions. Blough et al. (2010) estimated that the 
projected lifetime prosthetic costs for a veteran with unilateral lower limb amputation 
potentially range from $466 227 to $1 841 585 (USD). In this study, the costs of 
prostheses were lower for the veterans from Vietnam in contrast to those from 
Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF) due to the 
use of technologically less advanced prosthetic limbs and higher rates of prosthetic 
abandonment (Blough et al., 2010). Similar to the USA, the estimated 40 year costs 
were high for the 265 UK Afghanistan war veterans who sustained 461 amputations 
from 2003 to 2014 at £288 million GBP ($444 million USD) (Edwards, Phillip, 
Bosanquet, Bull, & Clasper, 2015). Dillingham, Pezzin, and Shore (2005) reported 
that in 1996, the 1 year acute and post-acute healthcare costs of people with 
atraumatic amputation exceeded $4.3 billion (USD). In 2009 the cumulative national 
hospital costs related to amputation were greater than $8.3 billion (USD) and $655 
million (USD) were reimbursed for lower limb prosthetic services by Medicare in the 
USA (Highsmith et al., 2016a; Ma et al., 2014).  
 
Highsmith et al. (2016a) performed a systematic review of the literature evaluating 
the cost of interventions for people with transtibial amputation. From the 6 articles 
analysed, the 3 topics related to rehabilitation of people with transtibial amputation 
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identified were: models of care, prosthetic treatment and prosthetic sockets 
(Highsmith et al., 2016a). Five empirical evidence statements were generated from 
the articles analysed by the reviewers (Highsmith et al., 2016a). The evidence 
statement reported with moderate confidence was that patella tendon bearing and 
total surface bearing sockets were functionally and economically equivalent in the 
short term, however longer term outcomes had not been investigated (Highsmith et 
al., 2016a). Highsmith et al. (2016a)  concluded that further research and economic 
analyses on interventions for people with transtibial amputation were required.  
 
Microprocessor knees have been reported as improving the safety and efficiency of 
prosthetic gait compared to conventional prosthetic knee components in people with 
transfemoral amputation (Highsmith et al., 2016b). Highsmith et al. (2016b) 
performed a randomised AB crossover study of 20 people with transfemoral 
amputation using the C-leg and Genium microprocessor knees to determine 
functional and economic benefits. The Genium was demonstrated to have 
significantly reduced (p < .05) four square step test (FSST) time, increased functional 
level (as measure by the Amputee Mobility Predictor (AMP)) and step activity 
compared to the C-leg (Highsmith et al., 2016b). The Genium knee was reported by 
participants as their preferred microprocessor knee during the study (Highsmith et 
al., 2016b). Highsmith et al. (2016b) concluded that due to improved function with 
activities of daily living the Genium knee component may be worth funding despite 
costing more at the time of purchase (approximately $30 000 to $55 000 USD) than 
the C-leg. However, a microprocessor knee component does not ensure long term 
functional use of a prosthesis in people with high levels of amputation. Karmarkar et 
al. (2009) investigated prosthesis and wheelchair use in 42 war veterans and 
demonstrated that a non-significant (p = .65) but higher number of participants who 
had a prosthesis with a microprocessor knee used a wheelchair as their primary 
mobility aid.    
 
There is the potential for cost savings if a person with transfemoral amputation has 
osseointegration as the prosthetic sockets required in conventional prostheses that are 
manufactured approximately every 3 years no longer having to be produced 
(Haggstrom et al., 2013). Haggstrom et al. (2013) compared the costs of 
conventional and osseointegrated transfemoral prostheses over a 10 year time frame 
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for 50 participants in a retrospective single centre study. The total costs of 
osseointegration and conventional prostheses were not significantly different in terms 
of new prostheses, services, repairs and adjustments however the people with 
osseointegrated prostheses had significantly fewer visits to the prosthetics workshop 
per year (Haggstrom et al., 2013). Haggstrom et al. (2013)  concluded that the cost 
outcomes were most likely due to technologically more advanced prosthetic 
components being used with people who had osseointegration.  
 
The defence service budgets for USA and UK war veterans do not represent the 
budgets of public health services rehabilitating civilians with lower limb amputation 
in Australia or aide organisations working in developing nations (Department of 
Health, 2008; ICRC, 2015; Sansam et al., 2014; WALSA, 2016). In WA 
microprocessor knees are not publicly funded by WALSA and only available to 
compensable  or self funding patients with transfemoral amputation (WALSA, 
2016). In the majority of countries resource limitations exist so optimising the 
allocation of healthcare resources (e.g. prosthetic components) to patients is an 
important issue (Erjavec et al., 2014; Sansam et al., 2014; Schaffalitzky et al., 2012).  
 
There is a paucity of literature on the economic costs of amputee rehabilitation in 
Australia (Davis et al., 2006; Gordon, Magee, Frazer, Evans, & McCosker, 2010). 
Gordon et al. (2010) compared the labour costs, functional outcomes and satisfaction 
of patients with unilateral transtibial amputation who underwent rehabilitation in the 
public (n = 34) and private (n = 26) model of care in New South Wales (NSW). 
Gordon et al. (2010) concluded that the public model of care was more cost effective 
with labour costs per patient being 29% lower at $1391.11 (AUD) than the private 
model at $1917.19 (AUD). The methodology used by Gordon et al. (2010) for 
calculating labour costs was challenged as underestimating the costs for the publicly 
funded prosthetist by Kohler (2010), Dillon (2010) and North (2010) on behalf of the 
Australian Orthotists and Prosthetists Association (AOPA). Functional and 
satisfaction outcomes were similar for both models of care (Gordon et al., 2010) as 
Dillon (2010) identified an error in the published SAT-PRO calculation.   
 
Davis et al. (2006) reported that the costs for the acute inpatient surgical admission 
of people who underwent major and minor lower limb amputation during the 
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Fremantle Diabetes Study in WA were median, $12 485 AUD (interquartile range 
(IQR), $6037 to $24 415 AUD) from 1993 to 2000 using a case mix approach. The 
length of stay was median, 24 (IQR, 10 to 14) days and a total of 44 patients without 
lower limb amputation at recruitment had their first ever diabetes related lower limb 
amputation during the period of study (Davis et al., 2006). Foot ulceration, ankle 
brachial index (ABI) of < 0.90, glycated haemoglobin (HbA1c) increase > 1%) and 
neuropathy were demonstrated by Davis et al. (2006)  as being independent 
predictors of lower limb amputation. Davis et al. (2006) did not report on 
rehabilitation outcomes or costs.  
 
The Western Australian Limb Service for Amputees (WALSA) reported that the total 
number of interim prosthetic limbs provided was 153 in 2005 to 2006 and 125 in 
2006 to 2007 (Department of Health, 2008). RPH provided 69 interim prostheses in 
2005 to 2006 and 55 in 2006 to 2007 (Department of Health, 2008). G. Caldwell 
(personal communication, November 23, 2016) estimates that the approximate cost 
of interim prostheses manufactured by the RPH onsite prosthetists were as follows:  
1. Transtibial prostheses with a supracondylar suspended patella tendon bearing 
socket (PTS) start at $2500 (AUD) for a homopolymer socket to $3400 
(AUD) with a laminated socket and heavy duty componentry. Total surface 
bearing prostheses (TSB) with a silicone liner and pin lock cost $4300. 
2. Transfemoral prostheses start at $4500 and increase to $6000 for a silicone 
liner with a pin lock and a custom silicone insert.     
 
WALSA pay $138.80 per hour for manufacture of prostheses by the private 
prosthetic service providers with the hours of manufacture paid for outlined in the 
WALSA manual (G. Caldwell, personal communication, November 23, 2016; 
WALSA, 2016). The hours that are reimbursed for labour are determined by the level 
of amputation and complexity of the prosthesis being manufactured (WALSA, 
2016). The cost of definitive prostheses manufactured by private prosthetic service 
providers is higher than interim prostheses due to the use of more expensive 
componentry determined by the person with amputation’s K-level classification 
(mobility class) and for billing per occasion of service (WALSA, 2016). The 
maximum funding from WALSA for a K-level 4 person with lower limb amputation 
is up $1300 (AUD) for a prosthetic foot and up to $3200 (AUD) a prosthetic knee 
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(WALSA, 2016). Costs may vary in both the interim and definitive phases of 
prosthetic manufacture depending on the level of amputation and complexity of the 
patient (G. Caldwell, personal communication, November 23, 2016; WALSA, 2016). 
 2.7. Prosthetic prescription 
In a multicentre observational study of 151 people with major lower limb 
amputation, Van der Linde, Geertzen, Hofstad, Van Limbeek, and Postema (2003) 
identified that clinical expertise was the main factor used for prosthetic prescription 
in the Netherlands. It was concluded that clinical practice guidelines for prosthetic 
prescription were needed in the Netherlands as there was no statistical consensus at 
study centres between prosthetic component prescription criteria and factors that may 
affect outcome such as activity level, amputation level, age or time since amputation 
(Van der Linde et al., 2003).  
 
Sansam et al. (2014) identified the following 4 key themes of clinical decision 
making for prosthetic prescription through interviewing 23 health professionals from 
the UK experienced in amputee rehabilitation: estimating outcome, difficulties 
predicting outcome, patient choice and barriers to prescribing. Only 1 of the 4 
rehabilitation centres involved in this study used formal prosthetic prescription 
guidelines. Similar to Van der Linde et al. (2003), a need for national prescription 
guidelines was identified by Sansam et al. (2014) to improve prescription 
consistency and equity of access to healthcare resources.  
 
The literature (Broomhead et al., 2012; Geertzen et al., 2015a; Kahle et al., 2016a; 
Meier & Melton, 2014; Sansam et al., 2014) recommends assessment by a 
multidisciplinary team to determine if the patient is a prosthetic candidate. Several 
factors have been associated with exclusion of patients from prosthetic prescription 
in the literature (Geertzen et al., 2015a; Geertzen et al., 2015b; Kahle et al., 2016a; 
Kurichi et al., 2007; Meier & Melton, 2014; Mundell, Kremers, Visscher, Hoppe, & 
Kaufman, 2016; Resnik & Borgia, 2015; Sansam et al., 2014; Schaffalitzky et al., 
2012; Van Velzen et al., 2006): comorbidities (e.g. congestive heart failure, renal 
failure, cerebrovascular accident), medications (e.g. warfarinisation), cognitive 
impairment, older age, high-level amputation, multiple limb amputation, remaining 
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limb pathology, increased body weight, mental health issues, poor motivation, lack 
of social support, poor premorbid mobility, history of falls, presence of residual limb 
contractures, impaired muscle strength, poor balance and inadequate cardiovascular 
fitness. In the Dutch evidence based guidelines for rehabilitation and prosthetics of 
people with lower limb amputation,Geertzen et al. (2015a) reported that adequate 
wound healing and management of residual limb oedema were important factors 
prior to prosthetic fitting. Mundell et al. (2016) demonstrated in a retrospective 
cohort study of 93 patients with transfemoral amputation that those who walked 
independently prior to amputation were 30 times more likely to be prescribed a 
prosthesis.  
 
Kahle et al. (2016a) noted that while several factors contribute to the clinical 
decision of prosthetic candidacy the guidelines reported in the literature remain 
unclear. This may potentially lead to a mismatch of patient to intervention and 
increase healthcare costs. Kahle et al. (2016a) advised that a full patient history and 
physical examination by the multidisciplinary team were warranted to determine 
prosthetic candidacy. Furthermore, it was recommended that the factors predictive of 
prosthetic candidacy including aetiology, physical fitness, living status prior to 
amputation, amputation level, age, comorbidities, cognition and mood disturbance 
should be documented in the patient’s medical record (Kahle et al., 2016a). The 
research in this thesis moves onto the next step: assessing the outcomes of people 
with lower limb amputation who were selected for prosthetic rehabilitation by the 
RPH multidisciplinary team based on factors associated with prosthetic outcome in 
the literature. 
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2.8. Physiotherapy intervention 
The physiotherapy intervention following lower limb amputation that has been 
documented in the literature (Broomhead et al., 2012; Broomhead et al., 2006; 
Gailey, 2004; Geertzen et al., 2015a; Geertzen et al., 2015b; Lusardi, 2013; Meier & 
Melton, 2014; Rau et al., 2007; Ries & Vaughan, 2013; US Department of Veterans 
Affairs, 2008; Yamato et al., 2016) is intensive, multimodal and individualised based 
on patient assessment findings and goals. Physiotherapy interventions contribute to 
the complexity of predicting rehabilitation outcomes following lower limb 
amputation (Meier & Melton, 2014; Wong et al., 2016a; Yamato et al., 2016). 
However, the majority of published evidence on physiotherapy inventions for people 
with lower limb amputation is based on expert opinion or low quality studies and 
clinical practice varies between rehabilitation centres (Broomhead et al., 2012; 
Broomhead et al., 2006; Gailey, 2004; Geertzen et al., 2015a; Geertzen et al., 2015b; 
Lusardi, 2013; Meier & Melton, 2014; Rau et al., 2007; Ries & Vaughan, 2013; US 
Department of Veterans Affairs, 2008; Wong et al., 2016a). The physiotherapy 
assessments and interventions were performed and progressed by a physiotherapist 
trained in amputee rehabilitation for studies in this thesis as advised in the literature 
(Broomhead et al., 2012; Broomhead et al., 2006; Gailey, 2004; Lusardi, 2013; 
Meier & Melton, 2014; Ries & Vaughan, 2013). The core components of 
physiotherapy intervention after amputation surgery include: mobility retraining 
without a prosthesis, oedema management, desensitisation of the residual limb, 
therapeutic exercise, pain management, scar tissue and wound management, 
prosthetic gait retraining, prescription of mobility aids or assistive devices and 
education (Butler & Moseley, 2013; Deutsch, English, Vermeer, Murray, & 
Condous, 2005; Gailey, 2004; Gailey, Gailey, & Angulo, 1989, 1994a, 1994b; 
Gailey, Gailey, Sendelbach, & Angulo, 1995; Geertzen et al., 2015a; Geertzen et al., 
2015b; Lusardi, 2013; MacLachlan, McDonald, & Waloch, 2004; Meier & Melton, 
2014; Moseley, 2012; Mulvey et al., 2013; Rau et al., 2007; Ries & Vaughan, 2013; 
Stokes et al., 2008; Stokes et al., 2009; US Department of Veterans Affairs, 2008). 
These physiotherapy interventions and some important interventions by other 
multidisciplinary team members have been summarised in appendix 2.1. 
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2.9. Outcome Studies and predictors of locomotor function following lower limb amputation 
Amputee rehabilitation is an intensive, protracted and costly process however long 
term functional outcomes are poorly understood and quantified by health services 
(Department of Health, 2008; Meier Iii & Heckman, 2014). It was identified by the 
working party for the Western Australian Amputee Rehabilitation Model of Care in 
2008, that rehabilitation outcomes and the rate of functional prosthetic use were 
unknown (Department of Health, 2008). In this thesis a successful prosthetic user 
was defined as a person who functionally uses their prosthetic limb for locomotor 
activities on all or some days of the week. A full-time prosthetic user was a person 
who uses their prosthesis on all 7 week days. A part-time prosthetic user was a 
person who uses their prosthesis on less than 7 week days. A prosthetic non-user was 
a person who did not functionally use their prosthesis for locomotor activities on any 
week days. People who reported wearing their prosthesis for cosmesis only were 
classified as prosthetic non-users.   
   
It has been identified that pre-operative factors such as comorbidities, age, condition 
of remaining limb, mobility status prior to amputation, skin integrity, ethnicity, 
socioeconomic status, cognition and social support influence ability to walk using a 
prosthesis (Meier & Melton, 2014; Sansam et al., 2009; Taylor et al., 2005).  Post-
operative factors such as level and number of limbs amputated, quality of residual 
limb, contractures, wound healing, post-operative complications, residual limb 
oedema, pain, energy cost and falls have been associated with walking ability using a 
prosthetic limb (Adams, 2005; Bhangu et al., 2009; Lim et al., 2006; Meier & 
Melton, 2014; Nehler et al., 2003; Sansam et al., 2009; Schoppen et al., 2003; Waters 
et al., 1976; Wezenberg, van der Woude, Faber, de Haan, & Houdijk, 2013). 
Improved functional outcome and reduced mortality have also been reported for high 
intensity, comprehensive multidisciplinary rehabilitation in specialised amputee units 
(Czerniecki et al., 2012a; Kurichi et al., 2009; Stineman et al., 2010). 
 
The majority of studies in lower limb amputation cohorts have demonstrated 
univariate association with limited high quality multivariate regression studies to 
guide clinical decision making (Sansam et al., 2009). Studies have reported on sub-
groups with poor rehabilitation capacity (e.g. bed bound prior to amputation), 
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focused on surgical outcome or factors associated with not fitting or prescribing a 
prosthetic limb as opposed to abandonment of prosthetic use after participating in 
rehabilitation (Fletcher et al., 2001; Fletcher et al., 2002; Resnik & Borgia, 2015). In 
the USA not fitting a prosthesis was associated with high amputation level, advanced 
age, cognitive impairment, comorbidities (e.g. renal failure, cardiovascular, 
cerebrovascular and neurological diseases) and geographical location (Fletcher et al., 
2001; Fletcher et al., 2002; Resnik & Borgia, 2015). Other studies have been limited 
to specific sub-groups (e.g. atraumatic amputation cause, unilateral transfemoral 
amputation) or recruited samples of convenience so the results were not generalisable 
to heterogeneous lower limb amputation cohorts managed by amputee rehabilitation 
services (Raya et al., 2010; Schoppen et al., 2003). Studies have reported high 
variation in functional prosthetic use following rehabilitation with rates ranging from 
36% to 95% (Fletcher et al., 2001; Jones et al., 1993; Lim et al., 2006; Pohjolainen & 
Alaranta, 1998; Schaffalitzky et al., 2012; Wu et al., 2010).  
 
A systematic review by Sansam et al. (2009) of 57 studies revealed that successful 
locomotor outcome after lower limb amputation was associated with factors 
including cognition, fitness, unilateral and distal levels of amputation, younger age, 
independence with single limb stance, activities of daily living and walking pre-
operatively. Poor outcome was associated with delay to rehabilitation and 
complications with the residual limb (Sansam et al., 2009). Comparison of studies 
was difficult due to the different methodologies, definitions for successful locomotor 
function and outcome measures used by researchers (Sansam et al., 2009). Sansam et 
al. (2009) called for further research to better define predictors of locomotor outcome 
following lower limb amputation.    
 
Cochrane reviews of prosthetic rehabilitation in older people (aged > 60 years) with 
atraumatic causes of unilateral transfemoral amputation demonstrated that there was 
limited quality evidence to guide clinical decision making in this sub-group 
(Cumming, Barr, & Howe, 2006; Cumming, Barr, & Howe, 2015). Cumming et al. 
(2006) and Cumming et al. (2015) included one short term randomised cross over 
clinical trial that tested the preference of different transfemoral prosthesis weights on 
10 participants when walking in their 2006 and 2015 Cochrane reviews. Both 
reviews concluded there was an urgent need for research on outcomes of older 
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people following atraumatic amputation (Cumming et al., 2006; Cumming et al., 
2015).  
 
In a consecutive audit of 553 subjects with lower limb amputation the factors 
identified as predictive of not wearing a prosthesis were: being non-ambulant or a 
home bound ambulator before amputation surgery, transfemoral level of amputation, 
age of 60 years or greater, having dementia, end stage renal failure and coronary 
artery disease (Taylor et al., 2005). These predictor variables were similar to factors 
reported for not fitting a prosthesis (Fletcher et al., 2001; Fletcher et al., 2002; 
Resnik & Borgia, 2015). However, the focus of the study by Taylor et al. (2005) was 
to improve surgical decision making through comparison of outcomes for limb 
revascularisation and amputation surgery therefore limited rehabilitation variables 
and participants with poor rehabilitation potential were included (Taylor et al., 2005).  
 
Schoppen et al. (2003) reported that at 2 weeks after amputation single limb balance 
of less than 10 seconds in combination with age, cognitive impairment and severe 
comorbidity were predictive of not using a prosthesis in a prospective cohort of 46 
subjects with unilateral lower limb amputation. In the 37 geriatric participants who 
were followed up at 12 months, only 49% (n = 18) had achieved functional prosthetic 
use as measured by an 8 point classification scale which ranged from non-
ambulatory requiring a wheelchair through to independent without mobility aids 
(Schoppen et al., 2003). This study highlighted that condition of the remaining lower 
limb was important for achieving functional mobility using a prosthesis following 
amputation (Schoppen et al., 2003). 
 
Australian studies of lower amputation cohorts have been descriptive with small 
numbers of participants, reported on institution specific variables (e.g. length of 
stay), and focused on sub-groups or surgical outcomes (Jones et al., 1993; Lim et al., 
2006; Wu et al., 2010). In a consecutive cohort of 65 people with lower limb 
amputation from the Royal South Sydney Hospital in 1988 to 1989, 82% (n = 52) 
had survived at 1 year after discharge (Jones et al., 1993). From the interview it was 
determined that a total of 93% of participants were community dwelling, 94% were 
successful prosthetic users and 25% had returned to driving (Jones et al., 1993). Only 
6 participants from the working age group had returned to work (Jones et al., 1993).   
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Wu et al. (2010) et al reported on a retrospective cohort of 208 people with lower 
limb amputation from 1994 to 2006 who underwent rehabilitation at the Prince of 
Wales Hospital. During this time frame only 135 (71%) of patients were assessed by 
the Rehabilitation Medicine Physician as suitable to participate in rehabilitation (Wu 
et al., 2010). In this study 24% of people used a wheelchair only for mobility and 
76% used a prosthesis for locomotor activities (Wu et al., 2010). Of the people who 
used a prosthesis, 44% were community ambulators, 20% used their prosthesis for 
household ambulation and 12% for transfers or exercise only (Wu et al., 2010).  
 
Lim et al. (2006) performed a retrospective audit of 87 people with lower limb 
amputation from 2000 to 2002 at Royal Perth Hospital to describe factors affecting 
contemporary surgical outcomes. High numbers of participants had atraumatic 
amputation with 75.9% of people having an amputation due to critical ischaemia and 
17.2% from diabetic foot infection (Lim et al., 2006). A total of 47 patients 
underwent rehabilitation and 39 of these people participated in prosthetic gait 
retraining (Lim et al., 2006). The short term outcome within 3 months of discharge 
was that 79.5% of people used a prosthesis for locomotor activities (Lim et al., 
2006).  
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2.10. Clinical prediction rules (CPRs)  
Clinical prediction rules (CPRs) are statistically derived tools that assist health 
professionals with clinical decision making (Childs & Cleland, 2006; Cleland et al., 
2007; Laupacis et al., 1997). CPR research methodology involves a 3 stage process 
of: derivation, validation and after a period of CPR implementation, impact analysis 
is performed (Childs & Cleland, 2006; Cleland et al., 2007; Laupacis et al., 1997). 
CPRs provide levels of evidence that enable health professionals to directly modify a 
model of care, improve patient outcomes or stratify patients to interventions based on 
a parsimonious set of predictor variables (Childs & Cleland, 2006; Cleland et al., 
2007; Laupacis et al., 1997). The most effective CPRs have been developed for 
heterogeneous conditions, with multiple treatment options and complex decision 
making (Fritz, 2009). The 4 levels of evidence for CPRs identified by Childs and 
Cleland (2006) and how they can be translated into clinical practice by health 
professionals have been described in figure 2.2. 
 
Review of the literature demonstrated there were no clinical prediction rules to 
identify patients at increased risk of abandoning prosthetic use after discharge from 
rehabilitation however there were many potential predictor variables that influenced 
functional outcome of people with lower limb amputation that made selection of 
patients for prosthetic gait retraining challenging (Gailey et al., 2002; Schoppen et 
al., 2003; Taylor et al., 2005). The rehabilitation model of care for amputation is 
varied and incorporates a lot in differential long term investments in time and 
personnel. Therefore, if developed and validated CPRs could be used to assist in 
optimising the investment by the health system as well as the informed decision 
making in a patient centric model of rehabilitation (given the high mortality rate). 
 
The first CPRs developed and validated for prosthetic non-use after rehabilitation 
discharge were published by Roffman, Buchanan, and Allison (2014). A second CPR 
was later developed by Wong, Young, Ow-Wing, and Karimi (2016b) to assist with 
determining ability of people with lower limb amputation to ambulate in the 
community.  
 
  
38 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Levels of evidence for clinical prediction rules (CPR).  
Adapted from Childs and Cleland (2006).  
Level I – CPR has been prospectively 
validated in a different population & 
1 impact analysis with change in 
clinician behaviour & beneficial 
consequences 
CPR Evidence Levels 
Level II – CPR has been validated in 
1 large prospective study, including 
a large variety of patients & 
clinicians, or at multiple centres of 
similar settings that differ in 
geographical location & clinicians’ 
levels of experience 
Use of CPR 
CPR can be used in a wide variety 
of settings with confidence that it 
change clinician behaviour & 
improve outcomes 
Level III – CPR validated in only 1 
narrow prospective sample 
Level IV – CPR derived but not 
validated, or validated only in split 
samples or large retrospective 
databases or by statistical 
techniques 
CPR can be used in various 
settings with confidence 
CPR can be used only with 
caution & only if patients in the 
study are similar to those in the 
clinician’s setting 
Further 
evaluation is 
required 
before the 
CPR can be 
applied 
clinically 
No CPRs exist on 
prosthetic non-
use following 
lower limb 
amputation. 
Studies have 
retrospectively 
derived 
associated 
variables but not 
validated.  
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2.11. Measurement of locomotor function following lower limb amputation 
Measurement of outcome following lower amputation is complex as recovery 
encompasses physical and psychosocial domains. The international classification of 
functioning, disability and health (ICF) provides a framework and common language 
to allow comparison of outcomes for health conditions such as lower limb 
amputation (Gaunaurd, 2012; Sansam et al., 2009; World Health Organization, 
2001). The ICF model involves the interaction of 5 domains which include: body 
structure and function, activity, participation, personal and environmental factors 
(see Figure 2.3) (Gaunaurd, 2012; Sansam et al., 2009; World Health Organization, 
2001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: Interactions of International classification of functioning, 
disability and health (ICF) categories.  
Figure from the World Health Organization (2001). 
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Amputation level and physical fitness are examples of body structure and function 
(Gaunaurd, 2012; Sansam et al., 2009; World Health Organization, 2001). 
Impairments of body structure and function may include reduced muscle strength or 
poor aerobic capacity (Gaunaurd, 2012; Sansam et al., 2009; World Health 
Organization, 2001). The ability to perform a specific task is an activity (e.g. donning 
or walking with a prosthesis) (Gaunaurd, 2012; Sansam et al., 2009; World Health 
Organization, 2001). Participation is involvement of the person in life situations such 
as work, sport or social gatherings (Gaunaurd, 2012; Sansam et al., 2009; World 
Health Organization, 2001). Examples of personal and environmental factors that 
may affect outcome include age, comorbidities, resource limitations in developing 
countries and social stigma surrounding the health condition (Gaunaurd, 2012; 
Sansam et al., 2009; World Health Organization, 2001).  
 
If CPRs for prosthetic non-use were developed and validated they would represent 
the multidimensional relationship of the 5 ICF domains in the social and political 
context of the country they were developed. The Medicare functional classification 
level (MFCL), Amputee Mobility Predictor (AMP), Functional Independence 
Measure (FIM), Locomotor Capabilities Index 5 (LCI5), 10 metre walk test 
(10MWT), timed up and go test (TUGT), 6 minute walk test (6MWT) and four 
square step test (FSST) are some examples of outcome measures that may be used by 
health professionals to identify activity and participation limitations in people with 
lower limb amputation during the 5 phases of amputee rehabilitation (Condie et al., 
2006; Dite et al., 2007; Franchignoni et al., 2004; Gailey et al., 2002; Heinemann et 
al., 2014; Schoppen et al., 2003; Stevens, 2010). The relationship of these outcome 
measures to locomotor function in lower limb amputation cohorts is now discussed. 
 2.11.1. Medicare functional classification level (MFCL)  
The Medicare functional classification level (MFCL) K-level system is used by 
amputee rehabilitation services to subjectively classify patients and allocate 
prosthetic components based on their potential or actual level of locomotor function 
(Borrenpohl et al., 2016; Gailey et al., 2002; Knapp, 2013; Meier & Melton, 2014; 
Ries & Vaughan, 2013; US Department of Veterans Affairs, 2008). Patients are 
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classified on a 5 point scale from K0 to K4 (see Table 2.2 for full definitions) 
(Borrenpohl et al., 2016; Gailey et al., 2002; Meier & Melton, 2014; US Department 
of Veterans Affairs, 2008). People with K0 classification are not prosthetic 
candidates and those with K4 classification are eligible for prosthetic components 
that enable high level function depending on the budget of the funding organisation 
or health service (Borrenpohl et al., 2016; Gailey et al., 2002; Meier & Melton, 2014; 
US Department of Veterans Affairs, 2008). Due to the subjectivity of the MFCL, 
health professionals and researchers have called for the use of objective outcome 
measures to supplement K-level classification in patients (Borrenpohl et al., 2016; 
Gaunaurd et al., 2015; Heinemann et al., 2016). However, clinicians have been slow 
to use objective outcome measures for people with lower limb amputation 
(Borrenpohl et al., 2016; Gaunaurd et al., 2015; Heinemann et al., 2016).  
 
Table 2.2: Medicare Functional Classification Level (MFCL) K-level system 
defined for prosthetic potential in people with lower limb amputation  
(Borrenpohl et al., 2016; Gailey et al., 2002; Knapp, 2013; Ries & Vaughan, 2013; 
US Department of Veterans Affairs, 2008). 
MFCL K-level Definition 
 
K0 The patient does not have the ability or potential to ambulate or transfer 
safely with or without assistance and a prosthesis does not enhance quality 
of life or mobility. 
K1 The patient has the ability or potential to use a prosthesis for transfers or 
ambulation on level surfaces at fixed cadence. Typical of the limited and 
unlimited household ambulatory. 
K2 The patient has the ability or potential for ambulation with the ability to 
traverse low-level environmental barriers such as curbs, stairs, or uneven 
surfaces. Typical of a limited community ambulator. 
K3 The patient has the ability or potential for ambulation with variable cadence. 
Typical of the community ambulator who has the ability to traverse most 
environmental barriers and may have vocational, therapeutic, or exercise 
activity that demands prosthetic utilization beyond simple locomotion. 
K4 The patient has the ability or potential for prosthetic ambulation that exceeds 
basic ambulation skills, exhibiting high impact, stress, or energy levels. 
Typical of the prosthetic demands of the child, active adult, or athlete. 
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2.11.2. Amputee Mobility Predictor (AMP) 
Gailey et al. (2002) developed the Amputee Mobility Predictor (AMP) in a 
convenience sample of 191 people with lower limb amputation to provide an 
objective measure of walking potential. The AMP can be performed without a 
prosthesis (AMPnoPro) and with a prosthesis (AMPPro). The AMP consists of 
activities including sitting balance, sit to stand, standing balance and locomotor 
activities using a prosthesis. The AMP has been demonstrated as a valid outcome 
measure with high inter-rater and intra-rater reliability with and without prosthesis 
for people with lower limb amputation (Gailey et al., 2002). The AMP was able to 
discriminate between 4 K-levels of the MFCL (as K-level 0 and 1 were combined 
into a single group) and was highly correlated with 6 minute walk test (6MWT) 
performance (Gailey et al., 2002).  
 2.11.3. Functional Independence Measure (FIM) 
The Functional Independence Measure (FIM) was developed for neurological 
populations and is the most common outcome measure performed by rehabilitation 
services following lower limb amputation (Condie et al., 2006; Hordacre et al., 
2013b). The FIM is assessed on admission and discharge from inpatient 
rehabilitation and scored using a 7 point ordinal scale that ranges from total 
dependence to complete independence (Condie et al., 2006; Hordacre et al., 2013b). 
The FIM consists of 18 items on motor and cognition subscales (Condie et al., 2006; 
Hordacre et al., 2013b). The 13 items in the motor subscale include: eating; 
grooming; bathing; dressing the upper body; dressing the lower body; toileting; 
bladder management; bowel management; transfers to the bed, chair and wheelchair; 
transfers to the toilet; bath and shower transfers; walking and wheelchair use; and 
stairs (Condie et al., 2006; Hordacre et al., 2013b). The 5 items in the cognition 
subscale include: comprehension; expression; social interaction; problem solving; 
and memory (Condie et al., 2006; Hordacre et al., 2013b).  
 
Condie et al. (2006) reported that the FIM was problematic as an outcome measure 
for people with lower limb amputation due to observed ceiling effect and lack of 
responsiveness. People with lower limb amputation can never score full points on the 
FIM for locomotion as the prosthesis is classified as an assistive device. Leung, 
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Rush, and Devlin (1996) have shown in 41 people with lower limb amputation that 
FIM score at admission was not predictive of future prosthetic use however the 
motor sub-scale score at discharge was predictive of prosthetic use. These issues with 
the FIM highlight the need for development and validation of clinical prediction 
rules that identify people at risk of future prosthetic non-use. 
 
In many countries funding of amputee rehabilitation services is based on change in 
FIM scores (Hordacre et al., 2013b). Hordacre et al. (2013b) reported change in FIM 
scores after inpatient rehabilitation in Australia between 2004 to 2010 of people with 
unilateral or bilateral major lower limb amputations. This study only reported 
separately on rehabilitation outcomes of New South Wales, Victoria, Queensland and 
South Australia (Hordacre et al., 2013b). The FIM scores of other Australian states 
and territories including WA were combined which assumes uniformity in the 
amputee rehabilitation models of care for these locations (Hordacre et al., 2013b). 
However in WA prosthetic gait retraining was performed as an outpatient service so 
the FIM scores submitted were for pre-prosthetic rehabilitation and do not reflect 
locomotor outcomes of people who underwent prosthetic rehabilitation. The study by 
Hordacre et al. (2013b)  lacks validity as the FIM was measuring and comparing 
different phases of amputee rehabilitation between Australian rehabilitation facilities. 
This study highlights the importance of further research into locomotor outcomes of 
people with lower limb amputation after discharge from outpatient rehabilitation.   
  2.11.4. Locomotor Capabilities Index 5 (LCI5)  
The Locomotor Capabilities Index (LCI) and the Locomotor Capabilities Index 5 
(LCI5) are validated amputee specific questionnaires, that assess basic (e.g. walk 
indoors) and advanced (e.g. walking while carrying an object) locomotor activities 
using a prosthesis and have been translated into many languages (Franchignoni et al., 
2007; Franchignoni et al., 2004; Salavati et al., 2011). Appendix 7.1B details the full 
LCI5 questionnaire (Franchignoni et al., 2007; Franchignoni et al., 2004). The 4 
point ordinal scale of the LCI was revised to a 5 point ordinal scale of the LCI5 to 
address the ceiling effect observed in younger people with traumatic causes of 
amputation (Franchignoni et al., 2007; Franchignoni et al., 2004). The basic, 
advanced and total test scores of the LCI5 provide clinicians with self reported 
44 
 
ability to perform locomotor activities and ambulate in the community using a 
prosthetic limb (Condie et al., 2006; Franchignoni et al., 2007; Franchignoni et al., 
2004). The LCI5 has been used to measure locomotor function across the amputee 
rehabilitation continuum (i.e. pre-operative to the long term follow-up phase) 
(Czerniecki, Turner, Williams, Hakimi, & Norvell, 2012b). The LCI5 may have 
utility as an outcome measure in the long term follow-up phase of amputee 
rehabilitation as its questionnaire format enables health professionals to efficiently 
assess if locomotor function has been sustained after rehabilitation discharge. 
Therefore, further investigation of the LCI5 is warranted.   
  2.12. Energy cost and walking ability with a prosthesis 
Laboratory studies of people with lower limb amputation treadmill walking have 
demonstrated that the energy cost of walking with a prosthesis is greater than 
walking in able bodied controls (Waters et al., 1976; Wezenberg et al., 2013). Waters 
et al. (1976) demonstrated that the energy cost of prosthetic gait increases as 
amputation level becomes higher. Wezenberg et al. (2013) investigated the relative 
aerobic load (VO2rel), walking speed and economy of people with vascular 
amputation (n = 10), traumatic amputation (n = 26) and able bodied controls (n = 
21). People with vascular and traumatic amputation walked at a slower preferred 
walking speed, had a higher VO2rel and had lower walking economy than able bodied 
people (Wezenberg et al., 2013). People with vascular amputation walked with a 
VO2rel that was 45.2% higher (p = .001) than those with traumatic amputation 
(Wezenberg et al., 2013). Wezenberg et al. (2013) estimated that a 10% increase in 
peak aerobic capacity of people with lower limb amputation, could reduce VO2rel and 
improve walking ability in terms of speed and economy. This study confirms the 
importance of pre-prosthetic rehabilitation of appropriate intensity. However, 
treadmill walking was identified as a study limitation because it was less efficient 
than walking overground (Wezenberg et al., 2013). It also did not consider the 
potential role that balance impairment may have played in the preferred walking 
speed of people with lower limb amputation. This study (Wezenberg et al., 2013) 
highlights the need for further research into field based locomotor tests (e.g. 
10MWT, TUGT, 6MWT and FSST) to improve understanding of the functional 
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domains of walking speed, distance and balance that contribute to walking ability in 
people with lower limb amputation.  
 2.13. Locomotor tests 
Locomotor tests including the 10 metre walk test (10MWT), timed up and go test 
(TUGT), 6 minute walk test (6MWT) and four square step test (FSST) have been 
used by clinicians to goal set and monitor a person’s progress with prosthetic gait 
retraining (Dite et al., 2007; Franchignoni et al., 2004; Gailey et al., 2002; 
Heinemann et al., 2014; Meier & Melton, 2014; Raya et al., 2010; Resnik & Borgia, 
2011; Schoppen et al., 2003; Stevens, 2010). Increased time to complete balance 
tasks, reduced walking speed and distance on locomotor tests following lower limb 
amputation have been associated increased risk of recurrent falls and poorer 
performance on outcome measures such as the LCI5 and AMP (Dite et al., 2007; 
Franchignoni et al., 2004; Gailey et al., 2002; Heinemann et al., 2014; Raya et al., 
2010; Resnik & Borgia, 2011; Schoppen et al., 2003; Stevens, 2010). There is 
limited locomotor performance data for lower limb amputation cohorts, studies have 
been on samples of convenience or sub-groups (e.g. military service personnel, 
unilateral transtibial amputation) and it remains unclear if performance on locomotor 
tests during rehabilitation can be used to identify people at future risk of abandoning 
prosthetic use (Dite et al., 2007; Gailey et al., 2002; Heinemann et al., 2014; Linberg 
et al., 2013; Resnik & Borgia, 2011; Stevens, 2010). The 10MWT, TUGT, 6MWT 
and FSST have been summarised below (Chapter 6 eAppendix details the procedures 
and psychometric properties of these locomotor tests in lower limb amputation 
cohorts).  
 2.13.1. 10 metre walk test (10MWT) 
The 10MWT is a timed walking test and walking speed can be derived from this test 
(Condie et al., 2006). Ability to walk the distance of 10 metres has been reported as 
the definition of successful prosthetic gait retraining by some rehabilitation services 
(Hordacre et al., 2013a). The 10MWT can be performed early in rehabilitation of 
people with lower limb amputation when the patient first starts to walk outside the 
parallel bars. The ability to modulate walking speed has been associated with balance 
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and the energy cost of walking with a prosthesis (Gailey et al., 2002; Wezenberg et 
al., 2013). The validity of 10MWT has been established in lower limb amputation 
cohorts however reliability has not been reported (Franchignoni et al., 2004).  
 2.13.2. Timed up and go test (TUGT) 
The TUGT is a measure of dynamic balance and functional ability as the person 
being assessed needs to perform the locomotor tasks of sit to stand, walking and 
turning around (Condie et al., 2006; Dite et al., 2007; Resnik & Borgia, 2011; 
Schoppen et al., 2003). The TUGT can be performed early in rehabilitation of people 
with lower limb amputation and reflects locomotor tasks that are performed by 
indoors ambulators (Condie et al., 2006; Dite et al., 2007; Resnik & Borgia, 2011; 
Schoppen et al., 2003). Increased risk of multiple falls has been reported in people 
with unilateral transtibial amputation who have TUGT of >19s (Dite et al., 2007). 
The TUGT has been demonstrated as reliable and valid for geriatric cohorts with 
lower limb amputation however ceiling effect has been demonstrated in the 
locomotor performance of people with lower limb amputation who were younger and 
fitter (Deathe & Miller, 2005; Resnik & Borgia, 2011; Schoppen et al., 2003).  
 2.13.3. 6 minute walk test (6MWT) 
The 6MWT in people with lower limb amputation reflects capacity to ambulate in 
the community (Gailey et al., 2002). The 6MWT is performed later in rehabilitation 
once a patient develops cardiovascular endurance (Brooks, Parsons, Hunter, Devlin, 
& Walker, 2001; Gailey et al., 2002). Some health professionals advocate use of the 
2 minute walk test (2MWT) as the shorter time frame allows people with atraumatic 
amputation to complete the test earlier in rehabilitation (Brooks et al., 2001). The use 
of a rectangular walking track is recommended for cohorts with lower limb 
amputation to optimise walking distance by minimising the impact of pivot turning 
(that is performed in the corridor 6MWT) on balance and cadence (Linberg et al., 
2013). Reliability and validity of the 6MWT has been established in cohorts with 
lower limb amputation (Gailey et al., 2002).  
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2.13.4. Four square step test (FSST) 
The FSST involves dynamic balance, the ability to negotiate obstacles and change 
directions (Dite et al., 2007). It uses dual tasking and represents high level balance 
skills for people with lower limb amputation (Dite et al., 2007). A FSST performance 
of >24s identified people with unilateral transtibial amputation who became multiple 
fallers (Dite et al., 2007). The relationship of FSST performance and future walking 
ability using a prosthesis has not been investigated for people with higher or multiple 
levels of lower limb amputation.  
 2.14. Conclusion  
This review of the literature has demonstrated that functional outcome following 
lower limb amputation is multifactorial and complex but there has been limited 
research on outcomes (Sansam et al., 2009). There have been no clinical prediction 
rule studies to determine the most important variables for discontinuing prosthetic 
use after rehabilitation discharge in people with lower limb amputation (Sansam et 
al., 2009). Amputee rehabilitation models of care and intervention guidelines are 
based mainly on low quality studies and expert opinion (Broomhead et al., 2012; 
Department of Health, 2008; Geertzen et al., 2015a; Geertzen et al., 2015b; Meier & 
Melton, 2014). Comorbidities influence mortality and functional outcomes following 
lower limb amputation however there is no consensus on how to measure burden of 
disease (Fortington et al., 2013). In WA, long term rehabilitation outcomes after 
lower limb amputation for prosthetic use, return to driving and work were unknown 
(Department of Health, 2008). Aboriginal people have high rates of amputation 
however their rehabilitation outcomes have not been reported (Department of Health, 
2010; Department of Health, 2008). There are few studies to assist with 
interpretation of locomotor tests (e.g. 10MWT, TUGT, 6MWT and FSST) for lower 
limb amputation cohorts during rehabilitation (Heinemann et al., 2014; Resnik & 
Borgia, 2011; Stevens, 2010). These issues make it difficult to determine the 
effectiveness of the intensive, multimodal physiotherapy intervention and other 
rehabilitation interventions (Gailey, 2004; Lusardi, 2013; Ries & Vaughan, 2013). 
This thesis will focus on the development and validation of CPRs for prosthetic non-
use following discharge from rehabilitation, mapping and measurement of 
comorbidities (including musculoskeletal pathology and mental health issues), 
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establishing utility of locomotor tests for identifying people at risk of future 
prosthetic non-use, and measurement of long term self reported outcomes in people 
with lower limb amputation. Lower limb amputation results in high global costs to 
health care systems and reduction in quality of life therefore further research is 
warranted to determine rehabilitation outcomes following amputation and develop 
targeted models of care. 
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Chapter 3 
 3. Common methods and how to read this thesis 
This thesis started in the rehabilitation gym where almost all people who have a 
lower limb amputation spend time. Similar to any public health system the optimal 
service should be one that is patient centric and have clinical utility. Although many 
studies had examined optimal care pathways to improve prosthetic technology or the 
rehabilitation strategy to optimise outcome – after speaking to clients it was apparent 
that many abandoned using their prosthesis and yet the rehabilitation goal was to 
ensure that they used the prosthesis. Therefore, the decision was to study questions 
that were clinically focused about the use of prostheses and outcomes for clients. In 
this sense it was to make a significant and original contribution to the knowledge in 
the area of amputee rehabilitation from a clinical perspective.  
 
From review of the literature it was determined that there was limited research on 
outcomes following lower limb amputation therefore a series of translational 
research projects were developed for this thesis to contribute to the knowledge base 
for models of care and clinical practice. The projects examine measurement of 
functional outcome from pre-operative through to the long term follow-up phase of 
amputee rehabilitation. 
 
Ethics approval was obtained from Royal Perth Hospital (RPH) and Curtin 
University Ethics committees. The Ethics approval numbers were EC 2009 / 090 for 
RPH and HR138/2009 for Curtin University. Full details in Appendix 3.1. 
 
The sample size estimates for the studies in this thesis were based on an 
understanding of the availability of data and the number of potential patients that 
could be recruited from the RPH Amputee Rehabilitation Service during the 3 years 
preceding commencement of this research in 2009. The sample size of 200 in the 
retrospective cohort reflects approximately 2 years of data. It was twice as large as 
the next published prognostic paper in this area (Schoppen et al., 2003). However, 
this was not over sampling since this number was appropriate for the number of 
potential factors that were independently associated with poor outcomes (Childs & 
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Cleland, 2006; Cohen, 1992). Furthermore, if we extended the data to a larger 
number of participants a greater proportion of patients would have died and therefore 
the data for the primary outcome of prosthetic non-use would be missing. The date of 
death for deceased participants was examined and deceased sub-group sensitivity 
analyses were performed for the clinical prediction rule development and validation 
studies. In a regression model with power at 80% and the assumption that the 
regressors were moderately related then a sample size of 100 (50% missing data) is 
able to detect a very weak association Rho (R2 in the regression model) less than 0.3 
(Cohen, 1992). With 40 participants in stage 2 (clinical prediction rule validation) 
and power at 80% we were 95% confident of detecting a rho of 0.45 (Cohen, 1992). 
A predictive model of less than 45% explained variance was unlikely to be of clinical 
value.   
 
The following figures (Figures 3.1 to 3.4) are provided to assist the readers with the 
flow of data and specific derived variables from different cohort studies that in some 
cases resulted in specific publications.  
 
Chapters 4 and 5 report on the development and validation of clinical prediction rules 
for prosthetic non-use. This research was published in the Journal of Physiotherapy 
and the manuscript is presented in Appendix 4.1. These were the first clinical 
prediction rule development and validation studies to be published for prosthetic 
non-use (Roffman et al., 2014).  
 
Chapter 6 is a manuscript that was published in Physical Therapy Journal on 
locomotor performance and prosthetic non-use following lower limb amputation 
(Roffman et al., 2016b). This is the first study to generate performance thresholds 
using receiver operator characteristic curves for common locomotor tests (i.e. 10 
metre walk test, timed up and go test, 6 minute walk test, four square step test) that 
health professionals may use during rehabilitation of people with lower limb 
amputation. Relative risk of prosthetic non-use at 12 months after discharge from 
rehabilitation was determined so that health professionals may use locomotor 
performance during rehabilitation to modify their intervention or allocation of 
resources based on presence of the performance threshold.  
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Chapter 7, Part A examines the construct validity of locomotor tests in a cohort with 
lower limb amputation. This study was developed due to the lack of performance 
data for locomotor tests in cohorts with lower limb amputation. Chapter 7, Part B 
examines long term self reported function following lower limb amputation. This 
research investigates the construct validity of the Locomotor Capabilities Index 5 
(LCI5) (Franchignoni et al., 2004) as a measure for the long term follow-up phase in 
the amputee rehabilitation model of care.  
 
Chapter 8 investigates comorbidity in a cohort with lower limb amputation at 
hospital admission. There is no gold standard for measuring comorbidity in cohorts 
with lower limb amputation. Therefore this study investigates common methods of 
measuring comorbidity. A manuscript that was published in Journal of Physiotherapy 
on the psychometric properties of the Charlson Comorbidity Index (Roffman et al., 
2016a) is presented in Appendix 8.1. 
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Figure 3.1: Methods and how to read Chapters 4 and 5 have been summarised in this figure.  
The development and validation of clinical prediction rules for prosthetic non-use was published in Journal of 
Physiotherapy (see appendix 4.1). 
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p < .05 
Journal of 
Physiotherapy 
Publication 
See appendix 
4.1 
Deceased 
sub-group 
sensitivity 
analysis 
 n = 8 
Chapter 5 
CPR  
Validation 
Medical record 
abstraction for 
CPR & descriptive 
variables 
Participant  
Interviews 
n = 66 
Chi squared analysis to 
determine likelihood of 
becoming a prosthetic 
non-user for the 
presence of variables 
p < .05 
Balanced 
accuracy 
Deceased 
sub-group 
sensitivity 
analysis 
 n = 29 
53 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2: Methods and how to read Chapter 6.  
The Locomotor Tests manuscript was published in Physical Therapy (see Chapter 6). 
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Figure 3.3: Methods and how to read the Chapters 7A and 7B of this thesis. 
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remaining limb complications.  
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Figure 3.4: Methods and how to read Chapter 8.  
The Charlson Comorbidity Index manuscript was published in the Journal of Physiotherapy (see appendix 8.1). 
 
Chapter 8 
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of a cohort 
with 
amputation 
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admission 
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Interviews 
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Mortality Risk & Disease Severity assessed using the 
Charlson Comorbidity Index (CCI) & Combined Age – 
Charlson Comorbidity Index (CA-CCI) 
Journal of 
Physiotherapy 
Publication on 
psychometric 
properties of 
the Charlson 
Comorbidity 
Index. See 
appendix 8.1 
Comorbidities 
were given a 
numerical code 
& number of 
comorbidities 
were counted 
for each 
participant then  
entered into 
database  
Functional Disease Burden was 
assessed using the Functional 
Comorbidity Index (FCI) 
• Linear transformation of number of 
comorbidities into CCI, CA-CCI & FCI scores. 
• Known Groups analysis of comorbidity in: 
Prosthetic non-users 
Above transtibial amputation level 
Atraumatic amputation cause 
Diabetes 
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Older age 
Major bilateral lower limb amputation 
Predictive validity of 
number of 
comorbidities was 
determined with 
ROC, > 19 
comorbidities was 
predictive of 
prosthetic non-use 
at 4 months after 
rehabilitation 
discharge. 
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Chapter 4 
 
 
 4. Predictors of prosthetic non-use in individuals with lower limb amputation after discharge from rehabilitation– the development of clinical prediction rules. 
 
 
 
 
 Synopsis 
This thesis chapter details development of clinical prediction rules for prosthetic non-
use. It forms 1 part of the manuscript in appendix 4.1 that was published in the Journal 
of physiotherapy: 
 
Roffman, Caroline E., Buchanan, John, & Allison, Garry T. (2014). Predictors of non-
use of prostheses by people with lower limb amputation after discharge from 
rehabilitation: development and validation of clinical prediction rules. Journal of 
Physiotherapy, 60(4), 224-231. doi: 10.1016/j.jphys.2014.09.003 
 
This chapter was presented at the following conferences: 
14th World Congress of the International Society for Prosthetics and Orthotics (ISPO), 
4th to 7th February 2013, Hyderabad, India. 
 
Momentum 2017 Physiotherapy Conference, Australian Physiotherapy Association, 19th 
to 21st October 2017, Sydney, Australia. 
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Predictors of prosthetic non-use in individuals with lower limb amputation after discharge from rehabilitation– the development of clinical prediction rules. 
 Abstract 
Research Question: Can clinical prediction rules (CPRs) be developed to identify 
increased risk of prosthetic non-use in individuals with lower limb amputation at 4, 6, 8 
and 12 months after discharge from rehabilitation?  
Design: Retrospective cohort study 
Participants: 135 consecutive tertiary rehabilitation patients (n = 103 males, age mean 
= 56.1 (SD = 15.1) years).  
Methods: Medical records were audited for potential predictor variables and 
participants interviewed at median = 1.9 (IQR = 1.4 to 2.5) years after discharge.  
Results: At 4, 8 and 12 months after discharge prosthetic non-use was 11% (15), 15% 
(20) and 19% (25) and CPRs were identified. The significant predictors and associated 
accuracy statistics (95% CI) for having a combination of predictor variables were:  
4 months: Amputation level above transibial, very high number of comorbidities, not 
having type 2 diabetes, using a mobility aid and dependence walking outdoors on 
concrete. If 4 out of 5 predictor variables were present, (LR+ = 32.0, CI = 3.61 to 748) 
probability of non-use increased to 80% (p < .0001).  
8 months: Amputation level above transibial, using a mobility aid and dependence 
walking outdoors on concrete. If 2 out of 3 variables were present, (LR+ = 3.5, CI = 2.31 
to 3.98) probability of non-use increased to 38% (p < .0001). 
12 months: Amputation level above transibial, using a mobility aid and delay to 
prosthesis. If all 3 predictor variables were present (LR+ = 26.4, CI = 3.4 to 580) 
probability of non-use increased to 86% (p < .0001). 
Conclusions: These CPRs have implications for rehabilitation and service model 
development. Validation is warranted.   
Key words: Clinical prediction rule, lower extremity, amputation, leg prosthesis, 
rehabilitation outcome 
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4.1. Introduction 
Multidisciplinary rehabilitation following lower limb amputation plays an important role 
in restoring function for activities of daily living, work and recreation (Roffman et al., 
2014). Amputee rehabilitation service models and clinical practice guidelines for 
prosthetic prescription vary widely throughout the world and have been developed 
largely from expert consensus (Broomhead et al., 2003; Roffman et al., 2014; van der 
Linde, Hofstad, Van Limbeek, Postema, & Geertzen, 2005). In Western Australia, 
patients achieve independent transfers and wheelchair mobility during inpatient 
rehabilitation while prosthetic gait retraining is performed as an outpatient service 
(Department of Health, 2008; Roffman et al., 2014).  
  
Limited research exists on long term prosthetic outcomes following discharge from 
rehabilitation. In particular, there is a lack of quality evidence to inform clinical 
decisions that may impact on the continued use of prostheses following lower limb 
amputation (Adams, 2005; Campbell & Ridler, 1996; Cumming et al., 2006; Jones et al., 
1993; Lim et al., 2006; Sansam et al., 2009). In a review of the contemporary literature, 
Sansam et al. (2009) called for further investigation of predictive factors to more 
accurately estimate walking potential as the studies they reviewed reported different 
predictors due to heterogeneous methodology, outcome measures and definitions of 
prosthetic rehabilitation success. 
 
Some studies have quantified prosthetic rehabilitation success relative to success of the 
surgical outcome, reported on cohorts with limited rehabilitation potential or duration 
the prosthesis worn as opposed functional use (Basu, Fassiadis, & McIrvine, 2008; Jones 
et al., 1993; Lim et al., 2006; Taylor et al., 2005). Taylor et al. (2005) reported that from 
553 consecutive vascular surgery patients with major lower limb amputation the factors 
related to not wearing a prosthesis included: being pre-morbidly non-ambulant or a 
homebound walker, aged >60 years, having a transfemoral amputation, dementia, renal 
failure and heart disease. Lim et al. (2006) focused on surgical outcomes and short term 
prosthetic use for 39 patients at 3 months after discharge following major lower limb 
amputation in Western Australia.  
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Long term functional prosthetic use following discharge from rehabilitation is important 
in understanding the quality of life of people with lower limb amputation but is poorly 
defined in the literature. People with atraumatic amputation experience a decline in 
health status and high 5 year mortality, up to 77% after discharge (Davies & Datta, 
2003; Fortington et al., 2013; Jones et al., 2013; Lim et al., 2006). However, while the 
physical activity associated with prosthetic gait may assist with management of risk 
factors for chronic disease, as many as 51% of people stop using their prosthesis within 
12 months of discharge (Davies & Datta, 2003; Pohjolainen, Alaranta, & Kärkäinen, 
1990; Schaffalitzky et al., 2012). In order to optimise the utilisation of healthcare 
resources a method to accurately identify people at high risk of prosthetic non-use is 
required so that patients can be stratified to targeted models of care.   
 
In individuals with limited rehabilitation capacity due to severe comorbidities, high level 
or multiple limb amputations, frailty and advanced age fulfilling goals of prosthetic gait 
retraining is not without risk of adverse health complications such as residual limb 
(stump) wounds, falls, fractures and myocardial infarction which may require 
hospitalisation, impair quality of life and mood. When considered in the context of 
increased morbidity and mortality, this patient journey to prosthetic non-use is extremely 
costly to the individual as well as the health care system.   
 
Univariate analyses have considered single factors associated with prosthetic non-use 
however the relationship between the multiple factors associated with prosthetic non-use 
in the literature has not been determined.  Pre-operative factors such as comorbidities, 
age, pre-morbid mobility, medications, skin integrity, ethnicity, socioeconomic status, 
cognition and social support have been reported as influencing prosthetic outcome 
(Adams, 2005; Kulkarni, Pande, & Morris, 2006; O'Neill & Evans, 2009; Pohjolainen et 
al., 1990; Sansam et al., 2009; Schoppen et al., 2003; Taylor et al., 2005). The 
association between prosthetic walking ability and psychological factors, self efficacy 
and motivation is supported by weak evidence (Sansam et al., 2009). Post-operative 
factors such as level and number of limbs amputated, post-operative complications, 
wound healing, oedema, contractures, pain, delay to prosthesis, falls, energy cost of gait 
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and rehabilitation model of care have been shown to affect outcome (Adams, 2005; 
Bhangu et al., 2009; Czerniecki et al., 2012a; Dillingham, Pezzin, MacKenzie, & 
Burgess, 2001; Goktepe, Cakir, Yilmaz, & Yazicioglu, 2010; Lim et al., 2006; Penn-
Barwell, 2011; Sansam et al., 2009; Schoppen et al., 2003; Waters et al., 1976). 
Functional factors have also been identified as predictive of walking potential (Condie, 
McFadyen, Treweek, & Whitehead, 2011; Gailey et al., 2002; Raya et al., 2010; 
Schoppen et al., 2003). 
 
Prosthetic outcome is therefore multifactorial and complex. To date, no studies have 
examined the factors that in combination are able to identify individuals at risk of non-
use following discharge from rehabilitation. A methodological approach of developing 
Clinical Prediction Rules (CPRs) has been used in similar prognostic studies (e.g. ankle 
fractures, neck pain) (Childs & Cleland, 2006; Cleland et al., 2007) and is yet to be 
established in the area of lower limb amputation.  
 
CPRs are tools that assist health professionals to make evidence based decisions and 
assign patients to interventions using a parsimonious subset of predictor variables 
(Childs & Cleland, 2006; Cleland et al., 2007; Cleland et al., 2010; Laupacis et al., 
1997). If CPRs could be generated to accurately identify individuals at risk of early 
prosthetic non-use then rehabilitation teams could intervene with targeted models of care 
and prosthetic innovations to optimise functional outcome. Therefore the research 
question for this study was: Can clinical prediction rules (CPRs) be developed to 
identify increased risk of prosthetic non-use in individuals with lower limb amputation 
at 4, 6, 8 and 12 months after discharge from rehabilitation?  
 4.2. Methods Participants 
This study was approved by the Royal Perth Hospital (RPH) and Curtin University 
Ethics Committees (see Appendix 3.1). Inclusion criteria were as follows: participants 
had at least one recent major lower limb amputation (i.e. transtibial level or above), were 
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community dwelling and ambulant prior to amputation, were Medicare Functional 
Classification Level K-level 1 to 4 (from Gailey et al. (2002)), had participated in and 
been discharged from prosthetic rehabilitation at RPH, the state centre for amputee 
rehabilitation. Individuals with multiple limb amputation were included as this was 
important for CPR validity.  
 
Participants were excluded if they were not prosthetic candidates (K-level 0), unable to 
communicate or did not consent. K-level 0 participants were assessed by the 
Rehabilitation Medicine Physician and Senior Physiotherapist. Participants were K-level 
0 due to comorbidities, high or multiple limb amputation, poor premorbid mobility and 
falls history. These participants were followed up through multidisciplinary amputee 
outpatient clinic and remained K-level 0.  
 
K-level 0 to 4 participants underwent inpatient rehabilitation to achieve independent 
transfers, wheelchair mobility and discharge home. Appendix 4.2 defines the 
standardised outpatient prosthetic rehabilitation service received by K-level 1 to 4 
participants (full intervention details in Appendix 2.1).  
 
From the Amputee Physiotherapy Service database 208 consecutive patients with lower 
limb amputation were identified between June 2006 and June 2009. Audit showed: 176 
(85%) were prosthetic users (K-level 1 to 4) at discharge from outpatient physiotherapy 
and 32 (15%) participants were K-level 0 (non-prosthetic rehabilitation). On review of 
audit data during the study period, 15 (47%) K-level 0 participants were deceased. Of 
the 176 (85%) who received full prosthetic targeted rehabilitation (K-level 1 to 4), 29 
(16%) were deceased.  
 
Of the remaining 147 patients, 4 participants were excluded as 1 did not have a major 
lower limb amputation and 3 participants were still receiving rehabilitation. A total of 
143 patients were eligible for the study and 138 (98%) were contacted. Five participants 
were unable to be contacted as they had moved interstate or overseas and 3 participants 
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did not consent to be interviewed. The final response rate was 94% (n = 135) with 
participants interviewed at median = 1.9 years (IQR = 1.4 to 2.5) post-discharge.  
 
The interview process involved coordinating telephone interviews with Country 
Physiotherapists, Aboriginal Health Workers, Nurses and the use of Telehealth. Table 
4.1 outlines the geographical distribution of participants as measured by Accessibility 
Remoteness Index of Australia (ARIA) (Trewin, 2005).  
 Procedure 
A retrospective cohort study design was used. Medical records were audited for potential 
predictor variables and this was undertaken blind to the telephone interviews. Figure 4.1 
outlines the predictor variable domains investigated. Charlson Comorbidity Index (CCI) 
and Combined Age CCI (CA-CCI) scores were calculated from participant medical 
comorbidities data (Charlson et al., 1987; Hall, Ramachandran, Narayan, Jani, & 
Vijayakumar, 2004; Roffman et al., 2014). 
 
Interviews were conducted using a survey previously developed and piloted by the 
Senior Physiotherapist Amputee Rehabilitation. The interviews were performed by: 
telephone (n = 123), Telehealth videoconference (n = 2) and in person (n = 10). Twelve 
interviews were performed with carer assistance due to language interpretation, hearing 
or intellectual impairment. 
 
The operational definition of a successful prosthetic user was use of the prosthesis for 
locomotor activities (e.g. transfers, standing, walking) on one or more week days. 
Prosthetic non-users did not functionally use their prosthesis on any week days or wore 
it for cosmesis only. Non-users were asked the reasons they stopped using their 
prosthesis and to recall how many months after physiotherapy discharge they stopped 
using their prosthesis. Important calendar events (e.g. last amputee outpatient clinic, 
birthday, Christmas) were used as verbal prompts to assist with recall accuracy. 
Participants were interviewed on their prosthetic use from 4 months onwards after 
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discharge and were re-interviewed at 2 monthly intervals until data were collected for 12 
months.  
 Statistical Analyses 
The primary outcome variable for prediction was the dichotomous variable of being 
prosthetic users or non-users at 4, 6, 8 and 12 months after discharge. Descriptive 
statistics were generated for all variables in each cohort.  
 
The univariate relationship between categorical variables and prosthetic users and non-
users were analysed using the chi-square test. For each of the continuous variables, 
Receiver Operator Characteristic curves were used to determine the threshold at which 
specificity and sensitivity were equal to generate dichotomous classification for the 
univariate analyses. Univariate contingency tables were used to identify a smaller subset 
of variables related to prosthetic non-use that had a significance level of 10% (Chi 
squared p < .1). This conservative significance level was selected to avoid missing 
critical predictor variables. Sensitivity, specificity, positive and negative likelihood 
ratios were calculated for the predictor variables.  
 
A backwards stepwise logistic regression model was used to reduce these predictor 
variables to a set of flags or key variables that contributed to predicting prosthetic non-
use. To generate CPRs for the time frames, the set of variables from the regression was 
used to establish cumulative numbers of items present for any one individual at 
discharge. A list of Likelihood Ratios (negative and positive, 95% CI) were calculated to 
determine the cumulative effect of having a number of these predictor variables (1, 2, 3 
etc.) on prosthetic non-use.  
 
For the univariate and CPR analyses, in circumstances where zero values were present in 
the frequency cells of the 2x2 contingency tables, a small positive constant of 0.5 was 
added to the zero cell values to enable calculation of the likelihood ratios and confidence 
intervals (Everitt, 1992). Extreme likelihood ratio upper confidence limits were 
truncated at 999. 
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Table 4.1: Demographic and amputation details of retrospective cohort.  
* n = 134, one user excluded as from overseas  
Demographic and Amputation Details 
 
Prosthetic 
Users 
(n = 94) 
Prosthetic Non-
users 
(n = 41) 
Total 
(n = 135) 
Gender,  Male,  n (%)  74 (79) 29 (71) 103 (76) 
Age at amputation, mean (SD) 55.1 (15.8) 58.3 (13.3) 56.1 (15.1) 
Indigenous status, Aboriginal, n (%) 12 (13) 9 (22) 21 (16) 
Accommodation after discharge from inpatient rehab’n, n (%)    
Home 91 (97) 37 (90) 128 (95) 
Residential Care (Hostel or Nursing Home) 3 (3) 4 (10) 7 (5) 
        Metropolitan 56 (60) 28 (68) 84 (62) 
Country  38 (40) 13 (32)  51 (38) 
Accessibility Remoteness Index of Australia (ARIA)*    
Major Cities of Australia (0 to 1.84) 66 (71) 34 (83) 100 (75) 
Inner Regional Australia (>1.84 to 3.51) 8 (9) 0 (0) 8 (6) 
Outer Regional Australia (>3.51 to 5.80) 5 (5) 2 (5) 7 (5) 
Remote Australia (> 5.80 to 9.08) 0 (0) 2 (5) 2 (1) 
Very Remote Australia (> 9.08 to 12) 14 (15) 3 (7) 17 (13) 
Social Support, lives with others, n (%) 77 (82) 31 (76) 108 (80) 
Charlson Comorbidity Index Score, median (IQR) 2 (1 to 4) 5 (2 to 5) 2 (1 to 4) 
Combined Age Charlson Comorbiditiy Index Score, median 
(IQR) 4 (1 to 5) 7 (3 to 7) 4 (1.5 to 6) 
Comorbidities, n (%)    
Diabetes 42 (45) 22 (54) 64 (47) 
Type 1 7 (8) 3 (7) 10 (7) 
Type 2 35 (37) 19 (46) 54 (40) 
Peripheral Arterial Disease 44 (47) 25 (61) 69 (51) 
Cardiac Condition 33 (35) 26 (63) 59 (44) 
Renal Failure 13 (14) 10 (24) 23 (17) 
       Cerebrovascular accident / Transient Ischemic Attack 8 (9) 5 (12) 13 (10) 
Arthritis 36 (38) 16 (39) 52 (39) 
Remaining Lower Limb Pathology 78 (83) 36 (88) 114 (84) 
Mental health issues, n (%) 24 (26) 8 (20) 32 (24) 
Substance abuse, n (%) 
Drugs 
Alcohol 
7 (8) 
10 (11) 
4 (10) 
5 (12) 
11 (8) 
15 (11) 
Amputation Cause, n (%)    
Circulatory 18 (19) 15 (37) 33 (24) 
Infection 42 (45) 17 (41) 59 (44) 
Trauma 29 (31) 9 (22) 38 (28) 
Cancer 5 (5) 0 (0) 5 (4) 
Amputation Level, n (%)    
Transtibial 78 (83) 25 (61) 103 (76) 
Knee disarticulation 4 (4) 2 (5) 6 (4) 
Transfemoral 20 (21) 28 (68) 48 (36) 
Major Bilateral Lower Limb Amputation  8 (9) 14 (34) 22 (16) 
Minor Amputation of Remaining Limb 15 (16) 3 (7) 18 (13)  
Upper Limb Amputation/s 8 (9) 0 (0) 8 (6) 
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Figure 4.1: Predictor variable domains for prosthetic users and non-users investigated by this study. 
*CVA/TIA – Cerbrovascular Accident / Transient Ischaemic Attack
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A sensitivity analysis of 29 (16%) deceased prosthetic rehabilitation patients who could 
not be interviewed was performed for 4, 6, 8 and 12 months after discharge from 
rehabilitation to identify the presence or absence of CPR variables. Date of death was 
used as the termination date for prosthetic use. 
 4.3. Results 
Participants were interviewed to determine prosthetic outcome from November 2009 
until August 2011. Figure 4.2 reports the timeframes from the post-operative stage of 
rehabilitation to interview including length of stay and time from initial amputation 
surgery until rehabilitation milestones (e.g. prosthetic casting, fitting and gait retraining) 
were achieved by the total cohort (n = 135). Of the 135 participants interviewed a total 
of 70% (94) were classified as successful prosthetic users and 30% (41) non-users. The 
multifactorial reasons for non-use reported by the 41 prosthetic non-users have been 
detailed in Table 4.2. At 4 (& 6), 8 and 12 months after discharge from rehabilitation 
11% (15), 15% (20) and 19% (25) of participants respectively were prosthetic non-users. 
Table 4.1 shows the cohort characteristics. CCI score was higher in non-users median = 
5 (IQR = 2 to 5) than users median = 2 (IQR = 1 to 4).  
 
Of the 40 variables investigated for the univariate analysis (Figure 4.1), 16 were 
significant (p < .1) for non-use at 4, 6 and 8 months and 15 were significant at 12 
months after discharge. The predictor variables were identical for 4 and 6 months. Table 
4.3 shows the significant univariate predictor variables for the time frames.  
 
The univariate predictor variables significant for prosthetic non-use that were common 
to all time frames included: amputation level above transtibial, mobility aid use, delay to 
prosthesis, inability to perform high level balance activities, dependence at discharge 
with locomotor activities, donning, doffing and monitoring prosthetic fit. Age >58 years, 
having a very high number of comorbidities (including mental health issues and 
musculoskeletal pathology) and not having diabetes were predictors of non-use at 4 (& 
6) months. Having a cardiac condition, inability to hop or run were predictors of non-use 
at 8 and 12 months.  
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Figure 4.2: Timeframes for the retrospective cohort (n =135) from the post-
operative stage of rehabilitation to interview.
Post-operative stage 
• Day 0 Amputation surgery 
• Inpatient length of stay (LOS) median, 18 days (IQR = 10 to 33) 
• Rehabilitation commences with daily physiotherapy as inpatient on Royal 
Perth Hospital (RPH) surgical ward 
• Post-operative assessment by Rehabilitation Physician & Senior 
Physiotherapist Amputee Rehabilitation 
Pre-prosthetic rehabilitation stage 
• Inpatient LOS median, 23 days (IQR = 13 to 41) 
• Specialised amputee inpatient rehabilitation from multidisciplinary team at 
RPH rehabilitation unit 
• 2 physiotherapy sessions per day (see Appendix 2.1 for full intervention 
details) 
Prosthetic rehabilitation stage 
• Outpatient LOS median, 174 days (IQR = 103 to 314), 2 to 3 outpatient 
physiotherapy sessions per week at RPH  
• Amputation surgery to interim prosthetic casting median, 44 days (IQR = 28 
to 101) 
• Amputation surgery to interim prosthetic fitting and commencement of 
prosthetic gait retraining median, 52 days (IQR = 34 to 109) 
• RPH physiotherapists and prosthetists worked collaboratively in the same 
gym during prosthetic gait retraining 
• Interim prosthetic sockets & adjustments performed as required for the 
individual patient  
• Amputation surgery to definitive prosthesis median, 322 days (IQR = 222 to 
447) 
• Definitive prosthesis manufactured, fitted & adjusted by private prosthetic 
service providers in the community 
Interview 
• Outpatient physiotherapy discharge to interview median, 1.9 years (IQR = 1.4 
to 2.5) 
• Amputation surgery to interview median, 2.7 years (IQR = 2.2 to 3.2) 
Physiotherapy Discharge 
• Amputation surgery to outpatient physiotherapy discharge median, 238 days 
(IQR = 142 to 377)  
Timeframes for the Retrospective cohort (n = 135) with lower limb amputation 
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Table 4.2: Multifactorial reasons for prosthetic non-use reported by 
participants classified as prosthetic non-users (n = 41). 
Multifactorial reasons for prosthetic non-use 
reported by prosthetic non-users (n = 41) 
 
% (n)* 
 
 
Issue with residual limb (stump) 37 (15) 
Prosthetic issue 27 (11) 
Issue with remaining Limb 24 (10) 
Pain 22 (9) 
Medical comorbidities 20 (8) 
Balance issues 12 (5) 
Fear of falling 7 (3) 
Energy cost or efficiency 7 (3) 
Amputation of remaining limb 7 (3) 
Body Weight fluctuations 5 (2) 
Unmotivated 5 (2) 
Unable to don independently 5 (2) 
Falls 2 (1) 
 
*Participants were able to report more than one reason for not using their prosthesis so the cumulative 
percentage exceeds 100. 
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Table 4.3: Significant univariate predictor variables (p < .1) for prosthetic non-use for 4 (& 
6), 8 and 12 months.  
 
*0.5 was added to 0 cell in 2 x 2 contingency table so a positive likelihood ratio could be reported.   
† n = 134, missing data for 1 subject. 
Variable Sensitivity Specificity LR+ LR- p value 
4 (& 6) months      
Age > 58  0.67 0.60 1.67 0.56 .049 
Amputation level above transtibial 0.67 0.66 1.95 0.51 .014 
Delay to prosthesis†  0.33 0.90 3.30 0.74 .011 
Mobility aid use at discharge 0.97 0.53 2.07 0.06 < .0001* 
Dependent at discharge with: 
Donning, doffing & monitoring  0.27 0.91 2.91 0.81 .042 
Prosthetic gait  0.20 0.94 3.43 0.85 .048 
Walking indoors  0.20 0.94 3.43 0.85 .048 
Walking outdoors on concrete  0.33 0.89 3.08 0.75 .016 
Walking up and down  stairs  0.47 0.84 2.95 0.63 .004 
Walking up and down slopes  0.40 0.83 2.40 0.72 .031 
Walking on grass  0.40 0.84 2.53 0.71 .023 
Walking on gravel & uneven terrain  0.47 0.82 2.55 0.65 .012 
Inability to perform high level balance activities at 
discharge 0.97 0.18 1.18 0.18 .133* 
High number of co-morbidities >19  0.27 0.91 2.91 0.81 .042 
Not having diabetes 0.73 0.50 1.47 0.53 .088 
Not having type 2 diabetes 0.80 0.43 1.39 0.47 .094 
8 months      
Amputation level above transtibial 0.70 0.68 2.18 0.44 .001 
Delay to prosthesis†  0.33 0.92 4.19 0.72 .001 
Inability to hop  0.50 0.70 1.64 0.72 .087 
Mobility aid use at discharge 0.98 0.56 2.20 0.04 < .0001* 
Dependent at discharge with: 
Donning, doffing & monitoring  0.30 0.92 3.83 0.76 .004 
Prosthetic gait 0.20 0.95 3.83 0.84 .020 
Walking indoors  0.20 0.95 3.83 0.84 .020 
Walking outdoors on concrete  0.35 0.90 3.66 0.72 .002 
Walking up and down stairs  0.50 0.86 3.59 0.58 .0002 
Walking up and down slopes  0.45 0.85 3.04 0.65 .002 
Walking on grass  0.45 0.86 3.23 0.64 .001 
Walking on gravel & uneven terrain  0.55 0.84 3.51 0.53 < .0001 
Inability to perform high level balance activities at 
discharge 0.98 0.19 1.21 0.13 .061* 
Inability to run at discharge 0.98 0.15 1.14 0.16 .125* 
Having a cardiac condition/s 0.65 0.60 1.63 0.58 .037 
Not having arthritis 0.80 0.42 1.37 0.48 .065 
12 months      
Amputation level above transtibial 0.64 0.68 2.01 0.53 .003 
Delay to prosthesis† 0.32 0.92 3.88 0.74 .001 
Inability to hop  0.48 0.70 1.60 0.74 .085 
Mobility aid use at discharge 0.96 0.57 2.25 0.07 < .0001 
Dependent at discharge with:   
Donning, doffing & monitoring  0.24 0.92 2.93 0.83 .023 
Prosthetic gait  0.16 0.95 2.93 0.89 .069 
Walking indoors 0.16 0.95 2.93 0.89 .069 
Walking outdoors on concrete  0.36 0.92 4.40 0.70 .0002 
Walking up and down stairs  0.48 0.87 3.77 0.60 < .0001 
Walking up and down slopes  0.44 0.86 3.23 0.65 .001 
Walking on grass 0.44 0.87 3.46 0.64 .0003 
Walking on gravel & uneven terrain  0.52 0.85 3.58 0.56 < .0001 
Inability to perform high level balance activities at 
discharge 0.98 0.20 1.22 0.09 .027* 
Inability to run at discharge 0.98 0.16 1.16 0.13 .067* 
Having a cardiac condition/s 0.68 0.62 1.78 0.52 .007 
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Table 4.7: Significant predictor variables for prosthetic non-use and associated accuracy statistics with 95% confidence intervals 
for having a combination of predictor variables. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*p < .05 is significant
Significant predictor 
variables for the time 
frames from backwards 
stepwise logistic regression 
analysis 
Associated accuracy statistics for having a combination of variables (e.g. 1, 2, 3… variables) at each of the time frames 
 
Number 
of 
Predictor 
variables 
Present 
Sensitivity Specificity Positive 
Likelihood Ratio 
Negative Likelihood 
Ratio 
Probability 
of prosthetic 
non-use (%) 
 
p value 
4 (& 6) months: 
• Amputation level above 
transtibial 
• Mobility aid use at 
discharge 
• Dependence walking 
outdoors on concrete at 
discharge 
• Very high number of 
comorbidities 
• Not having a diagnosis of 
type 2 diabetes 
 
 
1  
2  
3 
4 
5 
 
 
0.97 (0.74 to 1.00) 
0.97 (0.72 to 1.00) 
0.80 (0.53 to 0.95) 
0.27 (0.10 to 0.33) 
0.032 (0.0 to 0.06) 
 
0.16 (0.13 to 0.16) 
0.52 (0.48 to 0.52) 
0.75 (0.72 to 0.77) 
0.99 (0.97 to 1.00) 
0.99 (0.99 to 1.00) 
 
 
1.2 (0.85 to 1.19) 
2.0 (1.40 to 2.09) 
3.2 (1.87 to 4.08) 
32.0 (3.61 to 748) 
7.8 (0.00 to 999+) 
 
0.20 (0.0 to 2.04) 
0.06 (0.0 to 0.57) 
0.27 (0.07 to 0.65) 
0.74 (0.67 to 0.92) 
0.97 (0.94 to 1.01) 
 
13 
21 
29 
80 
0 
 
 
.183 
< .0001* 
< .0001* 
< .0001* 
.223 
8 months: 
• Amputation level above 
transtibial 
• Mobility aid use at 
discharge 
• Dependence walking 
outdoors on concrete at 
discharge 
 
1 
2 
3 
 
 
0.98 (0.78 to 1.00) 
0.90 (0.69 to 0.98) 
0.15 (0.04 to 0.26) 
 
 
 
0.43 (0.39 to 0.43) 
0.74 (0.70 to 0.75) 
0.97 (0.96 to 0.99) 
 
1.7 (1.29 to 1.76)  
3.5 (2.31 to 3.98) 
5.8 (0.96 to 34.3) 
 
0.06 (0.0 to 0.55) 
0.14 (0.02 to 0.44) 
0.87 (0.75 to 1.00) 
 
23 
38 
50 
 
.001* 
< .0001* 
.013* 
12 months: 
• Amputation level above 
transtibial 
• Delay to prosthesis 
• Mobility aid use at 
discharge 
 
1 
2 
3 
 
 
0.96 (0.79 to 0.99) 
0.72 (0.53 to 0.86) 
0.24 (0.12 to 0.28) 
 
 
0.42 (0.38 to 0.43) 
0.76 (0.72 to 0.8) 
0.99 (0.96 to 1.00) 
 
1.7 (1.28 to 1.74) 
3.05 (1.88 to 4.25) 
26.4(3.4 to 580) 
 
0.096 (0.005 to 0.55) 
0.37 (0.17 to 0.66) 
0.77 (0.72 to 0.91) 
 
 
27 
41 
86 
 
< .0001* 
< .0001* 
< .0001* 
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Appendix 4.3 Tables 4.4 to 4.6 summarise the backwards stepwise logistic regression 
data. The predictor variables significant (95% CI) for prosthetic non-use after being 
entered into the backwards stepwise logistic regression model for 4 (& 6), 8 and 12 
months were as follows (full details in Table 4.7):  
 CPR 4 months 
At 4 (& 6) months the 5 variables predictive of prosthetic non-use included: amputation 
level above transtibial, using a mobility aid, dependence walking outdoors on concrete, 
very high number of comorbidities and not having a diagnosis of type 2 diabetes. If 
subjects had 4 out of 5 variables, LR+ = 32.0 (CI = 3.6 to 748) the probability of non-
use increased from 11% to 80% (p < .0001).  
 CPR 8 months 
At 8 months the 3 variables predictive of prosthetic non-use included: amputation level 
above transtibial, using a mobility aid and dependence walking outdoors on concrete. If 
2 out of 3 variables were present, LR+ = 3.5 (CI = 2.31 to 3.98) the probability of non-
use increased from 15% to 38% (p < .0001).  
 CPR 12 months 
At 12 months the 3 variables predictive of prosthetic non-use included: amputation level 
above transtibial, using a mobility aid and delay to prosthesis. For prosthetic non-users 
cause of delay was multifactorial and included: wound complications (89%, n=8), 
medical comorbidities (33%, n=3), orthopaedic injuries (22%, n=2) and physical 
deconditioning (11%, n = 1). If all 3 variables were present, LR+ = 26.4 (CI = 3.4 to 
580) the probability of non-use increased from 19% to 86% (p < .0001). 
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Table 4.8: Significant predictor variables for prosthetic non-use and associated accuracy statistics with 95% 
confidence intervals for having a combination of predictor variables in the deceased sub-group (16% (n=29)). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*p < .05 is significant
Associated accuracy statistics for having a combination of variables (e.g. 1, 2, 3… variables) at each of the time frames 
 
Number of 
Predictor 
variables 
present 
Sensitivity Specificity Positive Likelihood 
Ratio 
Negative Likelihood 
Ratio 
Probability 
of prosthetic 
non-use (%) 
 
p value 
 
1  
2  
3 
4 
5 
 
 
0.889 (0.833 to 0.994) 
0.889 (0.629 to 0.994) 
0.444 (0.170 to 0.739) 
0.111 (0.006 to 0.371) 
0.053 (0 to 0.105) 
 
 
0.024 (0 to 0.071) 
0.200 (0.083 to 0.247) 
0.600 (0.476 to 0.732) 
0.800 (0.753 to 0.917) 
0.976 (0.951 to 1.00) 
 
0.911 (0.833 to 1.07) 
1.11 (0.686 to 1.32) 
1.11 (0.324 to 2.76) 
0.556 (0.024 to 4.48) 
2.16 (0 to 999+) 
 
4.56 (0.085 to 999+) 
0.556 (0.024 to 4.48) 
0.926 (0.356 to 1.74) 
1.11 (0.686 to 1.32) 
0.971 (0.895 to 1.05) 
 
29 
33 
33 
20 
50 
 
.324 
.558 
.822 
.558 
.689 
  
 
1  
2  
3 
4 
5 
 
 
0.929 (0.893 to 0.996) 
0.857 (0.708 to 0.973) 
0.357 (0.166 to 0.569) 
0.071 (0.004 to 0.242) 
0.034 (0 to 0.069) 
 
0.032 (0 to 0.093) 
0.200 (0.061 to 0.308) 
0.533 (0.355 to 0.731) 
0.733 (0.670 to 0.892) 
0.968 (0.935 to 1.00) 
 
0.960 (0.893 to 1.10) 
1.07 (0.753 to 1.41) 
0.765 (0.257 to 2.12) 
0.286 (0.011 to 2.24) 
1.07 (0 to 999+) 
 
2.21 (0.04 to 999+) 
0.714 (0.087 to 4.82) 
1.20 (0.589 to 2.35) 
1.27 (0.850 to 1.49) 
0.998 (0.931 to 1.07) 
 
46 
50 
42 
20 
50 
 
 
.629 
.684 
.550 
.164 
.973 
 
1 
2 
3 
 
 
0.941 (0.912 to 0.997) 
0.647 (0.487 to 0.810) 
0.294 (0.138 to 0.419) 
 
0.04 (0 to 0.116) 
0.417 (0.190 to 0.647) 
0.750 (0.529 to 0.927) 
 
0.980 (0.912 to 1.13) 
1.11 (0.601 to 2.30) 
1.18 (0.293 to 5.70) 
 
1.47 (0.028 to 999+) 
0.847 (0.294 to 2.70) 
0.941 (0.627 to 1.63) 
 
57 
61 
62 
 
.818 
.728 
.793 
 
1 
2 
3 
 
 
0.947 (0.921 to 0.997) 
0.421 (0.270 to 0.533) 
0.026 (0 to 0.051) 
 
0.048 (0 to 0.138) 
0.700 (0.412 to 0.912) 
0.952 (0.905 to 1.00) 
 
0.995 (0.921 to 1.16) 
1.404 (0.459 to 6.07) 
0.538 (0 to 999+) 
 
1.10 (0.021 to 999+) 
0.827 (0.512 to 1.77) 
1.02 (0.949 to 1.10) 
 
64 
73 
50 
 
 
.953 
.523 
.749 
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Of the 16% (29) participants who participated in prosthetic rehabilitation but were 
deceased and could not be interviewed: 29% (9) were deceased and non-users at 4 
months, 45% (14) at 6 months, 55% (17) at 8 months and 61% (19) at 12 months after 
discharge. There were no significant associations (p > .164) between having a number of 
CPR variables at these time frames and cessation of prosthetic use due to death (see 
Table 4.8 for full details).  4.4. Discussion 
Few studies have examined factors at the time of discharge to determine future 
prosthetic use. This study is the first to propose CPRs for timelines of 4, 8 and 12 
months post-discharge which use statistical optimisation modelling to select a 
parsimonious set of variables that predict increased likelihood of prosthetic non-use. 
Previous research has examined univariate associations with poor functional outcomes. 
This current study examined a much wider range of peri-operative and demographic 
factors and confirmed that a large number of factors are significantly related to 
prosthetic non-use. We have grouped these into intrinsic, amputation and functional 
domains.  
 
This study found that having a very high number of medical comorbidities (including 
mental health issues and musculoskeletal pathology) was significantly predictive of 
prosthetic non-use at 4 months but not at later time periods. This was an interesting 
finding as depending on how comorbidities are managed they may become worse with 
age (Charlson et al., 1987); however this finding may suggest that if prosthetic use can 
be sustained for the first 4 months after discharge in the presence of these comorbidities 
then such systemic conditions may not be most highly related to non-use at a later time. 
CCI and CA-CCI scores suggest that prosthetic non-users were at greater risk of 
mortality from comorbid disease than users (Charlson et al., 1987; Roffman et al., 
2016a). 
 
Poor pre-amputation mobility, cardiac disease, renal failure, severe comorbidities, 
cognitive impairment and advanced age have been shown to affect prosthetic outcome 
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(Bhangu et al., 2009; O'Neill & Evans, 2009; Sansam et al., 2009; Schoppen et al., 2003; 
Taylor et al., 2005). This current study’s univariate analysis found that having a cardiac 
condition was predictive of non-use at 8 and 12 months after discharge. Similar to 
findings within the literature (Schoppen et al., 2003; Taylor et al., 2005) individuals 
older than 58 years at the time of amputation were more likely to be non-users at 4 
months.  
 
The univariate results for this study were consistent with the literature on the importance 
of optimising a patient’s locomotor function prior to discharge (Gauthier-Gagnon, Grisé, 
& Potvin, 1999). Inability to walk on different surfaces (e.g. grass, gravel, slopes) and 
levels of prosthetic mobility attained were all predictors of non-use. Inability to don, 
doff and monitor prosthetic fit was a univariate predictor of non-use for all time frames. 
Inability to run was a predictor of non-use at 8 and 12 months.  
 
Mobility level achieved without a prosthesis including wheelchair mobility, transfers 
and hopping were analysed as some rehabilitation services (Department of Health, 2008) 
use these milestones as criteria for prosthetic prescription. Inability to hop was a 
significant univariate predictor of prosthetic non-use at 8 and 12 months. Inability to hop 
may be a marker of frailty, comorbidities, strength, balance, fitness and cognitive 
impairments that have been associated with poor prosthetic outcome in past studies 
(Raya et al., 2010; Schoppen et al., 2003).  
 
The key point of this study however, was the fact that multivariate predictive models 
were used with all the variables to determine a predictive model of outcome at three time 
points. Three CPRs were generated since the results for the 4 and 6 months outcomes 
were identic. This suggests that individuals who reported non-use at 6 months had not 
been using the prosthesis for at least 2 months prior to this date. From this, it would 
seem that there is a subgroup that ceases using the prosthesis almost immediately after 
discharge. Having a combination of amputation level above transtibial, very high 
number of comorbidities, inability to walk outdoors on concrete, using a mobility aid 
and not having a diagnosis of diabetes were prognostic markers prosthetic non-use 4 
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months post-discharge. The critical feature here is that these findings call for a 
validation of this rule to then develop a model of care that optimises outcome for these 
individuals. Rehabilitation may focus on optimising transfers, wheelchair mobility, 
physical fitness and mental wellbeing rather than prosthetic gait.  
 
The predictor variables for prosthetic non-use that all CPRs had in common were 
amputation level above transtibial and mobility aid use. High level or multiple limb 
amputation have been associated with poor prosthetic outcome due to the increased 
energy and skill level required for walking (Bhangu et al., 2009; Davies & Datta, 2003; 
Gauthier-Gagnon et al., 1999; Waters et al., 1976). From a functional perspective, a 
transtibial prosthesis assists an individual during transfers while a transfemoral 
prosthesis is only of assistance once standing or walking. This may result in some 
functional activities being performed with greater efficiency from a wheelchair (e.g. 
individuals with transfemoral amputation may use a commode for showering as it is 
more efficient than donning their prosthesis and walking).  
 
In this study mobility aid use at discharge was a strong predictor (p < .0001) of 
prosthetic non-use at all time periods. Mobility aid use at discharge is more common in 
individuals who premorbidly used a mobility aid, are frail or deconditioned, have 
remaining limb pathology (e.g. claudication, osteoarthritis), high or multiple limb 
amputation (Franchignoni et al., 2004; Gauthier-Gagnon et al., 1999). Mobility aids 
reduce the functionality of gait by limiting capacity to carry objects however, use may 
be necessary to prevent falls (Franchignoni et al., 2004; Gauthier-Gagnon et al., 1999). 
As mobility aid use at discharge is associated with prosthetic non-use clinicians may 
consider using intervention strategies (e.g. mobility aid type, back pack use) that 
potentially improve functionality of gait.  
 
At 4 and 8 months after discharge dependence walking outdoors on concrete was a 
significant predictor of prosthetic non-use. Association of this predictor with early 
prosthetic non-use following discharge is important as many locomotor activities require 
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the ability to walk outdoors on concrete (e.g. shopping). Poor prosthetic outcome has 
been associated with indoors only ambulation (Gailey et al., 2002; Taylor et al., 2005).  
  
Similar to the literature (Sansam et al., 2009), this study demonstrated a critical time 
frame in which gait retraining needs to occur as a delay to gait retraining was a predictor 
of non-use at 12 months. Delay to the gait retraining was also a univariate predictor for 
all the time frames. Wound complications (89%, n=8) were the commonest cause of 
delay. Delay to walking generally results in reduced physical activity and prolonged 
wheelchair sitting by individuals. Rehabilitation programs may not provide the exercise 
intensity to overcome deconditioning or prevent complications (e.g. joint contracture, 
muscle weakness) that limit walking capacity. Furthermore, individuals with severe 
comorbidities and frailty may adversely or not respond to the exercise intervention.   
 
Lower limb amputation rate has been reported as 38 times greater in Aboriginals2 who 
have diabetes (Department of Health, 2010; Norman et al., 2010). In this study 
indigenous status, geographical isolation from health services and having diabetes were 
not predictive of prosthetic non-use. Environmental conditions in Aboriginal 
communities where the terrain is rough, sociocultural factors and service model 
strategies such as Telehealth may have contributed to sustained prosthetic use.  
 
Similar to surgical outcome studies (Nehler et al., 2003; Taylor et al., 2005), this study 
highlights the importance of surgeons performing a transtibial (as opposed to 
transfemoral) amputation where feasible. However, the major point of difference from 
other studies (Davies & Datta, 2003; Dillingham et al., 2005; Dillingham et al., 2001) 
was that causative factors for amputation were not associated with non-use.  
 
These CPRs have the potential to assist with evidenced based health reform, improve 
quality of life and lead to cost savings within rehabilitation services by improving 
                                                             
2 Aboriginal and Torres Strait Islander people are the first inhabitants of Australia. An Aboriginal person is of 
Aboriginal descent, identifies as Aboriginal and is accepted as an Aboriginal person by their community. This 
study was conducted in Western Australia and only people who identified as Aboriginal participated. People of 
the Torres Strait are of Melanesian origin from the Torres Strait Islands and east coast of Australia. 
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patient selection for prosthetic rehabilitation and driving cost effective prosthetic 
innovation. The social, economic and ethical implications of CPRs for prosthetic non-
use may vary between developed and developing nations and different models of care. 
Future validation of these CPRs at other centres is therefore warranted.  
 
War veterans with lower limb amputation have reported that short residual limb (stump) 
length, prosthetic device being too heavy, cumulative trauma disorder of remaining 
lower limb, combat injuries, pain, paralysis and too much fuss were the main reasons 
they abandoned prosthetic use (Gailey et al., 2010; Laferrier, McFarland, Boninger, 
Cooper, & Reiber, 2010). Significantly higher rates of prosthetic abandonment were 
demonstrated in veterans with transfemoral amputation (or higher) and bilateral lower 
limb amputations (Gailey et al., 2010; Laferrier et al., 2010). Multifactorial reasons for 
abandoning prosthetic use reported by participants from our study were: issue with the 
residual limb, issue with the remaining limb, prosthetic issue, pain, medical 
comorbidities and balance issues. 
 
This retrospective study had some potential limitations. Retrospective studies may have 
missing data however a strength of this study is that it had minimal missing data. The 
prosthetic use interview relied on participant recall which is a potential source of error. 
Mortality rate within the review period was high for this cohort (n = 29 (16%)), however 
our sensitivity analysis demonstrated that the deceased sub-group did not bias 
development of the CPRs. The major limitation of the retrospective model of CPR 
development is the need to prospectively validate the developed CPR in a new cohort 
(Cleland et al., 2010), this is an area of future investigation. 
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In conclusion, this study confirmed that many variables can be considered to have 
univariate associations with prosthetic non-use after discharge. This is consistent with 
the various reports in the literature. However, this retrospective study is the first to 
integrate these into a parsimonious set of predictor variables significant for prosthetic 
non-use in individuals with lower limb amputation at 4, 8 and 12 months after discharge 
from rehabilitation. This study highlights a need to separate causative factors for 
amputation that impact on surgical outcome, from those related to prosthetic non-use. 
These CPRs may assist health professionals with clinical reasoning and rehabilitation 
service development, however the results should be interpreted with caution as the study 
requires validation.  
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Chapter 5 
 
 5. Validation of clinical prediction rules for prosthetic non-use in individuals with lower limb amputation at 4, 8 and 12 months after discharge from rehabilitation.  
 
 
 
 
 Synopsis 
This chapter details validation of clinical prediction rule for prosthetic non-use and 
forms part of the manuscript published in the Journal of Physiotherapy, please see 
appendix 4.1: 
 
Roffman, Caroline E., Buchanan, John, & Allison, Garry T. (2014). Predictors of 
non-use of prostheses by people with lower limb amputation after discharge 
from rehabilitation: development and validation of clinical prediction rules. 
Journal of Physiotherapy, 60(4), 224-231. doi: 10.1016/j.jphys.2014.09.003 
 
This chapter was presented at the following conferences: 
14th World Congress of the International Society for Prosthetics and Orthotics 
(ISPO), 4th to 7th February 2013, Hyderabad, India. 
 
Momentum 2017 Physiotherapy Conference, Australian Physiotherapy Association, 
19th to 21st October 2017, Sydney, Australia. 
 
  
 
 
80 
 
Abstract 
 
Research Question: Are clinical prediction rules (CPRs) that identify prosthetic 
non-use in people with lower limb amputation at 4, 6, 8 and 12 months after 
discharge from rehabilitation valid?  
Design: Prospective cohort study 
Participants: 66 consecutive tertiary rehabilitation patients (58 males, age mean 
(SD) 54.4 (16.4) years).  
Methods: Medical record and CPR data were collected during rehabilitation. 
Participants were interviewed at median 1.3 (IQR, 1.1 to 1.4) years after discharge.  
Results: CPRs were validated for 4, 8 and 12 months. Amputation level above 
transtibial and mobility aid use were common predictors for all 3 time frames. The 
associated accuracy statistics (95% CI) for having a combination of predictor 
variables were: 
4 months: If 4 out of 5 predictor variables were present (LR+ = 43.9, CI = 2.73 to 
999+) the probability of non-use increased from 12% to 86% (p < .0001).  
8 months: If all 3 predictor variables were present (LR+ = 33.9, CI = 2.1 to 999+) 
the probability of non-use increased from 15% to 86% (p < .0001).  
12 months: If 2 out of 3 predictor variables were present (LR+ = 2.8, CI = 0.9 to 6.6) 
the probability of non-use increased from 17% to 36% (p < .031). 
Conclusions: These validated CPRs have implications for changing patient 
rehabilitation services and clinical decision making.  
 
Key words: Clinical prediction rule, lower extremity, amputation, leg prosthesis, 
rehabilitation outcome 
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5.1. Introduction 
Prosthetic rehabilitation aims to restore locomotor function in individuals with lower 
limb amputation however, limited research exists on the sustained use of prostheses 
following discharge from rehabilitation (Adams, 2005; Campbell & Ridler, 1996; 
Cumming et al., 2006; Jones et al., 1993; Lim et al., 2006; Sansam et al., 2009). 
While prosthetic gait retraining which involves a combination of exercise, balance 
and functional locomotor activities in a range of contextual environments is 
considered standard clinical practice (Broomhead et al., 2003), the effectiveness of 
this intervention is unknown in Western Australia (WA) or poorly measured by 
many Australian amputee rehabilitation services (Department of Health, 2008; 
Hordacre et al., 2013b). Patient selection for prosthetic gait retraining varies between 
rehabilitation services and clinical practice guidelines have been developed largely 
through expert consensus (Broomhead et al., 2003; van der Linde et al., 2005).  
 
Clinical Prediction Rules (CPRs) are tools that assist health professionals to make 
evidence based decisions and assign patients to interventions using a subset 
parsimonious of predictor variables (Beneciuk et al., 2009; Childs & Cleland, 2006; 
Cleland et al., 2007; Cleland et al., 2009; Cleland et al., 2010; Fritz, 2009; Laupacis 
et al., 1997). Fritz (2009) reports that CPRs which have had the greatest impact on 
health care are those developed for heterogenous conditions, with multiple treatment 
options and complex decision making. CPRs have been derived for a wide range of 
medical conditions, some examples include: prediction of ankle and knee fractures 
and response to treatment for neck and low back pain (Bachmann, Kolb, Koller, 
Steurer, & Riet, 2003; Cleland et al., 2007; Cleland et al., 2009; Cleland et al., 2010; 
Stiell et al., 1996).  
 
Prosthetic non-use in individuals with lower limb amputation following discharge 
from rehabilitation is complex with many pre-operative and post-operative factors 
identified as having significant univariate associations (Adams, 2005; Bhangu et al., 
2009; Dillingham et al., 2001; Gailey et al., 2002; Goktepe et al., 2010; Kulkarni et 
al., 2006; Lim et al., 2006; Nehler et al., 2003; O'Neill & Evans, 2009; Penn-Barwell, 
2011; Pohjolainen et al., 1990; Raya et al., 2010; Sansam et al., 2009; Schoppen et 
al., 2003; Taylor et al., 2005; Waters et al., 1976). An understanding of the factors 
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which in combination are predictive of prosthetic non-use could assist 
multidisciplinary rehabilitation teams to develop targeted models of care and drive 
prosthetic innovation to improve functional outcome in those at risk of prosthetic 
non-use. 
 
Roffman et al. (2014) (see chapter 4 and appendix 4.1) derived a set of CPRs for 
prosthetic non-use at 4, 8 and 12 months after discharge in a retrospective cohort 
study of 135 consecutive patients with lower limb amputation (Figure 5.1). This CPR 
development study represented stage 1 in CPR research methodology (Roffman et 
al., 2014). From a broad range of intrinsic, amputation and functional variables it was 
determined that amputation level above transtibial and mobility aid use were 
significant predictors of prosthetic non-use that were common to all CPR time 
frames (Roffman et al., 2014). Identical predictor variables were derived at 4 and 6 
months after discharge suggesting there was a sub-group of patients who were likely 
to become early prosthetic non-users (Roffman et al., 2014).   
 
The second phase of CPR research methodology is validation of the derived CPRs in 
a prospective cohort of patients (Childs & Cleland, 2006; Roffman et al., 2014). The 
research question for this study was: Are clinical prediction rules (CPRs) that 
identify prosthetic non-use in people with lower limb amputation at 4, 6, 8 and 12 
months after discharge from rehabilitation valid?  
 5.2. Methods Participants 
This study was approved by the Royal Perth Hospital (RPH) and Curtin University 
Human Research Ethics Committees (see Appendix 3.1). Inclusion criteria were as 
follows: participants had at least one recent major lower limb amputation (i.e. 
transtibial level or above), were community dwelling and ambulant pre-amputation, 
were Medicare Functional Classification Level K-level 1 to 4 (from Gailey et al. 
(2002)), participated in and had been discharged from prosthetic rehabilitation at the 
state centre for amputee rehabilitation RPH. Individuals with multiple limb 
amputation were included for CPR validity.  
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Participants were excluded from the CPR validation if they were not prosthetic 
candidates (K-level 0, as assessed by the Rehabilitation Medicine Physician and 
Senior Physiotherapist Amputee Rehabilitation), unable to communicate or did not 
consent. K-level 0 individuals participated in inpatient rehabilitation to achieve 
independent transfers, wheelchair mobility and discharge home. As a strategy to 
improve external validity of the CPRs these excluded participants were monitored 
through amputee outpatient clinics to ensure that they were not misclassified. All 
remained K-level 0 and therefore did not contribute to a selection bias through the 
exclusion criteria.  
 
All individuals with a K-Level 1 to 4 participated in prosthetic rehabilitation as an 
outpatient service at RPH, the dedicated state amputee rehabilitation service. 
Participants progressed through a standardised gait retraining program which 
included: strengthening, balance, stretching and cardiovascular exercises, learning to 
don, doff and monitor prosthetic fit, weight shift and walking drills in the parallel 
bars, walking indoors and outdoors on a range of terrains and environmental 
conditions, stair climbing and progression of mobility aids. If required, the types of 
mobility aids issued at discharge to patients for prosthetic gait included: single point 
walking sticks, elbow crutches, wheeled or non-wheeled Zimmer® frames and 4 
wheeled walking frames. If a participant was unable to don their prosthesis or 
achieve locomotor milestones their carer was taught how to assist. Running, sports 
and work specific locomotor skills were taught to those patients who identified these 
as goals. Participants were discharged from physiotherapy when they achieved their 
individualised rehabilitation goals. 
  
Participants received standardised prosthetic management from the onsite RPH 
prosthetists during their gait retraining sessions at the physiotherapy gym. This 
included prosthetic adjustment and new sockets as required. When a participant’s 
gait retraining was completed and their residual limb volume had stabilised they 
were referred by the multidisciplinary team for a definitive prosthesis.  
 
From the Amputee Physiotherapy Service database 99 consecutive patients with 
lower limb amputation were identified between July 2009 and July 2011. Eighty 
seven met the inclusion criteria however 10 were still participating in outpatient 
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rehabilitation during the study period. Two had minor lower limb amputation. Eleven 
were excluded as they were K-level 0 (non-prosthetic rehabilitation). The remaining 
76 were prosthetic users (K-level 1 to 4) at discharge from outpatient physiotherapy.  
An independent research assistant attempted to contact these individuals to obtain 
informed verbal consent. During this process 8 (10%) were deceased. Four (36%) of 
the non-prosthetic rehabilitation (K-level 0) were deceased.  
 
Of the 68 patients who were eligible to participate in the study, 2 participants were 
unable to be contacted as they had moved. The final response rate was 97% (n = 66) 
with participants interviewed at median 1.3 (IQR, 1.1 to 1.4) years post-discharge. 
 
The interview process involved coordinating telephone interviews with Country 
Physiotherapists during remote community visits, Aboriginal Health Workers, and 
Nurses. Table 5.1 outlines the geographical distribution and isolation from health and 
other services for participants using the Accessibility Remoteness Index of Australia 
(ARIA) (Trewin, 2005).  
 Procedure 
A prospective cohort study design was used. Data were prospectively collected 
during the participants’ rehabilitation using a physiotherapy assessment form 
developed and implemented by the Senior Physiotherapist during the retrospective 
study (see Appendix 8.2) (Roffman et al., 2014). Charlson Comorbidity Index (CCI) 
and combined Age CCI (CA-CCI) scores were calculated from participant medical 
comorbidities data (Charlson et al., 1987; Hall et al., 2004; Roffman et al., 2014). 
Figure 5.1 shows the significant predictor variables for prosthetic non-use that were 
derived in the retrospective study by Roffman et al. (2014). Instructions on how to 
use the CPRs in figure 5.1 are outlined in Appendix 5.1.  
 
Interviews were performed using a previously piloted survey by telephone (n = 47) 
and in person (n = 19). Carers assisted with 2 interviews where patients had a hearing 
or intellectual impairment.  
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Figure 5.1: Validated CPRs for prosthetic non-use in individuals with lower limb amputation at 4, 8 and 12 months after 
discharge from rehabilitation  
(Roffman et al., 2014). 
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Table 5.1: Demographic and amputation details of prospective cohort. 
 
Demographic Details of Prospective Cohort 
 
Prosthetic 
Users 
(n = 55 ) 
Prosthetic 
Non-users 
(n =11) 
Total 
(n = 66) 
 
Gender, Male, n (%) 50 (91) 8 (73) 58 (88) 
Age at amputation, mean (SD) 55.3 (15.7) 49.5 (19.9) 54.4 (16.4) 
Indigenous status, Aboriginal, n (%) 6 (11) 2 (18) 8 (12) 
Accommodation, n (%)    
Home 55 (100) 11 (100) 66 (100) 
Residential Care  (Hostel & Nursing Home) 0 (0) 0 (0) 0 (0) 
Metropolitan 34 (62) 9 (82) 43 (65) 
Country  21 (38) 2 (18) 23 (35) 
Accessibility Remoteness Index of Australia (ARIA)    
Major Cities of Australia (0 to 1.84) 40 (73) 9 (82) 49 (74) 
Inner Regional Australia (>1.84 to 3.51) 7 (13) 0 (0) 7 (11) 
Outer Regional Australia (>3.51 to 5.80) 5 (9) 1 (9) 6 (9) 
Remote Australia (> 5.80 to 9.08) 2 (4) 0 (0) 2 (3) 
Very Remote Australia (> 9.08 to 12) 1 (2) 1 (9) 2 (3) 
Social Support, Lives with others, n (%) 42 (76) 10 (91) 52 (79) 
Charlson Comorbidity Index Score, median (IQR) 2 (0 to 4) 3 (0.5 to 5) 2 (0 to 4) 
Combined Age Charlson Comorbidity Index Score, 
median (IQR) 4 (1 to 6) 6 (1 to 7) 4 (1 to 7) 
Comorbidities, n (%)    
Diabetes 22 (40) 7 (64) 29 (44) 
Type I 1 (2) 1 (9) 2 (3) 
Type II 21 (38) 6 (55) 27 (41) 
Peripheral Arterial Disease 30 (55) 7 (64) 37 (56) 
Cardiac Condition 12 (22) 4 (36) 16 (24) 
Renal Failure 5 (9) 4 (36) 9 (14) 
Cerebrovascular accident / Transient Ischemic Attack 4 (7) 0 (0) 4 (6) 
Arthritis 12 (22) 5 (45) 17 (26) 
Remaining Lower Limb Pathology 36 (65) 11 (100) 47 (71) 
Mental health issues, n (%) 8 (15) 5 (45) 13 (20) 
Substance abuse, n (%) 
Drugs 
Alcohol 
 
2 (4) 
7 (13) 
 
3 (27) 
2 (18) 
 
5 (8) 
9 (14) 
Amputation Details    
Amputation Cause, n (%)    
Circulatory 16 (29) 3 (27) 19 (29) 
Infection 22 (40) 6 (55) 28 (42) 
Trauma 14 (25) 2 (18) 16 (24) 
Cancer 3 (5) 0 (0) 3 (5) 
Amputation Level, n (%)    
Transtibial 50 (91) 10 (91) 60 (91) 
Knee disarticulation 1 (2) 0 (0) 1 (2) 
Transfemoral 9 (16) 5 (45) 14 (21) 
Major Bilateral Lower Limb Amputation  5 (9) 4 (36) 9 (14) 
Minor amputation of remaining limb 2 (4) 1 (9) 3 (5) 
Upper Limb Amputation/s 9 (16) 3 (27) 12 (18) 
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The same operational definitions for prosthetic users, prosthetic non-users and 
methodology that were used in the retrospective CPR development study, were used 
in this CPR validation study (full definitions and methodology are reported in 
Roffman et al. (2014)). Participants were interviewed on their prosthetic use from 4 
months onwards after discharge and were re-interviewed at 2 monthly intervals until 
data were collected for 12 months after discharge.  
 Statistical Analyses 
Participants were classified as being prosthetic users or non-users at 4 specific time 
points (4, 6, 8 and 12 months) after discharge. Descriptive statistics were generated. 
The prospective cohort were analysed for the absence (score = 0) or presence (score 
= 1) of the significant predictor variables outlined in Figure 5.1 at 4, 6, 8 and 12 
months after discharge. Please refer to Appendix 5.1 for full instructions on using the 
CPRs. The validity of the cohort behaviours of prosthesis use were compared by 
plotting the pattern of prosthetic non-use over time for the retrospective (n = 135) 
(Roffman et al., 2014) and prospective (n = 66) cohorts investigated by these CPR 
studies (see figure 5.2). To enable comparison between research and healthcare 
facilities survival of prosthetic use from initial amputation surgery were also plotted 
for the retrospective and prospective cohorts (see figure 5.3).    
 
The thresholds for the continuous variables by Roffman et al. (2014) were used to 
generate dichotomous classification of these continuous variables in this prospective 
validation study. To validate the CPRs for each of the time frames, chi-square tests 
were calculated to generate a progressive list of Likelihood Ratios (negative and 
positive, 95% CI) to determine the cumulative effect of having a number (i.e. 1, 2, 3 
or more) of these predictor variables for prosthetic non-use. Sensitivity, specificity, 
positive prediction value (PPV), accuracy and balanced accuracy were calculated to 
define the accuracy and precision of CPRs in the prospective validation cohort 
(Brodersen, Ong, Stephan, & Buhmann, 2010). Balanced accuracy was calculated 
from the mean of the sum of the sensitivity and specificity (Brodersen et al., 2010).  
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In circumstances where zero cases were present in frequency cells of the 2 x 2 
contingency tables, 0.5 was added to the cell values to enable calculation of the 
likelihood ratios for the variables (Everitt, 1992). Extreme likelihood ratio upper 
confidence limits were truncated at 999. 
 
 
 
 
89 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2: A survival curve for the proportion of individuals using the prosthesis for every month in the year following hospital 
discharge.  
Note: The retrospective and prospective cohorts show similar patterns of prosthetic non-use with a similar rate of non-use. 
Time of initial amputation surgery to outpatient physiotherapy discharge were median 238 days (IQR = 142 to 377) for the 
retrospective cohort and median, 196 days (IQR = 126 to 260) for the prospective cohort.   
(Roffman et al., 2014).  
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Figure 5.3: Survival of prosthetic use from amputation surgery for the retrospective and prospective cohorts.  
Interim prosthetic fitting was median, 52 days (IQR = 34 to 109) for the retrospective cohort and median, 49 days (IQR = 34 to 
77) for the prospective cohort from initial amputation surgery. Discharge from physiotherapy was median, 238 days (IQR = 
142 to 377) for the retrospective cohort and median, 196 days (IQR = 126 to 260) for the prospective cohort from initial 
amputation surgery.
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A sensitivity analysis of the 8 (10%) deceased prosthetic rehabilitation patients who 
could not be interviewed was performed for 4, 6, 8 and 12 months after discharge 
from rehabilitation to identify the presence or absence of CPR variables. Date of 
death was used as the termination date for prosthetic use. 
 5.3. Results 
Subjects were interviewed to determine prosthetic outcome from March 2011 until 
December 2012. Figure 5.4 reports the timeframes from the post-operative stage of 
rehabilitation to interview including length of stay and time from initial amputation 
surgery until rehabilitation milestones (e.g. prosthetic casting, fitting and gait 
retraining) were achieved by the total cohort (n = 66). Table 5.1 shows the 
prospective cohort characteristics. Comorbidities (CCI score) were more frequent in 
non-users median = 3 (IQR = 0.5 to 5) than users median = 2 (IQR = 0 to 4).    
 
Of 66 participants interviewed, a total of 83% (55) were prosthetic users and 17% 
(11) were non-users. The multi-factorial, self reported reasons for prosthetic non-use 
in the 11 participants classified as prosthetic non-users have been detailed in table 
5.2. Prosthetic non-use was identical for 4 and 6 month time frames after discharge 
from rehabilitation at 12% (8). This was the same pattern observed in the 
retrospective cohort. At the 8 and 12 month timeframes, 15% (10) and 17% (11) of 
participants respectively were prosthetic non-users.  
 
The survival curves (Figure 5.2) demonstrated a high level of concordance between 
the retrospective and prospective cohorts. Initially there was a rapid progression to 
prosthetic non-use which then became linear after approximately 6 months. Time of 
initial amputation surgery to outpatient physiotherapy discharge were median 238 
days (IQR = 142 to 377) for the retrospective cohort and median, 196 days (IQR = 
126 to 260) for the prospective cohort. Survival of prosthetic use from initial 
amputation surgery for the retrospective and prospective cohorts is shown in Figure 
5.3.  
 
 
 
 
 
92 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4 Timeframes for the prospective cohort (n = 66) from the post-
operative stage of rehabilitation to interview.
Post-operative stage 
• Day 0 Amputation surgery 
• Inpatient length of stay (LOS) median, 15 days (IQR = 8 to 24) 
• Rehabilitation commences with daily physiotherapy as inpatient on Royal 
Perth Hospital (RPH) surgical ward 
• Post-operative assessment by Rehabilitation Physician & Senior 
Physiotherapist Amputee Rehabilitation 
Pre-prosthetic rehabilitation stage 
• Inpatient LOS median, 24 days (IQR = 13 to 36) 
• Specialised amputee inpatient rehabilitation from multidisciplinary team at 
RPH rehabilitation unit 
• 2 physiotherapy sessions per day (see Appendix 2.1 for full intervention 
details) 
Prosthetic rehabilitation stage 
• Outpatient LOS median, 138 days (IQR = 88 to 201), 2 to 3 outpatient 
physiotherapy sessions per week at RPH  
• Amputation surgery to interim prosthetic casting median, 43 days (IQR = 30 
to 71) 
• Amputation surgery to interim prosthetic fitting and commencement of 
prosthetic gait retraining median, 49 days (IQR = 34 to 77) 
• RPH physiotherapists and prosthetists worked collaboratively in the same 
gym during prosthetic gait retraining 
• Interim prosthetic sockets & adjustments performed as required for the 
individual patient  
• Amputation surgery to definitive prosthesis median, 299 days (IQR = 243 to 
380) 
• Definitive prosthesis manufactured, fitted & adjusted by private prosthetic 
service providers in the community 
Interview 
• Outpatient physiotherapy discharge to interview median, 1.3 years (IQR = 1.1 
to 1.4) 
• Amputation surgery to interview median, 1.8 years (IQR = 1.4 to 2.1) 
Physiotherapy Discharge 
• Amputation surgery to outpatient physiotherapy discharge median, 196 days 
(IQR = 126 to 260)  
Timeframes for the prospective cohort (n = 66) with lower limb amputation 
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Table 5.2: Multifactorial reasons for prosthetic non-use reported by 
participants classified as prosthetic non-users (n = 11). 
Multifactorial reasons for prosthetic non-use 
reported by prosthetic non-users (n = 11) 
 
% (n)* 
 
 
Issue with residual limb (stump) 55 (6) 
Issue with remaining Limb 46 (5) 
Pain 36 (4) 
Medical comorbidities 27 (3) 
Prosthetic issue 18 (2) 
Balance issues 9 (1) 
Fear of falling 9 (1) 
Unmotivated 9 (1) 
Unable to don independently 9 (1) 
Falls 0 (0) 
Body Weight fluctuations 0 (0) 
Energy Cost or efficiency 0 (0) 
Amputation of remaining limb 0 (0) 
 
*Participants were able to report more than one reason for not using their prosthesis so the cumulative 
percentage exceeds 100. 
 
 
 
 
94 
 
In the prospective cohort, the associated accuracy statistics for having a combination 
of predictor variables (95% CI) for 4 (& 6), 8 and 12 months were as follows with 
full details reported in Table 5.3:  
 CPR 4 months 
At 4 (& 6) months the 5 variables predictive of prosthetic non-use that were 
validated in the prospective cohort included: amputation level above transtibial, 
using a mobility aid, dependence walking outdoors on concrete, very high number of 
comorbidities (> 19) and a diagnosis of Type 2 diabetes. Very high comorbidities (> 
19) represented the 95th percentile of this cohort. The cohort probability of non-use 
was 12%, however in the presence of 4 out of 5 variables in the CPR the probability 
increased to 86% (p < .0001). This represents a LR+ of 43.9 (CI = 2.73 to 999+), 
sensitivity of 0.38 (CI = 0.12 to 0.44), specificity of 0.99 (CI = 0.96 to 1.0) accuracy 
of 92% and balanced accuracy of 68%. 
 CPR 8 months 
At 8 months the 3 variables predictive of prosthetic non-use that were validated in 
the prospective cohort included: amputation level above transtibial, using a mobility 
aid and dependence walking outdoors on concrete. The cohort probability of non-use 
was 15%. If all 3 predictor variables in the CPR were present, the probability 
increased to 86% (p < .0001), and the LR+ of 33.9 (CI = 2.1 to 999+), sensitivity of 
0.3 (CI = 0.09 to 0.35), specificity of 0.99 (CI = 0.96 to 1.0), accuracy of 89% and 
balanced accuracy of 65%. 
 CPR 12 months 
At 12 months the 3 variables predictive of prosthetic non-use included: amputation 
level above transtibial, delay to prosthesis (> 160 days) and using a mobility aid. 
Delay to prosthesis (> 160 days) represented the 95th percentile of this cohort. The 
causes of delay to prosthetic gait retraining in non-users were: wound complications 
67% (2) and orthopaedic complications 33% (1).  The cohort probability of non-use 
was 17% and if  2 out of 3 predictor variables in the 12 month CPR were present 
then the probability rose to 36% (p = .031). This represented a LR+ of 2.8 (CI = 0.9 
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Table 5.3: Associated accuracy statistics with 95% confidence intervals for having at combination of predictor variables at 4 (& 
6), 8 and 12 months.  
Number of 
Predictors 
present for 
time frame 
Sensitivity Specificity Positive Likelihood 
Ratio 
Negative Likelihood 
Ratio 
Probability of 
prosthetic 
non-use (%) 
 
p value 
4 (& 6) 
months: 
1  
2  
3 
4 
5 
 
 
 
0.94 (0.61 to 1.0) 
0.93 (0.53 to 1.0) 
0.5 (0.19 to 0.81) 
0.38 (0.12 to 0.44) 
0.06 (0 to 0.12) 
 
 
0.14 (0.09 to 0.15) 
0.66 (0.61 to 0.67) 
0.86 (0.82 to 0.90) 
0.99 (0.96 to 1.0) 
0.99 (0.98 to 1.0) 
 
 
1.09 (0.67 to 1.17) 
2.8 (1.36 to 3.03) 
3.6 (1.02 to 8.5) 
43.9 (2.73 to 999+) 
6.9 (0 to 999+) 
 
 
0.43 (04.40) 
0.10 (0 to 0.77) 
0.58 (0.21 to 0.99) 
0.63 (0.56 to 0.92) 
0.95 (0.88 to 1.0) 
 
 
14 
26 
33 
86 
50 
 
 
.519 
.002* 
.013* 
< .0001* 
.259 
8 months: 
1 
2 
3 
 
 
0.90 (0.57 to 0.99) 
0.70 (0.38 to 0.91) 
0.30 (0.09 to 0.35) 
 
 
0.50 (0.44 to 0.52) 
0.82 (0.76 to 0.86) 
0.99 (0.96 to 1.0) 
 
1.8 (1.0 to 2.06) 
3.9 (1.6 to 6.5) 
33.9 (2.1 to 999+) 
 
0.20 (0.01 to 0.98) 
0.37 (0.10 to 0.81) 
0.71 (0.65 to 0.95) 
 
24 
41 
86 
 
.019* 
.001* 
< .0001* 
12 months: 
1 
2 
3 
 
 
0.91 (0.60 to 0.99) 
0.46 (0.19 to 0.72) 
0.09 (0.005 to 0.14) 
 
0.51 (0.45 to 0.53) 
0.84 (0.78 to 0.89) 
0.99 (0.97 to 1.0) 
 
1.85 (1.08 to 2.1) 
2.8 (0.9 to 6.6) 
10.1 (0.19 to 999+) 
 
0.18 (0.009 to 0.9) 
0.65 (0.31 to 1.03) 
0.92 (0.86 to 1.02) 
 
27 
36 
67 
 
.011* 
.031* 
.095 
* p < .05 is significant 
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to 6.6), sensitivity of 0.46 (CI = 0.19 to 0.72), specificity of 0.84 (CI = 0.78 to 0.89), 
accuracy of 77% and balanced accuracy of 65%. 
 
Figures 5.5, 5.6 and 5.7 demonstrate the balanced accuracy for having a combination 
of predictor variables from the CPRs for each of the timeframes. 
 
Of the 10% (8) patients who participated in prosthetic rehabilitation but were 
deceased and could not be interviewed: 38% (3) were deceased and non-users at 4 
months, 62% (5) at 6 months, 62% (5) at 8 months and 88% (7) at 12 months after 
discharge from rehabilitation. There were no significant associations (p > .170) 
between having a number of CPR variables at these time frames after discharge and 
cessation of prosthetic use due to death (see Table 5.4 for full details). 
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Figure 5.5: Prospective clinical utility figure showing the percentage of 
users classified as non-users (False +ve) and non-users correctly 
identified (True +ve) for each risk variable identified for the 4 and 6 
months clinical prediction rules.  
Note: three of five variables present identified 50% of non-users with a 
false prediction of 14%. Four of five variables detected 38% of all non-
users.  
Figure 5.6: Prospective clinical utility figure showing the percentage of 
users classified as non-users (False +ve) and non-users correctly identified 
(True +ve) for each risk variable identified for the 8 months clinical 
prediction rules.  
Note: two of three variables present identified 70% of non-users with a 
false prediction of 18%. Three of three variables detected 30% of all non-
users.  
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Figure 5.7: Prospective clinical utility figure showing the percentage of 
users classified as non-users (False +ve) and non-users correctly identified 
(True +ve) for each risk variable identified for the 12 months clinical 
prediction rules.  
Note: one of three variables present identified 91% of non-users with a 
false prediction of 49%. Two of three variables detected 45% of all non-
users and falsely identified 16% of users.  
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Table 5.4: Significant predictor variables for prosthetic non-use and associated accuracy statistics with 95% confidence intervals for having a combination of predictor variables in the 
deceased sub-group (10% (n=8)).  
*p < .05 is significant. 
Associated accuracy statistics for having a combination of variables (e.g. 1, 2, 3… variables) at each of the time frames 
Number of 
Predictor 
variables 
present 
Sensitivity Specificity Positive Likelihood 
Ratio 
Negative Likelihood 
Ratio 
Probability 
of prosthetic 
non-use (%) 
p value 
1 
2 
3 
4 
5 
0.857 (0.587 to 1.00) 
0.667 (0.148 to 0.97) 
0.143 (0 to 0.413) 
0.143 (0 to 0.286) 
0.143 (0 to 0.286) 
0.200 (0.011 to 0.300) 
0.800 (0.489 to 0.982) 
0.800 (0.700 to 0.989) 
0.909 (0.818 to 1.00) 
0.909 (0.818 to 1.00) 
1.07 (0.594 to 1.43) 
3.33 (0.289 to 54.0) 
0.714 (0 to 37.2) 
1.57 (0 to 999+) 
1.57 (0 to 999+) 
0.714 (0 to 37.2) 
0.417 (0.03 to 1.74) 
1.07 (0.594 to 1.43) 
0.943 (0.714 to 1.22) 
0.943 (0.714 to 1.22) 
43 
67 
33 
50 
50 
.830 
.187 
.830 
.809 
.809 
1 
2 
3 
4 
5 
0.909 (0.737 to 1.00) 
0.400 (0.110 to 0.589) 
0.091 (0 to 0.263) 
0.143 (0 to 0.286) 
0.091 (0 to 0.182) 
0.333 (0.018 to 0.500) 
0.667 (0.184 to 0.982) 
0.667 (0.500 to 0.982) 
0.909 (0.818 to 1.00) 
0.857 (0.714 to 1.00) 
1.36 (0.75 to 2.00) 
1.20 (0.135 to 32.2) 
0.273 (0 to 14.3) 
1.57 (0 to 999+) 
0.636 (0 to 999+) 
0.273 (0 to 14.3) 
0.900 (0.419 to 4.85) 
1.36 (0.751 to 2.00) 
0.943 (0.714 to 1.22) 
1.06 (0.818 to 1.40) 
71 
67 
33 
50 
50 
.376 
.850 
.376 
.809 
.809 
1 
2 
3 
0.909 (0.737 to 1.00) 
0.091 (0 to 0.263) 
0.091 (0 to 0.182) 
0.333 (0.018 to 0.500) 
0.667 (0.500 to 0.982) 
0.857 (0.714 to 1.00) 
1.36 (0.751 to 2.00) 
0.273 (0 to 14.3) 
0.636 (0 to 999+) 
0.273 (0 to 14.3) 
1.36 (0.751 to 2.00) 
1.06 (0.818 to 1.40) 
71 
33 
50 
.376 
.376 
.809 
1 
2 
3 
0.857 (0.722 to 0.929) 
0.286 (0.151 to 0.357) 
0.067 (0 to 0.133) 
0.667 (0.037 to 1.00) 
0.667 (0.038 to 1.00) 
0.667 (0.333 to 1.00) 
2.57 (0.750 to 999+) 
0.857 (0.157 to 999+) 
0.200 (0 to 999+) 
0.214 (0.071 to 7.51) 
1.07 (0.643 to 22.6) 
1.40 (0.867 to 3.00) 
92 
80 
50 
.170 
.908 
.343 
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5.4. Discussion 
CPRs have been developed for a range of medical conditions however, very few 
have been validated which represents the second stage of CPR research methodology 
(Beneciuk et al., 2009; Stiell et al., 1993; Stiell et al., 1996). The CPRs for prosthetic 
non-use in people with lower limb amputation at time frames of  4 (& 6), 8 and 12 
months after discharge from rehabilitation that were derived in the retrospective 
cohort study by Roffman et al. (2014) were statistically validated in this prospective 
study. Three time points for prosthetic non-use were statistically validated with 
people who reported prosthetic non-use at 4 months being identical to those 
prosthetic non-users at 6 months. The number of variables (i.e. 4 out of 5, 3 out 3 and 
2 out of 3) associated with the greatest risk of prosthetic non-use were selected for 
each of the CPR timeframes (as demonstrated in figures 5.5, 5.6 and 5.7).  
 
The CPRs at 4 and 8 months after discharge had positive likelihood ratios of 43.9 
and 33.9 improving prediction accuracy of prosthetic non-use from 12% to 86% and 
15% to 86% respectively. These values statistically represent large shifts in pre-test 
to post-test probability and are consistent with the interpretation that a positive 
likelihood ratio of 5 or greater (Lesher et al., 2006) or greater than 10 (Childs & 
Cleland, 2006; Jaeschke, Guyatt, & Sackett, 1994) is clinically significant. Similar to 
the retrospective study there were sub-groups of prosthetic non-users at 4 and 8 
months after discharge who in addition to having an amputation level above 
transtibial were dependent walking outdoors on concrete and used mobility aids at 
discharge. These validated CPRs at 4 and 8 months have clinical implications for 
patient selection, interventions and targeted models of care. The findings highlight 
that ability to sustain prosthetic gait after discharge from rehabilitation should be an 
early assessment consideration by multidisciplinary teams. 
 
The CPR for 12 months was significantly predictive of prosthetic non-use (p = .031). 
However, the positive likelihood ratio was 2.8 with a small shift in pre-test to post-
test probability from 17% to 36%. This suggests that the CPR for 12 months did not 
have the predictive magnitude or clinical significance of the CPRs for 4 and 8 
months. Amputation level above transtibial, using a mobility aid and delay to 
prosthetic gait retraining were long term predictors of non-use at 12 months after 
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discharge. Similar to other studies (Sansam et al., 2009) the CPR for 12 months after 
discharge highlights the importance of optimising wound and fracture healing and 
commencing prosthetic gait retraining as soon as possible. To improve the clinical 
utility of the CPR for 12 months future research may incorporate a follow-up 
assessment at 6 months after discharge to identify predictors which impact on 
sustained prosthetic use in this sub-group for the subsequent 6 months. 
   
Similar to the retrospective study (Roffman et al., 2014), this prospective study 
demonstrated there was a sub-group of early prosthetic non-users. Individuals at risk 
of early prosthetic non-use are likely to have a combination of the following 
predictor variables: amputation level above transtibial, very high number of 
comorbidities, not have a diagnosis of Type 2 diabetes, use a mobility aid and 
dependence walking outdoors on concrete at discharge. CCI and CA-CCI scores 
suggest that prosthetic non-users were at greater risk of mortality from comorbid 
disease than users (Charlson et al., 1987; Roffman et al., 2014). Amputation level, 
number of comorbidities and the absence of Type 2 diabetes are known predictors 
before patient selection for prosthetic rehabilitation. While absence of Type 2 
diabetes cannot be considered in isolation as it is part of a parsimonious set of 
variables further research is required to determine the interaction of systemic 
comorbidities such as diabetes with other factors which may impact on the early 
prosthetic non-use. Subjective history on ambulatory function prior to amputation 
surgery to identify mobility aid use and ability to walk outdoors on concrete provides 
an early indication of potential to achieve these 2 predictor variables during 
rehabilitation. Past studies (Czerniecki et al., 2012b; Taylor et al., 2005) have 
demonstrated that poor mobility status prior to amputation was a prognostic indictor 
for poor prosthetic outcome. 
  
The survival curves for prosthetic non-use (figure 5.2) demonstrated a high level of 
concordance between the retrospective (Roffman et al., 2014) and prospective 
cohorts suggesting that there was no substantial change in clinical practice during the 
validation study. In both cohorts, initially, there was rapid progression to prosthetic 
non-use followed by a more linear decline to non-use after 6 months. A large 
proportion of the early non-users in both the prospective (63%) and retrospective 
(53%) cohorts ceased prosthetic use immediately after discharge. Large variation has 
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been reported in the literature for abandonment of prosthetic use (range 4% to 53%) 
and the time frame from amputation surgery to prosthetic non-use (range 6 months to 
36 years) (Chamlian, 2014; Gailey et al., 2010; Gauthier-Gagnon et al., 1999; 
Laferrier et al., 2010; McWhinnie, Gordon, Collin, Gray, & Morrison, 1994; 
Schaffalitzky et al., 2012). McWhinnie et al. (1994) reported that in people with 
peripheral arterial disease, prosthetic use was 85% (46) at 1 year after amputation 
surgery but at 5 years had decreased to 31% (17). In our study, prosthetic use at 24 
months after amputation surgery was 81% for the retrospective and 83% for the 
prospective cohorts respectively (figure 5.3). In the USA, the time frame to 
prosthetic abandonment was significantly shorter in war veterans from Operation 
Iraqi Freedom (OIF) / Operation Enduring Freedom (OEF) who had used a range of 
prosthetic technologies than veterans from the Vietnam war who abandoned mainly 
mechanical devices (Gailey et al., 2010; Laferrier et al., 2010). The main, 
multifactorial reasons for prosthetic non-use reported by the retrospective and 
prospective cohorts from our study were: issue with the residual limb (stump), issue 
with the remaining limb, prosthetic issue, pain, medical comorbidities and balance 
issues. Similar reasons for prosthetic non-use have been reported in the literature 
with cumulative trauma to the remaining lower limb from prosthetic gait being a 
major reason for war veterans ceasing prosthetic use and using a wheelchair as their 
primary mobility device (Chamlian, 2014; Gailey et al., 2010; Karmarkar et al., 
2009; Laferrier et al., 2010). 
 
Prosthetic components and innovations that may potentially assist those at risk of 
early prosthetic non-use with achieving functional locomotion are often not 
accessible due to cost and the fact that there is no guarantee that a more expensive 
prosthesis will sustain prosthetic use in this sub-group. Therefore, rehabilitation of 
those at risk of early prosthetic non-use may be best focused on transfers, wheelchair 
mobility, physical fitness, community access and mental wellbeing rather than 
prosthetic gait retraining. If an individual at risk of early prosthetic non-use has a 
trial of prosthetic gait retraining then clear time frames should be set for achievement 
of the locomotor goals. Functional assessment criteria should exist in the amputee 
model of care for progression from an interim to a definitive prosthesis in this early 
non-user sub-group as identification of these patients has potential cost savings for 
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rehabilitation services by minimising the provision of definitive prostheses to non-
users. 
 
The validated predictor variables for prosthetic non-use common to all 3 CPRs were 
amputation level above transtibial and mobility aid use at discharge. Mobility aids 
reduce the functionality of gait by limiting an individual’s ability to carry objects 
while walking but may be necessary to prevent falls (Gauthier-Gagnon et al., 1999). 
Mobility aids ranged from single point sticks to walking frames and were not 
weighted for their associated level of dependence in the statistical analysis. To 
minimise barriers to locomotor activities, health professionals may teach patients to 
walk without aids. In cases where it is not safe for an individual to walk unaided, 
health professionals may provide mobility aids or teach strategies that allow 
individuals to walk and carry objects. Future research into the efficacy of such 
strategies is warranted.  
 
Amputation level above transtibial has been associated in the literature (Nehler et al., 
2003; Taylor et al., 2005) with poor prosthetic outcome therefore surgeons aim to 
preserve the residual limb length to optimise locomotor function. Osseointegration is 
a surgical technique that may potentially improve locomotor outcome for some sub-
groups with transfemoral amputation (Guirao et al., 2016; Hagberg, Hansson, & 
Brånemark, 2014). Our prospective study highlights that health professionals need to 
ensure patients with high levels of amputation are selected appropriately for 
prosthetic gait retraining. Raya et al. (2010) demonstrated that strength of the hip 
extensor muscles and balance were significant predictors of 6 minute walk test 
distance in people with lower limb amputation. This study (Raya et al., 2010) 
provides support for optimising modifiable variables such as muscle strength, 
balance, joint range of movement and cardiovascular fitness so patients can manage 
the energy requirements and skill of prosthetic gait with a higher level of amputation.  
 
This prospective study had some potential limitations and factors that impact on 
generalisation in other healthcare settings. The prosthetic use interview relied on 
participant recall which is a potential source of error. Mortality rate within the review 
period was high for this cohort (n = 8 (10%)) however our sensitivity analysis 
demonstrated that the deceased sub-group did not bias validation of the CPRs. For 
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generalisation into other health care systems it was noted that the number of 
comorbidities and length of delay for the prosthesis may be population or 
institutional sensitive. Therefore other institutes may wish to identify comorbidities 
and delay in prosthetic gait retraining by taking the hospital context and flagging 
individuals who fall in the top 5 to 10 percentiles for each of these categories. 
 
In conclusion, these CPRs for prosthetic non-use at 4, 8 and 12 months after 
discharge have been prospectively validated. The CPRs for prosthetic non-use may 
be used by health professionals to guide their clinical reasoning however it should be 
noted that the CPRs for 4 and 8 months were statistically and clinically more 
significant than the CPR for 12 months after discharge. The study has also validated 
that a sub-group of early prosthetic non-users exist. Individuals with an amputation 
level above transtibial, who use a mobility aid and were unable to walk 
independently outdoors on concrete at discharge were more likely to become 
prosthetic non-users within 8 months of discharge. The evidence from this validation 
study needs to be implemented into the Western Australian amputee rehabilitation 
model of care where the current policy is to trial prosthetic gait retraining in people 
at risk of prosthetic non-use rather than targeting resources into improving quality of 
life, mobility support systems, home and community access. Translational research is 
required to determine if the health systems change of modifying clinical pathways 
for people at risk of prosthetic non-use improves clinical and cost outcomes in 
Western Australia. This study represents level III evidence in CPR research 
methodology. Future multicentre validation of these CPRs is warranted to generate 
the level II evidence for this CPR. 
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Chapter 6 
 6. Locomotor Performance During Rehabilitation of People With Lower Limb Amputation and Prosthetic Nonuse 12 Months After Discharge 
 
 
 
 Synopsis 
 
This chapter is a manuscript published in Physical Therapy Journal: 
 
 
Roffman, Caroline E., Buchanan, John, & Allison, Garry T. (2016). Locomotor 
Performance During Rehabilitation of People With Lower Limb Amputation and 
Prosthetic Nonuse 12 Months After Discharge. Physical Therapy, 96(7), 985-
994. doi: 10.2522/ptj.20140164 
 
This chapter was presented at the following conferences: 
15thWorld Congress of the International Society for Prosthetics and Orthotics (ISPO), 
22nd to 25th June 2015, Lyon, France. 
 
Australian New Zealand Society for Vascular Surgery (ANZSVS), 13th to 16th October 
2017, Perth, Western Australia 
 
Momentum 2017 Physiotherapy Conference, Australian Physiotherapy Association, 19th 
to 21st October 2017, Sydney, Australia. 
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Chapter 7  Construct validity of locomotor tests 
 7. Construct validity of locomotor tests in people with lower limb amputation. 
 Introduction  
There has been limited research on the psychometric properties of locomotor tests that 
may be used by health professionals during prosthetic rehabilitation and in the long term 
follow-up stage of rehabilitation for people with lower limb amputation (Heinemann et 
al., 2014; Resnik & Borgia, 2011). Validity is when a test accurately measures the 
domain it was designed to test (Hattie & Cooksey, 1984; Heale & Twycross, 2015). The 
3 main categories of validity are content, construct and criterion validity (Hattie & 
Cooksey, 1984). An improved understanding of a test’s validity contributes to clinical 
utility by assisting health professionals with interpretation of the test in the cohort of 
interest (Smart, 2006).  
 
Predictive validity is a sub-type of criterion validity that is present if a test can identify a 
future outcome (Hattie & Cooksey, 1984). Chapter 6 of this thesis explored whether 
locomotor tests performed during rehabilitation had predictive validity, by developing 
performance thresholds for locomotor tests that identified increased risk of prosthetic 
non-use at 12 months after discharge (Roffman et al., 2016b).  
 
Construct validity is a form of validity that is present when a test effectively measures a 
construct or abstract concept (Megens, Harris, Backman, & Hayes, 2007). The known 
groups method has been used to establish construct validity of a test by statistically 
distinguishing between 2 groups that are clinically known to differ and validated across 
multiple sources in the literature (Hattie & Cooksey, 1984; Megens et al., 2007). The 
known groups method has been used to test the scale of outcome measures in many 
clinical cohorts including lower limb amputation, stroke and infants with neuromotor 
delay (Gailey et al., 2002; Gailey et al., 2013; Golicki et al., 2015; Megens et al., 2007). 
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Gailey et al. (2002) used the known groups method to demonstrate the construct validity 
of the Amputee Mobility Predictor (AMP) for Medicare Functional Classification Levels 
(MFCL). Construct validity was tested in people with different levels of amputation for 
the Comprehensive High-Level Amputee Mobility Predictor (CHAMP) (Gailey et al., 
2013). 
 
Convergent validity is a sub-type of construct validity that is present when a test 
correlates with other tests that measure a similar domain (Heale & Twycross, 2015). 
Convergent validity can be calculated parametrically using the Pearson correlation and 
non-parametrically using the Spearman rank correlation depending on the data 
distribution (Golicki et al., 2015; Lin & Bose, 2008).  
 
Part A Balance and Locomotor function in known groups with lower limb amputation at high risk of prosthetic non-use. 
 
Part B Activity and participation levels after discharge from rehabilitation self reported by people with lower limb amputation. 
 
Chapter 7 of this thesis investigated construct and convergent validity of locomotor tests 
that may be used following lower limb amputation. In part A of Chapter 7 the 
locomotor tests including the 10 metre walk test (10MWT), timed up and go test 
(TUGT), 6 minute walk test (6MWT) and Four Square Step Test (FSST) were analysed 
using the known groups method and for convergent validity. In part B the locomotor 
capabilities index 5 (LCI5) was analysed using the known groups method. Long term, 
self reported activity and participation levels of people with lower limb amputation were 
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also measured in part B. In these studies, the known groups that were identified from 
the literature as at high risk of prosthetic non-use include people with above transtibial 
amputation level, bilateral lower limb amputation, diabetes, Aboriginal ethnicity, older 
age (> 58), atraumatic cause and high comorbidities (> 19) (Roffman et al., 2014; 
Sansam et al., 2009; Schoppen et al., 2003; Taylor et al., 2005; van Eijk et al., 2012; Vos 
et al., 2009; Webster et al., 2012). In this study, part-time prosthetic users (people who 
functionally use their prosthesis < 7 days per week) were also included as a high risk 
group for prosthetic non-use in the known groups analysis. Key points from the studies 
in part A and B have been summarised in the combined discussion at the end of 
chapter 7. 
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Chapter 7-A    
 
Part A 7.1. Balance and Locomotor function in known groups with lower limb amputation at high risk of prosthetic non-use.  
 
 
 Synopsis 
This chapter reports findings of a known groups analysis for performance measures 
including the 10MWT, TUGT, 6MWT and FSST that may be used during rehabilitation 
of people with lower limb amputation. The chapter forms a manuscript being prepared 
for peer review submission.   
 
This chapter was presented at the following conferences: 
15thWorld Congress of the International Society for Prosthetics and Orthotics (ISPO), 
22nd to 25th June 2015, Lyon, France. 
 
Australian New Zealand Society for Vascular Surgery (ANZSVS), 13th to 16th October 
2017, Perth, Western Australia 
 
Momentum 2017 Physiotherapy Conference, Australian Physiotherapy Association, 19th 
to 21st October 2017, Sydney, Australia. 
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Abstract 
Background: There is limited data for balance and locomotor performance of people 
with lower limb amputation who are undergoing rehabilitation to inform clinical 
decision making.  
Objectives: To gain knowledge on the balance and locomotor skills of known groups at 
high risk of discontinuing prosthetic use and test the construct validity of the 10MWT, 
TUGT, 6MWT and FSST in these groups. 
Design: Retrospective cohort study  
Methods: Descriptive variables and 10m walk (10MWT), timed up and go (TUGT), 6 
minute walk (6MWT) and four square step (FSST) tests were abstracted from the 
medical records for 201 consecutive participants with lower limb amputation. 
Participants were classified as in known high or low risk groups and the Mann Whitney 
U Test was used to analyse if there were differences in locomotor test performance.  
Results: Performance on locomotor tests were significantly impaired for people in 
known groups at high risk of prosthetic non-use including those with above transtibial 
amputation level, older age, bilateral amputation and high comorbidities (p < .025). 
However, performance on locomotor tests, were not significantly different (p > .449) for 
Aboriginal people and on the 10MWT and TUGT for the diabetes and atraumatic sub-
groups (p > .075).  
Limitations: Missing data, low numbers of participants in some known groups and 
assessment times varied. 
Conclusions: The 10MWT, TUGT, 6MWT and FSST have construct validity as they 
significantly differentiated between the locomotor performance of known groups at high 
risk of prosthetic non-use including above transtibial amputation level, older age, 
bilateral amputation and high comorbidities. However, it appears that the 6MWT was 
the best marker of locomotor performance during rehabilitation as it distinguished 
between all the groups at high and low risk of prosthetic non-use. 
  
Key words: Performance measures, lower extremity, amputation, leg prosthesis, 
rehabilitation outcome 
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Balance and Locomotor function in known groups with lower limb amputation at high risk of prosthetic non-use.  7.1.1. Introduction  
Locomotor tests may be used during prosthetic rehabilitation of people with lower limb 
amputation as they provide health professionals with objective information on a client’s 
potential to walk indoors, outdoors and to negotiate obstacles in complex walking 
environments (Dite et al., 2007; Franchignoni et al., 2004; Gailey et al., 2002; Schoppen 
et al., 1999). Although locomotor tests measure rehabilitation outcome and enhance 
communication between clients, clinicians, administrators and funding organisations less 
than 50% of health professionals routinely use locomotor tests during rehabilitation 
(Gaunaurd et al., 2015; Jette et al., 2009; Wong et al., 2016a). Some commonly 
perceived barriers to the implementation of locomotor tests in clinical practice include 
lack of time, space, equipment, knowledge, training and confidence with test 
administration and difficulty with interpretation (Gaunaurd et al., 2015; Jette et al., 
2009).  
  
To assist with interpretation of locomotor tests in lower limb amputation cohorts 
Roffman et al. (2016b) developed performance criteria for the 10 metre walk test 
(10MWT), Timed up and go test (TUGT), 6 minute walk test (6MWT) and Four square 
step test (FSST) that were moderately predictive of prosthetic non-use after discharge 
(see Table 7.1A). This study established predictive validity and clinical utility for the 
10MWT, TUGT, 6MWT and FSST during amputee rehabilitation as clients’ locomotor 
skills progressed (Roffman et al., 2016b).  
 
One of the gaps identified in the literature was the need for a known groups analysis to 
improve understanding of balance and locomotor skills in sub-groups at high risk of 
abandoning prosthetic use after rehabilitation discharge (Heinemann et al., 2014; 
Roffman et al., 2016b; Rogers & Stevens, 2015a, 2015b; Stevens, 2010; Wong et al., 
2016a). Known groups analyses have been used to determine construct validity for tests 
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Table 7.1A: Performance measure thresholds from ROC curve analysis and associated accuracy statistics (95% CI) for 
people who become prosthetic non-users at 12 months after discharge  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 (Roffman et al., 2016b). 
 
 
Performance 
Measure 
Optimal 
Performance 
Threshold 
(Criteria) for 
Prosthetic Non-
use (Roffman et 
al., 2016b)  
Sensitivity (%) Specificity (%) Area Under the 
Curve  
Youden Index 
J 
Relative Risk 
of prosthetic 
non-use 
p value 
10MWT < 0.44 ms-1 66.7  
(49.0 to 81.4) 
75.8  
(68.2 to 82.4) 
0.743 
(0.675 to 0.804) 
0.425 2.76  
(1.83 to 3.79) 
< .0001 
6MWT < 191 m 80.6 
(64.0 to 91.8) 
71.6 
(64.0 to 78.4) 
0.788 
(0.724 to 0.843) 
0.522 2.84  
(2.05 to 3.48) 
< .0001 
TUGT > 21.4 s 75.0 
(57.8 to 87.9) 
78.3 
(70.9 to 84.6) 
0.796 
(0.731 to 0.851) 
0.533 3.17  
(2.17 to 4.14) 
< .0001 
FSST > 36.6 s 80.6 
(64.0 to 91.8) 
71.4 
(63.6 to 78.4) 
0.762 
(0.694 to 0.820) 
0.520 2.76  
(1.99 to 3.39) 
< .0001 
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by demonstrating ability to significantly distinguish between groups that are known to 
differ in the literature based on the presence or absence of a characteristic (Gailey et al., 
2002; Gaunaurd, 2012; Hattie & Cooksey, 1984; Megens et al., 2007). Another form of 
construct validity is convergent validity which is demonstrated when a high level of 
correlation exists between tests that measure similar functional domains (Gailey et al., 
2013; Gaunaurd, 2012). An example of convergent validity is increased 6MWT distance 
as time decreases for TUGT (Bhangu et al., 2009).  
 
People at high risk of discontinuing prosthetic use include those with above transtibial 
amputation level, bilateral lower limb amputation, diabetes, Aboriginal ethnicity, older 
age, atraumatic cause and high comorbidities (Roffman et al., 2014; Sansam et al., 2009; 
Schoppen et al., 2003; Taylor et al., 2005; van Eijk et al., 2012; Vos et al., 2009; 
Webster et al., 2012). These high risk groups have impairments that potentially reduce 
walking speed, distance and balance limiting their ability to perform locomotor activities 
with a prosthesis but in contrast to other clinical populations (Asher, Aresu, Falaschetti, 
& Mindell, 2012; Dite & Temple, 2002; Forrest et al., 2014; Gardner, Katzel, Sorkin, & 
Goldberg, 2002; Jenkins, 2007; Shumway-Cook, Brauer, & Woollacott, 2000; Tilson et 
al., 2010; van Hedel, 2009) there is a paucity of performance data to assist with 
interpretation of locomotor tests in lower limb amputation cohorts (Akarsu, Tekin, 
Safaz, Goktepe, & Yazicioglu, 2013; Dite et al., 2007; Gailey et al., 2002; Heinemann et 
al., 2014; Resnik & Borgia, 2011; Stevens, 2010).  
 
People with high level and bilateral lower limb amputation may have impaired 
locomotor and balance function due to the increased energy cost of walking, decreased 
lever length of their residual limb and lack of proprioception from multiple prosthetic 
joint components (Akarsu et al., 2013; Erjavec et al., 2014; Gailey et al., 2002; 
Gaunaurd, 2012; Starholm et al., 2016; Su, Gard, Lipschutz, & Kuiken, 2008). 
Asymmetrical movement patterns have been identified in biomechanical studies as 
contributing to slower performance of locomotor activities such as sit to stand in people 
with unilateral lower limb amputation (Agrawal, Gailey, Gaunaurd, Gailey, & O'Toole, 
2011; Burger, Kuzelicki, & Marincek, 2005). Reduced walking speed, distance and 
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balance have been reported for older participants with atraumatic causes of amputation 
(Erjavec et al., 2014; Schoppen et al., 1999; Su et al., 2008; van Eijk et al., 2012; Waters 
et al., 1976). In many of these atraumatic cases of amputation the remaining limb is in a 
pre-amputation state with claudication pain or diabetic peripheral neuropathy limiting 
locomotor performance. It is unclear which locomotor tests are most valid in the clinical 
setting for assessment of heterogenous rehabilitation cohorts that have high variance in 
physical fitness, amputation cause, age and comorbidities. To date studies have been 
small, focused samples of convenience (e.g. military service personnel, experienced 
prosthetic users), specific groups (e.g. unilateral, transtibial) or have involved 
biomechanical analyses that are not easily replicated in busy clinical settings (Agrawal 
et al., 2011; Akarsu et al., 2013; Burger et al., 2005; Resnik & Borgia, 2011).  
 
In Aboriginal people (who were the first inhabitants of Australia), poor health outcomes 
due to geographical isolation from health services, high diabetes related amputation and 
mortality rates have been well documented (Norman et al., 2010; Vos et al., 2009). 
Language barriers, cultural and health beliefs also have the potential to impact on access 
to healthcare and functional outcome following lower limb amputation (Schoen et al., 
2010). However, amputation has been the primary endpoint of research and performance 
on locomotor tests using a prosthetic limb has not been investigated for Aboriginal 
people (Norman et al., 2010; Schoen et al., 2010; Vos et al., 2009). 
 
The hypotheses for this generated study were:  
1. That people with lower limb amputation in known groups at high risk of abandoning 
prosthetic use will have slower walking speeds, reduced distance and increased time for 
balance tasks on locomotor tests than those in lower risk groups during rehabilitation; 
and  
2. That the 10MWT, TUGT, 6MWT and FSST will be highly correlated as they all test a 
common domain of locomotor function.  
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Therefore, the study objectives were to gain knowledge on the balance and locomotor 
skills of known groups at high risk of abandoning prosthetic use and test the construct 
validity of the 10MWT, TUGT, 6MWT and FSST.  7.1.2. Methods Participants 
The Royal Perth Hospital (RPH) and Curtin University Human Research Ethics 
Committees approved this study (full details in Appendix 3.1). A research assistant who 
was unknown to potential participants recruited and obtained informed verbal consent 
from participants to abstract details from the medical records.  
 
Participants were included if: they had at least one recent major lower limb amputation 
(i.e. transtibial level or above) as their primary admission diagnosis, multiple limb 
amputation, lived in the community, were ambulant before amputation surgery, were 
Medicare Functional Classification Level (MFCL) K-level 1 to 4, had received 
prosthetic rehabilitation and been discharged from Royal Perth Hospital (RPH), the state 
centre for amputee rehabilitation. Recent major lower limb amputation was defined as 
surgery in the weeks or months preceding rehabilitation admission. This classification 
enabled identification of new amputee rehabilitation cases from multi-diagnostic cases 
with past medical history of amputation (e.g. fractured neck of femur and past 
amputation).      
 
K-levels were assigned collaboratively in the post-operative period by the Rehabilitation 
Physician and Senior Physiotherapist (who had 10 years of clinical experience in 
amputee rehabilitation) as part of the RPH assessment procedure for rehabilitation 
admission based on criteria outlined in Roffman et al. (2014). K-levels have been 
defined by Gailey et al. (2002).  
 
K-level 0 participants and those who did not consent were excluded from this study. K-
level 0 participants were monitored through the multidisciplinary amputee outpatient 
clinic for the duration of this study and remained K-level 0.  
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The flow chart in Chapter 6 Figure 1 details participant eligibility and recruitment into 
this study. A total of 307 consecutive potential participants were identified from the 
Amputee Physiotherapy Service Database from June 2006 to July 2011 and 264 of these 
participants were K-level 1 to 4 however 37 participants were deceased. A total of 201 
of the 211 eligible participants (95%) were recruited for this study.  
 Rehabilitation Intervention 
RPH, the state centre for amputee rehabilitation, provides comprehensive 
multidisciplinary rehabilitation for approximately 85% of all individuals with lower limb 
amputation in Western Australia (Department of Health, 2008; Roffman et al., 2014). 
Chapter 6, eAppendix, eFigure 1 summarises the 5 stages of amputee rehabilitation at 
RPH (Department of Health, 2008; Department of Veterans Affairs, 2008), service 
demographics and rehabilitation interventions (see Chapter 2, Appendix 2.1 and 
Roffman et al. (2016b) for full intervention details). Physiotherapy commenced in the 
post-operative stage once participants were medically stable. To achieve discharge home 
to the community, K-level 0 to 4 participants received multidisciplinary inpatient 
rehabilitation. K-level 1 to 4 participants received approximately 2 to 3 sessions per 
week of outpatient physiotherapy with discharge determined by individualised 
rehabilitation goals. 
 Data Collection During Rehabilitation 
The RPH amputee rehabilitation senior physiotherapist routinely assessed locomotor 
milestones to monitor rehabilitation progress and for patient goal setting. Once 
participants were able to walk outside the parallel bars they were assessed using the 
10MWT, TUGT, 6MWT and FSST. Procedures, scoring and psychometric properties 
for these performance measures are reported in Chapter 6 e-appendix. The senior 
physiotherapist amputee rehabilitation trained all physiotherapy staff working in the 
amputee rehabilitation division in the standardised administration procedures for the 
10MWT, TUGT, 6MWT and FSST. The physiotherapy staff trained in locomotor test 
administration, had 1 to 10 years of clinical experience. Standardised equipment was 
used to administer these tests for all participants. Type of mobility aids used and if 
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participants were unable to attempt, independently perform or complete any of the 
performance measures were recorded on the physiotherapy data collection sheet. The 
physiotherapist repeated performance measure assessments as participants progressed 
during rehabilitation from using mobility aids (e.g. walking frames, elbow crutches and 
sticks) to walking without aids. 
  Procedure 
Performance measure data (i.e. date, results, mobility aid use) and cohort descriptive 
variables were retrospectively abstracted from the medical records by the senior 
physiotherapist. Chapter 6 Figure 2 details the abstracted descriptive variables, 
performance measure data and assessment timeframes relative to physiotherapy 
discharge. 
 
In this study, above transtibial amputation level was defined as knee disarticulation level 
or above (Roffman et al., 2014). Major bilateral lower limb amputation was defined as 
transtibial amputation level or above of both lower limbs (Roffman et al., 2014). The 
type and number of medical comorbidities (including musculoskeletal pathology and 
mental health issues) were counted and recorded for each participant (Roffman et al., 
2014). Charlson Comorbidity Index (CCI) and age adjusted CCI were calculated 
(Charlson et al., 1987; Charlson, Szatrowski, Peterson, & Gold, 1994; Hall et al., 2004) 
for each participant. 10MWT, 6MWT, TUGT and FSST performance assessed closest to 
discharge were analysed for this study.  
 Statistical analysis 
Walking speed (ms-1), distance (metres) and time (seconds) were derived from the 
10MWT, 6MWT, TUGT and FSST data. In this study, the known groups at high risk of 
prosthetic non-use were identified from review of the literature (Roffman et al., 2014; 
Sansam et al., 2009; Schoppen et al., 2003; Taylor et al., 2005; van Eijk et al., 2012; Vos 
et al., 2009; Webster et al., 2012) and included: Aboriginal ethnicity, older age (>58 
years), above transtibial amputation level, bilateral lower limb amputation, atraumatic 
amputation cause, diabetes and high number of comorbidities (>19). Full methodology 
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for the previously validated prosthetic non-use criteria of age (>58 years) and high 
number of comorbidities (>19) were reported by Roffman et al. (2014). These criteria 
were generated using receiver operating characteristic (ROC) curves with an equal 
balance of sensitivity and specificity and the chi squared test to determine likelihood 
ratio of prosthetic non-use (Roffman et al., 2014). From the medical record data 
participants were classified as in these known groups “yes” or “no”. Using these binary 
classifications performance measure data were analysed.  
 
Shapiro Wilk tests demonstrated that the performance measure data were not normally 
distributed p < .01. Non-parametric analyses using the Mann-Whitney U test (95% 
Confidence Intervals (CI)) were performed to determine if differences were significant 
between rankings of locomotor test performances for those in known groups at high or 
low risk of prosthetic non-use.  
 
Spearman rank correlation coefficients were calculated for the total cohort to generate a 
correlation matrix and determine if there were any relationships between the 10MWT, 
TUGT, 6MWT and FSST. 
 
The proportion of participants in high risk groups with the locomotor test prosthetic non-
use criteria (Roffman et al., 2016b) (see table 7.1A for criteria) present were calculated. 
The descriptive amputation, demographic and comorbidity variables obtained from the 
medical record were analysed for the total cohort.  
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Data scoring and reduction 
Chapter 6 Figure 2 details the percentage of participants with missing performance 
measure data who were excluded from the statistical analyses. Participants with missing 
data did not systematically differ from the tested cohort in terms of demographic or 
amputation details. The main reasons that performance measure data were missing 
included: participants being medically unfit to attempt the test (e.g. stump wound), 
declining to perform the test or not attending their outpatient appointment.  
 
Participants who were unable to complete or perform the assessment during 
rehabilitation were included in the statistical analyses (see Chapter 6 Figure 2). These 
participants could not independently perform or attempt the locomotion tests (i.e. 
required physical assistance from another person or used their prosthesis for transfers 
only). To enable statistical analyses, these participants were scored as “0” for the 
10MWT and 6MWT (tests where low scores reflect poor performance) (Forrest et al., 
2014; Scrivener, Schurr, & Sherrington, 2014; van Hedel, 2009) and “999” for the 
TUGT and FSST (tests where high scores reflect poor performance). As non-parametric 
(distribution free) statistics were used in this study, assigning the lowest (“0”) and 
highest (“999”) scores for those unable to perform the test allowed this important sub-
group to be analysed (Conover & Iman, 1981; Hajian-Tilaki, Hanley, Joseph, & Collet, 
1997). This contributed to the external validity of the clinical study. Similar statistical 
management of participants unable to perform locomotor tests has been documented in 
the spinal and stroke literature (Forrest et al., 2014; Scrivener et al., 2014; van Hedel, 
2009). 
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7.1.3. Results 
Table 7.2A outlines demographic, comorbidity and amputation characteristics for the 
total cohort from the medical record abstraction.  
 Locomotor Performance of known groups  
Table 7.3A details locomotor test results of the known groups at high and low risk of 
prosthetic non-use. High risk groups including above transtibial amputation, older age 
(>58 years), bilateral amputation and high comorbidities had significantly poorer 
performances (z > 2.23, p < .025) on all of the locomotor tests. Locomotor performance 
of Aboriginal people was not significantly poorer (z < 0.760 p > .449) for the 10MWT, 
TUGT, 6MWT and FSST than non-Aboriginal people. In the diabetes and atraumatic 
groups, 10MWT and TUGT performance were not significantly poorer (z < 1.77, p > 
.075) than low risk groups.  
 Prosthetic non-use criteria and known groups 
Table 7.4A demonstrates that people at high risk of prosthetic non-use including those 
with above transtibial amputation, bilateral amputation and high comorbidities had the 
greatest proportion of participants with prosthetic non-use criteria for the 10MWT, 
TUGT, 6MWT and FSST present.  
 Correlation Matrix 
Relationships between performance measures are shown in a correlation matrix (See 
Appendix 7.1A, Table 7.5A). 10MWT velocity had strong negative correlations with 
TUGT (rs = - .84, p < .0001) and FSST (rs = - .77, p < .0001) and a strong positive 
correlation with 6MWT distance (rs = .79, p < .0001). 6MWT distance had strong 
negative correlations with TUGT (rs = - .85, p < .0001) and FSST (rs = - .86, p < .0001). 
TUGT had a strong positive correlation with the FSST (rs = .85, p < .0001).  
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Table 7.2A: Demographic, comorbidity and amputation details abstracted 
from the medical records for the total cohort. 
Demographic, Comorbidity and Amputation Details 
 
Total cohort 
(n = 201) 
 
Gender, Male, n (%) 161 (80) 
Age at amputation, mean (SD) 55.5 (15.5) 
Aboriginal, n (%) 23 (14) 
Accommodation after discharge from inpatient rehabilitation, n (%)  
Home (not residential care) 196 (98) 
Metropolitan (not country) 114 (57) 
Charlson Comorbidity Index (CCI), median (IQR) 2 (1 to 4) 
Combined Age CCI, median (IQR) 4 (1 to 6) 
Comorbidities, n (%)  
Diabetes Type I 12 (6) 
                       Type II 84 (42) 
Peripheral Arterial Disease 106 (53) 
Cardiac Condition 75 (37) 
Renal Failure 32 (16) 
       Cerebrovascular accident / Transient Ischemic Attack 17 (8) 
Arthritis 69 (34) 
Remaining Lower Limb Pathology 161 (80) 
Amputation Cause, n (%)  
Circulatory 52 (26) 
Infection 87 (43) 
Trauma 54 (27) 
Cancer 8 (4) 
Amputation Level, n (%)  
Transtibial 163 (81) 
Knee disarticulation 7 (3) 
Transfemoral 62 (31) 
Major Bilateral Lower Limb Amputation  31 (15.4) 
Bilateral transtibial 
Transtibial & transfemoral 
Knee disarticulation & transfemoral 
Bilateral transfemoral 
Minor Amputation of Remaining Limb*  
Toe amputation 
Transmetatarsal amputation 
Ankle disarticulation 
19 (9.5) 
8 (4) 
1 (0.5) 
3 (1.5) 
21 (10) 
18 (9) 
2 (1) 
1 (0.5) 
Upper Limb Amputation/s 20 (10) 
*Minor amputation of the remaining limb was defined as ankle disarticulation and below including partial foot and toe 
amputations.
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Table 7.3A: Median, interquartile range and Mann Whitney U test performance measure results for known groups at 
high and low risk of prosthetic non-use. 
Known Group Classifications for Performance measures n1 n2 n1 median (IQR) n2 median (IQR) U 
score 
Z 
score 
p 
value 
Aboriginal vs. Non-Aboriginal 10MWT (ms-1) 28 161 0.64 (0.26 to 0.91) 0.63 (0.36 to 0.94) 2370 0.432 .667 
6MWT (m) 28 170 262 (115 to 330) 240 (120 to 362) 2525 0.516 .609 
 TUGT (s) 28 160 16.7 (10.8 to 31.6) 14.0 (9.2 to 27.3) 2442 0.760 .449 
 FSST (s) 27 163 19.4 (13.9 to 999*) 19.8 (12.4 to 999*) 2204 0.013 .993 
Age > 58 vs. < 58 years 10MWT (ms-1) 87 102 0.54 (0.31 to 0.85) 0.72 (0.40 to 1.08) 5272 2.23 .025 
6MWT (m) 91 107 198 (107 to 294) 292 (168 to 410) 6442 3.92 < .001 
TUGT (s) 90 98 16.9 (10.5 to 31.0) 12.0 (8.1 to 21.9) 5266 2.30 .02 
 FSST (s) 90 100 43.5 (15.7 to 999*) 14.7 (11.2 to 38.9) 6122 4.29 < .001 
Above transtibial  vs. transtibial amputation 10MWT (ms-1) 57 132 0.37 (0.21 to 0.64) 0.75 (0.48 to 1.0) 5494 5.02 < .001 
6MWT (m) 64 134 148 (77 to 243) 284 (169 to 405) 6161 4.97 < .001 
 TUGT (s) 59 129 23.5 (15.4 to 44.6) 11.4 (8.03 to 19.1) 5752 5.62 < .001 
 FSST (s) 57 133 999* (25.4 to 999*) 15.5 (11.5 to 999*) 5527 5.00 < .001 
Bilateral vs. unilateral amputation 10MWT (ms-1) 30 159 0.42 (0.26 to 0.83) 0.67 (0.40 to 0.94) 3012 2.28 .022 
6MWT (m) 31 167 136 (44 to 360) 250 (127 to 359) 3269 2.32 .020 
 TUGT (s) 29 159 29.5 (11.8 to 56) 13.1 (9.2 to 23) 3074 2.85 .004 
 FSST (s) 29 161 999* (15.4 to 999*) 18.8 (12.1 to 999*) 2943 2.23 .025 
Diabetes vs. no diagnosis 10MWT (ms-1) 89 100 0.63 (0.30 to 0.88) 0.66 (0.39 to 1.09) 5027 1.54 .121 
6MWT (m) 94 104 229 (117 to 312) 257 (134 to 400) 5724 2.08 .037 
 TUGT (s) 92 96 14.8 (10.2 to 31.1) 13.2 (8.9 to 23.9) 4936 1.39 .160 
 FSST (s) 93 97 28.2 (14.6 to 999*) 17.6 (10.9 to 999*) 5621 2.93 .003 
High  (>19) vs. low (< 19) comorbidities 10MWT (ms-1) 18 171 0.29 (0.23 to 0.49) 0.69 (0.40 to 0.95) 2299 3.44 < .001 
6MWT (m) 18 180 126 (84.8 to 232) 248 (127 to 366) 2302 2.94 .003 
 TUGT (s) 18 170 27.4 (19.3 to 44.5) 13.3 (9.19 to 24.5) 2177 2.95 .003 
 FSST (s) 18 172 999* (55 to 999*) 18.6 (12.1 to 999*) 2326 3.50 < .001 
Atraumatic vs. traumatic amputation 10MWT (ms-1) 50 139 0.60 (0.31 to 0.90)  0.76 (0.43 to 1.08) 4064 1.77 .075 
6MWT (m) 54 144 224 (113 to 330) 299 (216 to 405) 4975 3.03 .002 
 TUGT (s) 47 141 15.4 (9.6 to 30) 12.3 (8.4 to 21.2) 3828 1.59 .109 
 FSST (s) 49 141 28.2 (14.5 to 999*) 13 (10.5 to 30.2) 4724 3.83 < .001 
*999 represents medians and IQR of participants who were unable to perform the FSST.
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Table 7.4A: Proportion of participants in high risk groups for prosthetic non-
use with the 10MWT, TUGT, 6MWT and FSST prosthetic non-use criteria. 
 
Known Groups at high risk of 
prosthetic non-use 
Prosthetic non-use criteria for locomotor tests 
10MWT 
(< 0.44ms-1)* 
% (n) 
TUGT 
(> 21.4s)* 
% (n) 
6MWT 
(< 191m)* 
% (n) 
FSST 
(> 36.6s)* 
% (n) 
Aboriginal ethnicity 
 
36 (10) 36 (10) 43 (12) 30 (8) 
Age (> 58 years) 
 
37 (32) 40 (36) 49 (45) 51 (46) 
Above transtibial amputation level 
 
54 (31) 59 (35) 59 (38) 65 (37) 
Bilateral lower limb amputation 
 
53 (16) 55 (16) 61 (19) 55 (16) 
Diabetes 
 
37 (33) 37 (34) 40 (38) 44 (41) 
High Comorbidities (> 19) 
 
67 (12) 67 (12) 72 (13) 83 (15) 
Atraumatic amputation cause 
 
35 (48) 36 (51) 44 (64) 44 (62) 
 
*Thresholds by Roffman et al. (2016b)    
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7.1.5. Discussion 
This study has demonstrated that people in groups at high risk of prosthetic non-use 
including those with above transtibial amputation, bilateral amputation, high 
comorbidities and older age have significantly slower walking speed, reduced walking 
distance and impaired balance compared to low risk groups. The locomotor tests have 
construct validity for use during rehabilitation as they distinguished between all groups 
at high and low risk of prosthetic non-use following lower limb amputation except the 
Aboriginal sub-group for 10MWT, TUGT, 6MWT and FSST; the diabetes and 
atraumatic sub-groups for 10MWT and TUGT.  
 
The findings for Aboriginal participants support earlier research by Roffman et al. 
(2014) that there were environmental, sociocultural and model of care factors 
contributing to this positive locomotor outcome. This was important as rehabilitation 
models of care should manage potential barriers such as language, geographical isolation 
from services, cultural and health beliefs to optimise the outcomes of people regardless 
of ethnicity (Schoen et al., 2010).  
 
Atraumatic and diabetic group findings for the 10MWT and TUGT were a major point 
of difference between our study and the literature as slower walking speeds and poor 
balance have been demonstrated for people with vascular causes of amputation 
(Schoppen et al., 2003; Schoppen et al., 1999; Su et al., 2008; Waters et al., 1976). 
However, ceiling effect has been reported for TUGT in people with lower limb 
amputation so this locomotor test may not be sensitive enough to discriminate between 
known groups during the later stages of rehabilitation (Deathe & Miller, 2005). Another 
potential rationale for the TUGT findings that requires further research is that 
participants with diabetic peripheral neuropathy may have adapted to walking without 
proprioception prior to their amputation and prosthetic gait retraining. McDermott et al. 
(2010) reported that walking speed was not associated with ankle brachial index and 
intermittent claudication symptoms in people with peripheral arterial disease however 
walking endurance in 6MWT was significantly associated. Consistent with this study 
(McDermott et al., 2010), our 10MWT results for the atraumatic and diabetic groups 
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may suggest that tests of walking endurance such as the 6MWT were better indicators of 
locomotor impairment.  
 10MWT 
There have been limited studies of the 10MWT in lower limb amputation cohorts and 
the methodology used differed from our study (Akarsu et al., 2013; Franchignoni et al., 
2004; Tekin, Safaz, Göktepe, & Yazýcýođlu, 2009). Soldiers from the Turkish armed 
forces with unilateral amputation (n = 15, median = 1.3ms-1) had significantly slower (p 
< .001) walking speed than those with bilateral (n = 15, median = 1.0ms-1) amputation 
(Akarsu et al., 2013). In our study, participants in the 75th quartile of the young, 
transtibial and traumatic groups performed at similar speeds to those reported by Akarsu 
et al. (2013) while all other participants had slower walking speeds. Franchignoni et al. 
(2004) reported gait speed as 1.11 ms-1 in people with transtibial amputation and 0.41 
ms-1 in people with transfemoral amputation which was similar to the above transtibial 
amputation group in this study. Similar to past studies (Akarsu et al., 2013; Franchignoni 
et al., 2004; Su et al., 2008; Tekin et al., 2009; Waters et al., 1976; Wong et al., 2016a), 
our participants with above transtibial amputation, bilateral amputation, older age and 
high comorbidities walked at significantly slower speeds than those with unilateral 
transtibial amputation, low comorbidities and younger age.  
 TUGT 
The TUGT has been used as a measure of dynamic balance function in amputation 
cohorts with a time of 19 seconds or greater associated with increased risk of multiple 
falls (Dite et al., 2007; Resnik & Borgia, 2011; Salavati et al., 2011; Schoppen et al., 
2003; Schoppen et al., 1999; van Eijk et al., 2012).  Consistent with the literature (Dite 
et al., 2007; Salavati et al., 2011; Schoppen et al., 2003; Schoppen et al., 1999; van Eijk 
et al., 2012), our study found significantly slower times in those with above transtibial 
amputation, bilateral amputation, high comorbidities and older age. In people with above 
transtibial and bilateral amputation slower times may be related to difficulty with sit to 
stand and turning when walking due to reduced proprioception, the need to control more 
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prosthetic joints and increased reliance on upper limb and trunk strength for locomotor 
activities (Burger et al., 2005; Linberg et al., 2013).  
 6MWT 
6MWT was used by Gailey et al. (2002) to validate the Amputee Mobility Predictor and 
the 6MWT is a good test of endurance locomotor function in amputation cohorts. 
6MWT distance for people with lower limb amputation varies widely in studies with 
distances over 800 metres reported in fit, young cohorts such as military service 
personnel who have traumatic amputation cause (Akarsu et al., 2013; Erjavec et al., 
2014; Gailey et al., 2002; Gailey et al., 2013; Linberg et al., 2013; Tekin et al., 2009). 
Reduced walking distances have been reported in those who were older, had atraumatic 
amputation cause, high comorbidities, transfemoral and bilateral amputations (Erjavec et 
al., 2014; Gailey et al., 2002; Raya et al., 2010). In a study of participants with 
transfemoral amputation from vascular causes (n = 101), 6MWT distance ranged from 
22 to 203 metres (median = 85 metres) which was lower than our study findings for the 
above transtibial and atraumatic amputation cause groups (Erjavec et al., 2014). 
Significant differences for the diabetes and atraumatic groups from their low risk groups 
supports the claudication research that tests of endurance such as 6MWT were more 
likely to reveal walking impairment (McDermott et al., 2010).   
 FSST 
Ability to dual task and perform multidirectional movement is important for outdoors 
ambulation and to walk in complex contexts (Dite et al., 2007; Gailey et al., 2013; 
Gaunaurd, 2012). Although FSST performance was significantly different for all of the 
groups, floor effect was detected.  A high proportion of the total cohort were unable to 
perform the FSST by discharge or were at greater risk of having multiple falls as they 
required >24 seconds to complete this test (Dite et al., 2007). Inability to perform the 
FSST was most pronounced in above transtibial amputation level, bilateral amputation 
and high comorbidities groups. An important part of this test is single prosthetic limb 
balance which may be a difficult task using a prosthetic knee joint, in people with 
bilateral lower limb amputation or comorbidities that affect balance. The results may 
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indicate that more high level balance skills need to be incorporated into the rehabilitation 
program. These findings suggest that the FSST has greatest utility in younger people 
with transtibial and traumatic amputation cause as these groups were able to perform the 
test.  
 Relationship between performance measures 
This study has shown that tests of walking speed, distance and balance have convergent 
validity as they were highly correlated with strong positive or negative relationships 
(Gailey et al., 2013; Gaunaurd, 2012). This supports earlier findings by Roffman et al. 
(2016b) where the locomotor tests had similar AUC (Area Under the Curve) and RR 
(Relative Risk) for predicting prosthetic non-use and correlation coefficients reported in 
the literature between TUGT and 6MWT (r = -.76, p = .004) and FSST and TUGT (r = 
.88, p < .001) (Dite et al., 2007; Lin & Bose, 2008).  
 Prosthetic non-use criteria 
A higher proportion of the performance thresholds for prosthetic non-use developed by 
Roffman et al. (2016b) were present in the groups with above transtibial amputation 
level, bilateral lower limb amputation and high comorbidities. These high risk groups 
have all been associated with prosthetic non-use in the literature (Roffman et al., 2014; 
Sansam et al., 2009; Schoppen et al., 2003; Taylor et al., 2005; Webster et al., 2012). 
 Clinical and Research Implications  
These study findings have shown that locomotor tests distinguish between high risk 
groups including those with above transtibial amputation, bilateral amputation and high 
comorbidities and lower risk groups. In heterogenous lower limb amputation cohorts 
where physical skill levels vary it is important that locomotor tests are sensitive for low 
and high performance. These results highlight the locomotor skills that lower limb 
amputation cohorts with different characteristics have difficulty in performing and form 
the first stage in developing normative data for amputee rehabilitation cohorts and to 
guide physiotherapy and prosthetic interventions. As a large proportion of the case mix 
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have diabetes and atraumatic amputation it may be suggested that the 6MWT is the best 
locomotor test for distinguishing between high and low risk groups and defining 
capacity to walk outdoors however further research is required to validate these findings.   
 Limitations 
There were some limitations with this study which have implications for interpretation 
of these results. There were missing retrospective locomotor test data and some known 
groups had small numbers which were a potential sources of bias. Individuals who were 
unable to attempt, independently perform or complete the tests were included and while 
their inclusion did not impact on the distribution free statistical analysis, this sub-group 
highlights the limitations of the more difficult performance measures in the 
heterogeneous cohorts with amputation (Roffman et al., 2016b). Performance measure 
assessment timeframes varied as it was dependent on the participants’ individualised 
rehabilitation progress. Future studies may control assessment times. Low numbers in 
some of the sub-groups investigated. In addition, Australia has a very low proportion of 
military personnel that have sustained amputation. Veterans with amputation, their 
associated rehabilitation models of care and funding have some fundamental differences 
from the Western Australian public health context.  
 7.1.6. Conclusion 
This study has demonstrated that tests of varying locomotor demand (i.e. 10MWT, 
6MWT, TUGT and FSST) may have construct validity when used during rehabilitation 
to evaluate locomotor performance in people with lower limb amputation. The four tests 
effectively discriminated between locomotor performance of groups at high risk of 
prosthetic non-use including above transtibial amputation level, older age, bilateral 
amputation, high comorbidities and those with lower risk. The locomotor tests were 
highly correlated which suggests they all measure a common functional domain. 
However, it appears that the 6MWT was the most sensitive and therefore has some 
clinical utility as a locomotor test as it differentiated between all the known groups 
including people with diabetes and atraumatic amputation.   
 
 
142 
 
 
Chapter 7-B 
 
Part B 7.2. Activity and participation levels after discharge from rehabilitation self reported by people with lower limb amputation. 
 
 
 
 
 Synopsis 
Long term activity and participation (including locomotor function, return to driving and 
work) following lower limb amputation have been described in this chapter. A known 
groups analysis of the LCI5 has been performed. Components of this chapter form a 
paper for publication in the future and were presented at the: 
  
International Society for Prosthetics and Orthotics (ISPO) 15th World Congress in Lyon, 
France, June 22nd to 25th June 2015.  
 
ISPO 16th World Congress in Cape Town, South Africa, May 8 to 11 2017. 
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Abstract 
Objectives: The objectives of this study were:  
1. To describe activity and participation levels including transfers, wheelchair or 
motorised scooter use, hopping, locomotor activities using a prosthesis, return to driving 
and work after discharge from rehabilitation in people with lower limb amputation.  
 
2. To determine if the locomotor capabilities index 5 (LCI5) has construct validity as a 
measure of long term locomotor function in known groups at high risk of prosthetic non-
use and groups with lower risk. 
 
3. To investigate if return to driving and work were associated with dichotomous 
variables including being a prosthetic user, transtibial amputation level, younger age, not 
having diabetes, traumatic amputation cause, metropolitan residence, unilateral lower 
limb amputation, self reported walking distance of > 500m and male gender.  
 
4. To describe complications of amputation including residual limb pathology, 
remaining lower limb pathology and falls after discharge from rehabilitation in people 
with lower limb amputation.  
  
Method: 201 consecutive tertiary rehabilitation participants from Royal Perth Hospital 
were interviewed using the LCI5 and a questionnaire on complications of amputation, 
activity and participation levels. Medical records were abstracted and descriptive 
statistics generated for the cohort. Chi squared analysis was used to determine if the 
presence or absence of dichotomous variables were associated (Confidence Intervals 
(CI) 95%) with return to driving or work in sub-groups who were drivers and workers 
prior to their amputation. Mann Whitney U Tests were used to compare locomotor 
capabilities of the prosthetic users and non-users and prosthetic users in known high and 
lower risk groups of prosthetic non-use.  
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Results: At median, 1.5 (IQR, 1.2 to 2.2) years after discharge, 74% (n = 149) of 
participants were prosthetic users. Long term wheelchair use and residual limb 
pathology were 71% (n = 143) and 72% (n = 144) respectively.  
 
LCI5 scores were significantly different (z > 2.10, p < .036) for all known groups at high 
risk of prosthetic non-use except the Aboriginal and above transtibial amputation level 
(z < 1.56, p < .12) groups. The maximum LCI5 score of 56 points was reported by 25% 
of the cohort and ceiling effect was demonstrated for the scale. 
 
A total of 61% (n = 122) of participants were drivers and 45% (n = 91) of participants 
were workers prior to their amputation. The rates of return to driving and work were 
91% (n = 111) and 62% (n = 56) respectively for these sub-groups. Return to driving 
was significantly associated being a prosthetic user (Positive likelihood ratio (+LR) = 
1.59, p = .006). Return to work was significantly associated with being a prosthetic user 
and transtibial amputation level (+LR < 2.36, p < .006).  
  
Conclusion: Rates of return to driving and work were similar to previous studies. The 
LCI5 has construct validity as a self reported locomotor outcome measure. However, 
25% of the total cohort reported maximum LCI5 scores which suggests the LCI5 scale 
may be less sensitive when measuring long term locomotor function or once locomotor 
capabilities have improved above a specific threshold. Further investigation of 
locomotor outcome measures to implement in the long term follow-up phase of amputee 
rehabilitation is warranted.    
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Activity and participation levels after discharge from rehabilitation self reported by people with lower limb amputation.  7.2.1. Introduction 
There is a paucity of information regarding outcomes of people with lower limb 
amputation following discharge from Australian rehabilitation centres (Hordacre et al., 
2013b; Jones et al., 1993; Lim et al., 2006; Roffman et al., 2014; Wu et al., 2010). 
Australian research (Hordacre et al., 2013b; Lim et al., 2006; Wu et al., 2010) has 
focused on population demographics, institution specific variables (e.g. average length 
of stay, time to prosthetic fitting) and function at discharge. Therefore limited 
knowledge exists on long term functional outcomes in people with lower limb 
amputation for the domains of activity and participation including transfers, wheelchair 
or motorised scooter use, hopping, locomotor activities using a prosthesis, return to 
driving and work. Depending on the model of care and associated time frames, some of 
these activity and participation milestones may be achieved after rehabilitation discharge 
and not captured by current outcome measures (e.g. Functional Independence Measure 
(FIM)) or healthcare data collection systems. Comorbidities and complications of 
amputation such as falls, residual and remaining limb pathology have the potential to 
limit activity and participation levels (Burger, 2012; Gailey et al., 2008; Kulkarni, 2008). 
It is vital for health professionals, administrators and funding organisations to know if 
the functional outcomes of individuals selected for rehabilitation inventions are 
sustained after discharge for future resource utilisation, model of care planning and 
funding. 
 
The FIM is used to report on inpatient rehabilitation outcomes of clinical cohorts 
(including amputation) and informs funding of health services (Eagar, 2011; Hordacre et 
al., 2013b). However, the FIM has limitations as an outcome measure for amputation 
cohorts due to lack of responsiveness and ceiling effect observed in the scale (Condie et 
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al., 2006; Franchignoni et al., 2004; Heinemann et al., 2014). The FIM is the main 
outcome measure used by Australian rehabilitation services and is only assessed at 
inpatient admission and discharge. In Western Australia, the FIM is only capturing pre-
prosthetic locomotor function during the inpatient admission because prosthetic gait 
retraining is conducted as an outpatient rehabilitation service  so due to the model of 
care, data on full locomotor capacity is not being collected (Department of Health, 2008; 
Roffman et al., 2014). These issues highlight a need for a locomotor outcome measure 
that is clinically relevant for amputation cohorts throughout the rehabilitation continuum 
and easy to administer in outpatient and community settings.  
 
The Locomotor Capabilities Index (LCI) and Locomotor Capabilities Index 5 (LCI5) are 
amputee specific locomotor outcome measures that generate a score based on a person’s 
self reported ability to complete basic and advanced locomotor activities (Agrawal, 
Skrabek, Embil, Gross, & Trepman, 2014; Condie et al., 2006; Gauthier-Gagnon et al., 
1999; Gauthier-Gagnon & Grisé, 2006; Heinemann et al., 2014). Psychometric 
properties of the LCI (Gauthier-Gagnon & Grise, 1994) and LCI5 (Franchignoni et al., 
2004; Larsson, Johannesson, Andersson, & Atroshi, 2009; Salavati et al., 2011) have 
been investigated during rehabilitation with limited studies on locomotor function post-
discharge (Agrawal et al., 2014; Czerniecki et al., 2012a; Czerniecki et al., 2012b; 
Gauthier-Gagnon et al., 1999). Assessment of locomotor function post-discharge is 
important as prosthetic prescription involves long term costs to healthcare services, 
however capacity to safely ambulate with a prosthesis is not necessarily maintained as 
people age (Schoppen et al., 2003). Australian studies (Gordon et al., 2010; Stepien, 
Cavenett, Taylor, & Crotty, 2007) have not used the LCI5 to measure long term 
locomotor outcomes after discharge from rehabilitation in sub-groups with lower limb 
amputation. 
 
Abandonment of prosthetic use after rehabilitation discharge and poorer locomotor 
function have been associated with high or multiple limb amputation, older age, 
atraumatic cause, comorbidities, impaired pre-morbid mobility and functional level 
achieved during rehabilitation (Roffman et al., 2014; Schoppen et al., 2003; Taylor et al., 
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2005). Roffman et al. (2014) identified that diabetes, Aboriginal ethnicity and 
geographical isolation from health services were not predictors of prosthetic non-use 
after discharge. However, further research into self reported locomotor function is 
warranted because factors associated with poor health outcomes (i.e. diabetes, increased 
chronic disease burden) have been well documented in Aboriginal people (Norman et 
al., 2010; Vos et al., 2009).  
 
Construct validity is demonstrated when the scale of an outcome measure has sensitivity 
to discriminate between low and high performance in sub-groups which are known to 
differ in the literature (Hattie & Cooksey, 1984; Megens et al., 2007). Knowledge of 
long term locomotor capabilities after rehabilitation discharge by sub-groups at high risk 
of prosthetic non-use including people with Aboriginal ethnicity, older age, amputation 
above transtibial level, bilateral lower limb amputation, diabetes, very high number of 
comorbidities, atraumatic amputation cause and part-time prosthetic users (< 7 days per 
week) would allow health professionals to develop targeted models of care to improve 
rehabilitation outcome and optimise allocation of resources.  
 
The objectives of this study were:  
1. To describe activity and participation levels including transfers, wheelchair or 
motorised scooter use, hopping, locomotor activities using a prosthesis, return to driving 
and work after discharge from rehabilitation in people with lower limb amputation.  
 
2. To determine if the locomotor capabilities index 5 (LCI5) has construct validity as a 
measure of long term locomotor function in known groups at high risk of prosthetic non-
use and groups with lower risk. 
 
3. To investigate if return to driving and work were associated with dichotomous 
variables including being a prosthetic user, transtibial amputation level, younger age, not 
having diabetes, traumatic amputation cause, metropolitan residence, unilateral lower 
limb amputation, self reported walking distance of > 500m and male gender.  
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4. To describe complications of amputation including residual limb pathology, 
remaining lower limb pathology and falls after discharge from rehabilitation in people 
with lower limb amputation.   
 7.2.2. Methods Participants 
Royal Perth Hospital and Curtin University Ethics approval were obtained for this study 
(see Appendix 3.1). Participants were recruited by an independent research assistant who 
obtained informed verbal consent for an interview. 
 
Participants were included if: they had at least one recent major lower limb amputation 
(i.e. transtibial level or above), had multiple limb amputation, were community dwelling 
and ambulant prior to amputation, were Medicare Functional Classification Level 
(MFCL) K-level 1 to 4, had participated in and been discharged from prosthetic 
rehabilitation at Royal Perth Hospital, the state centre for amputee rehabilitation 
(Roffman et al., 2014). K-level classifications are defined in Gailey et al. (2002).  
 
Participants were excluded if they did not meet the inclusion criteria, were K-level 0 (i.e. 
not prosthetic rehabilitation candidates), unable to communicate or did not consent 
(Roffman et al., 2014). K-level 0 participants were monitored in multidisciplinary 
outpatient clinic and remained K-level 0. 
 
A total of 307 consecutive tertiary rehabilitation patients with lower limb amputation 
were identified as potential participants from the Amputee Physiotherapy Services 
Database from June 2006 to July 2011. A flow diagram (see Figure 7.1B) demonstrates 
the participant eligibility and recruitment into this study. 
 
 
 
149 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.1B: Flow diagram of participant recruitment and eligibility for this study. 
 
Total number of consecutive tertiary rehabilitation potential participants identified in the 
Amputee Physiotherapy Services Database from June 2006 to July 2011  
n = 307 
Total number of eligible 
participants 211 
Final response rate for 
interview  
n = 201 (95%)  
K-level 0 not prosthetic 
rehabilitation candidates 
n = 43 (14%) 
K-level 1 to 4 prosthetic users at discharge 
n = 264 (86%) 
K-level 1 to 4 deceased  
n = 37 (14%) 
Excluded  
n = 16  
Not major lower 
limb amputation  
n = 3  
Still participating 
in rehabilitation  
n = 13  
Did not consent  
n = 3 
Unable to contact 
had moved n = 7  
K-level 0 deceased 
n = 19 (44%) 
Total contacted  
n = 204  
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Rehabilitation Intervention 
RPH provides a comprehensive multidisciplinary rehabilitation program for inpatients 
and outpatients. K-level 0 to 4 participants received inpatient rehabilitation to achieve 
independent wheelchair mobility, transfers and discharge home to the community. 
Prosthetic rehabilitation was performed by K-level 1 to 4 participants as an outpatient 
service at the dedicated state amputee rehabilitation service, Royal Perth Hospital (RPH) 
which rehabilitates approximately 85% of all individuals with lower limb amputation in 
Western Australia (Department of Health, 2008). 
 
Details of physiotherapy and prosthetic interventions are reported in Roffman et al. 
(2014) (and reported in full detail in Chapter 2, appendix 2.1). Participants received 2 to 
3 sessions per week of outpatient rehabilitation for median, 163 (IQR, 98 to 264) days 
and were fitted with an interim prosthesis at median, 51 (IQR, 34 to 96) days after initial 
amputation. Participants were progressed through a standardised gait retraining program 
and received prosthetic care during physiotherapy gait retraining sessions from onsite 
prosthetists. Participants were discharged from physiotherapy when they achieved their 
individualised rehabilitation goals. Once gait retraining was completed and residual limb 
volume had stabilised participants were referred by the multidisciplinary rehabilitation 
team for a definitive prosthesis at median, 314 days (IQR 229 to 415) after initial 
amputation surgery. Figure 7.2B details the timeframes from the post-operative stage of 
rehabilitation to interview including length of stay and time from initial amputation 
surgery until rehabilitation milestones (e.g. prosthetic casting, fitting and gait retraining) 
were achieved by the total cohort (n = 201). 
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Figure 7.2B: Timeframes for the total cohort (n = 201) from the post-
operative stage of rehabilitation to interview. 
Post-operative stage 
• Day 0 Amputation surgery 
• Inpatient length of stay (LOS) median, 17 days (IQR = 9 to 30) 
• Rehabilitation commences with daily physiotherapy as inpatient on Royal 
Perth Hospital (RPH) surgical ward 
• Post-operative assessment by Rehabilitation Physician & Senior 
Physiotherapist Amputee Rehabilitation 
Pre-prosthetic rehabilitation stage 
• Inpatient LOS median, 23 days (IQR = 13 to 38) 
• Specialised amputee inpatient rehabilitation from multidisciplinary team at 
RPH rehabilitation unit 
• 2 physiotherapy sessions per day (see Appendix 2.1 for full intervention 
details) 
Prosthetic rehabilitation stage 
• Outpatient LOS median, 163 days (IQR = 98 to 264), 2 to 3 outpatient 
physiotherapy sessions per week at RPH  
• Amputation surgery to interim prosthetic casting median, 44 days (IQR = 28 
to 89) 
• Amputation surgery to interim prosthetic fitting and commencement of 
prosthetic gait retraining median, 51 days (IQR = 34 to 96) 
• RPH physiotherapists and prosthetists worked collaboratively in the same 
gym during prosthetic gait retraining 
• Interim prosthetic sockets & adjustments performed as required for the 
individual patient  
• Amputation surgery to definitive prosthesis median, 314 days (IQR = 219 to 
415) 
• Definitive prosthesis manufactured, fitted & adjusted by private prosthetic 
service providers in the community 
Interview 
• Outpatient physiotherapy discharge to interview median, 1.5 years (IQR = 1.2 
to 2.2) 
• Amputation surgery to interview median, 2.7 years (IQR = 2.2 to 3.2) 
Physiotherapy Discharge 
• Amputation surgery to outpatient physiotherapy discharge median, 212 days 
(IQR = 129 to 328)  
Timeframes for the total cohort (n = 201) with lower limb amputation 
 
 
152 
 
Study Instruments 
The LCI5 is a 14 item questionnaire (Appendix 7.1B, Table 7.1B) that uses a 5 point 
ordinal scale (Franchignoni et al., 2007; Franchignoni et al., 2004). The scale range is as 
follows: 0 = No; 1 = Yes, if someone helps me; 2 = Yes if someone is near me; 3 = Yes, 
alone with ambulation aids; and 4 = Yes, alone without ambulation aids (Franchignoni et 
al., 2007; Franchignoni et al., 2004). This 5 point scale was developed to reduce the 
ceiling effects observed in the LCI (Franchignoni et al., 2007; Franchignoni et al., 2004; 
Gauthier-Gagnon et al., 1999). Participants can score a maximum of 28 for basic and 
advanced activities and total score of 56 (Franchignoni et al., 2007; Franchignoni et al., 
2004). The LCI5 can be self administered, performed in person or as a telephone 
interview (Franchignoni et al., 2007; Franchignoni et al., 2004; Gauthier-Gagnon et al., 
1999) and takes approximately 5 minutes to administer (Franchignoni et al., 2007; 
Franchignoni et al., 2004; Larsson et al., 2009).  
 
A questionnaire (Appendix 7.2B) developed and previously piloted by the Senior 
Physiotherapist Amputee Rehabilitation (with 10 years clinical experience) was 
administered to measure demographic details, amputation details, general health, 
transfers, wheelchair and motorised scooter use, hopping, prosthetic use, mobility aid 
type and use, falls history since amputation surgery, pain, remaining and residual limb 
pathology, return to driving and work. The questionnaire was approximately 15 minutes 
in duration. 
 Procedure 
Medical records were abstracted for medical history, demographic, amputation and 
rehabilitation details blind to participant interviews. Participants were interviewed using 
the questionnaire and LCI5.  
 
In this study, participants were classified as prosthetic users if they used their prosthesis 
for locomotor activities (e.g. transfers, standing, walking) on one or more week days. 
Prosthetic users were asked on which days they used their prosthesis and for one day of 
normal activity how long they wore the prosthesis; how many sit to stands they 
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performed; and the duration they performed prosthetic walking and standing activities. 
Verbal prompts were used to improve recall accuracy of prosthetic wearing and use (e.g. 
Do you put your prosthesis on when you first wake up? What time do you take off your 
prosthesis to go to bed?). From this information normal prosthetic use over one week 
was calculated for each participant. Self reported maximum walking distance before 
resting (for a recovery time frame selected by the participant) was also recorded for 
participants. Participants were classified as full-time prosthetic users if the used their 
prosthesis on all 7 week days and part-time users if they used their prosthesis < 7 days.  
 
Participants were prosthetic non-users if they did not use their prosthetic limb on any 
days for locomotor activities or wore their prosthesis for cosmesis only. Non-users were 
asked to recall how many months after physiotherapy discharge they ceased using their 
prosthesis and their reasons for non-use. Important calendar events (e.g. last amputee 
outpatient clinic, birthday, Christmas) were used as verbal prompts to assist with recall 
accuracy. 
 
Participants were instructed to answer the LCI5 questions based on their current 
perceived level of locomotor function and were asked, “Whether or not you use your 
prosthesis at the present time, would you say that you are able to do the following 
activities with your prosthesis on?” (Franchignoni et al., 2007; Franchignoni et al., 
2004; Gauthier-Gagnon et al., 1999). Basic, Advanced and Total LCI5 scores were 
calculated for all participants. Participants were interviewed from 4 months onwards 
after discharge and re-interviewed at approximately 6 monthly intervals until data were 
collected for 12 months. Participants were interviewed by telephone, in person and via 
telehealth videoconference. In remote Aboriginal communities, interviews were 
coordinated between the senior physiotherapist, country physiotherapists, community 
nurses and Aboriginal health workers.  
 
From the questionnaire it was recorded if participants had returned to driving and the 
type of modifications (if required) that had been done to the motor vehicle. Occupation, 
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return to work, study, retirement and disability support pension details were obtained 
through the participant interview.  
 
The Australian Standard Classification of Occupations (ASCO) (McLennan, 1997) were 
used to classify participant’s occupations into 9 major groups including: managers and 
administrators; professionals; associate professionals; tradespersons and related workers; 
advanced clerical and service workers; intermediate clerical, sales and service workers; 
intermediate production and transport workers; elementary clerical, sales and service 
workers; and labourers and related workers.  
 Statistical Methods  
Participants were classified as prosthetic users or non-users from the interview and LCI5 
scores were recorded for these groups. The participants who had remained prosthetic 
users were further classified into known groups at high and lower risk of prosthetic non-
use. Median and interquartile ranges were calculated for the LCI5 scores of the 
prosthetic non-users and users, prosthetic users in the known groups, prosthetic users 
who returned to driving and work. 
 
In this study, known groups at high and lower risk of prosthetic non-use were 
determined from the literature (Roffman et al., 2014; Schoppen et al., 2003; Taylor et 
al., 2005) and the dichotomous classifications for statistical analyses were: Aboriginal 
and non-Aboriginal, age > 58 and < 58 years, above transtibial and transtibial 
amputation level, diabetes and no diagnosis, part-time and full-time prosthetic users, 
very high number of comorbidities (> 19) and low comorbidities (< 19), atraumatic and 
traumatic amputation causes and bilateral and unilateral lower limb amputation. The 
thresholds used to dichotomise the continuous variables of age and number of 
comorbidities were generated by Roffman et al. (2014) (see chapter 4) using receiver 
operator characteristic (ROC) curves with an equal weighting of sensitivity and 
specificity.  
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Shapiro-wilk tests demonstrated LCI5 data were not normally distributed (p < .01) so 
non-parametric analyses using the Mann-Whitney U tests (MWUT) were performed to 
determine if differences in locomotor function between known high and lower risk 
groups were significant. The distribution of Basic, Advanced and Total LCI5 scores 
(from minimum to maximum), were examined for the total cohort and individual known 
groups. 
 
Descriptive statistics were calculated for the prosthetic user and non-user characteristics 
and questionnaire data on complications of amputation, activity and participation levels 
for the total cohort. Depending on the distribution of the data, cohort characteristics for 
prosthetic users and non-users were analysed using 2 proportion Z tests. Time from 
discharge to interview, time to prosthetic milestones and length of outpatient 
rehabilitation were calculated.  
 
Participants who were drivers and workers prior to amputation were recorded. Age and 
Charlson Comorbidity Index (CCI) score were calculated for the sub-groups who were 
drivers, non-drivers, workers and non-workers prior to amputation. In participants who 
were drivers and workers prior to amputation, chi squared analysis was used to 
determine if the presence or absence of dichotomous variables including being a 
prosthetic user, having traumatic amputation cause, transtibial amputation level, no 
diabetes, younger age (< 58 years), metropolitan residence, unilateral lower limb 
amputation, self reported walking distance > 500m and male gender were associated 
(Confidence Intervals 95%) with return to driving or work.  
 7.2.3. Results 
Participants were interviewed at median, 1.5 years (IQR, 1.2 to 2.2) after discharge from 
rehabilitation (full details of timeframes for length of stay and rehabilitation milestones 
have been reported in figure 7.2B). The final interview response rate was 95% (n = 201). 
A total of 74% (n = 149) of participants reported being prosthetic users. The 
multifactorial self reported reasons for prosthetic non-use by the 52 participants 
classified as prosthetic nonusers have been detailed in Table 7.2B 
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Table 7.2B: Multifactorial reasons for prosthetic non-use reported by 
participants classified as prosthetic non-users (n = 52). 
Multifactorial reasons for prosthetic non-use 
reported by prosthetic non-users (n = 52) 
 
% (n)* 
 
 
Issue with residual limb (stump) 40 (21) 
Issue with remaining Limb 29 (15) 
Prosthetic issue 25 (13) 
Pain 25 (13) 
Medical comorbidities 21 (11) 
Balance issues 12 (6) 
Fear of falling 8 (4) 
Energy Cost or efficiency 6 (3) 
Unmotivated 6 (3) 
Amputation of remaining limb 6 (3) 
Unable to don independently 6 (3) 
Body Weight fluctuations 4 (2) 
Falls 2 (1) 
 
*Participants were able to report more than one reason for not using their prosthesis so the cumulative 
percentage exceeds 100. 
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Appendix 7.3B Table 7.3B details the characteristics of prosthetic users and non-users 
from the medical record abstraction.  
 Activity and participation levels without a prosthesis  
Appendix 7.4B Table 7.4B details the frequency of mobility activities without a 
prosthesis such as transfers, hopping, wheelchair and motorised scooter use performed 
by a cohort with lower limb amputation after discharge from rehabilitation. A total of 
71% (n = 143) of the cohort still used a wheelchair for activities of daily living and 64% 
(n = 91) of prosthetic users still used a wheelchair.  
 Activity and participation levels with a prosthesis 
 LCI5 for Prosthetic Non-users and Users 
Basic locomotor capabilities reported by prosthetic non-users (median, 11 IQR, 3 to 21) 
were significantly lower (z = 8.27, p < .001) than users (median, 28 IQR, 22 to 28). 
Advanced locomotor capabilities reported by prosthetic non-users (median, 4 IQR, 1 to 
11) were significantly lower (z = 8.13, p < .001) than users (median, 24 IQR, 18 to 28). 
Total locomotor capabilities reported by prosthetic non-users (median, 16 IQR, 6 to 31) 
were significantly lower (z = 8.33, p < .001) than users (median, 51 IQR, 41 to 56). 
 Known groups analysis of LCI5 in long term prosthetic users at high and low risk of prosthetic non-use 
Locomotor capabilities were as follows for the participants that remained prosthetic 
users in the known high and lower risk groups for prosthetic non-use (full details in 
Table 7.5B): 
 Indigenous status 
Basic, Advanced and Total Locomotor Capabilities reported by Aboriginal participants 
were not significantly lower (z < 1.17, p > .25) than non-Aboriginal participants. 
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Table 7.5B: Known user group median (IQR) and Mann-Whitney U Test results for LCI5 Basic, Advanced and Total scores. 
(* p < .05)
Known Groups  n1 median (IQR) n2 median (IQR) U score z score p value 
Aboriginal (n = 18) vs. Non-
Aboriginal (n = 131)         
Basic LCI5 Score 28 (22 to 28) 28 (22 to 28) 1182 0.02 .99 
Advanced LCI5 Score 22 (16 to 26) 25 (18 to 28) 1380 1.17 .25 
Total LCI5 Score 48 (40 to 54) 52 (42 to 56) 1342 0.95 .34 
Age > 58 (n = 81) vs. < 58 years (n = 
68)         
Basic LCI5 Score 26 (22 to 28) 28 (26 to 28) 3430 2.57 .009* 
Advanced LCI5 Score 22 (16 to 26) 28 (20 to 28) 3680 3.53 < .001* 
Total LCI5 Score 46 (39 to 54) 56 (46 to 56) 3704 3.62 < .001* 
Amputation level above transtibial (n 
= 35) vs. transtibial (n = 114)         
Basic LCI5 Score 23 (22 to 28) 28 (23 to 28) 2344 1.56 .12 
Advanced LCI5 Score 22 (16 to 28) 25 (18 to 28) 2178 0.82 .41 
Total LCI5 Score 44 (38 to 56) 52 (43 to 56) 2244 1.11 .27 
Diabetes (n = 67) vs. no diagnosis (n = 
82)         
Basic LCI5 Score 26 (22 to 28) 28 (24 to 28) 3498 2.86 .004* 
Advanced LCI5 Score 21 (16 to 26) 27 (21 to 28) 3774 3.92 < .001* 
Total LCI5 Score 45 (38 to 54) 55 (44 to 56) 3759 3.86 < .001* 
Part-time (n = 16) vs. Full-time User 
(n = 133)         
Basic LCI5 Score 22 (17 to 23) 28 (23 to 28) 1669 3.71 < .001* 
Advanced LCI5 Score 13 (9 to 20) 25 (19 to 28) 1790 4.45 < .001* 
Total LCI5 Score 34 (26 to 42) 53 (43 to 56) 1777 4.37 < .001* 
High comorbidities (n = 9) vs. Low 
comorbidities (n = 140)         
Basic LCI5 Score 21 (7 to 26) 28 (22 to 28) 975 2.75 .005* 
Advanced LCI5 Score 18 (2 to 24) 25 (18 to 28) 895 2.11 .034* 
Total LCI5 Score 39 (9 to 50) 52 (42 to 56) 926 2.36 .017* 
Amputation Cause Atraumatic (n = 
106) vs. Traumatic (n = 43)         
Basic LCI5 Score 26 (22 to 28) 28 (28 to 28) 2926 2.71 .006* 
Advanced LCI5 Score 22 (17 to 27) 28 (26 to 28) 3230 3.98 < .001* 
Total LCI5 Score 47 (40 to 55) 56 (54 to 56) 3216 3.93 < .001* 
Bilateral (n = 13) vs. Unilateral 
Amputation (n = 136)         
Basic LCI5 Score 22 (17 to 26) 28 (23 to 28) 1282 2.68 .006* 
Advanced LCI5 Score 17 (12 to 21) 25 (18 to 28) 1292 2.75 .005* 
Total LCI5 Score 36 (29 to 47) 53 (43 to 56) 1292 2.74 .005* 
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Age  
Basic, Advanced and Total Locomotor Capabilities reported by older participants aged > 
58 years were significantly lower (z > 2.57, p < .009) than younger participants aged < 
58 years.  
 Amputation level 
Basic, Advanced and Total Locomotor Capabilities reported by participants with 
amputation level above transtibial were not significantly lower (z < 1.56, p > .12) than 
participants with transtibial amputation level. 
 Diabetes 
Basic, Advanced and Total Locomotor Capabilities reported by participants with 
diabetes were significantly lower (z > 2.86, p < .004) than participants with no 
diagnosis. 
 Part-time and Full-time Prosthetic Users 
Basic, Advanced and Total Locomotor Capabilities reported by part-time prosthetic 
users were significantly lower (z > 3.71, p < .001) than full-time prosthetic users. 
 Comorbidities 
Basic, Advanced and Total Locomotor Capabilities reported by participants with very 
high comorbidities were significantly lower (z > 2.11, p < .034) than participants with 
low comorbidities.  
 Amputation Cause 
Basic, Advanced and Total Locomotor Capabilities reported by participants with 
atraumatic amputation causes were significantly lower (z > 2.71, p < .006) than 
participants with traumatic amputation causes. 
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Bilateral and Unilateral Amputation 
Basic, Advanced and Total Locomotor Capabilities reported by participants with 
bilateral lower limb amputation were significantly lower (z > 2.68, p < .006) than 
participants with unilateral lower limb amputation. 
 Scale of the LCI5 and observed ceiling effect  
Maximum scores were reported by the total cohort (n = 201) for Basic LCI5 = 43% (n = 
86), Advanced LCI5 = 25% (n = 51) and Total LCI5 = 25% (n = 51) with ceiling effects 
observed. Ceiling effects were observed for Basic LCI5 scores with maximal scores of 
28 in the following sub-groups: prosthetic users, Aboriginal, non-Aboriginal, aged < 58 
years, transtibial amputation level, no diagnosis of diabetes, full-time prosthetic users, 
low comorbidities, traumatic amputation, and unilateral amputation. For Basic LCI5 
score, 100% of participants with traumatic amputation reported the maximum score of 
28. Ceiling effects were also observed for Advanced and Total LCI5 scores in 
participants with traumatic amputation and age < 58 years scoring maximum scores of 
28 and 56 respectively.  
 Mobility aid use and type of mobility aid used 
A total of 50% (75) participants reported using a mobility aid when walking with their 
prosthesis. The use of mobility aids and type of mobility aids used indoors and outdoors 
by participants that remained prosthetic users have been detailed in Appendix 7.5B 
Table 7.6B. 
 Amputation level and self reported prosthetic usage 
Appendix 7.6B Table 7.7B outlines the hours of reported prosthetic usage for locomotor 
activities of total prosthetic users (n = 149), transtibial (n = 114) and above transtibial (n 
= 35) prosthetic users and self reported maximal walking distance before resting. Users 
with transtibial amputation level reported wearing their prosthetic limb for significantly 
(z = 3.90, p < .001) more hours than those with above transtibial amputation. However, 
time walking, standing, number of sit to stands and maximal walking distance reported 
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were not significantly different (z < 1.80, p > .07) between users with transtibial and 
above transtibial amputation levels for weekly or daily usage. 
 Return to driving and work 
Table 7.8B describes the self reported work and driving characteristics of the cohort. 
Appendix 7.7B Table 7.9B details the age and CCI scores for participants who reported 
being drivers, non-drivers, workers and non-workers prior to amputation. CCI scores 
and age were significantly higher ( p < .0274) in participants who did not drive or work 
prior to amputation. Full details of the univariate analysis for return to driving and work 
have been reported in Table 7.10B. 
 Return to driving 
A total of 39% (79) did not drive prior to amputation. A total of 61% (122) of 
participants were drivers prior to amputation and 91% (111) of this sub-group had 
returned to driving after rehabilitation discharge. The type of car modifications required 
by participants to drive, have been described in Table 7.8B. Return to driving was 
significantly associated with being a prosthetic user (+LR = 1.59, CI = 1.04 to 3.40, p = 
.006) (full details in Table 7.10B). The Total LCI5 score was median, 54 (IQR, 47 to 56) 
for prosthetic users who returned to driving (n = 96). 
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Table 7.8B: Return to driving and work characteristics for a cohort with 
lower limb amputation. 
Return to driving and work characteristics 
 
n (%) 
Non-drivers before amputation 
 
Drivers before amputation 
 
Return to driving after amputation 
 
Amputation details 
Right unilateral lower limb amputation 
Bilateral lower limb amputation 
 
Type of motor vehicle driven 
Manual transmission  
Automatic transmission 
Left foot accelerator 
Hand controls 
 
61 (39) 
 
122 (61) 
 
111 (91) 
 
 
37 (33) 
6 (5) 
 
 
5 (4) 
84 (76) 
15 (14) 
7 (6)  
Occupational Details 
Paid work or studying prior to amputation surgery 
Employed after amputation from cohort who worked before amputation    
Study or retraining 
Time spent working, studying or retraining 
Full-time 
Part-time 
 
Unemployed 
Retired 
Disability support pension or compensation  
 
Australian Standard Classification of Occupations (ASCO) major 
groups for participants who returned to work (n = 56) 
1. Managers and Administrators 
2. Professionals 
3. Associate Professionals 
4. Tradespersons and Related Workers 
5. Advanced Clerical and Service Workers 
6. Intermediate Clerical, Sales and Service Workers 
7. Intermediate Production and Transport Workers 
8. Elementary Clerical, Sales and Service Workers 
9. Labourers and Related Workers 
 
91 (45) 
56 (62) 
3 (1.5) 
 
43 (73) 
16 (27) 
 
9 (4.5) 
108 (54) 
25 (12) 
 
 
 
5 (9) 
15 (27) 
6 (11) 
13 (23) 
3 (5) 
4 (7) 
9 (16) 
1 (2) 
0 (0) 
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Table 7.10B: Variables associated with return to driving and work (95% 
confidence intervals). 
 
*p < .05
 Return to driving 
Variables Chi Square 
(1 d.f.) 
Positive Likelihood 
Ratio (LR+) 
p value 
Prosthetic user 7.45 1.59 (1.04 to 3.40) < .006* 
Transtibial amputation level 0 1.00 (0.705 to 2.05) .983 
Younger age ( < 58 years) 0.021 1.05 (0.60 to 2.71) .884 
Not having diabetes 2.93 1.67 (0.89 to 4.94) .087 
Traumatic amputation cause 1.31 1.39 (0.80 to 3.53) .252 
Unilateral amputation  2.67 1.16 (0.96 to 1.74) .102 
Metropolitan residence 0.141 1.11 (0.709 to 2.50) .707 
Walking distance > 500m 1.71 1.81 (0.767 to 10.3) .191 
Male gender 0.475 0.932 (0.88 to 1.36) .491 
 Return to work 
Variables Chi Square  
(1 d.f.) 
Positive Likelihood 
Ratio (LR+) 
p value 
Prosthetic user 7.60 2.36 (1.12 to 7.15) .006* 
Transtibial amputation level 15.4 2.01 (1.33 to 3.08) < .0001* 
Younger age ( < 58 years) 1.07 1.19 (0.84 to 1.75) .301 
Not having diabetes 3.05 1.58 (0.89 to 2.71) .081 
Traumatic amputation cause 1.29 0.76 (0.47 to 1.29) .256 
Unilateral amputation  0.78 1.08 (0.91 to 1.29) .378 
Metropolitan residence 0.25 0.91 (0.61 to 1.41) .618 
Walking distance > 500m 1.42 1.25 (0.85 to 2.07) .233 
Male gender 0.68 0.93 (0.81 to 1.15) .408 
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Return to work 
A total of 54% (108) of participants were retired prior to amputation. A total of 45% 
(91) of participants worked prior to amputation and 62% (56) of this sub-group had 
returned to paid work after rehabilitation discharge. Return to work was significantly 
associated with being a prosthetic user (+LR = 2.36, CI = 1.12 to 7.15, p = .006) and 
transtibial amputation level (+LR = 2.01, CI = 1.33 to 3.08, p < .0001) (full details in 
Table 7.10B). The Total LCI5 score was median, 56 (IQR, 54 to 56) for prosthetic users 
who returned to work (n = 52). The Australian Standard Classification of Occupations 
(ASCO) major groups for participants who returned to work (n = 56) have been detailed 
in Table 7.8B. 
 Complications of amputation 
Appendix 7.8B Table 7.11B outlines pain, residual and remaining limb pathology for the 
cohort. Appendix 7.9B Table 7.12B details falls since amputation for the total cohort, 
prosthetic users and non-users. 
 7.2.4. Discussion 
This is the first Australian study to describe long term activity and participation levels 
including locomotor outcome using the LCI5, mobility without a prosthesis, return to 
driving and work, and complications of amputation in a consecutive cohort of people 
with lower limb amputation following discharge from rehabilitation. To date Australian 
outcome research has reported on institution specific variables such as average length of 
stay, time to prosthetic casting, inpatient FIM score and function at discharge (Hordacre 
et al., 2013b; Lim et al., 2006; Wu et al., 2010) or on samples of convenience with high 
variation in time since discharge (Stepien et al., 2007).  
 Activity and participation levels without a prosthesis  
Mobility without a prosthesis such as transfers, wheelchair mobility and hopping were 
sustained after rehabilitation discharge by participants in our study. A large proportion 
of the cohort (71%) still used a wheelchair for activities of daily living. Motorised 
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scooters were used for community access by 13% of participants. In contrast to our 
findings, Burger (2012) reported limitations in the activity and participation levels of 
participants with lower limb amputation who were 21.8 years post-amputation and had 
undergone comprehensive rehabilitation in Slovenia. These participants reported 
problems with transfers, locomotor activities, driving, transportation, community life 
and recreation (Burger, 2012). These activity and participation outcomes may potentially 
be related to differences in the Western Australian and Slovenian rehabilitation models 
of care. In Western Australia both wheelchairs and prostheses are funded for people with 
lower limb amputation however in Slovenia people with transfemoral amputation are 
funded for a prosthesis or wheelchair only (Erjavec et al., 2014). 
 Activity and participation levels with a prosthesis LCI5 for Prosthetic Non-users and Users 
This study has shown that 74% (n = 149) of participants continued using their prosthesis 
at median, 1.5 years (IQR, 1.2 to 2.2) after discharge from rehabilitation and that 
prosthetic non-users reported significantly lower locomotor capabilities than users. 
These results were similar to Gauthier-Gagnon et al. (1999) who reported that 85% of 
individuals sustained prosthetic use at 1 to 5 years after rehabilitation discharge and total 
LCI scores for non-users were significantly lower than users. Participants who became 
prosthetic non-users in our study reported multifactorial reasons for prosthetic non-use 
including: residual limb issues, remaining lower limb issues, prosthetic issues, pain, 
medical comorbidities and balance issues that have been identified in the literature 
(Gailey et al., 2010; Laferrier et al., 2010). 
 
Functional level achieved during rehabilitation has been associated with prosthetic non-
use after rehabilitation discharge (Roffman et al., 2014). It has been reported that the 
locomotor activities most likely to be performed independently using a prosthesis at 
discharge were rising from a chair, walking inside the house and outside on even 
ground; while the activities most difficult to perform were walking outside in inclement 
weather, going up and down steps without a handrail (Franchignoni et al., 2004; 
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Gauthier-Gagnon et al., 1999). Our study participants reported similar levels of ease and 
difficulty on these locomotor activities. 
 Known groups analysis of LCI5 in long term prosthetic users at high and low risk of prosthetic non-use  Indigenous Status 
An interesting finding of this research was that locomotor capabilities reported by 
Australian Aboriginal participants were not significantly different from non-Aboriginal 
participants. This was the first study to report on Aboriginal locomotor capabilities so 
we were unable to compare it with other Australian research (Hordacre et al., 2013b; 
Lim et al., 2006; Wu et al., 2010). These results were surprising as Aboriginal 
participants generally reside remote from health services and poor health outcomes have 
been reported (Norman et al., 2010; Vos et al., 2009). Our findings were similar to 
Agrawal et al. (2014) who demonstrated that LCI and prosthetic use for Canadian 
Aboriginal participants were not significantly different from non-Aboriginal 
participants.  
 Diabetes and Comorbidities 
In this study participants with diabetes reported significantly lower LCI5 scores than 
those with no diagnosis. Webster et al. (2012) and Meatherall et al. (2005) reported 
poorer locomotor function for individuals with diabetes. These results are in contrast to 
the findings of Roffman et al. (2014), who demonstrated that not having a diagnosis of 
diabetes was an early predictor of prosthetic non-use after discharge from rehabilitation. 
Those with high comorbidities were demonstrated to have lower LCI5 scores in our 
study. Severe comorbidities have been previously shown to reduce locomotor function 
for individuals with unilateral lower limb amputation in the literature (Schoppen et al., 
2003).  
 
 
 
167 
 
Amputation cause 
Czerniecki et al. (2012b) found in individuals with dysvascular amputation that LCI5 
score was reduced from pre-amputation (Total LCI5 mean = 48, SD = 10.7, n = 86), at 
12 months post-amputation surgery (Total LCI5 mean = 40.8, SD = 15.5, n = 75). 
However, there were limited details reported on participants’ prosthetic use or non-use 
for the LCI5 interview time frames in this longitudinal study (Czerniecki et al., 2012b). 
In our study prosthetic users with atraumatic amputation reported higher total LCI5 
scores than Czerniecki et al. (2012b) which may have been related to the later follow-up 
after discharge or the fact that only participants with dysvascular amputation were 
investigated by (Czerniecki et al., 2012b).  
 Prosthetic usage 
Our study demonstrated that there was a sub-group who used their prosthesis < 7 days 
per week who had significantly lower LCI5 scores than the full-time users. In part-time 
users the prosthesis appears to be used more like an exercise device with recovery days 
required by participants after walking days. Meatherall et al. (2005) have also reported 
part-time prosthetic use. Self reported hours a prosthesis was worn has been reported as 
significantly different (p < .001) between transtibial (mean = 84.8, SD = 30.4 hours per 
week) and transfemoral prosthetic users (mean = 75.0, SD = 31.6 hours per week) 
(Gauthier-Gagnon et al., 1999). Our study findings for time the prosthesis was worn 
were similar to Gauthier-Gagnon et al. (1999). This behaviour may be related to the 
additional energy costs associated with transfemoral prosthetic gait or the fact that 
transfemoral prosthetic sockets may be uncomfortable in sitting. Other studies 
(Meatherall et al., 2005; Miller, Deathe, & Speechley, 2001) have reported consistent 
prosthetic use times for activities of walking, standing and wearing with those in our 
study. 
 Amputation level 
In our study LCI5 scores were not significantly different for those with above transtibial 
and transtibial amputation levels. These findings were similar to past studies (Agrawal et 
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al., 2014; Czerniecki et al., 2012b; Gauthier-Gagnon et al., 1999) that reported no 
difference in Total LCI and LCI5 scores for individuals with transtibial and transfemoral 
amputation levels. However, other studies (Franchignoni et al., 2004; Salavati et al., 
2011) have demonstrated lower LCI5 scores at rehabilitation discharge in individuals 
with transfemoral amputation. The prosthetic users with above transtibial amputation 
level in our investigation may represent a fitter sub-group than other studies 
(Franchignoni et al., 2004; Salavati et al., 2011) as they have sustained prosthetic use for 
an extended time after discharge.  
 Unilateral and bilateral amputation 
Many studies (Czerniecki et al., 2012b; Franchignoni et al., 2004; Gauthier-Gagnon et 
al., 1999; Gordon et al., 2010) have reported on locomotor outcomes in sub-groups with 
unilateral or specific lower limb amputation levels while other studies (Agrawal et al., 
2014; Parker, Kirby, Adderson, & Thompson, 2010; Salavati et al., 2011) have not 
performed separate analyses for bilateral amputation level data due to small numbers. 
Larsson et al. (2009) reported significantly lower LCI scores in individuals with bilateral 
lower limb amputation. Our study demonstrated similar results to this research (Larsson 
et al., 2009) with significantly lower LCI5 scores in those with major bilateral lower 
limb amputation.    
 Age  
LCI5 scores were significantly lower in older participants aged > 58 years in this study. 
This is consistent with other studies (Franchignoni et al., 2004; Larsson et al., 2009) 
which have reported poorer locomotor function in older participants. In a Persian cohort 
where 98.1% of participants had traumatic amputation, total LCI5 score was mean = 
44.8, SD = 1.22 (Salavati et al., 2011). In our study total LCI5 score was higher (median, 
56 IQR 54 to 56) for individuals with traumatic amputation. This may be explained by 
the fact that some Persian participants had only been using their prosthesis for 6 months 
and possibly had further functional goals to achieve.  
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Scale of the LCI5 and observed ceiling effect 
The LCI5 was developed to address the ceiling effect that was observed in the scale of 
the LCI (Franchignoni et al., 2007). The frequency of maximum scores on the LCI5 has 
been reported as low as 5% (Franchignoni et al., 2007). In our study, maximum scores 
were demonstrated for the basic LCI5 scores in all the known groups but similar to the 
literature (Gauthier-Gagnon & Grisé, 2006) younger participants and those with 
traumatic causes of amputation had the highest frequency of maximum scores. 
Maximum total LCI5 scores were observed for 25% of the total cohort in our study. This 
was consistent with maximum scores of 23.6% or more reported by previous studies 
(Parker et al., 2010; Salavati et al., 2011). The PLUS-M (Prosthetic Limb Users Survey 
of Mobility) and CHAMP (Comprehensive High-level Activity Mobility Predictor) are 
amputee specific outcome measures that could potentially be implemented into future 
models of care for assessment of clients with capacity for higher level locomotor 
function (Gailey et al., 2013; Hafner et al., 2017). 
 Complications of amputation 
Similar to past reviews (Gailey et al., 2008; Kulkarni, 2008), participants in our study 
reported a high frequency of falls, residual and remaining limb pathology. Participants in 
other studies (Burger, 2012; Radhakrishnan et al., 2017) have reported issues with pain 
and skin following amputation that were identified by our participants. Further research 
is required into complications of amputation because issues with skin breakdown on the 
residual limb may potentially explain the high rate of long term wheelchair use reported 
by our participants.    
 Return to driving and work 
Our study demonstrated that return to driving and work both were significantly 
associated with participants who were prosthetic users. Future research may examine 
whether not fitting a prosthesis is an independent barrier to return to driving after 
amputation. High levels of locomotor function on the LCI5 were reported by participants 
who were prosthetic users and returned to driving or work. However, in contrast to 
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Schoppen et al. (2001b), self reported walking distance > 500m was not significantly 
associated with return to driving or work. In our study, return to work was also 
significantly associated with transtibial amputation level but amputation level has not 
been significantly associated with return to work in previous studies (Fisher, Hanspal, & 
Marks, 2003; Schoppen et al., 2001b). This finding was interesting because prosthetic 
use has been associated with transtibial amputation level in the literature (Sansam et al., 
2009). There was potential for male gender bias in the rates of return to driving and 
work due to the incidence of amputation in Australia being higher for males (Dillon et 
al., 2017b) and sociodemographic factors (e.g. caring for children may result in females 
leaving paid work for extended timeframes). Our study found that male gender was not 
associated with return to driving or work in the sub-groups who were drivers and 
workers prior to amputation. Similar to Schoppen et al. (2001a), the ASCO 
demonstrated that participants worked in less physically demanding occupations after 
amputation.     
 
The rate of return to driving was 91% in the sub-group who were drivers prior to 
amputation. Rates of return to driving have been reported as high as 80.5% in people 
with lower limb amputation with variables including wearing a prosthesis and male 
gender significantly associated ability to drive after amputation (Boulias, Meikle, 
Pauley, & Devlin, 2006; Burger, 2012; Engkasan, Ehsan, & Chung, 2012). In our study, 
61% of participants with left sided, unilateral amputation returned to driving. This 
higher proportion may be explained by the following: 
1. No car modifications were required if the participants owned automatic 
transmission cars because their right lower limb remained intact.  
2. It potentially reflects a pattern of right lower limb dominance in the cohort 
because more people with an intact right lower limb returned to driving and it 
was harder for participants with an amputated right lower limb to change 
dominance and learn to drive a car with a left foot accelerator. 
Similar patterns of limb dominance have been noted in the literature by Boulias et al. 
(2006) however left sided unilateral amputation was not significantly associated with 
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return to driving in a study by Engkasan et al. (2012). Future studies should investigate 
the role of laterality in return to driving.    
 
A total of 62% of participants who were employed prior to amputation, returned to paid 
work after amputation. Our findings were similar to previous studies that have reported 
rates up to 79% for return to work and job reintegration (Fisher et al., 2003; Penn-
Barwell, 2011; Schoppen et al., 2001a; Schoppen et al., 2001b).  
Issues with employment, driving, transportation and involvement in the community have 
been reported by participants with lower limb amputation in previous studies (Burger, 
2012; Radhakrishnan et al., 2017). In our study, the sub-groups who were not drivers or 
workers prior to amputation had significantly higher age and CCI scores than 
participants in the sub-groups who were drivers and workers prior to amputation. A total 
of 54% of participants reported they were retired prior to amputation. While these 
findings reflect the impact of older age and comorbidities on activity and participation 
levels after amputation they also highlight that a large proportion of the cohort had pre-
existing activity and participation limitations. Future research should include 
multivariate analysis and psychosocial variables including cognition, adjustment to 
amputation, educational level, family and financial support to assist in development of a 
rehabilitation model of care that facilitates return to work.   Limitations 
Our study had some limitations. Firstly, there was potential for recall bias in the patient 
interview. This may have been an issue particularly with the prosthetic use (e.g. hours 
worn, standing and walking). Verbal prompts were used to improve recall accuracy and 
our study results for hours of prosthetic use were consistent past studies (Gauthier-
Gagnon et al., 1999; Meatherall et al., 2005; Miller et al., 2001). However, some studies 
have found step activity monitors and GPS to be highly correlated with community 
ambulation (Hordacre, Barr, & Crotty, 2014) and poorly correlated with self reported 
estimates of step activity (Stepien et al., 2007). Although this is an area for future 
research as technology becomes more accessible in the clinical setting and device 
accuracy improves, there are potential ethical issues surrounding patient privacy with 
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this type of data collection (Maddison & Ni Mhurchu, 2009; McNamee, 2005; Michael, 
McNamee, & Michael, 2006). Secondly, some of the numbers were low in the known 
user groups (e.g. Aboriginal and high comorbidities) due to high mortality. However, 
our interviewed cohort of 201 participants (95% response rate) represents a large cohort 
for this area of research. The third limitation of this research was the observed ceiling 
effect for the LCI5 scale which suggests that the LCI5 may provide better locomotor 
activity discrimination early in rehabilitation for older participants with atraumatic 
amputation causes as previously reported (Condie et al., 2006; Gauthier-Gagnon & 
Grisé, 2006; Heinemann et al., 2014). Falls data was recorded from amputation surgery 
to the time of interview and not referenced to the time frame of 6 months from the date 
of interview. 
 7.2.5. Conclusion 
This was the first study in a consecutive Australian cohort with lower limb amputation 
to describe long term activity and participation levels including mobility with and 
without a prosthesis, complications of amputation, return to driving and work after 
rehabilitation discharge. The LCI5 has construct validity as it identified significantly 
lower LCI5 scores for prosthetic users in known groups at high risk of prosthetic non-
use including: age > 58, diabetes, part-time prosthetic users, high comorbidities, 
atraumatic amputation cause and bilateral amputation. However, maximum scores and 
ceiling effects were observed for 25% of the total cohort. This suggests the LCI5 scale 
may be less sensitive when measuring long term locomotor function or once locomotor 
capabilities have improved above a specific threshold. Similar to previous studies 
participants who returned to driving and work were prosthetic users and reported high 
levels of locomotor function on the LCI5. Further investigation of outcome measures for 
clients with high levels of locomotor function that can be implemented into the long 
term follow-up phase of rehabilitation service models is warranted.    
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Chapter 7    Discussion 
 7.3. Discussion 
Chapter 7 of this thesis has demonstrated that locomotor tests have construct validity and 
utility for assessment of people with lower limb amputation during prosthetic 
rehabilitation and the long term follow-up stages of rehabilitation. These studies have 
also contributed valuable performance data for locomotor tests by people with lower 
limb amputation. 
 Part A 
Key findings from the known groups analysis of the locomotor tests were: 
 
• 10MWT, TUGT, 6MWT and FSST were significantly different for all the known 
groups at high risk of prosthetic non-use including: above transtibial amputation, 
bilateral amputation, high comorbidities and older age  
• People with Aboriginal ethnicity did not perform significantly different from 
non-Aboriginal people on the locomotor tests  
• 10MWT and TUGT performance were not significantly different for the diabetes 
and atraumatic amputation groups  
• 6MWT performance was significantly different for the diabetes and atraumatic 
amputation groups and the lower risk groups  
• The 6MWT may be a more effective measure of locomotor function as it was 
better at discriminating between known groups at high and lower risk of 
prosthetic non-use 
• The 10MWT, TUGT, 6MWT and FSST have convergent validity as they were 
all highly correlated suggesting a common functional domain is being measured 
by these locomotor tests. This confirms previous findings in Chapter 6 by 
Roffman et al. (2016b) where area under the curve for these locomotor tests was 
similar.  
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Part B 
In the study of long term activity and participation: 
 
• LCI5 scores were reported as significantly different by known groups including: 
older age, diabetes, part-time prosthetic users, high comorbidities, atraumatic 
amputation and bilateral amputation  
• Aboriginal people and the above transtibial level of amputation group did not 
report significantly different locomotor function  
• These findings support earlier work by Roffman et al. (2014) that Aboriginal 
ethnicity was not a predictor of prosthetic non-use  
• The LCI5 may not be sensitive test of locomotor function in the long term 
follow-up phase of rehabilitation, due to the high ceiling effect observed for the 
lower limb amputation cohort. 
 
In conclusion, these known groups studies provide evidence for the validity and utility 
of locomotor tests during prosthetic rehabilitation. The findings that locomotor 
performance was not significantly different for Aboriginal people during rehabilitation 
and in the long term follow-up stage of rehabilitation were important as this group of 
people have many risk factors (e.g. high rates of diabetes, geographical isolation from 
health services) that could potentially impact on functional outcome. Further research is 
recommended to develop an outcome measure for the long term follow-up stage of 
rehabilitation due to high ceiling effect observed for the LCI5. 
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Chapter 8 
 Comorbidity Burden in a cohort with lower limb amputation 
 
 
 
 
 Synopsis  
This chapter explores comorbidity in a cohort with lower limb amputation. Construct 
validity for the Functional Comorbidity Index, Charlson Comorbidity Index and 
Combined Age Charlson Comorbidity Index is investigated using the known groups 
method. The manuscript in Appendix 8.1 published in Journal of Physiotherapy on the 
psychometric properties of the Charlson Comorbidity Index was an output of this 
chapter: 
 
Roffman, Caroline E., Buchanan, John, & Allison, Garry T. (2016). Charlson 
Comorbidities Index. Journal of Physiotherapy, 62(3), 171. doi: 
10.1016/j.jphys.2016.05.008 
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8. Comorbidity Burden in a cohort with lower limb amputation 
 8.1. Introduction  
The global incidence of lower limb amputation ranges from 5.8 to 31 per 100 000 total 
population and increases to 46.1 to 9600 per 100 000 population with diabetes (Moxey 
et al., 2011). Dillon et al. (2014) reported that between 2000 to 2010 the absolute 
number of lower limb amputations in Australia had increased 14% from 7000 to 8000 
per annum while the age standardised incidence of lower limb amputations remained 
stable at 37.41 ± 1.01 procedures per 100 000 population per annum. During this decade 
there was a significant increase (p = .001) in the incidence of minor lower limb 
amputation with a concomitant decrease in major lower limb amputation (Dillon et al., 
2014). The ratio of minor lower limb amputations was 3 times higher than major lower 
limb amputations (Dillon et al., 2014). 
 
People who undergo lower limb amputation for atraumatic causes have comorbidities 
that increase mortality; with 1 year mortality up to 48.3%. These comorbidities include 
systemic diseases such as diabetes, renal failure, cardiovascular and chronic obstructive 
pulmonary disease (COPD) and chronic disease risk factors such as physical inactivity, 
obesity and smoking. They also have non-life threatening musculoskeletal disorders 
such as arthritis, back, knee and shoulder pathology sometimes reported at a greater 
incidence for people with diabetes (Mueller, 2016).  
 
As a result of the chronic disease and comorbidities individuals with atraumatic lower 
limb amputations have significantly greater healthcare costs and poorer functional 
outcome (Fortington et al., 2013; Hoffstad, Mitra, Walsh, & Margolis, 2015; Jones et al., 
2013; Malone et al., 2014; Roffman et al., 2014; Schoppen et al., 2003; Taylor et al., 
2005; van Netten, Fortington, Hinchliffe, & Hijmans, 2016).  
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In the presence of such high mortality and extensive comorbidity burden it would seem 
logical that within the lower limb amputee patient cohort, models of care in the tertiary 
hospital setting would document the incidence of musculoskeletal disorders, mental 
health issues and systemic diseases. However, it appears that in many situations the 
presence of these conditions is poorly defined at hospital admission. Identification of 
musculoskeletal disorders is important for understanding functional potential in people 
with lower limb amputation. To date, the literature has focused on musculoskeletal 
disorders being sequelae to amputation due to asymmetrical movement patterns during 
activities of daily living and prosthetic gait (Devan, Hendrick, Ribeiro, Hale, & Carman, 
2014; Gailey et al., 2008; Kulkarni, 2008).  
 
Comorbidities are a major consideration by multidisciplinary teams for rehabilitation 
interventions such as wheelchair prescription, prosthetic gait retraining, return to driving 
and work. Moreover, a high number of comorbidities have been associated with poorer 
functional outcome and self reported by people with lower limb amputation as reasons 
for abandonment of prosthetic use (Agrawal et al., 2014; Roffman et al., 2014, 2016b). 
However, within the literature there is little consensus on the most valid method of 
measuring comorbidity in people with lower limb amputation (Agrawal et al., 2014; 
Davie-Smith et al., 2016; Gailey et al., 2002; Melchiorre, Findley, & Boda, 1996; 
Roffman et al., 2014; van Eijk et al., 2012; Webster et al., 2012). Early methodological 
processes undertaken within this thesis (see Roffman et al. (2014)) counted number of 
comorbidities in participants with amputation. From this comorbidity estimation a 
threshold was derived using receiver operating characteristic curve. It was demonstrated 
that having a very high number of comorbidities (> 19) was predictive of prosthetic non-
use at 4 months after discharge from rehabilitation. However, it is acknowledged that 
this method may not be generalisable to other international settings as all conditions 
were included even though some were not related to mortality or functional outcome. In 
busy clinical settings, counting comorbidities has limited utility as it is time consuming 
(Roffman et al., 2014). Furthermore, the use of a validated composite index that reduces 
a patient’s diseases into a single numeric score, based on a standardised list of 
comorbidities may be able to be used across multiple health contexts including 
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predicting mortality or functional outcome (Charlson et al., 1987; de Groot, Beckerman, 
Lankhorst, & Bouter, 2003; Groll et al., 2005; Roffman et al., 2014).  
 
The Charlson Comorbidity Index (CCI) and Combined Age-CCI (CA-CCI) have been 
widely used in clinical research including cohorts with lower limb amputation, to 
measure mortality risk and burden of disease (Charlson et al., 1987; Charlson et al., 
1994; Fortington et al., 2013; Hall et al., 2004; Hoffstad et al., 2015; Quan et al., 2011; 
Roffman et al., 2014; van Eijk et al., 2012; Webster et al., 2012; Wu, Hsu, Chang, Yu, & 
Lee, 2015). However, while the CCI and CA-CCI provide insight into mortality risk it is 
unclear whether these indices have adequate sensitivity to measure functional outcome 
following lower limb amputation (Gailey et al., 2002; Melchiorre et al., 1996; van Eijk 
et al., 2012; Webster et al., 2012).  
 
The Functional Comorbidity Index (FCI) has been proposed as the measure of 
comorbidity to use when physical function is the primary outcome of interest (Groll, 
Heyland, Caeser, & Wright, 2006; Groll et al., 2005; Haines, Berney, Warrillow, & 
Denehy, 2014). The FCI includes diseases that impact on function such as arthritis, 
obesity, visual impairment and mental illness but do not necessarily increased mortality 
(Groll et al., 2005). FCI is highly correlated with the physical function section of the 
SF36 (Spearman Rho up to 0.6) (Groll et al., 2006; Groll et al., 2005; Haines et al., 
2014) but there has been limited use in amputation cohorts (Davie-Smith et al., 2016; de 
Laat et al., 2014).  
 
In the literature, high comorbidities have been reported in sub-groups with lower limb 
amputation including atraumatic amputation cause, older age, diabetes, Aboriginal 
ethnicity, above transtibial amputation level, bilateral lower limb amputation and people 
who abandon using a prosthesis  (Fortington et al., 2013; Jones et al., 2013; van Netten 
et al.; Vos et al., 2009). The “known groups” method has been used to evaluate construct 
validity of tests by demonstrating their capacity to significantly discriminate between 
groups that are known to differ in the literature (Hattie & Cooksey, 1984; Megens et al., 
2007). However, construct validity of comorbidity indices has been rarely investigated 
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(Hall, 2006; Kiefe, Funkhouser, Fouad, & May, 1998; Moltó & Dougados, 2014; 
Spaetgens, Wijnands, van Durme, & Boonen, 2015). A known groups analysis in lower 
limb amputation sub-groups with high and low comorbidities would provide important 
knowledge on the level of sensitivity for the FCI, CCI and CA-CCI and clinical utility of 
comorbidity indices in amputation cohorts. 
 
The aims of this study were:  
1. To map comorbidities (including musculoskeletal pathology and mental illness) that 
were present at hospital admission in a cohort with lower limb amputation.  
2. To describe the relationship between number of comorbidities and FCI, CCI and CA-
CCI scores.  
3. To evaluate the construct validity of using comorbidity indices in people with lower 
limb amputation in known groups with high and low comorbidities.  
   
The hypotheses generated for this study were: 
1. Known groups reported in the literature as having high comorbidities including 
those with atraumatic amputation cause, diabetes, Aboriginal ethnicity, above 
transtibial amputation level, bilateral lower limb amputation, older age and those 
who become prosthetic non-users will have significantly higher scores on the 
FCI, CCI and CA-CCI than the groups with lower comorbidities. 
2. The FCI will identify lower limb amputation groups with known high and low 
comorbidities with greater sensitivity than the CCI and CA-CCI. 
 8.2. Methods Participants 
This study was approved by the Royal Perth Hospital (RPH) and Curtin University 
Human Research Ethics Committees (see Appendix 3.1). An independent research 
assistant recruited and obtained informed verbal consent from participants.  
 
Inclusion criteria for participants were: at least one recent major lower limb amputation 
(i.e. transtibial level or above), multiple limb amputation, lived in the community, 
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ambulant before amputation surgery, Medicare Functional Classification Level (MFCL) 
K-level 1 to 4 (Gailey et al., 2002), had undergone prosthetic rehabilitation and been 
discharged from Royal Perth Hospital (RPH), the state centre for amputee rehabilitation. 
K-levels were assigned collaboratively in the post-operative period by the Rehabilitation 
Physician and Senior Physiotherapist Amputee Rehabilitation (with 10 years of clinical 
experience) as part of the RPH assessment procedure for rehabilitation admission based 
on criteria outlined in Roffman et al. (2014).  
 
K-level 0 participants, those unable to communicate or who did not consent were 
excluded from this study. Participants were assessed as K-level 0 due to: comorbidities 
(e.g. heart failure, COPD, Parkinson’s disease), medications (e.g. warfarinisation), 
cognitive impairment, high level or multiple limb amputation, remaining limb 
pathology, increased body weight, mental health issues, poor motivation, no social 
support, poor premorbid mobility and falls history (Roffman et al., 2014). The 
multidisciplinary amputee outpatient clinic was used to monitor K-level 0 participants 
and K-level of these participants did not change during this study.  
 
Participant eligibility and recruitment into this study is outlined in Figure 8.1. A total of 
201 participants were recruited out of the 211 eligible participants for this study. The 
final response rate was 95%.  
 Procedure 
The Senior Physiotherapist developed and implemented a standardised physiotherapy 
assessment form for people with lower limb amputation to record data on comorbidity 
and rehabilitation outcome at RPH (see appendix 8.2). Medical records were abstracted 
for 201 consecutive participants with lower limb amputation by the Senior 
Physiotherapist Amputee Rehabilitation using a previously piloted and standardised data 
collection form (see appendix 8.3). Comorbidities at hospital admission for amputation 
were recorded for each participant. The operational definition of comorbidity in this 
study was any condition that was documented in the medical record including 
musculoskeletal pathology and mental illness (de Groot et al., 2003; Groll et al., 2005). 
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The comorbidities were given a numerical code and entered into a database. 
Comorbidities were totalled for each participant. Cohort characteristics including 
amputation, demographic and admission details were also abstracted from the medical 
records (figure 8.1).  
 
Table 8.1 summarises the comorbidities and scoring for the FCI, CCI and CA-CCI. The 
FCI is scored by binary classification (yes = 1, no = 0) of comorbidities, summed to a 
maximum score of 18 (Groll et al., 2005). The CCI consists of 17 comorbidities, with 2 
subcategories for diabetes and liver disease that have been weighted from 1 to 6 for 
mortality risk and disease severity (Charlson et al., 1987; Charlson et al., 1994; Roffman 
et al., 2014). The CA-CCI adds additional 1 point for each decade of age over 40 years 
to the CCI score to account for age being an independent predictor of mortality 
(Charlson et al., 1987; Charlson et al., 1994; Roffman et al., 2014). In this study, total 
CCI and CA-CCI scores were generated using the electronic calculator developed by 
Hall et al. (2004). Higher scores in the FCI, CCI and CA-CCI indicate increased disease 
severity (Charlson et al., 1987; Groll et al., 2005). One year mortality of 85% has been 
reported for CCI score > 5 and 10 year survival of 34% for CA-CCI scores of 5 
(Charlson et al., 1987). 
 
Inter-rater reliability has been reported as moderate to good for the FCI and CCI, with 
intraclass correlations (ICC) up to 0.91 and 0.945 respectively (Fan et al., 2012). The 
CCI has high test re-test reliability with an ICC of .92 (p < .0001) (Katz, Chang, Sangha, 
Fossel, & Bates, 1996). Criterion validity for comorbidity indices has generally been 
demonstrated through comparison to other indices (Hall, 2006). Strong correlation 
between the FCI and CCI has been reported for patients with Acute Respiratory Distress 
Syndrome (ARDS) (Spearman Rho = 0.62, p < .001) (Groll et al., 2006).  
 
Participants were interviewed after the medical record abstraction to determine if they 
were prosthetic users or non-users, their general health, condition of residual and 
remaining limbs, demographic, amputation, falls, physical function, return to driving and 
work details.
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Figure 8.1: Flow chart for participants and study methodology. 
  
Total number of consecutive tertiary rehabilitation participants identified in the Amputee 
Physiotherapy Services Database from June 2006 to July 2011 n = 307 
Total number of eligible participants 
n = 211 
Final response rate 
for interview  
n = 201 (95%)  
K-level 0 not prosthetic 
rehabilitation candidates 
n = 43 (14%) 
K-level 1 to 4 prosthetic users at discharge 
n = 264 (86%) 
K-level 1 to 4 deceased n = 37 (14%) 
Excluded  
n = 16  
Not major 
lower limb 
amputation  
n = 3  
Still 
participating in 
rehabilitation  
n = 13  
Did not consent n 
= 3 
Unable to contact 
had moved  
n = 7  
K-level 0 deceased 
n = 19 (44%) 
Total contacted  
n = 204  
Medical records abstracted 
for comorbidity details & 
cohort characteristics 
Calculated: 
• Number of comorbidities 
• CCI 
• CA-CCI 
• FCI 
Linear transformation of number of comorbidities 
into CCI, CA-CCI & FCI scores. 
Known Groups analysis of comorbidity in: 
• Prosthetic non-users 
• Above transtibial amputation level 
• Atraumatic amputation cause 
• Diabetes 
• Aboriginal Ethnicity 
• Older age 
• Major bilateral lower limb amputation 
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Table 8.1: Scoring and comorbidities for the Functional Comorbidity Index (FCI), Charlson Comorbidity Index (CCI) and Combined Age - Charlson Comorbidity 
Index (CA-CCI). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Functional Comorbidity Index  
(FCI) 
Charlson Comorbidity Index  
(CCI) 
Combined Age - Charlson Comorbidity Index 
(CA-CCI) 
1. Arthritis 
2. Osteoporosis 
3. Asthma 
4. Chronic Obstructive Pulmonary Disease 
(COPD), acquired respiratory distress 
syndrome (ARDS) or emphysema 
5. Angina 
6. Congestive heart failure (or heart disease) 
7. Heart attack (myocardial infarct) 
8. Neurological disease (such as multiple 
sclerosis or Parkinson’s disease) 
9. Stroke or TIA 
10. Peripheral vascular disease 
11. Diabetes type I or II 
12. Upper gastrointestinal disease (ulcer, 
hernia, reflux) 
13. Depression 
14. Anxiety or panic disorders 
15. Visual impairment (such as cataracts, 
glaucoma or macular degeneration) 
16. Hearing impairment (hard of hearing or 
even with hearing aids) 
17. Degenerative disc disease (back disease, 
spinal stenosis or severe back pain) 
18. Obesity and or body mass index  > 30 
 
1. Myocardial infarct 
2. Congestive heart failure 
3. Peripheral vascular disease 
4. Cerebrovascular disease 
5. Dementia 
6. Chronic pulmonary disease 
7. Connective tissue disease 
8. Ulcer disease 
9. Stroke or transient ischemic attack 
10. Diabetes 
11. Hemiplegia 
12. Moderate or severe renal disease 
13. Diabetes with end organ damage 
14. Any tumour 
15. Leukaemia 
16. Lymphoma 
17. Moderate or severe liver disease 
18. Metastatic solid tumour 
19. AIDS 
1. Myocardial infarct 
2. Congestive heart failure 
3. Peripheral vascular disease 
4. Cerebrovascular disease 
5. Dementia 
6. Chronic pulmonary disease 
7. Connective tissue disease 
8. Ulcer disease 
9. Stroke or transient ischemic attack 
10. Diabetes 
11. Hemiplegia 
12. Moderate or severe renal disease 
13. Diabetes with end organ damage 
14. Any tumour 
15. Leukaemia 
16. Lymphoma 
17. Moderate or severe liver disease 
18. Metastatic solid tumour 
19. AIDS 
 
Age range categories by decade: 
0 to 49 years 
50 to 59 years 
60 to 69 years 
70 to 79 years 
80 to 89 years 
90 to 99 years 
100 years + 
 
Scored by simple count of No = 0 & Yes = 1 for each 
comorbidity. Sum of scores equals total FCI out of 
18. 
  
Comorbidities have weighted scores if present. 
Numbers 1 to 10 score = 1. Numbers 11 to 16 score = 
2. Number 17 score = 3. Numbers 18 to 19 score = 6. 
Maximum total score = 37. 
Comorbidities are scored the same as the CCI. An 
extra 1 point is added for every decade the person 
is aged over 40 years up to 6 points for 100 years +  
Maximum total score = 43.  
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Statistical Methods 
Descriptive statistics were generated for the comorbidities data abstracted from the 
medical records and participant interview. Number of comorbidities, FCI, CCI and AC-
CCI were calculated for each participant. Comorbidities were assigned to the following 
categories: diabetes, cardiovascular, pulmonary, musculoskeletal, neurological, renal, 
cancer, urological, falls, vision, skin, gastrointestinal, endocrine, substance abuse, 
psychological, cognitive, infectious diseases and frequencies were calculated.  
Data were analysed in sub-groups using a known groups analysis methodology. 
 
The known high comorbidity groups for analysis were:  
• prosthetic non-users,  
• atraumatic amputation cause, 
• diabetes,  
• Aboriginal ethnicity,  
• older age (> 58 years),  
• above transtibial amputation, and  
• bilateral lower limb amputation 
(Fortington et al., 2013; Jones et al., 2013; Roffman et al., 2014; Schoppen et al., 2003; 
Taylor et al., 2005; van Netten et al.; Vos et al., 2009; Webster et al., 2012). 
  
Sharpiro Wilk tests demonstrated that the comorbidity data were not normally 
distributed so non-parametric analyses were performed using the Mann-Whitney U Test 
(MWUT) to determine the statistical separation between the known groups with high 
and low comorbidities (two tailed, 95% Confidence Intervals (CI)). The effect size was 
plotted for the each of the known groups analyses to demonstrate the effect size of the 
individual comorbidity indices. Effect size was calculated by dividing the Z score with 
the square root of the number of participants, using the following equation: 
 
  𝑟𝑟 = 𝑍𝑍
√𝑁𝑁
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Effect size of comorbidity indices was plotted for the known groups. The following 
values were used to define effect size of comorbidity indices: small effect = 0.1, medium 
effect = 0.3 and large effect = 0.5 (Field, 2009). Since the effect sizes were derived from 
the same cohort (split by the known group dichotomy) the sample size and degrees of 
freedom were identical for each statistical analysis. Therefore the 95% confidence limit 
for each analysis was identified for each of the group comparisons.  
 
To improve the generalisability and utility of the comorbidity count by Roffman et al. 
(2014) the threshold of >19 comorbidities was cross-validated with the FCI, CCI and 
CA-CCI. Number of comorbidities was plotted against FCI, CCI and CA-CCI scores to 
determine if there was a relationship between these measures of comorbidity. Bubble 
plots were used so that high frequency data points could be visualized (i.e. the higher the 
frequency of the data point the larger the bubble size). R2 and linear transformations 
were calculated for these bubble plots. Using the equation generated from the bubble 
plots FCI, CCI and CA-CCI score were calculated for having a very high number of 
comorbidities (>19).  
 8.3. Results 
A total of 26% (52) of participants were prosthetic non-users when interviewed at 
median, 1.5 (IQR, 1.2 to 2.2) years after discharge from rehabilitation. Table 8.2 shows 
the median and interquartile range of comorbidity index scores, age categories 
amputation and demographic details for the total cohort (n = 201). Appendix 8.4 Table 
8.3 summarises the frequency of common comorbidities including musculoskeletal 
pathology and mental illness in the total cohort. The rate of diabetes was significantly 
higher (z = 4.66, p < .0001) in participants of Aboriginal ethnicity at 86% (n = 25) in 
contrast to 40% (n = 68) for non-Aboriginal participants. A total of 33% (n = 67) had 
both the diagnoses of diabetes and peripheral arterial disease. Of the people with 
bilateral lower limb amputation, 61% (n = 19) had bilateral transtibial amputation levels. 
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Table 8.2: Median and interquartile range of number comorbidities, Functional Comorbidity 
Index (FCI), Charlson Comorbidity Index (CCI) and Combined Age - Charlson Comorbidity 
Index (CA-CCI), age categories and demographics for total cohort (n = 201). 
Comorbidity Index  Median (interquartile range) 
Total Cohort (n = 201) 
Number of comorbidities 10 (5 to 15) 
 
Functional Comorbidity Index (FCI) 3 (1 to 5) 
 
Charlson Comorbidity Index (CCI) 2 (1 to 4) 
 
Combined Age - Charlson Comorbidity Index (CA-CCI) 4 (1 to 6) 
 
Gender, males, n (%)  161 (80) 
 
Age at amputation, Mean (SD) 
 
Age Categories for CA-CCI, n (%) 
0 to 49 years 
50 to 59 years 
60 to 69 years 
70 to 79 years 
80 to 89 years 
90 to 99 years 
100 years + 
55.5 (15.5) 
 
 
63 (31) 
47 (23) 
50 (25) 
29 (14) 
12 (6) 
0 (0) 
0 (0) 
 
Amputation Level, n (%) 
Transtibial 
Knee disarticulation 
Transfemoral 
 
Minor amputation of remaining lower limb, n (%) 
 
Major Bilateral amputation, n (%) 
Bilateral transtibial  
Transtibial and transfemoral 
Knee disarticulation and transfemoral 
Bilateral transfemoral 
 
Upper limb amputation, n (%) 
 
163 (81) 
7 (3) 
62 (31) 
 
21 (10) 
 
31 (15) 
19 (9) 
8 (4) 
1 (0.5) 
3 (2) 
 
20 (10) 
 
Amputation Cause, n (%) 
Circulatory 
Infection 
Trauma 
Cancer 
 
52 (26) 
87 (43) 
54 (27) 
8 (4) 
 
Ethnicity, Aboriginal, n (%) 
 
29 (14) 
Accommodation, n (%) 
Home (not residential care) 
Metropolitan (not country) 
 
194 (96) 
127 (63) 
 
Social Support, lives with others (not alone), n (%) 160 (80) 
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Figures 8.2 to 8.4 demonstrate bubble plots with the linear transformations and R2 for 
number of comorbidities versus FCI, CCI and CA-CCI. Figures 8.5 to 8.7 demonstrate 
bubble plots between the comorbidity indices. A total of 9% (18) had >19 comorbidities. 
The equations generated from bubble plots in Figures 8.2 to 8.3 demonstrate that having 
19 comorbidities were associated with CCI = 5, FCI 6 and CA-CCI 7 (algebraic 
estimations were CCI = 4.95, FCI = 5.95, and CA-CCI = 7.05). 
 
Of the total cohort, 14% (29) scored > 6 on the FCI, 19% (39) scored > 5 on the CCI and 
20% (41) scored > 7 on the Aged Adjusted CCI.  
 
The FCI had the best model fit explaining 71% of the variance for number of 
comorbidities.   
 Known Groups Analysis 
Table 8.4 details the median, interquartile range (IQR) and Mann Whitney U Test results 
for measures of comorbidity in known groups with high comorbidity including 
prosthetic non-users, atraumatic amputation, Aboriginal ethnicity, older age (>58 years), 
above transtibial amputation and bilateral amputation. Figures 8.8 to 8.14 demonstrate 
the effect size of the comorbidity indices for the known groups. The alpha level of .05 
that occurred at an effect size of 0.138 was plotted on the graphs to demonstrate the 
magnitude of effect size for comorbidity indices in the known groups.  
 
Prosthetic non-users had significantly higher number of comorbidities, FCI and CCI 
scores than users (p < .0414) and effect size was greatest for number of comorbidities. 
The atraumatic, diabetes and older age (> 58 years) groups had significantly higher 
number of comorbidities, FCI, CCI and CA-CCI scores than the traumatic, no diabetes 
and younger groups (p < .0001). The Aboriginal group had significantly higher CCI than 
non-Aboriginal group (p = .0147). The above transtibial amputation group had 
significantly lower CCI and CA-CCI scores than the transtibial amputation group (p < 
.0203). Comorbidity scores for the bilateral lower limb amputation group were not 
significantly different from the unilateral amputation group (p > .0949). 
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Figure 8.2: Bubble plot of number of comorbidities versus Functional Comorbidity Index (FCI) scores for people with 
lower limb amputation (n = 201).  
The bubble size corresponds to frequency of the data point (i.e. larger bubbles for higher frequency data points).  
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Figure 8.3: Bubble plot of number of comorbidities versus Charlson Comorbidity Index (CCI) scores for people with 
lower limb amputation (n = 201).  
The bubble size corresponds to frequency of the data point (i.e. larger bubbles for higher frequency data points). 
 
 
y = 0.2725x - 0.2321
R² = 0.5896
-1
0
1
2
3
4
5
6
7
8
9
-5 0 5 10 15 20 25 30
CC
I
Number of comorbidities
 
 
190 
 
 
 
Figure 8.4: Bubble plot of number of comorbidities versus Combined Age Charlson Comorbidity Index (CA-CCI) scores 
for people with lower limb amputation (n = 201).  
The bubble size corresponds to frequency of the data point (i.e. larger bubbles for higher frequency data points).  
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Figure 8.5: Bubble plot of Functional Comorbidity Index (FCI) versus Charlson Comorbidity Index (CCI) scores for 
people with lower limb amputation (n = 201).  
The bubble size corresponds to frequency of the data point (i.e. larger bubbles for higher frequency data points).  
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Figure 8.6: Bubble plot of Functional Comorbidity Index (FCI) versus Combined Age Charlson Comorbidity Index (CA-
CCI) scores for people with lower limb amputation (n = 201).  
The bubble size corresponds to frequency of the data point (i.e. larger bubbles for higher frequency data points).  
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Figure 8.7: Bubble plot of Charlson Comorbidity Index (CCI) versus Combined Age Charlson Comorbidity Index (CA-
CCI) scores for people with lower limb amputation (n = 201).  
The bubble size corresponds to frequency of the data point (i.e. larger bubbles for higher frequency data points).  
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Table 8.4: Median, Interquartile Range (IQR) and Mann Whitney U Test for measures of comorbidity in known groups 
with high and low comorbidity (95% CI). 
Known groups & measures of comorbidity  n1 n2 n1 median (IQR) n2 median (IQR) U score Z score p value Effect size 
Prosthetic non-users vs. users 52 149            
No. of comorbidities     14 (7.75 to 17) 9 (5 to 14) 5026 -3.19 .0014 -0.225 
FCI     4 (2 to 5) 2 (1 to 4) 4778 -2.5 .0124 -0.176 
CCI     3 ( 1 to 5) 2 (0 to 4) 4612 -2.04 .0414 -0.144 
CA-CCI     4 (3 to 7) 4 (1 to 5) 4584 -1.96 0.05 -0.138 
Atraumatic vs. Traumatic 147 54            
No. of comorbidities     12 (8 to 15) 4 (1 to 9) 1740 6.1 < .0001 0.430 
FCI     4 (2 to 5) 0 (0 to 2) 1774 6 < .0001 0.423 
CCI     3 (2 to 5) 0 (0 to 1) 1138 7.74 < .0001 0.546 
CA-CCI     5 (3 to 7) 0 (0 to 2) 1158 7.69 < .0001 0.542 
Diabetes vs. No diabetes 
No. of comorbidities 
FCI 
CCI 
CA-CCI 
93 
 
108  
13 (9 to 17) 
4 (3 to 5) 
4 (2 to 5) 
5 (4 to 7) 
 
7 (3 to 12) 
1 (0 to 4) 
1 (0 to 2) 
2 (0 to 4) 
 
2330 
2244 
1304 
1904 
 
6.55 
6.75 
9.04 
7.58 
 
< .0001 
< .0001 
< .0001 
< .0001 
 
0.462 
0.476 
0.638 
0.535 
Age > 58 vs. < 58 years 92 109            
No. of comorbidities     13 (8 to 15) 8 (3 to 13) 6986 -4.8 < .0001 -0.339 
FCI     4 (2 to 5) 2 (0 to 4) 7382 -5.76 < .0001 -0.406 
CCI     3 (2 to 4) 1 (0 to 3) 6796 -4.33 < .0001 -0.305 
CA-CCI     5 (4 to 7) 2 (0 to 4) 8240 -7.85 <. 0001 -0.554 
Aboriginal vs. Non-Aboriginal 29 172            
No. of comorbidities     10 (7 to 15) 10 (5 to 15) 2648 -0.53 .5961 -0.037 
FCI     3 (1 to 5) 3 (1 to 5) 2606 -0.39 .6965 -0.028 
CCI     3 (2 to 5) 2 (0 to 4) 3201 -2.44 .0147 -0.172 
CA-CCI     4 (3 to 6) 4 (1 to 6) 2793 -1.03 .303 -0.073 
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Known groups & measures of comorbidity  n1 n2 n1 median (IQR) n2 median (IQR) U score Z score p value Effect size 
Above transtibial vs. transtibial 65 136            
No. of comorbidities     8 (4 to 15) 11 (7 to 15) 3836 1.51 .131 0.107 
FCI     2 (1 to 4) 3 (1 to 5) 3830 1.53 .126 0.108 
CCI     2 (0 to 3) 2.5 (1 to 4) 3524 2.32 .0203 0.164 
CA-CCI     3 (0 to 5) 4 (2 to 6) 3426 2.57 .0102 0.181 
Bilateral vs. unilateral 31 170            
No. of comorbidities     10 (6 to 16.5) 10 (5 to 14) 2942 -1.03 .303 -0.073 
FCI     4 (2 to 5) 3 (1 to 5) 3118 -1.62 .1052 -0.114 
CCI     3 (1 to 6) 2 (1 to 4) 3133 -1.67 .0949 -0.118 
CA-CCI     5 (2.5 to 7) 4 (1 to 6) 3085 -1.51 .131 -0.107 
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Figure 8.8: Effect size of comorbidity indices for people who become prosthetic users and non-users.  
Effect sizes above the line (alpha =0.05) identify significant differences between groups. The number of comorbidities 
separates the user and non-user groups showing greater sensitivity for this known dichotomy.  
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Figure 8.9: Effect size of comorbidity indices for people with atraumatic & traumatic amputation causes.  
All comorbidity scales are well above the line (alpha =0.05) identifying significant differences between groups. The 
CCI and Age adjusted CCI showed greater sensitivity for this known dichotomy. 
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Figure 8.10: Effect size of comorbidity indices in people with and without diabetes.  
All comorbidity scales are well above the line (alpha =0.05) identifying significant differences between groups. The 
CCI showed greater sensitivity for this known dichotomy. 
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Figure 8.11: Effect size of comorbidity indices for people with amputation who are older and younger.  
All comorbidity scales are above the line (alpha =0.05) identifying significant differences between groups. As expected 
the Combined Age CCI had the greatest sensitivity for this known dichotomy. 
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Figure 8.12: Effect size of comorbidity indices for people with Aboriginal and non-Aboriginal ethnicity.  
The only index to be sensitive to this known group dichotomy was the CCI. All other comorbidity scales failed to 
statistically separate the known groups.  
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Figure 8.13: Effect size of comorbidity indices for people with above transtibial and transtibial amputation.  
The CCI and the age adjusted version of the CCI were the only scales able to separate the groups statistically.  
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Figure 8.14: Effect size of comorbidity indices for people with unilateral and bilateral lower limb amputation.  
No comorbidity scale was able to separate the two known groups suggesting that there may not be any observable 
systematic differences between the known groups. 
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The CCI had the greatest effect size in the diabetes, atraumatic amputation, transtibial 
and Aboriginal known groups analyses of the comorbidity indices. Effect size was 
greatest for the CA-CCI for the older age known groups analysis. 
 8.4. Discussion 
This study has mapped comorbidities associated with function and mortality in a 
heterogeneous cohort with lower limb amputation who underwent prosthetic 
rehabilitation. The study has demonstrated that in people with lower limb amputation, 
FCI, CCI and CA-CCI scores all had strong positive correlations with number of 
comorbidities. From the known groups analysis, the CCI had the greatest construct 
validity which may be due to its stronger link to mortality. 
 
The FCI had the strongest relationship to number of comorbidities explaining 71% of 
variance in the model. A FCI score of 6 was equivalent to > 19 comorbidities reported 
by Roffman et al. (2014) as a predictor of prosthetic non-use at 4 months after 
rehabilitation discharge. This stronger relationship may have been related to the fact that 
FCI and number of comorbidities scales were both summed totals while scales for the 
CCI and CA-CCI had comorbidities that were weighted based on mortality risk, disease 
severity and age. Therefore, a known groups analysis was performed to determine which 
comorbidity index separated the scale most effectively in high and low comorbidity 
groups with lower limb amputation.  
 
It is difficult to compare CCI scores from the literature (Fortington et al., 2013; Hoffstad 
et al., 2015; van Eijk et al., 2012; Webster et al., 2012) due to different methodology 
used in amputation cohort studies, as some researchers have included or excluded 
diabetes and peripheral arterial disease while others have used the CCI to generate a 
standardised list of comorbidities and not reported scores. Webster et al. (2012) used the 
CCI to stratify 87 participants with transmetatarsal, transtibial and transfemoral 
amputation into low (0 to 3 points), moderate (3.1 to 5.9 points), high (6 to 7.9 points) 
and very high (> 8 points) burden of disease. In this study a total of  49% of participants 
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with transtibial and transfemoral amputation had moderate to very high CCI scores 
(Webster et al., 2012).  
 
The FCI scores in our study were similar to those reported in the literature for cohorts 
with amputation (Davie-Smith et al., 2016; de Laat et al., 2014). de Laat et al. (2014) 
reported that 39% of a cohort with both atraumatic and traumatic causes of amputation 
had an FCI > 4. In a cohort with amputation from vascular and diabetic causes, the mean 
FCI was 3.2 (SD = 1.9) (Davie-Smith et al., 2016).  
 Known Groups analysis 
The known groups analysis in our study has improved understanding of the scale for 
common comorbidity indices and provided representative scores for lower limb 
amputation in the WA health context. The magnitude of significance or effect size of 
comorbidity indices tested (as demonstrated by p and r values) was greatest for the 
atraumatic, diabetes and older age subgroups with high comorbidity and their associated 
lower comorbidity sub-groups with medium to large effect demonstrated. 
 Prosthetic non-users  
In the prosthetic non-user known group analysis, number of comorbidities was validated 
as having the greatest effect size and FCI was the second most sensitive method for 
analysing comorbidity. Comorbidity has been the main reason reported in the literature 
for not fitting a prosthetic limb and proceeding with gait retraining in people with lower 
limb amputation (Davie-Smith et al., 2016; Fletcher et al., 2001; Fletcher et al., 2002; 
Webster et al., 2012). People with 5 to 10 comorbidities have been shown to score 
significantly lower for functional prosthetic use on the Houghton Scale and LCI 
(Agrawal et al., 2014). de Laat et al. (2014) demonstrated that participants with higher 
FCI scores reported significantly greater difficulty performing rising activities using a 
prosthetic limb from the Locomotor Capabilities Index (LCI) including rising from a 
chair, picking up an object and floor transfers. Past studies (Gailey et al., 2002; 
Melchiorre et al., 1996) have also shown that as score on the Melchiorre Comorbidity 
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Index (a modified version of the CCI) increases, ability to walk using a prosthetic limb 
decreases.  
 Atraumatic amputation 
In our study participants with atraumatic amputation had significantly higher number of 
comorbidities, FCI, CCI and CA-CCI scores compared to those with traumatic 
amputation. Large effect was demonstrated by the CCI and CA-CCI. These findings 
were supported by Schoppen et al. (2003) who demonstrated that functional outcome 
could be predicted at 2 weeks after surgery in people with atraumatic causes of lower 
limb amputation through age at amputation, single limb balance on unaffected limb, 
cognitive impairment and the presence of severe comorbidity. In atraumatic amputation 
cohorts, poor functional outcome has been associated with comorbidities including end 
staged renal failure (ESRF), ischaemic heart disease, cerebrovascular disease, diabetes, 
depression, dementia and previous arterial revascularisation surgery (Schoppen et al., 
2003; Taylor et al., 2005; Webster et al., 2012). Webster et al. (2012) demonstrated that 
the number of hours people with atraumatic amputation walk using a prosthesis was 
significantly reduced in people with a history of end stage renal failure and major 
depressive episodes. However in contrast to our study, Webster et al. (2012) reported 
that CCI was not sensitive enough as a measure of disease burden to identify people with 
atraumatic amputation who were fitted with prosthesis. 
 Older age 
Similar to past studies (Schoppen et al., 2003; Taylor et al., 2005; van Eijk et al., 2012) 
we found participants with older age (> 58 years) had significantly higher number of 
comorbidities FCI, CCI and CA-CCI scores compared to younger participants. The CA-
CCI was validated as the most sensitive comorbidity index because it had the largest 
effect size. Independent association of older age with mortality has been demonstrated 
following lower limb amputation in the presence of heart failure, renal disease, cancer 
and COPD with every 5 year incremental increase of age (Jones et al., 2013). Studies 
(Roffman et al., 2014; Webster et al., 2012) have demonstrated ages of 55 years or 
greater and comorbidities were associated with prosthetic non-use or fewer hours of 
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prosthetic walking. In a geriatric lower limb amputation cohort where the median age 
was 79.7 years, only 36% of participants were successfully fitted with a prosthetic limb 
(Fletcher et al., 2001). In this study, advanced age, cerebrovascular disease, dementia 
and transfemoral amputation level were significantly associated with failure to fit a 
prosthetic limb (Fletcher et al., 2001).  
 Diabetes 
In our study people with a diagnosis of diabetes had significantly higher number of 
comorbidities, FCI, CCI and CA-CCI scores than those without diabetes. A large effect 
was demonstrated for the CCI. Higher comorbidity has been demonstrated in people 
with amputation that have diabetes than those with cardiovascular disease alone 
(Kurowski et al., 2015). In contrast to our study, Davie-Smith et al. (2016) reported that 
FCI was not significantly different between people with and without diabetes that had 
atraumatic causes of amputation. Many patients with diabetes who undergo amputation 
have end organ disease due to the macrovascular and microvascular complications of 
diabetes (Bate & Jerums, 2003; Hoffstad et al., 2015) which potentially explains the 
significant results and large effect size in CCI and CA-CCI scores. Some researchers 
(Davie-Smith et al., 2016; Webster et al., 2012) have demonstrated that diabetes is an 
independent factor associated with functional outcome as people with diabetes and 
transfemoral amputation were less likely to be fitted with a prosthesis. However other 
studies (Roffman et al., 2014; van Eijk et al., 2012) have reported that diabetes was not 
predictive of abandonment of prosthetic use. Studies (Davie-Smith et al., 2016; 
Fortington et al., 2013; Kurowski et al., 2015) have reported higher rates of distal 
amputation and contralateral lower limb amputation in people with diabetes. In our 
cohort 46.3% (n = 93) of participants had diabetes which was similar to rates reported in 
other studies (Davie-Smith et al., 2016; Fortington et al., 2013; van Eijk et al., 2012). 
There was significantly higher representation of diabetes in people with Aboriginal 
ethnicity which was similar to past demographic studies of Australian Aboriginal 
cohorts (Baba et al., 2015; Norman et al., 2010; Vos et al., 2009). Higher representation 
of diabetes has also been identified in ethnic groups with amputation in the USA, 
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Canada and New Zealand (Agrawal et al., 2014; Jones et al., 2013; Moxey et al., 2011; 
Schoen & Norman, 2014).  Aboriginal Ethnicity 
In 2003, a study of Disability Adjusted Life Years (DALYs) revealed a health gap of 
59% for Aboriginal people with 70% of the health gap explained by non-communicable 
diseases (i.e. diabetes, cardiovascular disease) and poorer health outcomes in remote 
regions of Australia (Vos et al., 2009). In our study, CCI score was significantly higher 
with a small effect size for participants of Aboriginal ethnicity. However, number of 
comorbidities, FCI and CA-CCI were not significantly different. These findings support 
previous research that Aboriginal people have higher mortality from chronic disease at a 
younger age while functional outcomes following lower limb amputation were not 
significantly different (Baba et al., 2015; Roffman et al., 2014; Schoen & Norman, 2014; 
Vos et al., 2009).  
 Above Transtibial Amputation Level 
The relationship between disease burden and level of amputation is unclear in the 
literature (Davie-Smith et al., 2016; Fortington et al., 2013; Jones et al., 2013). We 
hypothesised that people with above transtibial amputation would have higher 
comorbidity because it is often performed as a lifesaving procedure in older people. 
However, in our study participants with transtibial amputation had significantly higher 
CCI and CA-CCI scores than those with above transtibial amputation levels. Jones et al. 
(2013) reported significantly higher mortality rate for people with transfemoral 
amputation. Studies (Davie-Smith et al., 2016; Fortington et al., 2013) have reported 
higher rates of transtibial amputation in people with diabetes due to peripheral arterial 
disease in the distal arterial supply. Increased burden of disease and mortality risk have 
been associated with this diabetes sub-group (Bate & Jerums, 2003; Hoffstad et al., 
2015; Mueller, 2016). 
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Bilateral Amputation 
There were no differences in comorbidity scores between bilateral and unilateral 
participants in this study. This was unexpected as other studies (Davie-Smith et al., 
2016; Fortington et al., 2013; Kurowski et al., 2015) demonstrated that progression to 
bilateral lower limb amputation was more frequent in the diabetes sub-group which have 
significantly higher comorbidity. Fitting and capacity to walk using prostheses has also 
been reported as reduced in people with bilateral lower limb amputation (Davie-Smith et 
al., 2016; Sansam et al., 2009). Therefore, people who were selected and underwent 
prosthetic gait retraining after bilateral amputation in our study may represent a healthier 
cohort. These results highlight a need for longitudinal studies of bilateral lower limb 
amputation cohorts as there is potential to develop higher comorbidity over time due to 
the associated reduction in physical activity and quality of life.  
  Prevalence of Comorbidities 
Similar to past studies (Devan et al., 2014; Fortington et al., 2013; Jones et al., 2013) the 
most frequently occurring comorbidities were peripheral arterial disease, diabetes, 
ischaemic heart disease, hypertension, hypercholesterolaemia, renal failure, arthritis, 
back pain and obesity. A large proportion of the study cohort with diabetes had a history 
of peripheral neuropathy, toe, foot or leg ulcers prior to amputation. In people with 
diabetes, a triad of peripheral neuropathy, structural deformity and minor trauma have 
been identified as a causal pathway to ulceration that potentially leads to amputation 
(Reiber et al., 1999). In terms of disease risk factors many participants were ex-smokers 
(30.3%, n = 61) or continued to smoke (25.4%, n = 51) following lower limb amputation 
which has been reported by past studies (Agrawal et al., 2014; Baba et al., 2015; van 
Netten et al.). In this study depression was present in 13.4% (n = 27) of the cohort prior 
to amputation. Pre-existing mental illness may impact on adjustment to lower limb 
amputation, motivation, ability to manage chronic disease or engage in the 
rehabilitation.  
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Osteoarthritis, osteoporosis of the residual limb, back and shoulder pathology have been 
recognised as some of the musculoskeletal sequelae developed by people with lower 
limb amputation that affect long term ability to sustain prosthetic gait (Devan et al., 
2014; Gailey et al., 2008; Kulkarni, 2008). However, an important finding from our 
study was that many participants had musculoskeletal pathology including osteoarthritis, 
back, knee and shoulder pathology before they underwent amputation. Mueller (2016) 
identified higher rates of musculoskeletal pathology in people with diabetes and the 
potential for musculoskeletal injury with lower force. Knowledge of musculoskeletal 
pathology prior to rehabilitation commencing is useful for planning physiotherapy and 
rehabilitation interventions (e.g. prosthetic gait retraining, wheelchair prescription and 
driving).  
 Limitations and Future Research 
There were some limitations with this study that potentially impacted on the results. This 
was a single centre, retrospective study so possible sources of bias were missing data 
from the medical record and the interview relied on participant recall. However, 
accuracy of this study was improved through the auditing of individual medical records 
instead of using de-identified administrative health databases. Standardised 
physiotherapy assessment and data retrieval forms were also used to improve quality of 
the data abstracted from the medical record (see Appendices 8.2 and 8.3). The sample 
size in this study is relatively large in terms of amputation cohorts however a high 
proportion of the cohort were deceased and small numbers in some of the known groups 
have the potential to influence results. Therefore further research to validate these results 
is warranted. The interaction of comorbidities with capacity for prosthetic gait has not 
been directly measured by this study so it is unknown whether the increased exercise 
intensity of prosthetic gait offers any protective benefits or deleterious side effects for 
the management of chronic diseases such as diabetes, cardiovascular disease and renal 
failure in people with lower limb amputation.    
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8.5. Conclusion   
This study has demonstrated high burden of disease in sub-groups with lower limb 
amputation who were selected for prosthetic rehabilitation. Comorbidity indices of both 
function and mortality have construct validity in people with lower limb amputation. 
The FCI had the strongest relationship with number of comorbidities however the CCI 
was more sensitive and had greater effect size for more sub-groups in the known groups 
analysis. This was the first study to map the frequency of musculoskeletal pathology and 
mental illness at hospital admission prior to rehabilitation intervention. This study 
highlights a need to standardise measurement of comorbidity in clinical practice to 
enable comparison of long term outcome and plan resource allocation for amputation 
cohorts. Further research to validate these results and understand how disease 
progression is modified by physical activity through sustained prosthetic use is 
indicated.   
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Chapter 9   Discussion 
 9. Discussion and future research directions  
This thesis has made an original and significant contribution to rehabilitation 
outcomes following lower limb amputation that will be translated into future models 
of care, interventions, funding and social policy. At the time of submission in July 
2017 for this thesis, the findings have been crossed referenced in most recent 
research clinical reports3.   
 
This thesis has achieved the following objectives: 
• Development of clinical prediction rules (CPRs) for prosthetic non-use 
• Validation of clinical prediction rules for prosthetic non-use 
• Development of performance thresholds for locomotor tests during 
rehabilitation that identify increased risk of prosthetic non-use at 12 months 
after discharge 
• Measurement of construct validity of locomotor tests in a cohort with lower 
limb amputation 
• Mapping of comorbidities at admission and measurement of the construct 
validity of using comorbidity indices in a cohort with lower limb amputation 
• The first study to report rehabilitation outcomes in (Australian) Aboriginal 
people with amputation 
• Determined long term self reported outcomes of people with lower limb 
amputation after rehabilitation discharge including sociodemographic 
characteristics, complications of amputation, prosthetic locomotor function 
using the locomotor capabilities index 5 (LCI5), mobility without a 
                                                             
3 (Rogers and Stevens 2015a, Rogers and Stevens 2015b, Stevens 2015, Joubert 
2016, Kahle, Klenow et al. 2016, Šrubařová and Stašková 2016, Felice, Kerekes et 
al. 2017, Ioannidis, Kitsikosta et al. 2017, Jakobsen, Biering et al. 2017, Kelly, 
Pedersen et al. 2017, McCabe, Butler et al. 2017, Rossiter, Knoop et al. 2017, Seng, 
Traore et al. 2017) 
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prosthesis, use of wheelchair and assistive devices, return to driving and 
work. 
 
To date amputee rehabilitation models of care and clinical practice guidelines have 
been predominantly based on the lowest level (level 5) of evidence such as expert 
clinical opinion (Broomhead et al., 2006; Department of Health, 2008; Highsmith, 
2013; Schaffalitzky et al., 2012; US Department of Veterans Affairs, 2008; van der 
Linde et al., 2005). The knowledge gaps in the literature, key findings and limitations 
of the studies in this thesis are discussed in this chapter to demonstrate how this 
research has contributed to evolution of the evidence base and areas for future 
scientific investigation. The levels of evidence used to appraise the research in this 
thesis were based on the criteria reported by Childs and Cleland (2006) for the 
clinical prediction rule studies and the Oxford Centre for Evidenced-Based Medicine 
(OCEBM) (Howick, 2009) for the cohort studies.  
    9.1. Clinical Prediction Rules developed and validated for prosthetic non-use 
  9.1.1. Knowledge Gaps 
The CPR development and validation studies in this thesis have addressed the 
following knowledge gaps that were identified in the literature (Cumming et al., 
2006; Department of Health, 2008; Gailey et al., 2002; Jones et al., 1993; Lim et al., 
2006; Sansam et al., 2009; Schaffalitzky et al., 2012; Schoppen et al., 2003; Taylor et 
al., 2005): 
• No CPRs to identify people with lower limb amputation at risk of prosthetic non-
use after discharge from rehabilitation existed 
• Studies have focused on factors associated with not fitting a prosthesis, surgical 
outcomes and people with limited rehabilitation potential 
• There were mainly literature reviews, univariate and descriptive studies with 
limited multivariate studies or randomised controlled trials 
• Studies have used sub-groups with lower limb amputation (e.g. unilateral 
amputation, transfemoral level, atraumatic cause, geriatric) or samples of 
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convenience (e.g. peer support groups, military service personnel) that were 
several years post-amputation reducing generalisability to the early rehabilitation 
context 
• Rehabilitation outcomes in Western Australia were unknown.  
 9.1.2. Similarities and differences with the literature 
This was the first study to develop and validate clinical prediction rules (CPRs) for 
prosthetic non-use at 4 (& 6), 8 and 12 months after discharge from rehabilitation in 
a heterogeneous cohort with lower limb amputation (Roffman et al., 2014). Although 
many CPRs have been developed in the health literature, the second stage of 
validation requires a substantial and sustained second phase of research that often 
tests the validity of the first research project. It is unclear if the lack of follow-up is 
related to the research question changing or the possibility of a publication bias but 
in the clinical context there is a very small conversion of CPRs being reported in 
second phase validation studies (Stiell et al., 1993; Stiell et al., 1996). Based on 
criteria for rating levels of evidence in CPRs our research represents level 3 evidence 
(Beneciuk et al., 2009; Childs & Cleland, 2006; Cleland et al., 2007). The OCEBM 
appraisal system (used to determine levels of evidence for the other studies in this 
thesis) rates the retrospective CPR development study as level 2b and the prospective 
CPR validation study as level 1b evidence (Howick, 2009). Although randomised 
controlled trials (RCTs) are the gold standard for treatment efficacy studies, for 
complex models of care in cases where there is substantial therapeutic opinion that 
the best practice methods are being used – CPR studies often form the basis to 
change decision pathways and practices in the model to facilitate evidence based 
change or additional options for clients (Beneciuk et al., 2009; Childs & Cleland, 
2006; Cleland et al., 2007).  
 
The majority of studies in lower limb amputation cohorts have focused on variables 
associated with “not fitting prostheses” (i.e. choosing not to proceed to prosthetic 
rehabilitation) rather than predictors for discontinuing prosthetic use after a patient 
has been discharged from prosthetic rehabilitation (Davie-Smith et al., 2016; Fletcher 
et al., 2001; Fletcher et al., 2002; Resnik & Borgia, 2015; Webster et al., 2012). 
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These studies have answered a different research question to our CPR study making 
comparison or generalisation difficult because they are not testing effectiveness of 
the prosthetic rehabilitation intervention or variables associated with sub-groups who 
have undergone this rehabilitation. However, both lines of research provide 
important insight into patient selection for prosthetic rehabilitation.  
 
Prior to the CPR studies reported in this thesis (Roffman et al., 2014), there were 
limited studies using multivariate statistical methods with the majority of evidence 
coming from descriptive studies, univariate association and interpretative summaries 
of these sources in literature reviews (Cumming et al., 2006; Gauthier-Gagnon et al., 
1999; Jones et al., 1993; Lim et al., 2006; Sansam et al., 2009; Schoppen et al., 2003; 
Taylor et al., 2005; Webster et al., 2012). Furthermore, studies focused on sub-
groups with limited potential to rehabilitate and surgical outcomes limiting external 
validity of the findings (Lim et al., 2006; Taylor et al., 2005).  
 
Our research has investigated a broad range of amputation, intrinsic and functional 
predictor variables from the literature that influence prosthetic use and non-use in 
people with lower limb amputation who have undergone prosthetic rehabilitation 
(see Chapter 4, figure 4.1). Similar to the literature review by Sansam et al. (2009), 
the univariate analysis in our CPR development study demonstrated that many 
variables had univariate association with prosthetic non-use. These variables were 
further reduced to key variables or flags using backwards stepwise logistic regression 
to generate the CPRs for different time points. The variables in the final CPRs were 
considered to be parsimonious and acting in combination to predict the outcome of 
prosthetic non-use (e.g. 4 out of 5 variables at 4 months, 3 out of 3 variables at 8 
months, 2 out of 3 variables for 12 months). Therefore, it is important to consider 
these variables in combination for the CPR timeframes, rather than in isolation 
because the combined effect of different variables represents different sub-groups at 
risk of prosthetic non-use who may benefit from different clinical decision making 
(Childs & Cleland, 2006).  
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9.2. Amputation Predictor Variables 9.2.1. Amputation level and energy cost of prosthetic gait 
Similar to the many studies, above transtibial amputation level and using a mobility 
aid at discharge were significant predictors across all time frames. Higher levels of 
amputation have been consistently associated with reduced capacity to walk using a 
prosthesis (Davies & Datta, 2003; Dillon, Major, Kaluf, Balasanov, & Fatone, 2017a; 
Gauthier-Gagnon et al., 1999; Moore et al., 1989; Nehler et al., 2003; Sansam et al., 
2009; Taylor et al., 2005; Webster et al., 2012). Higher energy cost has been reported 
for walking with a transfemoral prosthesis compared to walking with a transtibial 
prosthesis or in able bodied participants (Waters et al., 1976; Wezenberg et al., 
2013). Waters et al. (1976) demonstrated significantly higher heart rate in people 
with atraumatic transfemoral amputation in contrast to able bodied participants. Chin 
et al. (2002) demonstrated that predicted VO2max derived from an incremental 1 leg 
cycle test was significantly higher in people who were able to walk 100m with a 
transfemoral prosthesis than those who did not achieve this milestone during 
rehabilitation. From this study it was suggested that people with atraumatic 
amputation and a working capacity of 50% predicted VO2max or greater were more 
likely to be successful at walking 100m with a transfemoral prosthesis.  
 
Erjavec et al. (2014) reported that people with atraumatic transfemoral amputation 
who performed an intermittent, incremental, submaximal arm ergometry test at a 
working capacity of 30 Watts (W) or greater were able to complete a 6MWT using a 
prosthesis. Participants performed 2 minutes of arm ergometry at 10W and 50 to 55 
RPM, with 1 minute rest between increments that increased by 10W. An interesting 
finding of the study by Erjavec et al. (2014) was the high number of participants with 
detected cardiovascular complications (e.g. electrocardiogram changes, coronary 
ischaemia, hypertension) resulting in the exercise test being ceased before steady 
state was achieved. The cardiac load of prosthetic gait is a major clinical decision for 
rehabilitation teams when selecting clients for prosthetic rehabilitation that remains 
important during the other phases of rehabilitation because health professionals may 
need to advise clients to stop using their prosthesis due to progression of cardiac 
conditions such as ischaemic heart disease, heart failure or arrhythmias.  
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Wezenberg et al. (2013) demonstrated that the predicted relative aerobic load VO2rel 
walking on a treadmill with a prosthesis, was significantly higher in people 
atraumatic amputation compared to those with traumatic causes of amputation. 
However, while studies of energy cost in people with varying levels and causes of 
lower limb amputation have demonstrated the importance of physical fitness for 
walking performance, there have been no longitudinal studies of VO2rel and VO2max 
to quantify if energy cost is the primary causative factor for abandoning use of a 
prosthesis. This line of research assumes there is a central limitation (e.g. ischaemic 
heart disease, chronic obstructive pulmonary disease) to function as opposed to the 
peripheral limitation or impairment (e.g. peripheral arterial disease, motor peripheral 
neuropathy). In clinical practice, a combination of central and peripheral limitations 
may be present during exercise testing of sub-groups with atraumatic amputation. 
This may result in fatigue or claudication pain in lower limb muscles before 
shortness of breath and at a lower anaerobic threshold than sub-groups with 
traumatic amputation. It also contributes to the cycle of physical deconditioning (i.e. 
person does not walk due to fatigue resulting in decreased muscle strength, muscle 
mass and VO2max).  
 
Research is required to determine if the difference between atraumatic and traumatic 
outcomes following lower limb amputation relate to the differences in central and 
peripheral limitations to exercise. Future studies may investigate whether prosthetic 
non-use is related to individual relative capacity or absolute capacity following lower 
limb amputation. For example, walking efficiency in a sedentary, overweight person 
with ischaemic heart disease and an atraumatic transtibial amputation is potentially 
lower than an athlete of normal weight without ischaemic heart disease and a 
traumatic transfemoral amputation. Furthermore, research is required to validate 
whether attrition of prosthetic use correlates with a decline in ambulation efficiency. 
This research could improve rehabilitation models of care through development of 
screening protocols, targeted exercise guidelines and prosthetic gait retraining 
strategies as well as enhance understanding of the relationship between physical 
fitness and prosthetic non-use. 
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9.2.2. Amputation level and other factors impacting on prosthetic use 
Other factors such as inability to independently don the prosthesis, automaticity or 
cognitive load of prosthetic gait, socket discomfort, muscle biomechanics, residual 
limb length, skin or soft tissue issues, hip joint range of movement, weight of the 
prosthesis and physical impairments of balance and strength have been associated 
with poor prosthetic outcome for people with above transtibial amputation level in 
the literature (Brånemark et al., 2014; Dillingham et al., 2001; Gailey et al., 2010; 
Gailey et al., 2002; Gauthier-Gagnon et al., 1999; Gottschalk, 2002; Hagberg, 
Haggstrom, Uden, & Branemark, 2005; Laferrier & Gailey, 2010; Legro, Reiber, del 
Aguila, & Ajax, 1999; Lusardi, 2013; Meier & Melton, 2014; Schoppen et al., 2003; 
Waters et al., 1976). Prosthetic and surgical technologies such as microprocessor 
knee components, brimless sockets, vacuum assisted suspension and osseointegration 
are examples of clinical research that aim to improve efficiency of gait, balance and 
prosthetic use in people with higher levels of amputation (Brånemark et al., 2014; 
Frossard, Merlo, Quincey, Burkett, & Berg, 2017; Hafner, Willingham, Buell, Allyn, 
& Smith, 2007; Hagberg et al., 2005; Hagberg et al., 2014; Kahle & Highsmith, 
2014; Kaufman et al., 2008; Laferrier & Gailey, 2010). However, although these 
technologies may potentially improve prosthetic outcome they are currently not 
funded in the WA public health context (or the majority of Australian public health 
service systems). Frossard et al. (2017) recently reported on the development of a 
procedure for government provision of bone anchored prosthesis using 
osseointegration in 18 people with transfemoral amputation from Queensland, 
Australia. 
 
There are some key anatomical differences between transtibial, knee disarticulation 
and transfemoral amputation levels that have been associated with functional 
outcome in the literature (Gottschalk, 2002; Knapp, 2013; Lusardi, 2013; Lusardi & 
Pepe, 2013; Meier & Melton, 2014; Psonak, 2013; Ries & Vaughan, 2013). Absence 
of the plantar flexors is the main muscle group that people with transtibial 
amputation have to compensate for during prosthetic gait by using the hip abductor 
and extensor muscle groups (Ries & Vaughan, 2013). Preservation of the knee joint 
in people with transtibial amputation means that the quadriceps, hamstrings, satorius, 
tensor fasciae latae/iliotibial band and hip adductor muscle groups remain functional 
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and the longer lever length of the transtibial residual limb allows greater force 
generation when performing locomotor activities (Lusardi, 2013). In contrast, muscle 
group insertions including quadriceps, hamstrings, satorius, hip adductors (in 
particular adductor magnus) and tensor fasciae latae/iliotibial band have undergone 
myodesis, myoplasty or been completely transected in people with transfemoral 
amputation level (Gottschalk, 2002; Lusardi, 2013; Lusardi & Pepe, 2013). 
Transfemoral amputation surgery results in hip muscle imbalance and reduced 
muscle mass that changes the biomechanical line of pull so the residual femur is 
abducted (Gottschalk, 2002; Lusardi, 2013). This may cause lateral shift of the pelvis 
and impact on the efficiency of transfemoral prosthetic gait because the normal 
anatomical alignment of the human femur in able bodied people, is in adduction with 
the femoral shaft axis at 9 degrees from the vertical (Gottschalk, 2002; Lusardi, 
2013). People with knee disarticulation level of amputation have the functional 
advantages of a residual limb with longer lever length, preservation of the thigh 
musculature including the hip adductor muscle group and proprioception during 
prosthetic gait (due to weight bearing through the femoral condyles) that are not 
present in people with transfemoral amputation (Baumgartner, 1979; Psonak, 2013). 
 
From a functional perspective the transtibial prosthesis assists people with transtibial 
amputation during seated transfers (e.g. wheelchair to bed) while the knee 
disarticulation and transfemoral prostheses with prosthetic knee joints are only 
functionally useful once standing or walking (Meier & Melton, 2014). The human 
knee joint anatomically has a combination of flexion and extension (i.e. hinge) and 
rotational movements that are challenging to replicate in a prosthetic knee joint 
(Psonak, 2013). Stability of the prosthetic knee joint during the stance phase of gait 
and trusting the prosthetic knee have been reported as major concerns that may affect 
prosthetic use in people with transfemoral amputation (Hafner & Smith, 2009; 
Kaufman et al., 2008; Mundell et al., 2017; Psonak, 2013). Furthermore, the 
cognitive load of learning to control and stabilise the mechanical prosthetic knee 
joint has been identified as challenging for some sub-groups with transfemoral 
amputation level (Lee & Costello, 2018; Sansam et al., 2009; Schoppen et al., 2003). 
This need for improved stability during the stance phase of prosthetic gait (especially 
walking down ramps and on uneven terrain) has led the design evolution from 
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mechanical to microprocessor prosthetic knees (Hafner & Smith, 2009; Laferrier & 
Gailey, 2010; Psonak, 2013). 
  
Proprioception is not present at the ankle or knee joint for people with transfemoral 
amputation using conventional socket prostheses so the balance compensatory 
strategies used are at the hip joint level. This lack of proprioception in people with 
tranfemoral amputation contributes to the difficulty of controlling the prosthetic knee 
during locomotor activities. Restoration of proprioception referred to as 
‘osseoperception’ has been reported in people with transfemoral amputation who 
have undergone osseointegration (Brånemark et al., 2014; Frossard et al., 2010; 
Laferrier & Gailey, 2010). Osseoperception occurs because the bony anchoring of 
the prosthesis to the femur and suspension of the prosthetic components from this 
bony anchor provides vibratory feedback when weight bearing through the prosthetic 
foot, that is not present in people who use conventional transfemoral prosthetic 
sockets (Brånemark et al., 2014; Laferrier & Gailey, 2010).  
 
Frossard et al. (2010) investigated the temporal gait characteristics of 12 people with 
transfemoral amputation who had undergone osseointegration and then compared 
these characteristics to the normative data reported in the literature for people with 
transfemoral amputation who use conventional socket prostheses and able bodied 
people. The cadence of people with osseointegrated prostheses was 46 ± 4 strides per 
minute, duration of gait cycle was 1.29 ± 0.11 seconds, support phase was 0.73 ± 
0.07 seconds, 57% ± 3% of the cadence cycle and swing phase was 0.56 ± 0.07 
seconds, 43% ± 3% of the gait cycle. These gait cycle characteristics for people with 
osseointegration were 2% faster, 3% and 6% shorter, and 1% longer respectively 
than people who used conventional transfemoral prosthetic sockets. The gait cycle 
characteristics for people with osseointegration were 11% slower and 9%, 6% and 
13% longer than able bodied people respectively. Although further longitudinal and 
cross-sectional studies were recommended, this study demonstrated that 
osseointegration enabled people with transfemoral amputation to walk with a 
biomechanically more efficient gait pattern than conventional prosthetic sockets 
(Frossard et al., 2010). 
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Prosthetic socket designs for people with transtibial and knee disarticulation levels of 
amputation generally do not cause any functional limitations during sitting. 
However, restriction of hip range of movement and socket discomfort in sitting 
positions have been reported as issues by people with transfemoral amputation who 
use conventional prosthetic sockets (Hagberg et al., 2005). Hagberg et al. (2005) 
compared hip range of movement and socket comfort in people with transfemoral 
amputation who used conventional transfemoral sockets (n = 43) and people with 
transfemoral amputation who had undergone osseointegration (n = 20). Hip range of 
movement was significantly reduced in all directions (i.e. flexion, extension, 
abduction, adduction, internal and external rotation) for people who used 
conventional transfemoral prosthetic sockets (Hagberg et al., 2005). A total of 37% 
(16) of subjects in the conventional transfemoral socket group had less than 90 
degrees hip flexion while none of the subjects in the osseointegration group had less 
than 90 degrees hip flexion (Hagberg et al., 2005). A discomfort level of moderate to 
a great deal of trouble when sitting were reported by 44% (19) in the conventional 
transfemoral socket group and 5% (1) in the osseointegration group (Hagberg et al., 
2005). This study demonstrated that conventional transfemoral prosthetic sockets 
limited active hip range of movement in users of conventional transfemoral 
prosthetic sockets and that active hip range of movement was not restricted in any 
direction for people who used osseointegrated prostheses (Hagberg et al., 2005). 
 9.2.3. Bilateral lower limb amputation 
Studies (Bhangu et al., 2009; Datta, Nair, & Payne, 1992; Moore et al., 1989) have 
demonstrated reduced capacity to walk in people with bilateral lower limb 
amputation however bilateral lower limb amputation was not a predictor of prosthetic 
non-use in our study. This may reflect the high number of participants with bilateral 
transtibial amputation in our study. In a review of ideal functional outcomes for 
different amputation levels, Meier and Melton (2014) reported that people with 
bilateral amputation were more likely to use their prostheses than people with 
unilateral amputation.    
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9.2.4. Delays after amputation surgery to prosthetic rehabilitation 
Delay after amputation surgery to prosthetic fitting of >160 days was a predictor of 
prosthetic non-use at 12 months after discharge in our study. Studies (Pohjolainen & 
Alaranta, 1991; Traballesi et al., 1998) have made a clear association between delays 
from surgery to prosthetic rehabilitation negatively impacting on mobility. The 
factors that underpin delays in systems or client complications may be a significant 
focus for future health systems research.  
 9.2.5. Amputation cause  
Past studies (Davies & Datta, 2003; Geertzen, Bosmans, van der Schans, & Dijkstra, 
2005; Pohjolainen & Alaranta, 1991; Schoppen et al., 2003; Webster et al., 2012) 
have reported poorer prosthetic outcome in people with atraumatic causes of 
amputation. In contrast to these studies, atraumatic amputation cause was not a 
predictor of prosthetic non-use in our study. A recent study by Dillon et al. (2017a) 
demonstrated that atraumatic amputation cause was not an independent predictor of 
MFCL K-level. 
 9.3. Functional Predictor Variables 9.3.1. Use of a mobility aid  
The role of the mobility aid would seem paradoxical in various contexts for 
predicting future prosthetic outcomes. For example, it could be suggested that people 
with greater levels of ambulatory impairment or higher amputation levels may need a 
mobility aid and yet the compensatory value of the mobility aid has been identified 
in the literature as a major factor that enables prosthetic gait in the community or 
challenging environments (Franchignoni et al., 2004; Gauthier-Gagnon et al., 1999; 
Pohjolainen & Alaranta, 1991; Wong et al., 2016b). Furthermore, the type of 
mobility aid used has the potential to enhance or reduce the functionality of 
prosthetic gait by impacting on the person’s capacity to carry objects (e.g. four 
wheeled walking frame with carry basket versus elbow crutches). In regression 
analyses by Gauthier-Gagnon et al. (1999) using a mobility aid was one of the 
significant variables associated with duration a prosthesis was worn and capacity to 
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walk indoors and outdoors with a prosthesis. Capacity to walk indoors using a 
prosthesis was associated with being able to carry an object while walking and the 
type of mobility aid used (i.e. crutches, cane or walking frame) (Gauthier-Gagnon et 
al., 1999). Some participants in this study by Gauthier-Gagnon et al. (1999) reported 
that they did not use their prosthesis to walk inside their home because they required 
a mobility aid and could not carry objects while walking. 
 
The dichotomous classification of using a mobility aid at discharge (i.e. yes or no) 
was used as a variable in our CPR study. The type of mobility aid used by 
participants was not statistically weighted for the amount of support provided and the 
environment or tasks in which it was required. However, our study in Chapter 7 part 
B on long term self reported activity and participation highlighted that the 50% (75) 
of participants who used a mobility aid may choose to use different types of mobility 
aids depending on the walking environment or task (e.g. indoors, outdoors, stairs) 
(see appendix 7.5B, table 7.6B). Schoppen et al. (2003) used an eight point mobility 
scale that incorporated mobility aids (i.e. walking stick, crutches, walking frame, 
wheelchair) and walking environment (i.e. indoors, outdoors) to score participants 
who were prosthetic users and non-users at 1 year post-amputation. In this study 
functional prosthetic use was only achieved by 49% (18) participants (Schoppen et 
al., 2003). To improve clinical utility, future CPR studies may statistically weight the 
type of mobility aid for the level of assistance it provides or develop a cut-off score 
from an amputee specific mobility scale using receiver operating characteristic 
(ROC) curves.  
 9.3.2. Mobility without a prosthesis 
The univariate phase of our study analysed functional variables related to both low 
and high functioning people with lower limb amputation because this was 
representative of milestones achieved by heterogeneous rehabilitation cohorts. 
Rehabilitation teams may use achievement of the lowest level of functional 
milestones early during pre-prosthetic rehabilitation such as independence with 
wheelchair mobility, transfers, standing and hopping before progressing onto 
prosthetic gait retraining (Roffman et al., 2014, 2016b). Hopping is a method of 
assessing functional lower limb strength, balance and aerobic capacity in people with 
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unilateral amputation. Waters et al. (1976) demonstrated that the energy cost of 
hopping with crutches was equivalent to walking with a transfemoral prosthesis. 
Therefore, hopping is one of the quick screening tests used by our rehabilitation team 
for clients with unilateral transfemoral amputation before prescribing a prosthesis. 
However, after analysing the pre-prosthetic locomotor variables (i.e. wheelchair 
mobility, transfers and hopping) in our study, inability to hop was the only univariate 
predictor of prosthetic non-use at 8 and 12 months. The ability to hop is a factor that 
may be mediated by the level of peripheral limitation in function (e.g. claudication, 
peripheral neuropathy, impaired muscle strength and balance) present as an 
independent factor within lower limb amputation cohorts. Future research may 
investigate the 6 minute wheelchair propulsion test or other tests of peripheral 
impairment (e.g. muscle strength, balance, proprioception) to determine their 
association with prosthetic non-use.  
 9.3.3. Mobility with a prosthesis 
Ability to don, doff and monitor prosthetic fit and mobility level achieved using a 
prosthesis at discharge from rehabilitation were examined to assess the whole 
continuum of locomotor skill and association with prosthetic non-use. The following 
prosthetic gait variables were analysed: walking indoors, outdoors, stairs, slopes, 
grass, gravel, uneven terrain, high-level balance activities and running. Dependence 
or inability to perform these locomotor milestones, were univariate predictors of 
prosthetic non-use for 4, 8 and 12 months. These functional variables confirmed that 
people who achieved low locomotor skill levels during rehabilitation were at greater 
risk of becoming prosthetic non-users (e.g. unable to walk outdoors on grass) while 
those who achieved high locomotor skill levels (e.g. able to run which represents an 
extremely high level of locomotor skill achieved by a small proportion of clients) 
continued to use their prosthesis. The other studies in this thesis have quantified 
these locomotor outcomes associated with prosthetic non-use using performance 
based locomotor tests (i.e. 10MWT, TUGT, 6MWT, FSST) and self reported 
function (i.e. LCI5).  
 
In our final CPR model, dependence walking outdoors on concrete was the 
functional milestone that predicted prosthetic non-use at 4 and 8 months after 
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discharge. This finding in the CPR was consistent with the work of Taylor et al. 
(2005) who reported that being unable to ambulate outdoors prior to amputation 
surgery was a predictor of prosthetic non-use. This CPR variable validates the 
indoors and outdoors walking dichotomy associated with prosthetic use and non-use 
in the literature (Gailey et al., 2002; Gauthier-Gagnon et al., 1999; Taylor et al., 
2005). Gauthier-Gagnon et al. (1999) demonstrated that capacity to walk outdoors 
using a prosthesis was associated with being able to independently don a prosthesis, 
climb stairs with a handrail, the type of mobility aid used and absence of stairs in the 
outdoors walking environment. In contrast to Gauthier-Gagnon et al. (1999) 
dependence with donning the prosthesis and walking up and down stairs were only 
univariate predictors of prosthetic non-use for the timeframes in our study.    
 9.4. Intrinsic Predictor Variables 9.4.1. Comorbidities 
In our study the cumulative effect of having a very high number of comorbidities 
was a predictor of prosthetic non-use at 4 months post-discharge this is consistent 
with well reported findings showing that as comorbidities increase, capacity to walk 
with a prosthesis decreases (Gailey et al., 2002; Schoppen et al., 2003; Taylor et al., 
2005). Diabetes is a major comorbidity of high prevalence in the lower limb 
amputation population. However, at 4 months after discharge from rehabilitation in 
the presence of the other parsimonious variables, not having a diagnosis of type 2 
diabetes was a predictor of prosthetic non-use in our study. The impact of diabetes on 
prosthetic outcome is unclear in the literature, as some studies have reported that 
diabetes was not associated with prosthetic outcome (Moore et al., 1989; Taylor et 
al., 2005) while other studies have demonstrated poorer functional outcomes in 
people with diabetes and lower limb amputation (Davie-Smith et al., 2016; Geertzen 
et al., 2005; Webster et al., 2012). Our findings suggest that there may be a sub-
group without type 2 diabetes but with high chronic disease burden and other CPR 
variables that increase the risk of becoming an early prosthetic non-user at 4 months. 
Future research may focus on developing models of care that optimise chronic 
disease management, exercise and rehabilitation strategies in this sub-group.       
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The presence of cardiac disease was another comorbidity that has been associated 
with prosthetic non-use in the literature (Moore et al., 1989; Pohjolainen & Alaranta, 
1991; Taylor et al., 2005) however in our study having a cardiac condition was only 
a univariate predictor of prosthetic non-use at the 8 and 12 months. Heart failure is 
one of the common cardiac conditions in people with atraumatic lower limb 
amputation. Ejection fraction may be reduced or preserved in clients with heart 
failure and this influences response to exercise and physical activity (De Maeyer, 
Beckers, Vrints, & Conraads, 2013). Further research is required to develop exercise, 
prosthetic prescription and user guidelines for sub-groups with lower limb 
amputation and cardiac conditions such as heart failure. Other comorbidities 
including peripheral arterial disease, type 1 diabetes, renal failure, stroke, arthritis 
and remaining lower limb pathology were not predictors of prosthetic non-use in our 
study. This was an interesting finding because clients with these comorbidities may 
be less physically active and therefore at higher risk of becoming prosthetic non-
users. For example, clients with renal failure who undergo haemodialysis are inactive 
up to 15 hours per week during their haemodialysis sessions which may impair 
physical fitness and capacity to use a prosthesis.  
 9.4.2. Sociodemographic variables 
Resnik and Borgia (2015) reported that prosthetic prescription rates were 
significantly lower in people of African American ethnicity and the southern regions 
of the USA. Important findings of our study were that geographical isolation from 
health services and Aboriginal ethnicity were not predictors of prosthetic non-use. 
Health care services are centralised to Perth the capital city in Western Australia 
however 43% of our cohort reside in country regions. A large proportion of people 
with Aboriginal ethnicity live in country or remote regions of WA. These findings 
suggest that the long established Telemedicine and service linkage strategies with 
local health professionals that form part of our model of care were successful in 
addressing any issues that may lead to prosthetic non-use in these clients. 
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9.4.3. Age 
Older age (55 years and over) has been a predictor of poor prosthetic outcome in past 
studies (Davies & Datta, 2003; Dillon et al., 2017a; Pohjolainen & Alaranta, 1991; 
Schoppen et al., 2003; Taylor et al., 2005; Webster et al., 2012). Age > 58 years was 
only a univariate predictor of prosthetic non-use in our study. These findings suggest 
there may be critical factors related to human mobility (e.g. physical fitness, 
comorbidities) as people enter the 6th decade of life that warrant further investigation. 
 9.5. Multifactorial reasons for prosthetic non-use reported by participants who became prosthetic non-users  
Multifactorial reasons for prosthetic non-use were reported by participants who 
became prosthetic non-users in the CPR development and validation studies. The 
main reasons reported for prosthetic non-use were similar between the retrospective 
and prospective cohorts and included: issue with the residual limb (stump), issue 
with the remaining limb, prosthetic issue, pain, medical comorbidities and balance 
issues. Similar reasons for abandoning prosthetic use have been reported in the 
literature and associated with transfemoral (or higher) and bilateral lower limb 
amputations (Chamlian, 2014; Gailey et al., 2010; Karmarkar et al., 2009; Laferrier 
et al., 2010). Single limb balance at 2 weeks after amputation has been associated 
with prosthetic non-use (Schoppen et al., 2003). In our CPR study, participants 
reported that medical comorbidities were one of the main reasons for prosthetic non-
use which corresponds with the significant variables associated with prosthetic non-
use in the univariate and multivariate regression analyses. Although falls and fear of 
falling have been reported as contributing to prosthetic non-use and morbidity in the 
literature (Gauthier-Gagnon et al., 1999; Hafner & Smith, 2009; Mundell et al., 
2017), balance issues were reported more frequently than falls as reasons for 
prosthetic non-use by our participants. Prosthetic issues (e.g. socket discomfort or 
difficulty controlling the mechanical prosthetic knee) have led to important clinical 
research into prosthetic design and surgical techniques such as osseointegration 
(Brånemark et al., 2014; Fatone & Caldwell, 2017; Hafner & Smith, 2009; Hafner et 
al., 2007; Laferrier & Gailey, 2010; Mundell et al., 2017). However, Gallagher, 
O'Donovan, Doyle, and Desmond (2011) noted that there has been limited literature 
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on how the type of prosthesis contributes to environmental, activity and participation 
restrictions.  
 
Our study did not report the individualised prosthetic components used by each 
participant in the interim and definitive prostheses which is a limitation of this 
research. Instead we provided detailed definitions of the interim and definitive 
prostheses funded and supplied to participants through RPH amputee rehabilitation 
model of care in WA (refer to Chapter 2, section 2.5). Due to the funding model in 
WA, only participants who were compensable due to motor vehicle accidents and 
worker’s compensation claims were fitted with microprocessor knees for their 
definitive prostheses. In our study, the majority of participants with above transtibial 
amputation levels had mechanical prosthetic knee joints. To improve comparison of 
clinical outcomes, future research may classify prostheses as being advanced 
technology, mechanical and speciality as defined by Gailey et al. (2010). Higher 
rates of prosthetic abandonment were reported by US veterans from the Vietnam war 
(11%) who used mechanical prostheses in contrast to veterans from Operation Iraqi 
Freedom (OIF) / Operation Enduring Freedom (OEF) (4%) who had trialled and 
abandoned a range of advanced, mechanical and speciality prosthetic devices (Gailey 
et al., 2010). The most common reasons for prosthetic abandonment reported by the 
Vietnam veterans were: short residual limb, prosthetic device too heavy and pain 
(Gailey et al., 2010). Issues with the remaining lower limb (from cumulative trauma 
associated with prosthetic use) were present in 50% (Gailey et al., 2010). The OIF / 
OEF veterans abandoned prosthetic use most frequently due to combat injuries and 
cumulative trauma injuries to the remaining lower limb (Gailey et al., 2010). Issues 
with the remaining lower limb were one of the main reasons participants in our study 
reported becoming prosthetic non-users. An interesting finding by Gailey et al. 
(2010) was that the OIF / OEF veterans abandoned prosthetic use in significantly 
shorter time frames (mean = 7 months, SD = 5 months, p = .03) than Vietnam 
veterans (mean = 13 years, SD = 13.5 years). Similar to Karmarkar et al. (2009), 
these findings by Gailey et al. (2010) highlight that the use of advanced or 
specialised prosthetic technologies may not translate into a person using a prosthetic 
limb as their primary mobility aid.     
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The other limitations of our research were that the multifactorial reasons were not 
ranked in order of importance by the participants, objective measures of prosthetic 
satisfaction, adjustment to amputation, locus of control, health literacy and quality of 
life were not used in the CPR development or validation models. As prosthetic issues 
were reported by participants as one of the main reasons for prosthetic non-use in our 
CPR research, there is the potential that prosthetic dissatisfaction may have been a 
significant predictor variable of prosthetic non-use. Above transtibial amputation 
level was a significant predictor of prosthetic non-use for all the CPR timeframes, 
therefore future research may examine the impact of prosthetic componentry (such as 
mechanical versus microprocessor knees) on longitudinal outcomes to validate the 
self reported reasons for prosthetic non-use identified by this research.  
 
Dunne, Coffey, Gallagher, Desmond, and Ryall (2015) demonstrated that the way 
people with lower limb amputation perceive and experience assistive technologies 
has meaning beyond functional restoration and may influence use of the device. The 
socket comfort score, Trinity Amputee Prosthetic Experience Scale (TAPES) and 
TAPES revised (TAPES-R) are examples of objective measures of prosthetic 
satisfaction, adjustment to amputation and quality of life that could be implemented 
into future research and models of care (Gallagher, Franchignoni, Giordano, & 
MacLachlan, 2010; Gallagher & Maclachlan, 2004; Gallagher & MacLachlan, 2000; 
Hanspal, Fisher, & Nieveen, 2003). The inclusion of psychosocial variables such as 
adjustment to amputation, locus of control and health literacy in combination with 
prosthetic satisfaction scales provides important insight into the experiences of the 
prosthetic user and consumer expectations of prostheses.   
 9.6. CPR Validation  
The survival curves for prosthetic non-use demonstrated a high level of concordance 
between the retrospective and prospective cohorts and identified there was a sub-
group of early prosthetic non-users who abandoned prosthetic use almost 
immediately after discharge. One of the main reasons why researchers do not 
undertake the second phase CPR validation study is that the model of care changes 
during the phase 1 CPR development study (i.e. the system changes). The second 
reason is that the population changes the primary outcome or there is contamination 
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of practice by health professionals who are informed of the studies. This is a major 
source of bias in model of care research and specifically in complex long term 
rehabilitation protocol studies where development and validation phases are 
performed sequentially. The similarity of the curves in two concurrent cohorts 
demonstrates that there was limited contamination of the model of care and the 
rehabilitation intervention was stable during the studies (Roffman et al., 2014). 
 
An alternative rehabilitation pathway focusing on optimisation of wheelchair seating, 
physical fitness, mental health and community access may be best for the sub-group 
who are at risk of becoming early prosthetic non-users. If prosthetic gait retraining is 
undertaken in this sub-group at risk of early prosthetic non-use the physiotherapy 
time frames should be clearly set prior to commencing this phase of rehabilitation. 
For example, an initial outpatient rehabilitation time frame of 8 weeks (with 3 
physiotherapy sessions per week) for prosthetic gait retraining may be set, with the 
client discharged from physiotherapy or rehabilitation lengthened based on 
functional progress with locomotor milestones at this assessment time frame. 
Improved standardisation of time frames for assessment of locomotor function in the 
model of care would also assist in identifying complications of amputation that 
impact on functional progress (e.g. residual limb pathology such as stump blisters, 
back pain, falls). This sub-group of early prosthetic non-users also provide evidence 
for having an interim prosthetic phase in our model of care, to trial if someone will 
sustain prosthetic use prior to progressing to more expensive definitive prosthetic 
components (Department of Health, 2008; Roffman et al., 2014). A limitation of our 
CPR study was that many of the functional variables were at the end of rehabilitation 
reducing the ability to use them as early screening tools. However, using a mobility 
aid and not walking outdoors are functional variables that can be easily determined 
prior to prosthetic rehabilitation from the physiotherapy subjective assessment of 
pre-amputation mobility. Future CPR research may incorporate pre-amputation 
mobility as well as focus on impairments and locomotor tests that can be assessed 
post-operatively or early in rehabilitation and correlate with prosthetic non-use.     
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9.6.1. Other CPR for ambulation in people with lower limb amputation 
Since development and validation of clinical prediction rules for prosthetic non-use 
described within this thesis, a second CPR has been developed by Wong et al. 
(2016b) for determining ability of people with lower limb amputation to ambulate 
using a prosthesis in the community at 1 year. A total of 40 out of 54 participants 
initially assessed participated in this study (74.1% follow-up rate). The participants 
were an average of 6.6 (11.0) years post-amputation and recruited from local peer 
support groups and prosthetic clinics.  
 
The 8 variables investigated for the outcome of ability to ambulate in the community 
using a prosthesis were: age, amputation level, amputation cause, years since 
amputation, number of lower limbs amputated (unilateral or bilateral), initial 
Houghton score, Activities-specific Balance Confidence (ABC) score and Berg 
Balance Score (Wong et al., 2016b). A CPR for predicting community ambulation at 
1 year was generated with the following 4 criteria included: initial Houghton cut off 
score < 7, ABC cut off score < 65, Berg Balance task 9 (retrieve an object from the 
floor) cut off score < 3 and Berg Balance task 10 (look behind shoulders) cut off 
score < 3 (Wong et al., 2016b). The number of lower limbs amputated (unilateral or 
bilateral) was not included in the final CPR because it did not have the prediction 
accuracy (Wong et al., 2016b). The post-test probability was 90% or higher for not 
becoming a community ambulator using a prosthesis at 1 year in participants who did 
not exceed 2 or more of the criteria cut off scores (Wong et al., 2016b). Amputation 
level, amputation cause and age of participants were not significant predictor 
variables in the logistic regression analysis (Wong et al., 2016b).  
  
The key differences between Wong et al. (2016b) and our CPR studies were: 
1. Our CPR studies investigated variables associated with prosthetic outcome of 
a consecutive cohort of participants who recently underwent tertiary 
rehabilitation. Wong et al. (2016b) had a non-consecutive, sample of 
convenience recruited from community organisations that were several years 
post-amputation. Therefore, walking capacity was defined prior to the study. 
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2. We validated the CPRs that were developed for prosthetic non-use in a new 
cohort of people with lower limb amputation. Wong et al. (2016b) have not 
validated their CPRs. 
3. Amputation level was not a predictor of prosthetic walking capacity in the 
study by Wong et al. (2016b). This result reflects a cohort of prosthetic users 
that have been recruited several years after their amputation surgery resulting 
in people at risk of becoming prosthetic non-users already being excluded 
from the study. 
 
The research reported in this thesis informs clinical decision making of health 
professionals by assisting them to stratify patients for inventions based on the future 
risk of prosthetic non-use and with developing targeted amputee rehabilitation 
models of care. The CPR research represents the first 2 stages of CPR research 
development (Childs & Cleland, 2006). Multi-centre prospective validation of the 
CPRs and implementation followed by impact analysis (which represents the third 
stage of CPR methodology) would improve the generalisability and levels of 
evidence for this research (Childs & Cleland, 2006).  9.7. Locomotor Performance Measures 9.7.1. Knowledge Gaps 
The following knowledge gaps were identified from the literature (Deathe & Miller, 
2005; Dite et al., 2007; Gailey et al., 2002; Heinemann et al., 2014; Raya et al., 2010; 
Resnik & Borgia, 2011; Schoppen et al., 2003; Stevens, 2010) as having implications 
for the use of locomotor tests in cohorts with lower limb amputation:   
• No consensus on whether a single locomotor test during rehabilitation could 
identify increased risk of  prosthetic non-use at 12 months after discharge 
• The clinical utility of locomotor tests during rehabilitation was unknown 
• Limited studies and performance data to assist interpretation of locomotor tests in 
amputation cohorts 
• Past studies have used samples of convenience which has limited the 
generalisability of results 
• The psychometric properties of some locomotor tests (including construct 
validity) had not been established in lower limb amputation cohorts 
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9.7.2. Similarities and differences with the literature 
There have been few studies to assist with interpretation of locomotor tests in people 
with lower limb amputation and it was unknown whether performance on a single 
test can be used to predict future issues with prosthetic gait (Gailey et al., 2002; 
Resnik & Borgia, 2011; Roffman et al., 2016b). In comparison to other clinical 
populations (e.g. COPD, neurological) there was limited performance data on 
locomotor tests in people with lower limb amputation and as samples of convenience 
have been used, the results cannot be easily generalised to populations participating 
in amputee rehabilitation (Resnik & Borgia, 2011; Roffman et al., 2016b).  
 
In amputee rehabilitation, Medicare Functional Classification Level (MFCL) K-
levels are the main subjective criteria used by rehabilitation services to classify 
functional status of people with lower limb amputation and allocate prosthetic 
components (Borrenpohl et al., 2016; Gailey et al., 2002; Gaunaurd et al., 2015; 
Roffman et al., 2016b). There has been limited implementation of performance based 
outcome measures in clinical practice with recent surveys of health professionals 
calling for the K-level system to be supplemented with locomotor performance 
measures (Borrenpohl et al., 2016; Gaunaurd et al., 2015). Prior to our study there 
was minimal published data on locomotor test performance in people with lower 
limb amputation to guide clinical decision making during rehabilitation (Gailey et al., 
2002; Resnik & Borgia, 2011; Roffman et al., 2016b).  
 
Ambulation is a multifactorial domain and there are well known locomotor tests used 
in rehabilitation that are considered to assess different sub-domains such as aerobic 
capacity, balance, speed, dual tasking and other ambulatory factors. Our study 
examined multiple locomotor tests to see if they were sensitive enough to detect 
prosthetic non-use at 12 months after discharge. The majority of rehabilitation 
assessments and studies have been used to describe thresholds for functional 
outcomes such as crossing the road, falls, mortality or psychometric properties of 
new outcome measures (e.g. concurrent validity, construct validity). The following 
discussion speaks to the literature about the thresholds determined in our study on 
prosthetic non-use and the concordant literature for other functional thresholds. 
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This was the first study to develop performance thresholds that identified increased 
risk of prosthetic non-use in people with lower limb amputation from locomotor tests 
commonly used during rehabilitation including the 10 metre walk test (10MWT), 
timed up and go test (TUGT), 6 minute walk test (6MWT) and four square step test 
(FSST). Area under the curve (AUC) demonstrated that performance thresholds were 
all moderately predictive of prosthetic non-use at 12 months. This suggests the 
locomotor tests were all measuring a similar functional domain. Based on these 
findings, health professionals can select the test that is most appropriate for the 
client, situation and healthcare setting.    
 9.7.3. 10MWT 
The 10MWT can be performed early in rehabilitation when people with lower 
amputation first walk out of the parallel bars. Gait speeds ranging from 0.75 ms-1 to 
1.3 ms-1 have been reported for people with atraumatic and traumatic causes of lower 
limb amputation (Akarsu et al., 2013; Tekin et al., 2009; Waters et al., 1976). 
Although studies have used the 10MWT in cohorts with lower limb amputation 
(Akarsu et al., 2013; Deathe & Miller, 2005; Franchignoni et al., 2004; Tekin et al., 
2009) there were no studies examining the relationship between gait speed from the 
10MWT and prosthetic non-use.  
 
van Hedel (2009) used gait speed derived from the 10MWT to determine mobility 
categories for 886 people with incomplete spinal cord injury. The 10MWT threshold 
for not being a community ambulator in people with incomplete spinal cord injury of 
0.44 ms-1 was identical to the 10MWT threshold for prosthetic non-use in people 
with lower amputation from our study (Roffman et al., 2016b; van Hedel, 2009). A 
minimum gait speed of 0.70 ms-1 was required by people with incomplete spinal cord 
injury to walk without mobility aids in the community (van Hedel, 2009). Since 
mobility aid use was a predictor of prosthetic non-use in our CPR studies, future 
studies should investigate the relationship between gait speed and the need for 
mobility aids in people with lower limb amputation. Salbach et al. (2014) reported 
that gait speeds ranging from 0.44 ms-1 to 1.32 ms-1 were required to safely walk 
across the road at pedestrian crossings in the community.  
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A gait speed of 0.53 ms-1 was derived from the 6MWT threshold of < 191 m in our 
study which was faster than 0.44 ms-1. This increase in gait speed suggests 
progression of locomotor skills in participants who were able to perform the 6MWT 
during rehabilitation. The gait speeds derived from 6MWT distance for MFCL K 
levels in a study by Gailey et al. (2002) were: K0 to 1 = 0.138 ms-1; K2 = 0.528 ms-1; 
K3 = 0.805 ms-1 and K4 = 1.16 ms-1. The K0 to 1 gait speed of  
0.138 ms-1 for prosthetic non-users and people who use their prosthesis for transfers 
or household ambulation only by Gailey et al. (2002) was slower than our threshold 
of 0.44 ms-1 for prosthetic non-use. The findings from our study validate the 
literature (Salbach et al., 2014; van Hedel, 2009) that gait speed is a marker of ability 
to ambulate in the community and increased risk of prosthetic non-use.  
 
The 10MWT has utility as a measure that can be performed early in rehabilitation by 
the greatest number of participants to detect increased risk of prosthetic non-use. It 
does not require extensive training, is efficient and easy to administer in a small 
space. The 10MWT can be performed by clients with low and high levels of 
locomotor function. The 10MWT can be adapted to enable video gait analysis and 
progressed to a 10 metre running test for clients with sport and recreational goals. 
However, further research is required to determine the psychometric properties of the 
10MWT and 10 metre running test in people with lower limb amputation.  
 9.7.4. 6MWT 
Capacity to walk distances of 200 m or greater have been proposed as important for 
community ambulation following lower limb amputation (Gauthier-Gagnon et al., 
1999; Salbach et al., 2014). The 6MWT is a performance measure that provides 
insight into a person’s capacity for community ambulation with distances ranging 
from 4 m to 858 m in people with lower limb amputation (Akarsu et al., 2013; Gailey 
et al., 2002; Lin & Bose, 2008; Linberg et al., 2013; Raya et al., 2010; Resnik & 
Borgia, 2011). In our study, the 6MWT threshold for prosthetic non-use of < 191m 
was similar to the distance reported for MFCL K level 2 (limited community 
ambulator) of average, 189.9 m (SD = 111.3) reported by Gailey et al. (2002). A 
shorter 6MWT distance average of 49.86 m (SD = 29.82) was reported by Gailey et 
al. (2002) for people who were K level 0 to 1 (non-prosthetic, prosthesis for transfers 
 
 
235 
 
only or household ambulators). In our study, 6MWT had the highest sensitivity out 
of all the locomotor tests investigated, correctly classifying 80.6% of participants 
who became prosthetic non-users.  
 
Raya et al. (2010) demonstrated that hip extensor strength of the residual limb was 
the strongest predictor of 6MWT distance in 72 participants with atraumatic and 
traumatic lower limb amputation. Hip extensor muscle strength explained 30.9% of 
the variance in the regression model. Single limb balance was also associated with 
6MWT distance in this study. These findings were important because muscle 
strength and balance can be modified through exercise and prosthetic gait retraining 
to increase 6MWT distance and improve functional outcome.  
 
Resnik and Borgia (2011) reported that minimal detectable change (MDC) for the 
6MWT was 45 m in people with lower limb amputation. This is a large improvement 
in walking distance to be made by clients during rehabilitation so the distance is not 
considered statistical error or variance. However further research is required because 
minimal clinically important difference (MCID) is yet to be determined for 6MWT 
distance of people with lower limb amputation and improvements of < 45 m may 
increase capacity to progress from walking indoors to community ambulation using a 
prosthesis (Resnik & Borgia, 2011).   
 
Similar to the literature, findings from our study suggest that the 6MWT has utility as 
a measure of capacity to ambulate in the community. The 6MWT requires a large, 
rectangular space to be performed effectively in amputation cohorts (Linberg et al., 
2013). While the 10MWT can be performed early in rehabilitation once the client 
with lower limb amputation is walking outside the parallel bars, the 6MWT may 
need to be performed later in rehabilitation once the locomotor skills have improved. 
This highlights the importance of progressing assessments as a client’s locomotor 
function improves during rehabilitation. Future studies may investigate a combined 
testing protocol of the 10MWT and 6MWT to determine factors associated with 
prosthetic non-use.  
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9.7.5. TUGT 
The TUGT incorporates the frequently used locomotor tasks of sit to stand, walking 
and turning with times reported as ranging from 7.2 s to 102 s in people with lower 
limb amputation. The locomotor tasks associated with the TUGT reflect skills 
required by an indoors ambulator with lower limb amputation. Increased risk of 
multiple falls by people with transtibial amputation, have been associated with a 
criterion of > 19 s on the TUGT (Dite et al., 2007). Schoppen et al. (2003) reported 
that the 18 elderly, participants who were able to perform the TUGT at 1 year post-
amputation completed the test in average 23.9 s (SD = 13.2). These times were 
similar to our threshold for identifying increased risk of prosthetic non-use of  
> 21.4 s.  
 
Deathe and Miller (2005) have identified ceiling effect for the TUGT in high 
functioning people with lower limb amputation. Therefore, the TUGT identifies 
increased risk of falls in lower functioning clients but is not sensitive enough to 
detect change in high functioning clients. Resnik and Borgia (2011) reported that 
MDC was 3.6 s for the TUGT in people with lower limb amputation. Due to reported 
ceiling effect and an MDC of 3.6 s, the TUGT has greatest utility when performed as 
a locomotor test early in rehabilitation, in domiciliary settings to identify increased 
risk of falling and prosthetic non-use.  
 9.7.6. FSST 
The FSST provides information on high level balance, ability to negotiate obstacles, 
change direction and dual task (Dite et al., 2007; Dite & Temple, 2002). Dite et al. 
(2007) reported that people with transtibial amputation who were at risk of multiple 
falls performed this test in > 24 s. Studies of people with transfemoral amputation 
testing different styles of prosthetic socket and knee components have reported faster 
times on the FSST than our study with averages ranging between 13.2 s (SD = 2.2) to 
18.1 s (SD = 11.5) (Highsmith et al., 2016b; Lythgo, Marmaras, & Connor, 2010). 
The threshold for prosthetic non-use was > 36.6 s in our study which included people 
with all levels of amputation (i.e. transtibial and above) and bilateral lower limb 
amputation. This threshold was generated from balanced sensitivity and specificity 
with the extreme score of 999 used so that people unable to perform the FSST were 
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included in the ROC analysis. As a non-parametric ROC analysis was used, the 
inclusion of people unable to perform the FSST with an extreme 999 score did not 
bias our results. However, the FSST had limited utility because 32% of the cohort 
could not perform this test. The participants who could perform this test were 
unlikely to become prosthetic non-users therefore this test is better suited to high 
functioning clients and determining the effectiveness of components that enable high 
level function. 
 9.8. Known Groups Analysis   
Slower walking speed, reduced walking distance and increased time to complete 
balance tasks have been associated with older age, transfemoral amputation level, 
atraumatic amputation cause, bilateral lower limb amputation and comorbidities in 
people with lower limb amputation (Akarsu et al., 2013; Christiansen, Fields, Lev, 
Stephenson, & Stevens-Lapsley, 2015; Dite et al., 2007; Dite & Temple, 2002; 
Franchignoni et al., 2004; Gailey et al., 2002; Raya et al., 2010; Schoppen et al., 
2003; Tekin et al., 2009). Our known groups analysis validated  that locomotor 
performance on the 10MWT, TUGT, 6MWT and FSST was poorer for people in 
known groups at high risk of prosthetic non-use including: above transtibial 
amputation, bilateral amputation, high comorbidities and older age. Locomotor 
performance of people with Aboriginal ethnicity was not significantly different from 
non-Aboriginal people. An important finding from our study was that the 6MWT 
discriminated difference in locomotor performance more effectively for the 
atraumatic and diabetes sub-groups from lower risk sub-groups than the 10MWT and 
TUGT. This was similar to findings for locomotor tests in cohorts with intermittent 
claudication (McDermott et al., 2010).  
 
Investigating the outcome of prosthetic non-use at 12 months after discharge and 
variation in the assessment times for performance measures were limitations of our 
research. To improve the power of our study, prosthetic non-use at 12 months after 
discharge from physiotherapy was the primary outcome instead of investigating time 
intervals such as 4, 6, 8 and 12 months. However, at 12 months after discharge there 
were potentially multiple variables in addition to locomotor test performance 
associated with prosthetic non-use and our CPR research (Chapters 4 and 5) 
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demonstrated that a sub-group of early prosthetic non-users existed. Future research 
may investigate time intervals to identify locomotor performance limitations of this 
sub-group or test the effects of interventions on outcome. In the literature timeframes 
have been censored since amputation surgery rather than discharge therefore we have 
provided supplementary information (see Chapters 4, 5 and 7.2B) on time since 
amputation to enable comparison with other research and health care facilities.  
 
Locomotor tests were assessed as patients progressed with their individualised 
rehabilitation goals. A future system change could be standardisation of the 
assessment time frames for the locomotor tests in the prosthetic and long term 
follow-up phases of rehabilitation. Standardisation of assessment time frames (i.e. 
repeated measures design) is important to implement in the model of care because 
the locomotor tests do not measure the activity and participation limitation related to 
lower limb amputation in isolation and reflect limitations of the individual client’s 
other comorbidities (e.g. heart failure, back or claudication pain). This approach may 
identify sub-groups who progress slower or faster with rehabilitation, enable research 
on change in locomotor performance during rehabilitation and identify functional 
decline in the long term follow-up phase that potentially responds to physiotherapy 
or prosthetic interventions.  
 
Our study findings for performance on locomotor tests highlight there is an indoors 
and outdoors walking dichotomy similar to that identified in our CPR studies. The 
10MWT, TUGT, 6MWT and FSST represent a continuum of locomotor tests with 
increasing physical and cognitive demand. Clinical utility was similar for all the 
locomotor tests in terms of cost, time, training and equipment. The 10MWT is a good 
locomotor test early in rehabilitation and could be adapted for high level 
performance later in rehabilitation. The 6MWT is most accurate in detecting 
prosthetic non-use and was more effective at separating high and low level 
locomotor performance in the known groups study compared to the 10MWT and 
TUGT. The TUGT provides information about falls risk, sit to stand and turning but 
is better suited to domiciliary settings or healthcare facilities with limited space. The 
FSST has utility for high functioning clients and research settings because it is 
attained by few participants. In public healthcare settings with time and resource 
limitations, a combined testing protocol of the 10MWT and 6MWT has high 
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interpretive value for identifying increased risk of prosthetic non-use. Future studies 
may investigate improvements during rehabilitation on locomotor test performance.   
 
This research on locomotor test represents level 2b evidence (Howick, 2009). The 
performance thresholds and data from the known groups analyses of locomotor tests 
in this thesis may be used to inform clinical decision making however before they 
can be implemented into policy and funding models, validation is required in a 
prospective cohort. In summary, locomotor tests assess multiple domains within the 
ambulatory framework including functional balance and community participation. 
The findings in this thesis concur that at the time of rehabilitation they are also a 
marker for prosthetic non-use. Future studies would need to investigate if this is an 
independent predictive factor or a concordant element of overall functional 
outcomes. Furthermore, are the domains of gait speed, balance and endurance 
modifiable after discharge to alter the attrition seen over time for prosthetic use? 
From a hypothetical perspective, the answer to this question is yes with the 
rehabilitation program of appropriate intensity gait speed, balance and endurance are 
variables that can be maintained or improved. However, rehabilitation teams, 
administrators, funding and peer support organisations need to develop and fund 
community based models of care that target these functional domains. It has been 
identified in the literature that many patient cohorts find it challenging to transition 
from tertiary to community based rehabilitation, sports or recreation resulting in high 
rates of physical inactivity (Bragaru et al., 2013; de Oliveira et al., 2016; Jaarsma, 
Dijkstra, Geertzen, & Dekker, 2014; Kars, Hofman, Geertzen, Pepping, & Dekker, 
2009; Langford, Dillon, Granger, & Barr, 2018). 
 9.9. Comorbidity in people with lower limb amputation 9.9.1. Knowledge Gaps 
The following knowledge gaps were identified from the literature (Charlson et al., 
1987; Charlson et al., 1994; Davie-Smith et al., 2016; de Laat et al., 2014; Fortington 
et al., 2013; Gailey et al., 2002; Groll et al., 2006; Hall, 2006; Hall et al., 2004; 
Hoffstad et al., 2015; Jones et al., 2013; Melchiorre et al., 1996; van Eijk et al., 2012; 
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Webster et al., 2012) for measuring comorbidity in people with lower limb 
amputation: 
• Comorbidity is a major consideration for clinical pathway decisions in 
rehabilitation interventions e.g. prosthetic prescription, return to driving and 
work. However, there is no commonly used measure of comorbidity in people 
with amputation. 
• Construct validity has not been tested for comorbidity indices in amputation 
cohorts  
• A limitation of past studies was the incidence of musculoskeletal pathology and 
mental health issues prior to admission have not been reported. 
 9.9.2. Similarities and differences with the literature 
It is well known that various comorbidities exist in the population with atraumatic 
amputation and that these are strongly correlated to high mortality, burden of disease 
and healthcare costs (Fortington et al., 2013; Hoffstad et al., 2015; Jones et al., 2013; 
Lazzarini, Gurr, Rogers, Schox, & Bergin, 2012; van Netten et al., 2016). Similar to 
these aforementioned studies, investigation of comorbidity in this thesis has 
demonstrated high burden of disease and mortality risk in sub-groups with atraumatic 
cause of amputation. Comorbidities such as diabetes, peripheral arterial disease, 
cardiovascular disease, renal failure and back pain consistently reported in the 
literature (Fortington et al., 2013; Gailey et al., 2008; Jones et al., 2013) as being of 
high frequency for lower limb amputation cohorts were identified by our study. 
  
Our CPR research demonstrated that the cumulative effect of having a very high 
number of comorbidities was predictive of prosthetic non-use at 4 months after 
discharge from rehabilitation rather than specific comorbid conditions (Roffman et 
al., 2014). Comorbidity was also one of the multi-factorial, self reported reasons for 
abandoning prosthetic use by participants in our study (Roffman et al., 2016b). 
However, counting number of comorbidities lacked external validity and clinical 
utility.  
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Comorbidity indices provide a standardised method of measuring the cumulative 
effect of having multiple comorbidities in clinical populations. FCI and CCI scores in 
our study were similar to past studies of people with lower limb amputation (Davie-
Smith et al., 2016; de Laat et al., 2014; Webster et al., 2012). Our study 
demonstrated that the FCI, CCI and CA-CCI significantly discriminated between the 
scores of lower limb amputation groups with known high comorbidity including: 
prosthetic non-users, atraumatic amputation, diabetes and age > 58 years and groups 
with low comorbidity. However, analysis of effect size for these comorbidity indices 
in the known groups revealed that separation of the scores was greatest by the CCI 
for the diabetes, atraumatic amputation, transtibial amputation level and Aboriginal 
sub-groups. CA-CCI was validated as it was most effective at separating scores for 
the older and younger groups – which is inherently obvious as the scale is age 
corrected. Number of comorbidities from our CPR study was validated as having the 
greatest effect size in prosthetic non-users and FCI was the second most effective 
method of analysing comorbidity in this group. Therefore, the CCI was the best 
indicator of comorbidity in lower limb amputation cohorts probably due to its 
stronger link with mortality. The findings within this known groups analysis are the 
first to demonstrate such construct validity for this patient cohort.  
 
The incidence of musculoskeletal pathology and mental health issues (e.g. 
depression) at hospital admission were unknown for people with lower limb 
amputation as research has been limited to investigating these comorbidities as 
complications of amputation (Gailey et al., 2008; Webster et al., 2012). Webster et 
al. (2012) reported that having a major depressive episode after amputation was one 
of the predictors of poor prosthetic outcome at 12 months after amputation. Past 
studies have reported musculoskeletal issues as secondary complications of 
amputation with asymmetrical movement patterns (Devan et al., 2014; Gailey et al., 
2008; Kulkarni, 2008). Our study demonstrated high rates of musculoskeletal 
pathology and mental health issues present at hospital admission. These pre-existing 
musculoskeletal problems such as back and shoulder pathology may be exacerbated 
by activities including propelling a manual wheelchair, asymmetry of locomotor 
activities and using a mobility aid. Mueller (2016) reported that people with diabetes 
(a common comorbidity in amputation cohorts) had increased frequency of 
musculoskeletal pathology and were at risk of musculoskeletal injury at lower forces 
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than other sub-groups. These findings have implications for exercise prescription in 
amputation cohorts.  
 
Single tracking of public hospital notes was a methodological limitation of our 
comorbidity study. However, a standardised physiotherapy assessment form was 
implemented for our study to improve the quality of comorbidity data collected from 
the medical records and subjective interviews of participants. This comorbidity 
research will assist with future service model planning and resource allocation. This 
thesis provides evidence for standardised methods of measuring comorbidity in 
cohorts with lower limb amputation. This research represents level 2b evidence 
(Howick, 2009). Prospective validation of this study is warranted. Future studies may 
investigate whether participants with different sub-clusters of comorbidities benefit 
from alternative models of care, exercise prescription guidelines and chronic disease 
management strategies. 
 9.10. Outcomes for Aboriginal people with lower limb amputation  9.10.1. Knowledge Gaps 
The following knowledge gaps on lower limb amputation in people with Aboriginal 
ethnicity were identified from the literature (Baba et al., 2015; Norman et al., 2010; 
Schoen et al., 2010; Schoen & Norman, 2014; Vos et al., 2009): 
• High diabetes related amputation rates and mortality risk due to chronic disease 
has been the primary end point of research with no investigation of rehabilitation 
outcomes 
• The impact of residing in geographically isolated regions of Western Australia on 
rehabilitation outcome was unknown 
• Performance on locomotor tests during rehabilitation for amputation were 
unknown for people of Aboriginal ethnicity 
• Self reported function after amputation was unknown for people of Aboriginal 
ethnicity. 
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9.10.2. Similarities and differences with the literature 
Rehabilitation outcomes have not been reported for Aboriginal people with lower 
limb amputation high rates of diabetes related amputation and mortality have been 
the primary endpoint of health outcomes research (Baba et al., 2015; Norman et al., 
2010; Schoen & Norman, 2014; Vos et al., 2009). This is the first research to 
demonstrate that rehabilitation outcomes including prosthetic use, locomotor 
performance and self reported functional ability in people of Aboriginal ethnicity 
with lower limb amputation were not significantly different from non-Aboriginal 
people. Similar to past Australian studies (Baba et al., 2015; Norman et al., 2010; 
Schoen & Norman, 2014; Vos et al., 2009), we found significantly higher 
representation of diabetes in people with Aboriginal ethnicity. 
 
Armstrong, Gillespie, Leeder, Rubin, and Russell (2007) identified that innovation 
and improved links were required between primary, acute and rehabilitation 
healthcare services in Australia to manage to the challenges of chronic disease and 
health outcomes of Aboriginal people residing in rural and remote communities. Our 
CPR studies validated that Aboriginal ethnicity and geographical isolation from 
health services were not predictors of prosthetic non-use. These findings were 
important because it suggests that the long term model of care strategies (i.e. 
Telemedicine, linkage with local health professionals) to provide equity of access to 
health services for people residing in rural and remote regions have been successful 
in addressing any issues (e.g. socket fit, residual limb wound, health professional 
skills training) that may lead to prosthetic non-use in these clients. However, further 
research is required to analyse the psychosocial, cultural, lifestyle and environmental 
factors that contribute to these positive rehabilitation outcomes. For example, 
Aboriginal people from rural and remote areas generally lead a physically active 
lifestyle that involves camping and transferring on and off the floor using anti-
gravity muscles and balance skills that may contribute to locomotor performance 
using a prosthesis. Cultural factors such as inclusion and not wanting to be different 
from their community may increase prosthetic use, activity and participation levels 
of Aboriginal people. Health beliefs regarding amputation, disease, healing and death 
warrant further investigation to identify factors that may improve the model of care 
for Aboriginal people. Schoen et al. (2010) consulted 60 Aboriginal people from 
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Western Australia on diabetic foot health promotion and education resources. 
Participants preferred real pictures of foot problems rather than cartoons and to 
develop their own messages for resources so that they were used by and inclusive of 
the whole community (Schoen et al., 2010). 
 
Performance on locomotor tests during rehabilitation and long term self reported 
function after rehabilitation discharge on the LCI5 by Aboriginal participants were 
not significantly different from non-Aboriginal participants. There were no 
Australian studies (Hordacre et al., 2013b) to compare functional outcomes for 
Aboriginal participants. However, our study results were consistent with Agrawal et 
al. (2014) who demonstrated that locomotor function using the LCI and prosthetic 
use for Canadian Aboriginal participants was not significantly different from non-
Aboriginal participants.  
 
This research represents level 2b evidence (Howick, 2009). A limitation of our study 
was small numbers of Aboriginal participants. Future multicentre research may 
increase the number of participants recruited to studies and address the need for 
innovative models of care that are culturally sensitive and facilitate rehabilitation 
closer to rural and remote areas.  
 9.11. Self reported outcomes and sociodemographic characteristics 9.11.1. Knowledge Gaps 
The following knowledge gaps were identified from the literature (Department of 
Health, 2008; Dillon et al., 2014; Hordacre et al., 2013a; Hordacre et al., 2013b; 
Jones et al., 1993; Lim et al., 2006; Wu et al., 2010): 
• Limited reporting of long term outcomes following discharge from rehabilitation 
in Australia  
• Rehabilitation outcomes including sociodemographic characteristics, mobility 
without a prosthesis, mobility with a prosthesis, return to work, return driving 
and complications of amputation (e.g. stump pathology, falls) were unknown in 
Western Australia  
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• It is unknown whether rehabilitation outcomes achieved during rehabilitation are 
sustained after discharge. Therefore, the effectiveness of intervention with 
comprehensive multidisciplinary rehabilitation program for people with lower 
limb amputation in Western Australia is unknown 
• The FIM is used for reporting outcomes in Australia however it has limitations 
with observed ceiling effect and lack of responsiveness in amputation cohorts 
The FIM is performed at inpatient rehabilitation admission and discharge so 
many rehabilitation outcomes (e.g. locomotor function with a prosthesis) are not 
captured in Western Australia because prosthetic gait retraining is performed as 
an outpatient service4.    
 9.11.2. Similarities and differences with the literature 
Our study has reported on sociodemographics, complications of amputation, 
functional outcomes with and without a prosthesis, return to driving and work for a 
consecutive cohort with lower limb amputation. We used the locomotor capability 
index 5 (LCI5) because it is a self reported, amputee specific measure of basic and 
advanced locomotor function that has been administered throughout the 
rehabilitation continuum in past studies (Czerniecki et al., 2012b; Franchignoni et al., 
2007; Franchignoni et al., 2004; Gauthier-Gagnon et al., 1999).  
 
In the context of high 1 year mortality for people with atraumatic amputation our 
interview time frame of median, 1.5 (IQR, 1.2 to 2.2) years after rehabilitation 
discharge as opposed to the censor date of 12 months after amputation surgery 
reported in the literature, represents long term follow-up in this cohort with lower 
limb amputation. In our study, the actual time from amputation surgery to interview 
was median, 2.7 years (IQR = 2.2 to 3.2) and timeframe data from amputation 
surgery has been reported in Figure 7.2B (see Chapter 7 Part B) to enable 
comparison with other research and healthcare facilities. Rehabilitation outcomes 
were unknown in WA so this timeframe was selected to answer the global research 
question of: What outcomes were sustained after discharge from amputee 
                                                             
4 This was the endorsed rehabilitation model of care for duration of studies in this thesis.  
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rehabilitation? Furthermore, the outcomes of return to driving and work represented 
long term rehabilitation goals for the majority of patients so this timeframe was 
selected to capture this data. This survey methodology provided a snapshot of 
function and was only valid for that particular point in time however functional 
ability may fluctuate. Amputee models of care may implement longitudinal follow-
up interviews at regular time intervals (e.g. 6, 12, 18, 24 months) during the 
rehabilitation continuum to identify changes in function and measure the reliability 
of self reported data for future research.  
 
There have been limited studies on long term functional outcomes following lower 
limb amputation in Australia (Hordacre et al., 2013a; Hordacre et al., 2013b; Jones et 
al., 1993; Lim et al., 2006; Roffman et al., 2014; Wu et al., 2010). Studies have 
focused on institution specific variables such as length of stay and despite major 
limitations with ceiling effect and timing of this assessment the Functional 
Independence Measure (FIM) has been the main outcome measure reported 
(Hordacre et al., 2013a; Hordacre et al., 2013b; Wu et al., 2010).  
 
This is the first study of consecutive Australian participants to measure construct 
validity of the LCI5 in known groups who were at high risk of future prosthetic non-
use including people with Aboriginal ethnicity, older age, above transtibial 
amputation, bilateral lower limb amputation, atraumatic amputation cause, diabetes, 
very high number of comorbidities, part-time prosthetic users and lower risk groups. 
Participants in our study reported higher LCI5 scores than Czerniecki et al. (2012b). 
The difference in findings was most likely due to the fact that only participants with 
dysvascular causes of amputation were investigated by Czerniecki et al. (2012b). 
Similar to past studies (Parker et al., 2010; Salavati et al., 2011), our study 
demonstrated maximum scores for 25% of the total cohort and ceiling effect of the 
LCI5 scale. These results suggest that the LCI5 has construct validity but due to the 
observed ceiling effect it lacks sensitivity as a measure of long term locomotor 
function. The PLUS-M (Prosthetic Limb Users Survey of Mobility) is a new self 
reported outcome measure with good psychometric properties that may have utility 
in the long term follow-up phase of rehabilitation (Hafner et al., 2017). 
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Long term wheelchair use for mobility activities and rates of residual limb pathology 
were high in our cohort. This is consistent with the literature where both prostheses 
and wheelchairs have been used for functional activities and wheelchairs used as a 
primary mobility device by people who abandon prosthetic use (Gailey et al., 2010; 
Karmarkar et al., 2009). Functional activities such as sit to stand, time the prosthesis 
was used and maximal walking distance were by self report so recall bias was a 
limitation of our study. Future amputee models of care and research may incorporate 
the use of wearable technology such as step activity monitors to objectively measure 
functional activity.    
 
Participants who were non-drivers and non-workers prior to amputation had 
significantly higher Charlson Comorbidity Index (CCI) scores and ages than 
participants who were drivers and workers prior to amputation reflecting high burden 
of disease. Return to work and driving were both significantly associated with being 
a prosthetic user and participants reported high levels of locomotor function on the 
LCI5. Rates up to 80.5% and 79% have been reported for return to driving and work 
respectively in people with lower limb amputation by other countries (Boulias et al., 
2006; Burger, 2012; Engkasan et al., 2012; Fisher et al., 2003; Penn-Barwell, 2011; 
Schoppen et al., 2001a; Schoppen et al., 2001b). These were consistent with our 
findings of 91% and 62% for return to driving and work respectively. Similar to past 
studies (Fisher et al., 2003; Schoppen et al., 2001a; Schoppen et al., 2001b), 
participants in our study worked in less physically demanding occupations after their 
amputation. A self reported walking distance of > 500m has been associated with 
return to work following lower limb amputation (Schoppen et al., 2001b). However, 
self reported walking distance of > 500m was not validated as a variable significantly 
associated with return to driving or work in our univariate analysis. Future research 
on return to work and driving should include multivariate analysis and psychosocial 
variables such as cognition, adjustment, family and financial support to address the 
limitations of our study and enable improvements to the model of care. 
 
This research represents level 2b evidence (Howick, 2009). This research will assist 
with planning models of care and future service utilisation of people with lower limb 
amputation in Australia and internationally (Armstrong et al., 2007; Department of 
Health, 2008). Due to high ceiling effect observed on the LCI5 scale, future studies 
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should focus on development and implementation of self reported outcome measures 
such as the PLUS-M that can be easily administered in the long term follow-up phase 
of rehabilitation for people with lower limb amputation.  
 9.12. Reform to the Western Australian Amputee Rehabilitation Model of Care in 2014 
In October 2014 the Western Australian State Amputee Rehabilitation Service 
moved to the newly commissioned State Rehabilitation Service campus of Fiona 
Stanley Hospital. The 4 major changes to the model of care were: introduction of 
Activity Based Funding, implementation of policy by hospital administrators that 
clients were only permitted to receive 6 occasions of service (OOS) for outpatient 
physiotherapy with a total of 15 OOS permitted for outpatient physiotherapy per 
week for the service, restrictions on issue of stump shrinkers for oedema 
management and trial of the National Disability Insurance Scheme. The prognostic 
research in this thesis identifies sub-groups who would potentially benefit from 
alternative models of care so that health professionals can improve the match of 
client to intervention and modify the clinical decision pathway earlier in 
rehabilitation which is important in resource limited healthcare settings. However, 
the intensity and time frames reported in this thesis for outpatient prosthetic gait 
retraining were higher than the new model of care. The Activity Based Funding 
model has led to prosthetic gait retraining being provided as an inpatient service over 
an approximately 3 to 4 week time frame which is different to the outpatient based 
service delivery model reported for prosthetic gait retraining in this thesis. During the 
studies in this thesis intensive oedema management with stump shrinkers was 
performed in combination with other oedema management interventions to expedite 
client recovery and minimise costs associated with manufacture of multiple 
prosthetic sockets. In the trial suburbs, the National Disability Insurance Scheme has 
funded definitive prosthetic components which may improve functional outcome of 
clients that were not funded by WALSA in the previous model of care. Therefore, 
comparative effectiveness research is warranted to determine the impact of changes 
to the model of care in October 2014 on outcomes for people with lower limb 
amputation, systems efficiency and cost to public health.  
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9.13. General limitations of this research 
The research in this thesis had the following limitations: 
• The thesis represents the Western Australian health context. It is valid to say 
that the models of care and pathway trajectory may be different in different 
contexts 
• The thesis is relevant for western models of care and aetiologies of 
amputation and therefore does not reflect areas of warfare, civil unrest or 
terrorism  
• The literature review includes grey literature from health services and 
clinical practice guidelines 
• The health systems changes were true at the time of this study 
• As the clinical prediction rule study was validated at a single centre it lacks 
generalisability until future validation in other health contexts 
• Our research questions investigated what happened with prosthetic use for 
timeframes after physiotherapy discharge, which contributed to the 
originality of this thesis. However, this may be a potential limitation as the 
literature has focused on time since amputation surgery. To enable 
benchmarking between healthcare settings and research projects, we have 
provided supplementary data on time frames for significant rehabilitation 
milestones from date of initial amputation surgery (see Chapters 4, 5 and 
7.2B)  
• The timeframes for measurement of the locomotor tests were individualised 
to the patient’s progress and not standardised during rehabilitation; and the 
survey of activity and participation in people with lower limb amputation 
was only valid for the point in time the participant was interviewed. Future 
models of care and research should implement longitudinal follow-up at 
standardised timeframes throughout the rehabilitation continuum   
• Mobility aids were not statistically weighted for the level of assistance that 
they provided the patient in our CPR study. Future CPR studies may 
consider statistically weighting the mobility aid for the level of assistance or 
using an amputee specific mobility scale 
• Recall bias was a limitation of the research in this thesis. No objective 
measures such as a step activity monitor or GPS monitoring were used to 
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ensure that the self reported mobility data in Chapter 7.2B were reliable. The 
use of wearable technology may be implemented in future studies and 
rehabilitation models of care to measure the reliability of self reported 
functional activity, support prescription of prosthetic components and 
achievement of mobility goals during rehabilitation 
• Prosthetic componentry was not reported for the participants in this research 
instead we provided a detailed summary of the prosthetic componentry that 
were funded for participants in Chapter 2. Prosthetic prescription was stable 
during this research and access to advanced technologies (e.g. 
microprocessor knees) in the definitive stage was limited to participants who 
were compensable. To facilitate comparison between health care and 
research facilities, future studies should classify prosthetic components as 
advanced technology, mechanical and specialised as reported by Gailey et al. 
(2010)     
• Participants reported multifactorial reasons for becoming prosthetic non-
users. Prosthetic issues were one of the most frequent reasons reported by 
participants for abandoning prosthetic use. We did not enter prosthetic issues 
and types of prosthetic componentry as variables into the CPR or use 
objective measures of prosthetic satisfaction. Future research and models of 
care may incorporate the socket comfort score, TAPES or TAPES-R because 
it is important to consider prosthetic satisfaction in combination with the 
patient’s adjustment to amputation. 
 
Future research and amputee rehabilitation models of care should aim to address the 
limitations identified for the research in this thesis to improve the quality of evidence 
for clinical practice. 
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9.14. Conclusion 
In conclusion, this thesis has contributed to evidence based assessment and treatment 
of people with lower limb amputation across the rehabilitation continuum. It is 
recognised that rehabilitation models of care for people with lower limb amputation 
vary widely in developed and developing countries. Rehabilitation interventions for 
prosthetic gait retraining may be a few days, months or many years depending on the 
social and political context of the health service (Rau et al., 2007; Roffman et al., 
2014). However, limited health resources (e.g. budget, staffing, equipment and 
infrastructure) and matching of clients to interventions are universal challenges 
experienced by all health professionals in contemporary practice. This thesis may 
assist with guiding clinical decision making, resource allocation and development of 
future amputee rehabilitation models of care. It also directs future research to 
optimise outcomes following lower limb amputation.   
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Appendix 2.1: Physiotherapy and other important 
interventions during amputee rehabilitation. 
There are many complex pathway elements in the rehabilitation model of care for 
people with lower limb amputation. Although the literature refers to these elements 
in the explicit terms and activities, when it comes to the final outcome of prosthetic 
use after discharge, many of these variations on care have not been considered.  
 Mobility retraining without a prosthesis 
The person with lower limb amputation is taught how to move safely without a 
prosthetic limb (Broomhead et al., 2012; Broomhead et al., 2006; Gailey, 2004; 
Geertzen et al., 2015a; Lusardi, 2013; Meier & Melton, 2014). This includes 
propelling and manipulating parts of a wheelchair for mobility, transfers and if 
appropriate hopping (Broomhead et al., 2012; Broomhead et al., 2006; Gailey, 2004; 
Geertzen et al., 2015a; Lusardi, 2013; Meier & Melton, 2014). Pivot, slide board, lift, 
car and floor transfers are the types of transfers taught to patients after an amputation 
(Gailey, 2004; Geertzen et al., 2015a; Lusardi, 2013). Sit to stand and standing 
balance are functional exercises performed with people who have unilateral lower 
limb amputation (Broomhead et al., 2012; Broomhead et al., 2006; Gailey, 2004; 
Geertzen et al., 2015a; Lusardi, 2013; Meier & Melton, 2014). Although not 
documented clearly as a functional milestone in the literature (Broomhead et al., 
2012; Broomhead et al., 2006; Department of Health, 2008; Geertzen et al., 2015a; 
Meier & Melton, 2014; US Department of Veterans Affairs, 2008), people with 
unilateral knee disarticulation or higher levels of amputation need to have standing 
endurance holding onto parallel bars or a mobility aid for a minimum of 20 minutes 
at Royal Perth Hospital as this is the duration it takes prosthetists to cast these types 
of prostheses with the patient in standing. In people with unilateral lower limb 
amputation where the remaining foot is not at high risk of amputation due to ulcer, 
diabetes related complications (e.g. Charcot foot, peripheral neuropathy) or 
peripheral arterial disease, hopping using a mobility aid may be taught as a form of 
locomotion and to maintain cardiovascular fitness (Geertzen et al., 2015a; Meier & 
Melton, 2014; Stokes et al., 2008; Stokes et al., 2009; US Department of Veterans 
Affairs, 2008). As hopping increases the risk of falls the patients selected also must 
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have adequate balance and muscle strength (Stokes et al., 2008; Stokes et al., 2009; 
US Department of Veterans Affairs, 2008). 
 Oedema management 
There many factors that are critical in the management of the residual limb (stump) 
but these have not been well integrated into studies for predicting future 
rehabilitation outcomes. The literature focuses on oedema (swelling) of the residual 
limb as this has been shown to have major clinical and cost implications for wound 
healing and prosthetic rehabilitation (Broomhead et al., 2012; Broomhead et al., 
2006; Deutsch, English, Vermeer, Murray, & Condous, 2005; Gailey, 2004; 
Geertzen et al., 2015a; Geertzen et al., 2015b; Knapp, 2013; Lusardi, 2013; Meier & 
Melton, 2014; Psonak, 2013; Ries & Vaughan, 2013; US Department of Veterans 
Affairs, 2008).  
 
The residual limb has oedema following amputation surgery (Broomhead et al., 
2012; Broomhead et al., 2006; Deutsch et al., 2005; Gailey, 2004; Geertzen et al., 
2015a; Geertzen et al., 2015b; Knapp, 2013; Lusardi, 2013; Meier & Melton, 2014; 
Psonak, 2013; Ries & Vaughan, 2013; US Department of Veterans Affairs, 2008). 
Residual limb oedema is managed by a physiotherapist trained in amputee 
rehabilitation to: facilitate wound healing, shape the residual limb for the prosthesis, 
stabilise the residual limb volume in order to maintain the prosthetic fit and minimise 
complications such as stump blisters (Broomhead et al., 2012; Broomhead et al., 
2006; Deutsch et al., 2005; Gailey, 2004; Geertzen et al., 2015a; Geertzen et al., 
2015b; Knapp, 2013; Lusardi, 2013; Meier & Melton, 2014; Psonak, 2013; Ries & 
Vaughan, 2013; US Department of Veterans Affairs, 2008). Lusardi (2013) and 
Psonak (2013) report that oedema management is generally required for 
approximately 6 to 12 months following surgery until the oedema stabilises however 
some patients have comorbidities (e.g. renal failure, heart failure) resulting in long 
term volume fluctuations of the residual limb. 
  
The literature uses colloquial terms that reflect the devices and systems that are used 
in rehabilitation to reflect strategies to manage oedema (Broomhead et al., 2012; 
Broomhead et al., 2006; Gailey, 2004; Geertzen et al., 2015a; Geertzen et al., 2015b; 
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Meier & Melton, 2014). Oedema management involves the use of stump bandaging, 
stump shrinkers or other compressive garments, rigid removable dressings (for 
people with a transtibial amputation level), positioning of residual limb so it is not 
dependent and the use of intermittent pneumatic compression pump therapy 
(Broomhead et al., 2012; Broomhead et al., 2006; Deutsch et al., 2005; Gailey, 2004; 
Geertzen et al., 2015a; Geertzen et al., 2015b; Knapp, 2013; Lusardi, 2013; Meier & 
Melton, 2014; Psonak, 2013; Ries & Vaughan, 2013; US Department of Veterans 
Affairs, 2008). Progression of the oedema management program is individualised for 
the patient depending on their residual limb wound, circulation and comorbidities 
(Broomhead et al., 2012; Broomhead et al., 2006; Gailey, 2004; Geertzen et al., 
2015a; Geertzen et al., 2015b; Knapp, 2013; Lusardi, 2013; Meier & Melton, 2014; 
Psonak, 2013; Ries & Vaughan, 2013). Rigid removable dressings can be applied to 
patients with transtibial amputation in the operating theatre or in the days after 
surgery by a physiotherapist or prosthetist (Broomhead et al., 2012; Broomhead et 
al., 2006; Deutsch et al., 2005; Geertzen et al., 2015b; Lusardi, 2013). The rigid 
removable dressing assists with reducing oedema and protects the residual limb from 
injury that may occur if a patient falls or knocks their residual limb (Broomhead et 
al., 2012; Broomhead et al., 2006; Deutsch et al., 2005; Geertzen et al., 2015b; 
Knapp, 2013; Lusardi, 2013). However, the timing of rigid dressing application 
depends on the residual limb wound, size and shape of the residual limb, patient’s 
comorbidities and surgeon preference (Broomhead et al., 2012; Broomhead et al., 
2006; Deutsch et al., 2005; Geertzen et al., 2015b; Lusardi, 2013). Gailey (2004) 
notes that the compression from the stump bandaging or stump shrinker also assists 
with management of phantom limb pain and desensitisation of the residual limb.  
 Densensitisation of the residual limb 
Desensitisation of the nerves supplying the residual limb is performed after 
amputation surgery to facilitate normal movement during activities of daily living 
and in preparation for using a prosthetic limb (Lusardi, 2013; Meier & Melton, 2014; 
Ries & Vaughan, 2013; US Department of Veterans Affairs, 2008). The main 
desensitisation techniques that patients are taught by the physiotherapist include 
touch, massage and compression of the residual limb tissues by the patient while 
looking at the residual limb (Lusardi, 2013; Meier & Melton, 2014; Ries & Vaughan, 
A.6 
 
2013; US Department of Veterans Affairs, 2008). Stump shrinker use, exercise and 
movement during activities of daily living also help to desensitise the residual limb 
(Gailey, 2004).  
 
Scar tissue and wound management 
Patients are taught by the physiotherapist about hygiene and how to care for their 
residual limb with massage using moisturiser and scar tissue mobilisation to the 
suture line (Broomhead et al., 2012; Gailey, 2004; Geertzen et al., 2015b; Lusardi, 
2013; Meier & Melton, 2014; Ries & Vaughan, 2013; US Department of Veterans 
Affairs, 2008). The residual limb massage and scar tissue mobilisation improves the 
patient’s skin integrity, minimises complications such as hypertrophic scarring and 
adherent scar tissue which are associated with residual limb blistering during 
prosthetic gait retraining (Lusardi, 2013; Meier & Melton, 2014; Ries & Vaughan, 
2013). Patients are educated by the physiotherapist during prosthetic gait retraining 
on how to protect fragile skin and manage stump blisters using protective dressings 
(Lusardi, 2013; Meier & Melton, 2014; Ries & Vaughan, 2013). 
 Therapeutic exercise 
Therapeutic exercise is performed by patients after amputation to enable return to 
activities of daily living without a prosthesis, locomotor activities with a prosthesis 
and to prevent complications such as contracture of the lower limb joints, 
deconditioning, loss of muscle strength and mass (Broomhead et al., 2012; 
Broomhead et al., 2006; Gailey, 2004; Gailey, Gailey, & Angulo, 1989, 1994a, 
1994b; Gailey, Gailey, Sendelbach, & Angulo, 1995; Geertzen et al., 2015a; 
Geertzen et al., 2015b; Lusardi, 2013; Meier & Melton, 2014; Ries & Vaughan, 
2013; US Department of Veterans Affairs, 2008). Strength, range of movement, 
stretching, cardiovascular and balance exercises are prescribed to patients and 
individualised to their needs (Lusardi, 2013; Meier & Melton, 2014; Ries & 
Vaughan, 2013). Strength exercises targeting the quadriceps, hip abductor and 
extensors muscle groups are important for prosthetic gait retraining (Broomhead et 
al., 2012; Broomhead et al., 2006; Gailey, 2004; Gailey et al., 1989, 1994a, 1994b; 
Gailey et al., 1995; Geertzen et al., 2015a; Geertzen et al., 2015b; Lusardi, 2013; 
Meier & Melton, 2014; Ries & Vaughan, 2013; US Department of Veterans Affairs, 
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2008). Upper limb, abdominal and trunk muscle strengthening exercises, sitting and 
standing balance exercise are performed to improve functional ability at activities 
with and without a prosthesis (Gailey, 2004; Gailey et al., 1989, 1994a, 1994b; 
Gailey et al., 1995; Geertzen et al., 2015a; Geertzen et al., 2015b; Lusardi, 2013; 
Meier & Melton, 2014; Ries & Vaughan, 2013).  
 
Strengthening exercises involve isometric, isotonic and isokintetic exercises using a 
combination of no weights, body weight, free weights, theraband, weight machines 
(e.g. leg press, seated rowing, latissimus dorsi pull down) and exercise equipment 
including rolls, theradiscs and fitballs (Broomhead et al., 2012; Broomhead et al., 
2006; Gailey, 2004; Gailey et al., 1989, 1994a, 1994b; Gailey et al., 1995; Lusardi, 
2013; Meier & Melton, 2014; Ries & Vaughan, 2013; US Department of Veterans 
Affairs, 2008). Muscle length in the hip flexor and hamstring muscle groups are 
improved through stretching and positioning (Broomhead et al., 2012; Broomhead et 
al., 2006; Gailey, 2004; Gailey et al., 1989, 1994a, 1994b; Gailey et al., 1995; 
Lusardi, 2013; Meier & Melton, 2014; Ries & Vaughan, 2013; US Department of 
Veterans Affairs, 2008). Arm ergometry, propelling the wheelchair and hopping (in 
patients without a high risk remaining foot) are the main types of cardiovascular 
exercise performed until a patient is fitted with a prosthesis (Broomhead et al., 2012; 
Broomhead et al., 2006; Gailey, 2004; Gailey et al., 1989, 1994a, 1994b; Gailey et 
al., 1995; Lusardi, 2013; Meier & Melton, 2014; Ries & Vaughan, 2013; US 
Department of Veterans Affairs, 2008). Hydrotherapy is used as indicated when the 
residual limb wound is healed to improve strength, cardiovascular fitness and for 
return to aquatic activities such as swimming (Ries & Vaughan, 2013). All exercises 
are progressively overloaded by the physiotherapist as the patient’s muscle strength, 
muscle length and cardiovascular fitness improves (Broomhead et al., 2012; 
Broomhead et al., 2006; Gailey, 2004; Gailey et al., 1989, 1994a, 1994b; Gailey et 
al., 1995; Lusardi, 2013; Meier & Melton, 2014; Ries & Vaughan, 2013; US 
Department of Veterans Affairs, 2008). Hip and knee strengthening exercises, 
treadmill walking and cycling are performed using a prosthetic limb by patients who 
do prosthetic gait retraining as part of their rehabilitation program (Broomhead et al., 
2012; Broomhead et al., 2006; Gailey, 2004; Gailey et al., 1989, 1994a, 1994b; 
Gailey et al., 1995; Lusardi, 2013; Meier & Melton, 2014; Ries & Vaughan, 2013; 
US Department of Veterans Affairs, 2008). Full intervention and exercise details are 
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outlined in Gailey (2004); Gailey et al. (1989, 1994a, 1994b); Gailey et al. (1995) 
Lusardi (2013) and Ries and Vaughan (2013). 
 Pain management 
Patients may have residual limb pain, phantom limb pain and phantom sensation 
after amputation surgery (Broomhead et al., 2012; Broomhead et al., 2006; Butler & 
Moseley, 2013; Geertzen et al., 2015a; Geertzen et al., 2015b; Lusardi, 2013; 
MacLachlan, McDonald, & Waloch, 2004; Meier & Melton, 2014; Moseley, 2012; 
Mulvey et al., 2013). In addition to the medical management of phantom limb pain 
with medications, the physiotherapist may prescribe interventions including graded 
motor imagery and transcutaneous electrical nerve stimulation (TENS) to manage 
phantom limb pain (Butler & Moseley, 2013; Lusardi, 2013; MacLachlan et al., 
2004; Moseley, 2012; Mulvey et al., 2013). Graded motor imagery is a 3 staged 
process which involves left - right discrimination, explicit motor imagery through 
mental rehearsal of movements and mirror box therapy (Butler & Moseley, 2013; 
MacLachlan et al., 2004; Moseley, 2012; Mulvey et al., 2013). Mirror box therapy 
uses the reflection of the patient’s remaining lower limb in a mirror to reduce 
phantom limb pain by retraining the messages between the nerves and 
somatosensory cortex in the brain (Butler & Moseley, 2013; MacLachlan et al., 
2004; Moseley, 2012; Mulvey et al., 2013). Full details of this graded motor imagery 
including mirror box therapy are outlined by Moseley (2012), Butler and Moseley 
(2013) and MacLachlan et al. (2004). TENS is applied using a machine and re-
useable gel electrodes on the skin of either the residual or remaining limb. TENS 
assists with managing phantom limb pain by inhibiting the pain signals from the 
nerves in the lower limbs to the brain (Lusardi, 2013; Mulvey et al., 2013).     
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Prosthetic casting and fitting by the Prosthetist 
The onsite prosthetists at Royal Perth Hospital (RPH) take a cast of the patient’s 
residual limb, manufacture and then fit the interim prosthetic limb (Department of 
Health, 2008; Meier & Melton, 2014; WALSA, 2016). Prosthetic adjustments and 
modifications are performed during physiotherapy gait retraining sessions and the 
RPH Prosthetists work collaboratively with the physiotherapists (Department of 
Health, 2008). New prosthetic sockets are manufactured as required when a patient’s 
residual limb volume has significantly reduced and the old socket and liner is too 
large (i.e. cannot be packed) to address the reduced volume (Department of Health, 
2008). When residual limb volume has stabilised (usually at 6 to 9 months after 
prosthetic gait retraining commences) and the patient has achieved their full 
locomotor capacity they are prescribed a definitive prosthesis by the 
multidisciplinary team which is manufactured by private prosthetic companies in the 
community (Department of Health, 2008; Meier & Melton, 2014; WALSA, 2016). 
Patients receive some additional prosthetic gait retraining from the physiotherapist to 
optimise their use of new definitive prosthetic components. 
 Prosthetic gait retraining  
The goal of prosthetic gait retraining is to restore locomotor function, achieve a 
symmetrical gait pattern and prevent or minimise gait deviations (Broomhead et al., 
2012; Broomhead et al., 2006; Gailey, 2004; Gailey et al., 1989, 1994a; Meier & 
Melton, 2014; Ries & Vaughan, 2013; US Department of Veterans Affairs, 2008). 
Patients with lower limb amputation are progressed through a standardised gait 
retraining program by a physiotherapist trained in amputee rehabilitation 
(Broomhead et al., 2012; Broomhead et al., 2006; Gailey, 2004; Gailey et al., 1989, 
1994a; Meier & Melton, 2014; Ries & Vaughan, 2013; US Department of Veterans 
Affairs, 2008). Prosthetic gait retraining includes: care and hygiene of the residual 
and remaining limbs; learning to don, doff and manage the fit of the prosthesis; how 
to optimally use the features of their prosthetic foot or knee components; sit to stand; 
weight shift and walking drills in the parallel bars using the prosthesis; transfers 
using the prosthesis; walking indoors and outdoors on a range of terrains and 
environmental conditions (e.g. tiles, grass, gravel, slopes, concrete, different weather 
conditions); stair climbing; progression of mobility aids to walking without aids (if 
A.10 
 
safe); strengthening, balance, stretching and cardiovascular exercises using the 
prosthesis; running, sports and work-specific locomotor skills and education of 
carers or family members on how to assist with prosthetic activities if the patient is 
not independent with the activity (Broomhead et al., 2012; Broomhead et al., 2006; 
Gailey, 2004; Gailey et al., 1989, 1994a; Meier & Melton, 2014; Ries & Vaughan, 
2013; US Department of Veterans Affairs, 2008). Full details of prosthetic gait 
retraining programs following lower limb amputation are outlined by Gailey et al. 
(1989, 1994a, 1994b) and Ries and Vaughan (2013). 
 Mobility aids and assistive devices  
Mobility aids including slide boards, wheeled or non-wheeled Zimmer frames, four 
wheeled walking frames, elbow crutches, axillary crutches and single point walking 
sticks may be prescribed by the physiotherapist to assist the person with lower limb 
amputation to safely mobilise when transferring, hopping or walking with a 
prosthetic limb (Broomhead et al., 2012; Broomhead et al., 2006; Gailey, 2004; 
Lusardi, 2013; Meier & Melton, 2014; Ries & Vaughan, 2013; US Department of 
Veterans Affairs, 2008). 
 Home modifications and equipment 
The Occupational therapist assesses the patient’s ability to perform activities of daily 
living and access their home (Lusardi, 2013; Meier & Melton, 2014; US Department 
of Veterans Affairs, 2008). Assistive devices such as wheelchairs, slide boards, 
commodes, shower benches and stools may be prescribed by the Occupational 
therapist for mobility during activities of daily living such as showering, toileting 
and cooking (Lusardi, 2013; Meier & Melton, 2014; US Department of Veterans 
Affairs, 2008). The patient’s home may be modified with grab rails and ramps to 
enable wheelchair accessibility to house (Lusardi, 2013; Meier & Melton, 2014; US 
Department of Veterans Affairs, 2008). 
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Return to driving 
A full assessment by the Rehabilitation medicine physician and Occupational 
therapist is performed to enable the patient with lower limb amputation to return to 
driving (Department of Health, 2008; Meier & Melton, 2014; US Department of 
Veterans Affairs, 2008). The laws vary throughout the Australia and the world 
regarding the type of vehicle that a person may drive after a lower limb amputation 
(Department of Health, 2008; Meier & Melton, 2014; US Department of Veterans 
Affairs, 2008). Patients may be required to have car modifications and a driving 
examination, depending on their comorbidities, number, side and level of limb 
amputation (Meier & Melton, 2014; US Department of Veterans Affairs, 2008).  
 Return to work, sport and recreational activities 
Specific work, sport and recreational activities are incorporated into the 
physiotherapy rehabilitation program based on the patient’s individualised 
rehabilitation goals (Gailey, 2004; Meier & Melton, 2014; Ries & Vaughan, 2013; 
US Department of Veterans Affairs, 2008). This may include activities such as lifting 
or carrying objects, climbing ladders or running (Gailey, 2004; Meier & Melton, 
2014; Ries & Vaughan, 2013; US Department of Veterans Affairs, 2008). In WA 
return to work after lower limb amputation, requires an assessment and medical 
clearance by the Rehabilitation Medicine Physician which is similar to the USA 
model of care (Meier & Melton, 2014). The patient may also be required to have a 
return to work assessment by their employer depending on their occupation. 
Prosthetic components have weight limitations that the Prosthetist educates the 
patient about as this can impact on return to work or sports (Ries & Vaughan, 2013; 
US Department of Veterans Affairs, 2008). Sports and recreational prostheses (e.g. 
running and aquatic prostheses) are not funded by the Western Australian Limb 
Service for Amputees (WALSA). In some cases, people with lower limb amputation 
may retrain or seek alternative employment due to the physical demands of their 
former occupation (Geertzen et al., 2015a; Meier & Melton, 2014). 
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Education 
The patient, family members and carers are educated on the amputee rehabilitation 
process, falls prevention, care of the remaining limbs and residual limb by the 
physiotherapist (Broomhead et al., 2012; Broomhead et al., 2006; Gailey, 2004; 
Geertzen et al., 2015a; Geertzen et al., 2015b; Lusardi, 2013; Meier & Melton, 2014; 
Ries & Vaughan, 2013). Family and carers are also taught by the physiotherapist (if 
required) how to assist the patient with transfers, prosthetic gait and exercise 
programs (Broomhead et al., 2012; Broomhead et al., 2006; Gailey, 2004; Geertzen 
et al., 2015a; Geertzen et al., 2015b; Lusardi, 2013; Meier & Melton, 2014; Ries & 
Vaughan, 2013). The physiotherapist assists with linkage of the patient with peer 
support and disabled sporting associations (Broomhead et al., 2012; Broomhead et 
al., 2006; Gailey, 2004; Geertzen et al., 2015a; Geertzen et al., 2015b; Lusardi, 2013; 
Meier & Melton, 2014; Ries & Vaughan, 2013). 
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CPR Manuscript Appendices 
 
Appendix 1. Standard Outpatient Prosthetic 
Rehabilitation 
K-level 1 to 4 participants underwent prosthetic rehabilitation as an outpatient 
service at the dedicated state amputee rehabilitation service, Royal Perth Hospital. 
Participants were progressed through a standardised gait retraining program, which 
included: strengthening; balance; stretching and cardiovascular exercises; learning to 
don, doff the prosthesis and monitor prosthetic fit; sit to stand; weight shift and 
walking drills in the parallel bars; transfers using the prosthesis; walking indoors and 
outdoors on a range of terrains and environmental conditions; stair climbing; and 
progression of mobility aids. Mobility aids included: single point walking sticks, 
elbow crutches, wheeled or non-wheeled Zimmer frames and four-wheeled walking 
frames. They were issued to individuals assessed as requiring a mobility aid at 
discharge. If a participant was unable to don their prosthesis or achieve locomotor 
milestones, their carer was taught how to assist. Running, sports and work-specific 
locomotor skills were taught to those who identified these as goals. Participants were 
discharged from physiotherapy when they achieved their individualised rehabilitation 
goals.  
 
Participants received standardised prosthetic care from the onsite Royal Perth 
Hospital prosthetists during their physiotherapy gait-retraining sessions. This 
included prosthetic adjustment and new sockets, as required. Once gait retraining 
was completed and residual limb volume had stabilised, participants were referred by 
the multidisciplinary rehabilitation team for a definitive prosthesis.  
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Appendix 2. Instructions on how to use the clinical 
prediction rules for prosthetic non-use. 
 
To use the clinical prediction rules for prosthetic non-use these scoring guidelines 
apply: 
1. Amputation level – individuals with amputation level above transtibial (ie, 
knee disarticulation and above) score 1. Individuals with bilateral amputation 
where one side is above transtibial level (ie, knee disarticulation and above) 
score 1. Individuals with a transtibial level of amputation or bilateral 
transtibial amputations score 0. 
 
2. Very high number of medical comorbidities – individuals with a total of 19 or 
more comorbidities score 1. This represents approximately the 95th 
percentile* of the prospective cohort.  All medical conditions are counted 
including musculoskeletal pathologies (eg, back pain, adhesive capsulitis, 
etc) and mental health issues (eg, depression, anxiety, etc). Individuals with 
less than 19 comorbidities score 0. 
 
3. Not having a diagnosis of type II diabetes – individuals score 1 if they do not 
have a diagnosis of type II diabetes. Individuals score 0 if they do have a 
diagnosis of type II diabetes; this includes those with type II diabetes that is 
diet controlled, medication or insulin controlled. 
 
4. Delay to prosthesis – individuals with a delay to prosthetic fitting of 160 days 
or greater score 1. This represents approximately the 95th percentile* of the 
prospective cohort. Individuals with less than 160 days to prosthetic fitting 
score 0. Number of days to prosthetic fitting is calculated by counting the 
number of days from initial major lower limb amputation surgery to 
prosthetic fitting. 
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5. Mobility aid use at discharge – individuals who require a walking aid, 
including walking stick, crutches or walking frames, to walk indoors or 
outdoors during locomotor activities score 1. Those who do not use any form 
of mobility aid score 0. 
 
6. Dependence walking outdoors on concrete at discharge – individuals who are 
unable or require physical assistance or another person standing by for 
assistance to walk outdoors on concrete or paved ground score 1. Those who 
are independent and able to walk outdoors on concrete or paved ground 
including those who require a mobility aid score 0. 
 
Individuals score 1 or 0 based on the presence or absence of predictor variables for 
the time frames of 4, 8 and 12 months. The total number of predictor variables is 
summed for each of the time frames. The positive likelihood ratios from Table 6 
allow health professionals to identify the level of risk that an individual has for 
prosthetic non-use based on having a number of predictor variables (eg, 1, 2, 3 or 
more) for the time frames.  
 
*For generalisation into other healthcare systems it was noted that the number of 
comorbidities and length of delay to prosthetic gait might be population or 
institutional sensitive. Therefore, other institutes may wish to identify 
comorbidities and delay in prosthetic gait retraining by taking the hospital context 
and flagging individuals who fall in the top 5 to 10 percentiles for each of these 
categories. 
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Figure 3. Prospective clinical utility figure showing the percentage of users 
classified as non-users (False +ve) and non-users correctly identified 
(True +ve) for each risk variable identified for the 4 and 6 months clinical 
prediction rules. Note: three of five variables present identified 50% of 
non-users with a false prediction of 14%. Four of five variables detected 
38% of all non-users.  
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Figure 4. Prospective clinical utility figure showing the percentage of users 
classified as non-users (False +ve) and non-users correctly identified 
(True +ve) for each risk variable identified for the 8 months clinical 
prediction rules. Note: two of three variables present identified 70% of 
non-users with a false prediction of 18%. Three of three variables 
detected 30% of all non-users.  
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Figure 5. Prospective clinical utility figure showing the percentage of users 
classified as non-users (False +ve) and non-users correctly identified 
(True +ve) for each risk variable identified for the 12 months clinical 
prediction rules. Note: one of three variables present identified 91% of 
non-users with a false prediction of 49%. Two of three variables detected 
45% of all non-users and falsely identified 16% of users.  
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Table 1. Dichotomous classifications of potential predictor variables used 
in CPR development. 
Variables investigated 
Dichotomous classification for 
CPR development 
Gender  male or female 
Indigenous status Aboriginal or not Aboriginal 
Amputation cause atraumatic or traumatic 
Age at amputation <58 years or >58 years 
Amputation level transtibial or above transtibial 
Major bilateral amputation yes or no 
Time from initial amputation to 2nd lower limb amputation  < 343 days or > 343 days 
Place of residence metropolitan or country 
Discharge destination home or residential care 
Time  from amputation to prosthetic casting < 156 days or > 156 days 
Time from amputation casting to fitting < 6 days or > 6 days 
Time from amputation to prosthetic fitting < 160 days or > 160 days 
Time from amputation to definitive prosthesis < 301 days or > 301 days  
Wheelchair mobility in all environments independent or dependent 
Wheelchair type manual or power 
Transfer independent or dependent 
Transfer type pivot or slideboard 
Hopping independent or dependent 
Floor transfer independent or dependent 
At discharge:   
Mobility aid use yes or no 
Donning, doffing and monitoring prosthetic fit independent or dependent 
Prosthetic gait independent or dependent 
Indoors gait independent or dependent 
Outdoors gait on concrete independent or dependent 
Stairs independent or dependent 
Slopes independent or dependent 
Grass independent or dependent 
Gravel and uneven terrain independent or dependent 
High level balance activities independent or dependent 
Running independent or dependent 
Number of comorbidities 
<19 comorbidities  or >19 
comorbidities 
Diabetes yes or no 
Type I diabetes yes or no 
Type II diabetes yes or no 
Peripheral arterial disease yes or no 
Cardiac condition/s yes or no 
Renal failure yes or no 
Cerebrovascular accident and transient ischaemic attack yes or no 
Arthritis yes or no 
Remaining lower limb pathology yes or no 
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Table 4. Significant univariate predictor variables (p < 0.100) for prosthetic non-use for 4 (and 6), 8 and 12 months.  
a 0.5 was added to cells in the 2 x 2 contingency table where there was a zero count. b n = 134. 
LR+ = positive likelihood ratio, LR- = negative likelihood ratio.
Timeframe Variable Sensitivity Specificity LR+ LR– p-value 
4 (and 6) 
months Age > 58 yr 0.67 0.60 1.67 0.56 0.049 
 Amputation level above transtibial 0.67 0.66 1.95 0.51 0.014 
 Delay to prosthesisb  0.33 0.90 3.30 0.74 0.011 
 Mobility aid use at discharge 0.97 0.53 2.07 0.06 < 0.001a 
 Dependent at discharge with:      
 donning, doffing and monitoring 0.27 0.91 2.91 0.81 0.042 
 prosthetic gait  0.20 0.94 3.43 0.85 0.048 
 walking indoors  0.20 0.94 3.43 0.85 0.048 
 walking outdoors on concrete  0.33 0.89 3.08 0.75 0.016 
 walking up and down  stairs  0.47 0.84 2.95 0.63 0.004 
 walking up and down slopes  0.40 0.83 2.40 0.72 0.031 
 walking on grass  0.40 0.84 2.53 0.71 0.023 
 walking on gravel and uneven terrain  0.47 0.82 2.55 0.65 0.012 
 
Inability to perform high-level balance activities at 
discharge 0.97 0.18 1.18 0.18 0.133a 
 High number of co-morbidities > 19  0.27 0.91 2.91 0.81 0.042 
 Not having diabetes 0.73 0.50 1.47 0.53 0.088 
 Not having type II diabetes 0.80 0.43 1.39 0.47 0.094 
8 months Amputation level above transtibial 0.70 0.68 2.18 0.44 0.001 
 Delay to prosthesisb  0.33 0.92 4.19 0.72 0.001 
 Inability to hop  0.50 0.70 1.64 0.72 0.087 
 Mobility aid use at discharge 0.98 0.56 2.20 0.04 < 0.001a 
 Dependent at discharge with:      
 donning, doffing and monitoring 0.30 0.92 3.83 0.76 0.004 
 prosthetic gait 0.20 0.95 3.83 0.84 0.020 
 walking indoors  0.20 0.95 3.83 0.84 0.020 
 walking outdoors on concrete  0.35 0.90 3.66 0.72 0.002 
 walking up and down stairs  0.50 0.86 3.59 0.58 < 0.001 
 walking up and down slopes  0.45 0.85 3.04 0.65 0.002 
 walking on grass  0.45 0.86 3.23 0.64 0.001 
 walking on gravel and uneven terrain  0.55 0.84 3.51 0.53 < 0.001 
 
Inability to perform high-level balance activities at 
discharge 0.98 0.19 1.21 0.13 0.061a 
 Inability to run at discharge 0.98 0.15 1.14 0.16 0.125a 
 Having a cardiac condition/s 0.65 0.60 1.63 0.58 0.037 
 Not having arthritis 0.80 0.42 1.37 0.48 0.065 
12 
months Amputation level above transtibial 0.64 0.68 2.01 0.53 0.003 
 Delay to prosthesisb 0.32 0.92 3.88 0.74 0.001 
 Inability to hop  0.48 0.70 1.60 0.74 0.085 
 Mobility aid use at discharge 0.96 0.57 2.25 0.07 < 0.001 
 Dependent at discharge with:        
 donning, doffing and monitoring 0.24 0.92 2.93 0.83 0.023 
 prosthetic gait  0.16 0.95 2.93 0.89 0.069 
 walking indoors 0.16 0.95 2.93 0.89 0.069 
 walking outdoors on concrete  0.36 0.92 4.40 0.70 0.0002 
 walking up and down stairs  0.48 0.87 3.77 0.60 < 0.001 
 walking up and down slopes  0.44 0.86 3.23 0.65 0.001 
 walking on grass 0.44 0.87 3.46 0.64 0.0003 
 walking on gravel and uneven terrain  0.52 0.85 3.58 0.56 < 0.001 
 
Inability to perform high-level balance activities at 
discharge 0.98 0.20 1.22 0.09 0.027a 
 Inability to run at discharge 0.98 0.16 1.16 0.13 0.067a 
 Having a cardiac condition/s 0.68 0.62 1.78 0.52 0.007 
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Appendix 4.2: Summary of prosthetic and 
physiotherapy intervention. 
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Appendix 4.2 Summary of prosthetic and physiotherapy 
intervention. 
Prosthetic rehabilitation was performed by K-level 1 to 4 participants as an 
outpatient service at the dedicated state amputee rehabilitation service, Royal Perth 
Hospital (RPH). Participants were progressed through a standardised gait retraining 
program which included: strengthening, balance, stretching and cardiovascular 
exercises, learning to don, doff and monitor prosthetic fit, weight shift and walking 
drills in the parallel bars, walking indoors and outdoors on a range of terrains and 
environmental conditions, stair climbing and progression of mobility aids. Mobility 
aids including: single point walking sticks, elbow crutches, wheeled or non-wheeled 
Zimmer frames and 4 wheeled walking frames were issued to individuals assessed as 
requiring a mobility aid at discharge. If a participant was unable to don their 
prosthesis or achieve locomotor milestones their carer was taught how to assist. 
Running, sports and work specific locomotor skills were taught to those patients who 
identified these as goals. Participants were discharged from physiotherapy when they 
achieved their individualised rehabilitation goals.  
 
Participants received standardised prosthetic care from the onsite RPH prosthetists 
during their physiotherapy gait retraining sessions. This included prosthetic 
adjustment and new sockets as required. Once gait retraining was completed and 
residual limb volume had stabilised participants were referred by the 
multidisciplinary team for a definitive prosthesis.  
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Appendix 4.3 Summary of stepwise logistic regression 
data 
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Logistic regression information 
 
A backward logistic regression was used to be inclusive of variables. In such cases 
the model has to be significantly improved to remove a variable. (As opposed to a 
forward model that requires the next variable to be included must significantly 
improve the model).   
IBM SPSS Statistics 21.0 was used for the backward logistic regression.   
The predictive outcomes for the 4 and 6 months were the same therefore the 
regression was run for both time periods.  
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Table. 4.4:. For the 4/6 months outcome there were 11 steps.  
The last 4 steps were:  
Step  Variable  Model Log 
Likelihood 
Change in Log 
Likelihood 
Significance 
Step 8 *Age 58 or greater   -32.357 4.294 .038 
 Above transtibial amputation -32.140 3.860 .049 
 Mobility aid at discharge -31.651 2.881 .090 
 Dependence outdoors 
concrete 
-37.492 14.56 .000 
 Dependence on stairs -32.089 3.756 .053 
 Dependence on gravel & 
uneven terrain 
-32.065 4.705 .030 
 Comorbidities 19 or greater -31.880 4.335 .037 
 Not having type 2 diabetes -30.210 .995 .319 
Step 9 Above transtibial amputation -31.566 3.707 .054 
 Mobility aid at discharge -37.487 15.54 .000 
 Dependence outdoors 
concrete 
-31.961 4.496 .034 
 *Dependence on stairs -31.672 6.143 .013 
 Dependence on gravel & 
uneven terrain 
-31.135 5.069 .024 
 Comorbidities 19 or greater -30.159 3.116 .078 
 Not having type 2 diabetes -29.713 2.225 .136 
step 10 Above transtibial amputation -29.812 2.422 .120 
 Mobility aid at discharge -36.238 15.27 .000 
 Dependence outdoors 
concrete 
-30.885 4.569 .033 
 *Dependence on gravel & 
uneven terrain 
-31.427 6.493 .011 
 Comorbidities 19 or greater -30.470 4.578 .032 
 Not having type 2 diabetes -29.686 3.010 .083 
Step 11 Above transtibial 
amputation 
-29.446 2.530 .112 
 Mobility aid at discharge -29.311 2.259 .133 
 Dependence outdoors 
concrete 
-34.666 12.97 .000 
 Comorbidities 19 or greater -30.474 4.586 .032 
 Not having type 2 diabetes -28.601 .839 .360 
*Red variables are the step variable change.   
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Table 4.5:. For the 8 months there was a change, the regression took 13 
steps.  
The last 4 steps were:  
Step  Variable  Model Log 
Likelihood 
Change Log 
Likelihood 
Significance 
Step 10 Above transtibial 
amputation 
-39.399 3.464 .063 
 Delay to prosthesis 156 or 
greater 
-46.940 18.54 .000 
 Mobility aid at discharge -40.491 5.647 .017 
 Dependence outdoors 
concrete 
-37.668 2.472 .116 
 *Cardiac Conditions -37.960 3.056 .080 
 Arthritis -45.720 18.57 .000 
Step 11 Above transtibial 
amputation   
-38.885 4.907 .027 
 *Delay to prosthesis 156 or 
greater 
-36.938 2.820 .093 
 Mobility aid at discharge -36.460 1.864 .172 
 Dependence outdoors 
concrete 
-44.284 17.51 .000 
 Arthritis -36.432 1.808 .179 
Step 12 Above transtibial 
amputation 
-37.809 4.562 .033 
 Mobility aid at discharge -36.759 4.009 .045 
 Dependence outdoors 
concrete 
-35.528 1.546 .214 
 *Arthritis -35.774 2.038 .153 
Step 13 Above transtibial 
amputation 
-41.846 14.18 .000 
 Mobility aid at discharge -35.721 1.933 .164 
 Dependence outdoors 
concrete 
-37.070 4.631 .031 
*Red variables are the step variable change.   
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Table 4.6:. For the 12 months there was a change in the outcomes 
compared to 8 months.  The regressions identified 12 steps.  
The last 4 steps were:  
Step  Variable  Model Log 
Likelihood 
Change Log 
Likelihood 
Significance 
Step 9 Above transtibial amputation -53.126 17.846 .000 
 Delay to prosthesis 156 or greater -46.957 5.507 .019 
 Mobility aid at discharge -46.362 4.318 .038 
 Dependence outdoors concrete -44.203 1.751 .186 
 *Dependence on slopes -50.674 14.692 .000 
 Cardiac Conditions -45.073 3.490 .062 
Step 10 Above transtibial amputation -45.914 5.173 .023 
 Delay to prosthesis 156 or greater -43.328 1.123 .289 
 Mobility aid at discharge -43.739 1.945 .163 
 Dependence outdoors concrete -48.506 11.479 .001 
 *Cardiac Conditions -44.513 3.493 .062 
Step 11 Above transtibial amputation -45.410 5.286 .022 
 Delay to prosthesis 156 or greater -42.851 1.687 .194 
 Mobility aid at discharge -42.767 1.519 .218 
 *Dependence outdoors concrete -43.704 3.392 .065 
Step 12 Above transtibial amputation -48.201 12.388 .000 
 Delay to prosthesis 156 or 
greater 
-43.996 3.978 .046 
 Mobility aid at discharge -45.209 6.403 .011 
*Red variables are the step variable change.   
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Appendix 5.1: Instructions on using the clinical 
prediction rules. 
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Appendix 5.1: Instructions on using the clinical 
prediction rules. 
 
To use the clinical prediction rules for prosthetic non-use these scoring guidelines 
apply: 
 
1. Amputation level – Individuals with amputation level above transtibial (i.e. 
knee disarticulation and above) score 1. Individuals with bilateral amputation 
where one side is above transtibial level (i.e. knee disarticulation and above) 
score 1. Individuals with a transtibial level of amputation or bilateral 
transtibial amputations score 0. 
 
2. Very high number of medical comorbidities – Individuals with a total of 19 or 
more comorbidities score 1. This represents approximately 95th percentile of 
the prospective cohort.  All medical conditions are counted including 
musculoskeletal pathologies (e.g. back pain, adhesive capsulitis etc.) and 
mental health issues (e.g. depression, anxiety etc.). Individuals with less than 
19 comorbidities score 0. 
 
3. Not having a diagnosis of Type 2 diabetes – Individuals score 1 if they do not 
have a diagnosis of Type 2 diabetes. Individuals score 0 if they do have a 
diagnosis of Type 2 diabetes; this includes those with Type 2 diabetes that is 
diet controlled, medication or insulin controlled. 
 
4. Delay to prosthesis – Individuals with a delay to prosthetic casting of 160 
days or greater score 1. This represents approximately 95th percentile of the 
prospective cohort. Individuals with less than 160 days to prosthetic casting 
score 0. Number of days to prosthetic casting is calculated by counting the 
number of days from initial major lower limb amputation surgery to 
prosthetic casting. 
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5. Mobility aid use at discharge – Individuals who require a walking aid 
including walking stick, crutches, or walking frames to walk indoors or 
outdoors during locomotor activities score 1. Those who do not use any form 
of mobility aid score 0. 
 
6. Dependence walking outdoors on concrete at discharge – Individuals who are 
unable or require physical assistance or another person standing by to walk 
outdoors on concrete or paved ground score 1. Those who are independent 
and able to walk outdoors on concrete or paved ground including those who 
require a mobility aid score 0. 
 
Individuals score 1 or 0 based on the presence or absence of predictor variables for 
the time frames of 4, 8, and 12 months. The total number of predictor variables are 
summed for each of the time frames. The positive likelihood ratios from Table 5.2 
allow health professionals to identify the level of risk that an individual has for 
prosthetic non-use based on having a number of predictor variables (e.g. 1, 2, 3 or 
more) for the time frames. 
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Appendix 7.1A: Table 7.5A Correlation matrix (rs) of 
locomotor tests. 
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Table 7.5A: Correlation matrix (rs) for performance measures 
 
*p < .0001 (two tailed)  
 
 
 
 
 
 
 
 
 rs  
 10MWT TUGT 6MWT FSST 
10MWT 
(n) 
1.0 
189  
-.84* 
183 
.79* 
188 
-.77* 
184 
TUGT 
(n) 
 1.0 
188 
-.85* 
187 
.85* 
182 
6MWT 
(n) 
 
 
 1.0 
198 
-.86* 
189 
FSST 
(n) 
  
 
 1.0 
190 
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Appendix 7.1B Table 7.1B: The locomotor capabilities 
index 5 (LCI5). 
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Table7.1B: The locomotor capabilities index 5 (LCI5) by Franchignoni, 
Orlandini et al. (2004) has a 5 point ordinal scale.  
THE LOCOMOTOR CAPABILITIES INDEX 5 (LCI5) 
For interview subjects are asked, “Whether or not you wear your prosthesis, at the present time, 
would you say that you are “able” to do the following activities with your prosthesis on?” 
ITEM SCALE 
1.    Get up from a chair 0 1 2 3 4 
2.    Walk in the house 0 1 2 3 4 
3.    Walk outside on even ground 0 1 2 3 4 
4.    Go up the stairs with a handrail 0 1 2 3 4 
5.    Go down the stairs with a handrail 0 1 2 3 4 
6.    Step up a sidewalk curb 0 1 2 3 4 
7.    Step down a sidewalk curb 0 1 2 3 4 
                Basic LCI5 score                                        ____/28 
 
1.    Pick up an object from the floor (when you are standing up 
in your prosthesis) 
0 1 2 3 4 
2.    Get up from the floor (e.g. if you fell) 0 1 2 3 4 
3.    Walk outside on uneven ground (e.g. grass, gravel, slope) 0 1 2 3 4 
4.    Walk outside in inclement  weather (e.g. snow, rain, ice) 0 1 2 3 4 
5.    Go up a few steps (stairs) without a handrail 0 1 2 3 4 
6.    Do down a few steps (stairs) without a handrail 0 1 2 3 4 
7.    Walk while carrying an object 0 1 2 3 4 
              Advanced LCI5 score                                ____/28 
 
              Total LCI5 score                                        ____/56 
 
        Ordinal scale score definitions: 
             0 = No      
             1 = Yes with help     
             2 = Yes with supervision 
             3 = Yes, alone, with ambulation aids        
             4 = Yes, alone, without ambulation aids 
 
Franchignoni, Orlandini et al. (2004)                                                                           
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Appendix 7.2B: Activity and participation questionnaire 
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Royal Perth Hospital Amputee Prosthetic Use Questionnaire 
*Please note this questionnaire is a data cuing device for an experienced telephone interviewer.  
Date:  …….…………   Subject Code:  ……………….  Verbal Consent:       Yes       No      
Amputation Surgery Date/s: ………………………..   Hospital for Surgery:  ……………… 
Accommodation: Home  Hostel Nursing Home   Remote Community     Other 
Do you live:   Alone  with husband / wife / partner    with others? ……………… 
Driving:  Yes    No  ………………………………………………………………… 
Work:  Yes    No    Occupation:…………………………………………………… 
Age:  …………           Gender:       Male        Female               Post Code:  ……………… 
Amputation Cause:      Circulatory      Infective        Trauma        Other  ………… 
Amputation Level/s:   
(L) Lower Limb:         Symes   TTA     KD       TFA       HD    HP     Other:  
(R) Lower Limb:         Symes   TTA     KD       TFA        HD   HP     Other: 
 Bilateral:            Yes            No 
Upper Limb:        Yes         No     If yes, list:  …………………………… 
Diabetes:   Yes   No  Type 1   Type 2  Insulin   Medication   Diet Controlled 
Peripheral Arterial Disease:          Yes         No 
Renal Failure:     Yes          No   Haemodialysis     Peritoneal dialysis Days: …… 
General Health?: ……………………………………………………………………………… 
When did you last attend an Amputee Clinic? Date: ……… RPH-SPC SCGH FHHS 
1. Do you ever have falls?    Yes         No 
 
When? …………………………………………………………………………………… 
Describe / cause …………………………………………………………………………. 
Injuries …………………………………………………………………………………... 
No. of falls since amputation (fall frequency) …………………………………………. 
 
2. Could you get up off the floor independently after the fall (i.e. floor transfer)?  
Yes    No  
 
3. Are you using your prosthesis?  
     
Yes    No 
If yes what days of the week do you use your prosthesis? 
Mon    Tues         Wed        Thurs       Fri       Sat      Sun   
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4. What type of prosthesis are you using?      Interim prosthesis        Definitive 
prosthesis 
  
5. Who made your definitive prosthesis? 
 
TLC  FOS       SWOPS         Other ………………………………… 
 
6. If you are not using your prosthesis, why not? ……………………………………… 
 
7. How long after discharge from physiotherapy at RPH-SPC did you stop wearing 
your prosthesis? (*Cue with weeks, months & years)  
 
…………………………………………………………………………………………… 
 
8. Do you have pain in your good “remaining” leg? 
   Yes  No 
  
If yes, describe Pain Type: 
             Claudication          Orthopaedic         Other ………………………………… 
9. Do you have any other problems with your good leg?(Cue:  ulcers, numbness, pins & needles, 
muscles not working) 
Yes            No     If yes, describe: ………………………………………………… 
10. Are you able to hop? 
Yes        No 
  
If yes, what aid do you use? 
No aids EC        AC        WZF          ZF       Other:…………… 
11. How do you transfer? 
 
Pivot       Slide Board        Bottom Shuffle       Fwds-Bwds Shuffle    Other   
(* If prosthetic non-user go to question 18) 
 
12. Do you use your prosthesis to transfer? 
Yes               No 
 
13. Can you put on your prosthesis by yourself?  
 Yes               No 
 
14. How many times each day do you transfer (sit to stand) using your prosthesis? 
(*Cue:  wheelchair, car, toilet etc) 
 
……………………………………………………………………………………………. 
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15. For how long each day do you perform activities in standing using your prosthesis? 
(*Cue: Minutes, hours)  
 
……………………………………………………………………………………………. 
16. For how long each day do you wear your prosthesis? 
       ……………………………………………………………………………………………. 
17. For how long each day do you walk in your prosthesis?  
…………………………………………………………………………………………….. 
18. Do you use a walking aid to walk with your prosthesis? 
Yes       No   
 
If yes list type:  
 EC   WZF          ZF         4WF       walking stick       Other ………… 
Indoors aid: …………………. Outdoors aid: …………………….. 
19. How far can you walk in your prosthesis before resting? (*Cue:  no. of blocks, 
metres, Km) 
 
……………………………………………………………………………………………. 
20. Do you use a wheelchair?   
Yes   No Type:   MWC  EWC  Scooter Other……………………… 
 
21. Do you use a wheelchair while also wearing your prosthesis?      Yes   No 
 
22. Stump problems?  Yes   No 
 
Skin …………………………………………………………………………………….. 
 
Circulation …………………………………………………………………………….. 
 
Swelling ………………………………………………………………………………... 
 
Pain PLP  Stump  Other 
…………………………………………….. 
 
Other …………………………………………………………………………………… 
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Appendix 7.3B Table 7.3B: Cohort characteristics for 
prosthetic users and non-users. 
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Table 7.3B: Cohort characteristics for prosthetic users and non-users. 
 
 
Demographic and Amputation Details 
Users  
(n = 149) 
Non-users  
(n = 52) 
z or t 
value 
p value 
Gender, Male, n (%) 124 (83) 37 (71) 1.88 .06 
Age at interview, mean (SD) 58.0 (15.6) 59.4 (15.6) .745 .457 
Indigenous status, Aboriginal, n (%) 18 (12) 11 (21) -1.6 .11 
Accommodation after discharge from inpatient 
rehabilitation, n (%)     
Home (not residential care) 146 (98) 48 (92) 1.92 .06 
Metropolitan (not country) 90 (60) 37 (71) -1.38 .17 
Social Support, Lives with others, n (%) 119 (80) 41 (79) 0.16 0.87 
Accessibility Remoteness Index of Australia (ARIA)†     
Major Cities of Australia (0 to 1.84) 106 (72) 43 (83) -1.64 .101 
Inner Regional Australia (>1.84 to 3.51) 15 (10) 0(0) 2.38 .017* 
Outer Regional Australia (>3.51 to 5.80) 10 (7) 3 (6) 0.24 .81 
Remote Australia (> 5.80 to 9.08) 2 (1) 2 (4) -1.11 .267 
Very Remote Australia (> 9.08 to 12) 15 (10) 4 (8) 0.50 .617 
Charlson Comorbidity Index (CCI), median (IQR) 2 (0 to 4) 3 (1 to 5) 2.04 .04* 
Combined Age CCI, median (IQR) 4 (1 to 5) 4 (3 to 7) 1.96 .05 
Comorbidities, n (%)     
Diabetes Type I 8 (5) 4 (8) -0.61 .542 
                       Type II 59 (40)  25 (48) -1.07 .285 
Peripheral Arterial Disease 74 (50) 32 (62) -1.48 .139 
Cardiac Condition 45 (30) 30 (58) -3.53 .0004* 
Renal Failure 18 (12) 14 (27) -2.52 .018* 
       Cerebrovascular accident / Transient Ischemic Attack 12 (8) 5 (10) -0.35 .726 
Arthritis 48 (32) 21 (40) -1.07 .285 
Remaining Lower Limb Pathology 114 (77) 47 (90) -2.16 .031* 
Mental health issues, n (%) 32 (21) 13 (25) -0.525 .603 
Mild cognitive impairment, n (%) 5 (3) 5 (10) -1.78 .0735 
Intellectual disability, n (%) 2 (1) 0 (0) 0.84 .401 
Substance abuse, n (%)     
Drugs 9 (6) 7 (13) -1.70 .089 
Alcohol 17 (11) 7 (13) -0.393 .697 
Current smoker 33(22) 18 (35) -1.78 .075 
Amputation Cause, n (%)     
Circulatory 34 (23) 18 (35) -1.67 .095 
Infection 64 (43) 23 (44) -0.16 .873 
Trauma 43 (29) 11 (21) 1.08 .280 
Cancer 8 (5) 0 (0) 1.70 .087 
Amputation Level, n (%)     
Transtibial 128 (86) 35 (67) 2.95 .003* 
Knee disarticulation 5 (3) 2 (4) -0.17 .865 
Transfemoral 29 (19) 33 (63) -5.92 <.0001* 
Major Bilateral Lower Limb Amputation  13 (9) 18 (35) -4.45 <.0001* 
Minor Amputation of Remaining Limb 17 (11) 4 (8) 0.75 .453 
Upper Limb Amputation/s 17 (11) 3 (6) 1.17 .242 
† One user excluded from the retrospective ARIA analysis as he resided overseas after discharge (n = 148). Please note that all 
other descriptive data analyses for prosthetic users (n = 149).  
* p < .05 
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Appendix 7.4B Table 7.4B: Frequency of mobility 
activities without a prosthesis performed by a cohort with 
lower limb amputation (n = 201) after discharge from 
rehabilitation. 
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Table 7.4B: Frequency of mobility activities without a prosthesis performed 
by a cohort with lower limb amputation (n = 201) after discharge from 
rehabilitation. 
 
Functional Activity 
 
n (%) 
Wheelchair use 
Wheelchair type 
Manual wheelchair 
Power wheelchair 
Motorised scooter 
Both manual wheelchair and motorised scooter 
 
143 (71) 
 
112 (78) 
13 (9) 
1 (1) 
17 (12) 
Transfer type 
Pivot 
Slide board 
Lift or bottom shuffle transfer 
Hoist 
Hopping with or without a mobility aid 
Do not transfer only use prosthesis and sit to stand  
 
Floor Transfer 
 
 
128 (64) 
6 (3) 
21 (10) 
5 (3) 
4 (2) 
37 (18) 
 
165 (82) 
 
Hopping (in participants with unilateral lower limb amputation 
(n = 150))  
 
Type of mobility aid used for hopping 
No mobility aid used 
Elbow crutches 
Axillary crutches 
Wheeled Zimmer frame 
Zimmer frame 
Rails 
Holding onto car 
Other 
 
91 (61) 
 
 
33 (36) 
33 (36) 
3 (3) 
12 (13) 
3 (3) 
4 (4) 
2 (2) 
1 (1) 
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Appendix 7.5B Table 7.6B: Mobility aid use reported by 
participants who were prosthetic users (n = 149). 
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Table 7.6B: Mobility aid use reported by participants who were prosthetic 
users (n = 149). 
Details of mobility aid use and type of aid % (n) 
 
Participants who did not use a mobility aid 50 (74) 
 
Participants who used a mobility aid 50 (75) 
 
Type of mobility aid used indoors 
No aid 
1 walking stick 
2 walking sticks 
1 elbow crutch 
2 elbow crutches 
Wheeled Zimmer frame 
4 wheeled walking frame 
Gutter frame 
 
 
40 (30) 
21 (16) 
3 (2) 
3 (2) 
11 (8) 
5 (4) 
16 (12) 
1 (1) 
Type of mobility aid used outdoors 
No aid 
1 walking stick 
2 walking sticks 
1 elbow crutch 
2 elbow crutches 
Wheeled Zimmer frame 
4 wheeled walking frame 
Gutter frame 
 
 
3 (2) 
48 (36) 
11 (8) 
4 (3) 
13 (10) 
4 (3) 
17 (13) 
0 (0) 
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Appendix 7.6B Table 7.7B: Self reported daily and weekly 
prosthetic use, daily and weekly number of sit to stands 
and maximal walking distance for prosthetic users. 
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Table 7.7B: Self reported daily and weekly prosthetic use, daily and weekly number of sit to stands and maximal 
walking distance for prosthetic users. Weekly usage was calculated by multiplying the number of week days the 
prosthesis is used by the number of hours it is used for each activity.    
 
* p < .0001 
†p < .001  
Note other categories were not significantly different (z < 1.80; p > .07) for reported weekly or daily usage by participants with transtibial or above transtibial 
amputation level. 
 
 
Total users  
(n = 149) 
Transtibial Amputation Group  
(n = 114) 
Above Transtibial Amputation  
Group (n = 35) 
Self Reported Variables, 
median (IQR) Daily Use Weekly Use Daily Use Weekly Use Daily Use Weekly Use 
Time standing, (hours)  2 (0.8 to 3.5) 14 (4.5 to 24.5) 2 (0.81 to 4)  14 (5.25 to 28) 2 (0.5 to 2.75) 14 (3.5 to 17.5) 
Time walking, (hours)  2.5 (1.5 to 4.5) 17.5 (10.5 to 31.5) 3 (1.5 to 4.5) 21 (10.5 to 31.5) 2 (1.25 to 3) 14 (7 to 21) 
Time worn, (hours)  14 (10.5 to 15.5) 98 (70 to 108) 14 (12 to 16)* 98 (84 to 112)† 10.5 (8 to 13)* 70 (45.8 to 91)† 
Number of sit to stands 35 (25 to 55) 245 (161 to 385) 38 (25 to 59) 245 (175 to 411) 35 (25 to 55) 245 (140 to 385) 
Maximal walking 
distance before resting, 
(m) 475 (138 to 2000) 400 (100 to 2000) 500 (200 to 1500) 
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Appendix 7.7B Table 7.9B: Age, comorbidity and gender 
characteristics of participants who do drive or work and 
those who do drive or work after amputation. 
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Table 7.9B: Age, comorbidity and gender characteristics of participants who 
do drive or work and those who do not drive or work after amputation. 
Characteristic Worker Non-worker Z score 
or t score 
p value 
Age, (years), mean (SD) 
 
50.5 (14.5) 64.2 (13.8) 6.82 < .0001 
Charlson Comorbidity Index 
(CCI) Score, median (IQR) 
 
1 (0 to 2) 3 (2 to 5) 5.93 < .0001 
Characteristic Driver Non-driver Z score 
or t score 
p value 
Age (years), mean (SD) 
 
56.0 (16.2) 61.0 (14.3) 2.22 .0274 
Charlson Comorbidity Index 
(CCI) Score, median (IQR) 
 
2 (0 to 3) 4 (2 to 5) 5.76 < .0001 
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Appendix 7.8B Table 7.11B: Complications of amputation, 
other pathologies and problems reported by a cohort with 
amputation. 
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Table 7.11B: Complications of amputation, other pathologies and problems 
reported by a cohort with amputation. 
 
 
 
*Participants were able to report more than 1 residual limb issue therefore scores do not tally to 100%. 
† Participants were able to report more than 1 remaining limb pain, pathology or symptom therefore 
scores do not tally to 100% and those with major bilateral lower limb amputation (n = 31) were excluded 
 
 
Self reported complications of amputation, other pathologies and 
problems 
n (%) 
 
Residual Limb (stump) issues 
Type of issue* 
Wound or skin breakdown 
Circulation 
Oedema 
Heterotrophic ossification 
Pain  
Phantom limb pain 
Stump pain 
 
144 (72) 
 
82 (57) 
13 (9) 
38 (26) 
3 (2) 
116 (81) 
97 (67) 
35 (24) 
 
Pain in Remaining Lower Limb 
 
Type of lower limb Pain†  
Claudication 
Orthopaedic or musculoskeletal 
Neuropathic 
Other nociceptive pain 
 
Other lower limb pathology and symptoms reported by 
participants† 
Wounds 
Peripheral neuropathy 
Motor 
Sensory 
Mixed 
Charcot foot 
Ankle or knee instability 
Balance impairment 
Cellulitis 
Oedema 
Cramps 
Poor circulation 
Other 
83 (49) 
 
29 (33) 
66 (76) 
2 (2) 
3 (3) 
 
 
75 (44) 
26 (35) 
 
15 (20) 
39 (52) 
15 (20) 
3 (4) 
11 (15) 
1 (1) 
3 (4) 
10 (13) 
4 (5) 
6 (8) 
5 (7) 
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Appendix 7.9B  Table 7.12B: Self reported falls data for 
the total cohort with lower limb amputation, prosthetic 
users and non-users.  
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Table 7.12B: Self reported falls data for the total cohort with lower limb amputation, prosthetic users and non-users. 
Falls category Prosthetic Non-users 
(n = 52) 
Prosthetic Users 
(n = 149) 
Total 
(n = 201) 
Frequency of falls since lower limb amputation, median 
(IQR) 
2 (2 to 5) 2 (1 to 3) 2 (1 to 4) 
Number of individuals who reported having a fall/s since 
amputation surgery, n (%) 
37 (71) 102 (68) 139 (69) 
Fall Mechanism, n (%): 
Transferring 
Hopping 
Walking with prosthesis 
Recreational activities, exercise & sport 
Phantom sensation 
Wheelchair activities 
Fell out or off bed 
Medical cause (e.g. hypotension, hypoglycemia) 
Equipment failure 
17 (46) 
3 (8) 
11 (30) 
2 (5) 
3 (8) 
11 (30) 
5 (14) 
3 (8) 
0 (0) 
21 (21) 
14 (14) 
61 (60) 
8 (8) 
3 (3) 
9 (9) 
2 (2) 
3 (3) 
1 (1) 
38 (27) 
17 (12) 
72 (52) 
10 (7) 
6 (4) 
20 (14) 
7 (5) 
6 (4) 
1 (1) 
Injury from fall, n (%): 
No injury 
Minor injury 
Major injury requiring medical treatment 
16 (31) 
11 (21) 
10 (19) 
59 (58) 
28 (27) 
15 (15) 
75 (54) 
39 (28) 
25 (18) 
Individuals who could independently perform a floor 
transfer after fall, n (%): 
26 (70) 90 (88) 116 (83) 
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Appendix 8.1: Charlson Comorbidity Index Manuscript 
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Appendix 8.2: Amputee Assessment Form 
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AMPUTEE REHABILITATION ASSESSMENT FORM 2009 
SUBJECTIVE:    Initial Assessment Date:   Case Manager:   
Microalert 
Card:   
No Yes  White  Orange  Blue Pre-operative 
Consultation: 
No Yes 
Address:   
 
Telephone:   Home Mobile Next of Kin Details: 
 
Home Environment:   
Stairs: 
Other discharge issues (eg Bathroom, Slopes, Aboriginal Community): 
 
SHx:   
 
Care 
Packages:  
No Yes Details: 
Hobbies, Interests, Occupation: 
 
HPC:   
 
 
Date of Amputation:    
Aetiology:               Circulatory  Infection  Trauma  Neoplasm  Other:    
Side & Level/s of Amputation:   
 
Revision 
Surgery:   
No Yes Date & Details: 
 
Other 
Surgical 
Procedures: 
Date & Details: 
 
 
 
 
 
 
ICU 
Admission 
No Yes Date & Details: 
 
Post-operative 
Complications 
No Yes Date & Details (eg wound infection, MI, bladder, pressure area): 
 
 
 
 
 
 
Acute 
Facility:   
 Admission Date:   Discharge Date: 
 
SPC Inpatient 
Rehabilitation  
No 
 
Yes Admission Date/s:   Discharge Date/s: 
WellTel: No 
 
Yes Admission Date/s:   Discharge Date/s: 
 
SPC 
Outpatient  
No Details: 
 
Yes Start Date:   Discharge Date: 
Amputee Study 
Information & 
Consent 
 Mobility 
Chart 
 Education Booklet  Exercise 
Card 
 Wheelchair  Shoes & 
gym 
clothes 
Goal Setting Meeting Date: CMP  Discharge 
Summary 
 Volunteer Transport  
A.70
PMH: 
Peripheral Arterial 
Disease: 
No Yes Hypertension: No Yes Hypercholesteraemia
: 
No Yes 
Remaining Limb 
Pathology:  
No Yes Vascular Surgery (eg angiogram, angioplasty, FPBG, stents): 
Claudication Pain: 
Ulcers: 
Other: 
Diabetes Type 
1  
Type 2 Diabetic Complications: 
Retinopathy 
Peripheral Neuropathy 
Nephropathy 
Cardiovascular 
CVA 
Other 
Renal 
Failure: 
No Yes Details: 
Haemodialysis:  
Peritoneal Dialysis: 
Renal Transplant: 
Cardiovascular 
Disease:  
Details: 
Acquired Brain 
Injury:    
No Yes Traumatic Brain Injury 
CVA 
Other Neurology:  
Respiratory Disease: COPD Interstitial Lung Disease Other: 
Non-Smoker: Ex-smoker, quit: Smoker: 
Eyesight: Hearing: Cognition: 
Arthritis: Osteoarthritis: Rheumatoid Arthritis: Gout Other: 
Musculoskeletal Injuries & / or Multiple Trauma: 
Weight Bearing Precautions:  
Mobility Pre-operatively: Distance: Aids: Limiting Factors: 
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The Locomotor Capabilities Index 5 
Initial Assessment Mobility 6 months Pre-amputation   Date Assessed:  
______________   
For face-to-face interview: subjects to be asked “Whether or not you wear your prosthesis, at the 
present time, would you say that you are “able” to do the following activities WITH YOUR 
PROSTHESIS ON?” 
   ITEM      SCALE 
1.    Get up from a chair 0 1 2 3 4 
2.    Walk in the house 0 1 2 3 4 
3.    Walk outside on even ground 0 1 2 3 4 
4.    Go up the stairs with a handrail 0 1 2 3 4 
5.    Go down the stairs with a handrail 0 1 2 3 4 
6.    Step up a sidewalk curb 0 1 2 3 4 
7.    Step down a sidewalk curb 0 1 2 3 4 
                Basic activities score                                        
____/28 
     
1.    Pick up an object from the floor (when you are 
standing up in your prosthesis) 
0 1 2 3 4 
2.    Get up from the floor (e.g. if you fell) 0 1 2 3 4 
3.    Walk outside on uneven ground (e.g. grass, gravel, 
slope) 
0 1 2 3 4 
4.    Walk outside in inclement  weather (e.g. snow, 
rain, ice) 
0 1 2 3 4 
5.    Go up a few steps (stairs) without a handrail 0 1 2 3 4 
6.    Do down a few steps (stairs) without a handrail 0 1 2 3 4 
7.    Walk while carrying an object 0 1 2 3 4 
              Advanced activities score                                 
____/28 
     
                          TOTAL SCORE                           ____/56 
     
0 = No      
1             = Yes with help     
2 = Yes with supervision 
3 = Yes, alone, with ambulation aids        
4 = Yes, alone, without ambulation aids                                Franchignoni, et al (2004) 
 
  
A.72 
 
The Locomotor Capabilities Index 5  
3 months post-operatively & Discharge    Date Assessed:  
______________ 
For face-to-face interview: subjects to be asked “Whether or not you wear your prosthesis, at the 
present time, would you say that you are “able” to do the following activities WITH YOUR 
PROSTHESIS ON?” 
   ITEM      SCALE 
1.    Get up from a chair 0 1 2 3 4 
2.    Walk in the house 0 1 2 3 4 
3.    Walk outside on even ground 0 1 2 3 4 
4.    Go up the stairs with a handrail 0 1 2 3 4 
5.    Go down the stairs with a handrail 0 1 2 3 4 
6.    Step up a sidewalk curb 0 1 2 3 4 
7.    Step down a sidewalk curb 0 1 2 3 4 
                Basic activities score                                        
____/28 
     
1.    Pick up an object from the floor (when you are 
standing up in your prosthesis) 
0 1 2 3 4 
2.    Get up from the floor (e.g. if you fell) 0 1 2 3 4 
3.    Walk outside on uneven ground (e.g. grass, gravel, 
slope) 
0 1 2 3 4 
4.    Walk outside in inclement  weather (e.g. snow, 
rain, ice) 
0 1 2 3 4 
5.    Go up a few steps (stairs) without a handrail 0 1 2 3 4 
6.    Do down a few steps (stairs) without a handrail 0 1 2 3 4 
7.    Walk while carrying an object 0 1 2 3 4 
              Advanced activities score                                 
____/28 
     
                          TOTAL SCORE                           ____/56 
     
0 = No      
1             = Yes with help     
2 = Yes with supervision 
3 = Yes, alone, with ambulation aids        
4 = Yes, alone, without ambulation aids                                Franchignoni, et al (2004) 
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OBJECTIVE ASSESSMENT:   Pre-Prosthetic 
 
                                                                            
 
 
                                                                             
 
 
                                                                              
 
 
 
 
                                                                               
 
 
 
 
Stump Description (eg scab, slough, SSG, 
circulation):   
 
 
Sutures / Staples 
 
 
Removal Date/s:  
 
 
Sensation: 
 
 
Scar Tissue: 
Oedema Description    Date 
Commenced 
Management   Bandage   
  Shrinker  
  RRD  
  Compression Pump  
  Massage  
  Other  
Phantom Limb 
Sensation: 
No Yes Description: 
Pain Description & Pain Score 0-10: Phantom Limb Pain Neuropathic Stump Other: 
  
Pain Management: Date Commenced 
Medications  
Massage & Desensitisation Techniques  
Mirror Box  
Recognise CD  
TENS  
Other:  
Remaining Limb Details (eg toe amputation, ulcers, claudication pain, Charcot foot, altered sensation 
ABI’s): 
 
 
Lower Limb ROM     Date: Left Right  Left Right Other 
Joint 
ROM:   
Thomas Test / Modified Thomas Test   Knee Extension    
Prone Hip Extension:   Knee Flexion   
Hip Flexion   Ankle Dorsiflexion   
Hip abduction   Ankle Plantarflexion   
Hip adduction   Ankle Inversion   
Hip Internal / External Rotation     Ankle Eversion   
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Muscle Strength    Date: Left Right Functional Strength & Endurance   Date: 
Hip extensors: Achieved 
Task 
No. of 
Repetitions 
Hip Flexors: Single Limb Calf 
Raise: 
Hip abductors: Squat: 
Hip adductors: Hop: 
Knee extensors: Tricep Paddles: 
Knee flexors: Upper Limb Strength: Abdominal Strength: 
Plantar flexors: 
Dorsiflexors: 
Ankle Invertors / Evertors: 
Toe DF /PF’s: 
Bed Mobility: Transfer:  
Bridging: Pivot  
Rolling: Slide Board 
Supine to Sitting: Bottom Shuffle (eg Forwards-Backwards, 
Sideways)  
Bottom walking: Other: 
Wheelchair 
Manipulation: 
 Indoors: Outdoors:  Slopes: 
MWC EWC 
Sitting Balance & Posture: 
Single Limb Balance & Posture: Timed Standing Balance (TFA & KD): 
Hopping  No Yes Date Out of Parallel Bars: Aid used: Stairs: 
Floor Transfer & mobility: 
Kneeling / Knee walking: 
Other: 
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OBJECTIVE:     Post-prosthetic & Outcome Measures 
Casting Date: 
 
Fitting Date: Prosthesis type: 
Donning, doffing, monitoring fit: 
 
In The Parallel Bars:  Date: Date: Date: Date: 
Weight + Prosthesis     
Weight Through Prosthesis 
(3s) 
    
% Weight Borne     
NPRS (0-10/10)     
Observational Gait Analysis:   
 
 
Date First Out of the Parallel Bars: 
Aid Used: 
 
Date Prosthesis First Taken Home: 
AMPUTEE OUTCOME MEASURES 
10MWT: Date: Date: Date: Date: Date: 
Aid Used      
Mean Time (s)      
No. of Steps      
Velocity (ms-1)      
TUGT: Date: Date: Date: Date: Date: 
Aid Used      
Total Time (s)      
E/C’s on/off 
Time 
     
Carrying Cup      
6MWT: Date: Date: Date: Date: Date: 
Aid Used      
Distance (m)      
Time & No. of 
Rests 
     
RPE      
4SST: Date: Date: Date: Date: Date: 
Aid Used      
Time (s)      
Walking Environment Progress: High Level Balance: 
Indoors: 
 
Stepping onto Prosthetic Limb: 
Stairs: 
 
Balance on Prosthetic Limb: 
Outdoors: Jumping: 
Grass: Hopping: 
Slopes: Dual Task: 
Gravel: Running Drills: 
Floor Transfer with Prosthesis: Running: 
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Team Meeting & Discharge Planning: 
Date: Information: Discharge Planning: 
 
 
 
 
 
 
 
 
Discharge Date: 
 
Discharge Destination: 
 
Care Management Plan: 
 
Physiotherapy Follow-up: 
 
Physiotherapy Days: 
  
Telehealth: 
 
Clinic Appointment: 
 
Volunteer Transport: 
 
Other (eg hydrotherapy referral): 
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Appendix 8.3: Data Retrieval Tool 
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Data Retrieval Tool for Amputee Patient Notes 
Category Data 
Subject Code: DOB: Age at 
Amputation: 
 
Date of Death: 
Gender:  Male  Female Indigenous 
Status: 
1 A not 
TSI 
2 TSI 
not A 
3 A 
& 
TSI 
4 Not TSI 
or A 
Home Location: Post Code:  Metropolitan suburb 
 Rural 
 Remote Community 
 Interstate 
 Overseas 
Pre-operative Education: No Yes Details: 
 
MicroAlert Card No Yes Details: 
 
Amputation Date/s: 
 
 
 
ASA Score 
Amputation Side: 
 
Left Right 
Amputation Level: 
 
TTA 
 
TFA Other: 
Revision Surgery of Amputation 
Level: 
No Yes Revision Dates & Details: 
 
 
Surgical Procedures:  
 
 
 
 
 
 
 
 
 
No Yes Dates & Details: 
Bilateral Amputee: No Yes Details, Date of Contralateral Limb 
Amputation: 
 
Upper Limb Amputation: No Yes Details: 
 
Amputation Cause: 
 
 Circulatory 
 Infective 
 Trauma 
 Neoplasm 
 Other: 
Acute Hospital: RPH-WSC SCGH FHHS Other: 
Acute Inpatient Episode: Admission Date: Discharge Date: 
LOS: 
Inpatient SPC Rehabilitation Episode: No Yes Admission 
Date: 
Discharge Date: 
LOS: 
 
WellTel Episode: No Yes Admission Date: Discharge Date: 
Number of 
admissions: 
LOS: 
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Stump Wound No Yes Stump Wound Infection 
 
No Yes Stump Circulation (eg poor blood supply, 
haemorrhage) 
 
No Yes Delayed Healing (> 
21 Days) 
 
Time to healing: 
 
No Yes Stump Trauma (eg haematoma from fall or 
bump) 
 
No Yes Split Skin Graft 
Residual Limb Characteristics: Wound ( eg sutures, staples, eschar, slough, 
hypergranualtion) 
 
Length (eg short, normal, long) 
 
Shape (eg normal, dog ear, bulbous) 
No Yes Special Surgical Techniques (eg bony fusion 
Tibia To Fibula) 
No  
 
Yes Stump complications (eg blisters, ulcers, fragile skin, 
scar tissue, heterotrophic ossification) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sutures  Removal Date: 
 
ICU Admission No  Yes Dates & Details: 
 
Post-operative Complications No Yes Wound Infection 
 
No  Yes Circulatory (eg ischaemic stump, DVT, PE, 
haemorrhage, CVA) 
 
No  Yes Cardiac (eg MI, heart failure etc) 
 
No  Yes Respiratory Complications (eg pneumonia, 
Respiratory Failure) 
 
No  Yes Organ Failure (eg Renal failure, other) 
No  Yes Sepsis 
No  Yes Bladder complications 
No  Yes Hypoglycemia 
No  Yes Other (eg pressure sore) 
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Traumatic Amputee  No Yes Injury List: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Comorbidities / PMH: No Yes List: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Smoking No Yes 
 ___/day            
Ex-smoker 
quit  _______  
Alcohol Excess No Yes  Details: 
Drug Abuse No Yes Details: 
Hypercholesterolaemia No Yes  
Hypertension No Yes  
Obesity No  Yes  
Peripheral Arterial Disease No Yes  
 
 
 
Cardiovascular Disease No Yes  
 
 
 
 
Lung Disease No  Yes COPD 
No  Yes Interstitial Lung Disease 
No Yes Home Oxygen 
No  Yes Other 
AAA 
 
No  Yes Details: 
 
 
 
A.81 
 
Diabetes No  Yes Type 1 Type 2 
 
 
 
Diabetic 
Complications 
Microvascular 
 
 
 
 
 
 
 
Macrovascular 
No 
 
Yes Peripheral 
Neuropathy: 
Lower 
Limbs  
Upper 
Limbs 
No Yes Charcot Foot: 
No Yes Retinopathy: 
 
No Yes Nephropathy: 
 
No Yes Peripheral Vascular Disease: 
 
No Yes Cardiovascular Disease: 
 
No Yes CVA: 
No Yes Bladder: 
 
No Yes Other: 
 
Renal Failure No  Yes 
No Yes Peritoneal Dialysis 
No Yes Haemodialysis 
No Yes Renal Transplant 
 
Acquired Brain Injury No Yes CVA 
 
No Yes Traumatic Brain Injury 
 
Cognitively Impaired No Yes MMSE / Other: 
 
Cancer No Yes Details: 
 
 
 
 
 
Remaining Limb Pathology No Yes Toe, forefoot or other amputation 
 
 
No Yes Pressure sores, Ulcers 
No Yes Claudication pain 
No Yes Vascular Surgery – bypass graft, angioplastly, 
stent, other 
 
 
No Yes Neuropathic foot / Peripheral neuropathy 
Details: 
 
No Yes Charcot foot 
 
No Yes Orthopaedic Surgery (eg TKR, THR) 
No Yes Orthopaedic Injuries Weight bearing 
precautions / other 
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No Yes Contracture (eg hip, knee, ankle joint) 
No Yes Other: 
Ankle Brachial Indexes No Yes Left Lower 
Limb 
 
Right Lower Limb 
 
 
 
 
 
 
 
 
 
 
Musculoskelatal Injuries No Yes Upper Limb Injuries with weight bearing 
precautions 
No Yes Shoulder Pain 
 
No Yes Back Pain 
 
No Yes Hip Pain 
 
No Yes Knee Pain 
 
No Yes Arthritis (eg OA, RA, gout) 
 
No Yes Other 
 
Vision No Yes Normal 
Deficit Details:  
 
Hearing No Yes Normal 
Deficit Details:  
Pre-operative mobility Distance Walked 
No Yes Walking Aid 
No Yes Limiting Factors 
Falls No  Yes Pre-operative 
No  Yes Post-operative 
No  Yes Post-prosthetic fitting 
LCI  Results 
 
 
Wheelchair mobility at inpatient 
discharge 
No  Yes Independent all environments 
If assistance, details: 
 
 
 
Transfer at inpatient discharge No  Yes Pivot 
No  Yes Slide board 
No  Yes Bottom shuffle (forwards, sideways, 
backwards) 
Hop No  Yes Independent, Aid Used: 
No  Yes Stairs 
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Floor transfer & mobility No  Yes Bed to floor  
No  Yes Wheelchair to floor 
No  Yes Floor mobility (eg Bottom walking, crawling, knee 
walking) 
No  Yes Other (eg step to floor) 
 
Interim Prosthesis No Yes Details: 
 
 
No Yes Casting Date: 
 
Time to 
Casting: 
 
No Yes Fitting Date: 
 
Time to 
Fitting: 
 
Donning / Doffing / monitoring fit of 
prosthesis 
No Yes Independent 
 
If No, state assistance level 
 
 
 
10MWT Results 
 
 
 
 
 
TUGT Results 
 
 
 
 
 
6MWT Results 
 
 
 
 
 
 
FSST Results 
 
 
 
 
 
Prosthetic Gait at Discharge from 
SPC:  
No Yes Independent 
If No, state assistance level 
Aids used 
No Yes Independent indoors 
 
No Yes Independent outdoors on concrete 
 
No Yes Independent up and down stairs  
 
No Yes Independent on slopes 
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No Yes Independent on grass 
 
No Yes Independent on gravel, uneven terrain 
 
No Yes Independent at high level balance activities (eg 
single prosthetic limb balance, hopping, jumping, dual 
tasks & walking) 
 
No Yes Running 
 
No Yes Other 
 
Social Support at discharge No Yes Lives alone 
No Yes Spouse or partner 
 
No Yes Other  (eg carer, son, daughter, sister, brother, 
mother, father) 
Destination Discharged To:  No Yes Home 
No Yes Hostel 
No Yes Nursing Home  
No Yes Hospital Transfer, Details: 
No Yes Other 
Outpatient Physiotherapy No Yes SPC Outpatients Number of sessions 
No Yes WellTel  
No Yes Referral to country outpatient physiotherapy 
No Yes Referral to other outpatient physiotherapy  
Telehealth 
 
No  Yes Dates 
 
 
 
 
Definitive Prosthesis Prescription 
Date: 
 
Last SPC Amputee Clinic Date: 
Definitive Manufacturer FOS TLC SWOPS Other 
Clinic attendance at SCGH or FHHS No  Yes Details 
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Appendix  8.4 Table 8.3: Summary of comorbidities and 
procedures for a cohort with lower limb amputation (n 
= 201) at hospital admission. 
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Table 8.3: Summary of comorbidities and procedures for a cohort with 
lower limb amputation (n = 201) at hospital admission. 
Comorbidity or procedure n (%) 
 
Diabetes 
Type 1 
Type 2 
 
Macrovascular complications of diabetes 
Stroke / TIA 
Peripheral Arterial Disease 
Ischaemic Heart Disease  
 
Microvascular complications of diabetes 
Peripheral neuropathy 
Retinopathy 
Nephropathy 
Renal failure 
Autonomic neuropathy 
Charcot arthropathy 
 
93 (46.3) 
12 (6) 
81 (40.3) 
 
 
17 (8.5) 
67 (33.3) 
40 (19.9) 
 
 
62 (30.8) 
32 (15.9) 
38 (18.9) 
32 (15.9) 
1 (0.5) 
8 (4.0) 
Cardiovascular disease 
IHD 
Heart failure 
Cardiomyopathy 
Arrhythmias 
Angina 
Peripheral arterial disease 
Abdominal Aortic Aneurysm 
Hypertension 
Hypercholesterolaemia 
Cerebrovascular disease / CAD  
DVT 
PE 
 
Surgical Procedures 
Cardiac surgery 
CABG 
Coronary angioplasty or stents 
Permanent Pacemaker 
Mitral or Aortic valve replacement 
 
Lower limb Revascularisation surgery 
Bypass graft surgery 
Angioplasty 
Stents  
Endarterectomy 
Thrombectomy 
 
Abdominal Aortic Aneurysm repair 
Carotid endarterectomy 
 
 
62 (30.8) 
16 (8) 
4 (2.0) 
13 (6.5) 
7 (3.5) 
105 (52.2) 
2 (1.0) 
103 (51.2) 
81 (40.3) 
7 (3.5) 
10 (5.0) 
5 (2.5) 
 
 
 
21 (10.4) 
9 (4.5) 
2 (1.0) 
4 (2.0) 
 
 
26 (12.9) 
9 (4.5) 
9 (4.5) 
4 (2.0) 
1 (0.5) 
 
4 (2.0) 
7 (3.5) 
Previous amputation surgery to lower or upper limbs 
Toe amputation 
Transmetatarsal or Transtarsal amputation 
Transtibial amputation 
Knee disarticulation 
Transfemoral amputation 
Upper limb amputations 
 
19 (9.5) 
5 (2.5) 
6 (3.0) 
1 (0.5) 
0 (0) 
3 (1.5) 
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Comorbidity or procedure n (%) 
 
Respiratory Disease 
COPD 
Asthma 
Bronchiectasis 
Asbestosis & Interstitial lung disease 
OSA 
Pneumonia 
ARDS 
Aspergillous 
Sarcoidosis 
 
 
12 (6.0) 
18 (9.0) 
3 (1.5) 
5 (2.5) 
6 (3.0) 
6 (3.0) 
1 (0.5) 
1 (0.5) 
1 (0.5) 
 
Rheumatologic Disease 
OA 
RA 
SLE 
Gout 
Septic arthritis 
 
48 (24) 
11 (5.5) 
2 (1.0) 
22 (10.9) 
3 (1.5) 
 
Musculoskeletal Pathology 
Back pathology 
Neck Pathology 
Hip pathology 
Knee pathology 
Ankle pathology 
Shoulder pathology 
Elbow pathology 
Wrist pathology 
Hand or Finger 
Upper limb fractures 
Lower limb fractures 
Lower limb deformity 
Osteoporosis 
 
Orthopaedic procedures 
Total hip replacement 
Total knee replacement 
Total ankle replacement 
Ankle fusion 
Total shoulder replacement 
ACL reconstruction 
Spinal fusion 
 
45 (22.4) 
6 (3.0) 
16 (8.0) 
51 (25.4) 
3 (1.5) 
51 (25.4) 
8 (4.0) 
9 (4.5) 
14 (7.0)  
10 (5.0) 
19 (9.4) 
7 (3.5) 
9 (4.5) 
 
 
8 (4.0) 
15 (7.5) 
5 (2.5) 
4 (2.0) 
1 (0.5)  
4 (2.0) 
6 (3.0) 
 
Falls 6 (3.0) 
 
Neurological Disease 
Stroke 
TIA 
Traumatic Brain Injury 
Brain tumour 
Epilepsy 
Polio 
 
 
12 (6) 
5 (2.5) 
3 (1.5) 
1 (0.5) 
6 (3.0) 
1 (0.5) 
 
Dementia or mild cognitive impairment 
Intellectual disability 
11 (5.5) 
2 (1.0) 
 
Renal failure 
Renal impairment 
Renal transplant 
32 (15.9) 
38 (18.9) 
5 (2.5) 
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Comorbidity or procedure n (%) 
Skin disorders 
Toe, foot and leg ulcers 
Burns to feet 
Cellulitis of lower limbs 
67 (33.3) 
3 (1.5) 
12 (6.0) 
Cancer 18 (9.0) 
Mental Illness 
Depression 
Anxiety or panic disorders 
Schizophrenia 
Attempted suicide or self harm 
27 (13.4) 
7 (3.5) 
1 (0.5) 
2 (1.0) 
Substance Abuse (current or past use) 
ETOH (current or past use) 
Smoking 
Ex-smoker 
16 (8.0) 
24 (11.9) 
51 (25.4) 
61 (30.3) 
Visual impairment 
Cataract 
22 (10.9) 
20 (10.0) 
Hearing impairment 17 (8.5) 
Gastrointestinal disease 
Bowel cancer 
Hernia 
Peptic ulcer disease 
Liver failure 
Hepatitis 
Alcoholic liver disease 
GORD 
Colonic polyps 
Procedures 
Hernia repair 
Bowel surgery 
Appendicectomy 
Cholecystectomy 
8 (4.0) 
5 (2.5) 
5 (2.5) 
0 (0) 
4 (2.0) 
2 (1.0) 
16 (8.0) 
4 (2.0) 
4 (2.0) 
8 (4.0) 
10 (5.0) 
7 (3.5) 
Obesity and or body mass index  > 30 41 (20.4) 
Sepsis 3 (1.5) 
Hypothyroidism 8 (4.0) 
AIDS 0 (0) 
Pain disorders 
Complex regional Pain Syndrome 
Chronic headaches 
Neuropathic leg pain 
3 (1.5) 
3 (1.5) 
3 (1.5) 
A.89
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